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ABSTRACT 
Prevention of cardiovascular disease (CVD), a leading cause of death in men and women, 
is both a global and national public health priority. Prevention efforts have generally focused on 
well-known lifestyle (e.g., physical inactivity, unhealthy diet, smoking) and metabolic (e.g., 
overweight/obesity, hypertension, hyperlipidaemia) risk factors. It is also important for public 
health strategies to consider emerging risk factors, innovative approaches to risk factors, and 
evidence in middle-aged men and women, to develop effective prevention strategies.  
This thesis explored innovative aspects of cardiovascular risk in a large cohort of middle-
aged and older Australian men and women (“the 45 and Up Study”) by examining: 1) emerging 
or lesser known risk factors such as raw vegetable intake (Chapter 3), sedentary behaviour 
(Chapter 4, Appendix 1) and psychological distress (Chapter 5); 2) the single versus joint 
influence of lifestyle risk factors on incident type 2 diabetes (Chapter 4, Appendix 1) and 
hypertension (Chapter 5); 3) potential gender differences (Chapters 3-5, Appendix 1), and 
female-specific behaviours such as breastfeeding (Chapters 6-7).  
Overall, findings support Australian recommendations for fruit and vegetable intake, 
physical activity, alcohol intake and infant breastfeeding. While the importance of reducing 
known risk factors for CVD prevention was evident, the role of raw vegetable intake, sedentary 
behaviour and psychological distress was inconclusive. Breastfeeding was associated with a 
lower maternal risk of CVD. Findings confirmed that adopting a cluster of healthy lifestyle 
behaviours can reduce CVD risk in the middle-aged and older population. Potential gender 
differences were explored and identified. This thesis contributes to the literature by exploring 
innovative aspects of cardiovascular risk that are relevant to middle-aged adults, particularly 
women, as well as informs health care providers, researchers and policy makers. 
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CHAPTER ONE: Thesis overview 
 BACKGROUND 
  Cardiovascular disease (CVD) refers to diseases of the heart and blood vessels. It is the 
leading cause of death globally and is responsible for a third of deaths worldwide.1 Despite 
significant reductions in deaths from CVD in high-income countries in the last four decades, 
CVD remains the leading cause of death in developed countries, including Australia.2 As CVD is 
substantially preventable, public health efforts and guidelines worldwide have focused on 
prevention strategies aimed at improving healthy lifestyle behaviours in both populations and 
individuals.3 Even modest changes in lifestyle risk factors can lead to substantial reduction in the 
risk of CVD mortality.4 According to the World Health Organization (WHO), up to 80% of 
premature heart disease and stroke could be prevented by a healthy lifestyle.5 The four major 
behavioural risk factors include physical inactivity, an unhealthy diet, tobacco smoking, and 
excessive alcohol consumption.6 These can lead to metabolic or physiological changes, or 
intermediate risk factors of developing CVD, including overweight/obesity, hypertension, 
hyperlipidaemia, hyperglycaemia and diabetes.6  
Prevention efforts and research have historically focused on these well-established lifestyle 
and physiological risk factors. In recent years, these factors have been explored from new 
research angles, generating additional knowledge about how these factors may relate to CVD. 
There is also growing evidence for associations between emerging lifestyle risk factors, such as 
sedentary behaviour, and CVD, that highlight the potential importance of lesser known factors. 
CVD is a complex disease that arises not from one, but several causes which can occur in 
multiple combinations and interact with each other.7 As evidence continues to grow, it is 
important for researchers to consider innovative aspects of cardiovascular risk to improve 
understanding of how lifestyle/metabolic risk factors contribute to CVD, and to continually 
inform prevention strategies. 
Global efforts, including prevention strategies targeting risk reduction, have been dedicated 
to reducing premature deaths from CVD. The United Nations (UN) and WHO have been the 
main drivers behind a global commitment to reduce premature deaths from four main non-
communicable diseases (NCDs) including CVD, by a relative 25% from its 2010 levels by the 
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year 2025.8 A substantial proportion of deaths and disease burden attributed to CVD occur 
prematurely before the age of 70,9 and many of these deaths are preventable. Hence, identifying 
evidence that can inform prevention approaches involving cardiovascular risk factors in the 
middle-aged population should be a public health priority. 
Another key public health and research priority that deserves attention is cardiovascular 
risk and CVD prevention in women. While CVD is the leading cause of death among women,10 
historically there has been a general lack of awareness about CVD risk in women, an under-
representation of women in cardiovascular research, and a lack of research on women’s 
health.11,12 Previous research has highlighted gender differences in the epidemiology, symptoms, 
management and disease outcomes of CVD which need to be further examined.13 As such, 
several international and national health bodies with a primary interest in CVD have raised a 
“red alert for women’s heart” to increase awareness about the importance of CVD in women and 
have urged for more gender-specific research.13-16 Compared to men, women generally have a 
later onset of CVD and sometimes present with atypical or under-recognised symptoms which 
can cause delay in seeking treatment, under-diagnosis of CVD, and a lower likelihood of being 
referred to appropriate diagnostic and treatment procedures.17 The effectiveness of treatment may 
also vary by gender where poorer clinical outcomes have been reported in women, possibly due 
to poorer psychosocial adjustment or delayed or under-recognition of cardiac conditions among 
women.17 With respect to CVD risk factors, while gender difference is observed in the 
prevalence and incidence of traditional risk factors, such as smoking and physical inactivity,17,18 
women also have their unique risk factors, including reproductive risk factors that could be 
further explored.13 Pursuing gender-specific research on cardiovascular risk factors could help 
inform healthcare providers, the population, and public health programs and policies.  
As CVD continues to account for the largest number of deaths worldwide, both prevention 
and research efforts that focus on cardiovascular risk factors are important. While previous 
efforts have focused for the most part on known risk factors for CVD such as smoking and 
physical inactivity, there has been limited research about novel approaches to risk factors, such 
as examining the joint influence of risk factors rather than examining individual risk factors in 
isolation. In addition, emerging knowledge about other less traditional lifestyle behaviours, such 
as sedentary behaviour or breastfeeding in mothers, may also be valuable to consider in CVD 
prevention strategies. Therefore, the aims of this thesis are to explore less well researched 
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aspects of CVD prevention, within the context of the 45 and Up Study, an Australian population 
study involving middle-aged and older men and women. This thesis also provides an example of 
using an Australian population cohort in thematically linked cardiovascular research. This thesis 
is innovative because: 1) it examined less established cardiovascular risk factors, including raw 
vegetable consumption, sedentary behaviour and poor mental health; 2) it applied novel 
methodologies in several studies by comparing the single and combined influence of multiple 
lifestyle risk factors; and 3) of its consideration of gender by either examining potential gender 
differences or focusing on cardiovascular risks of behaviours specific to women, such as 
breastfeeding. 
 
 PURPOSE AND SIGNIFICANCE OF THE RESEARCH 
The purpose of this thesis is to gain a deeper understanding of the relationship among 
innovative cardiovascular risk factors principally in a large cohort study of middle-aged and older 
Australian adults. Findings from this research can significantly contribute to the evidence base for 
chronic disease prevention, particularly in relation to CVD, and help inform public health 
recommendations on innovative cardiovascular risk factors in both men and women. The specific 
aims of this research are to examine: 
1. The relationship between the consumption of fruit and vegetables (considered separately 
or combined) and mortality from all causes, with an innovative examination of the 
influence of raw versus cooked vegetables (Chapter 3); 
2. The separate and combined influence of overweight/obesity, physical activity, and 
sedentary behaviour on the development of type 2 diabetes, a strong risk factor for CVD 
(Chapter 4, Appendix 1); 
3. The separate and combined influence of six lifestyle risk factors, including known and 
lesser known lifestyle risk factors, on the development of hypertension, the most important 
single risk factor for CVD (Chapter 5); 
4. The relationship between breastfeeding and maternal cardiovascular risk factors and 
outcomes (both as a systematic review [Chapter 6] and a longitudinal study [Chapter 7]); 
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5. Potential differences between women and men in all of the above examined relationships 
involving innovative angles of cardiovascular risk (Chapters 3-5, Appendix 1), in a large 
Australian cohort of adults aged 45 years and over.  
 
 THESIS OUTLINE 
This thesis comprises eight chapters and presents findings relating to five peer-reviewed 
papers (four published, one in press). Collectively, the studies presented in this thesis (Chapters 
3-7) explore less well researched aspects of cardiovascular risk including dietary (Chapter 3), 
metabolic (Chapters 4-6), and gender-specific risk (Chapters 3-7), mainly in a large Australian 
cohort of middle-aged and older adults from the “45 and Up Study” (Chapters 3-5, 7). An 
overview of innovative aspects of cardiovascular risk examined in this thesis, and 
chapters/appendices relating to cardiovascular risk factors considered, is presented in Figure 1.1. 
An outline of the thesis is presented below. 
Chapter 1 provides a brief background to the research undertaken in this thesis and outlines 
the research project’s novelty, purpose, significance, and the structure of the thesis.  
Chapter 2 presents an overview of the literature relating to CVD and risk factors for CVD, 
including innovative ones examined in this thesis. 
Chapter 3 describes findings from a peer-reviewed paper investigating the relation between 
individual and combined fruit and vegetable consumption and all-cause mortality in the 45 and Up 
Study cohort. In addition, we further addressed the lesser known question regarding the 
consumption of raw versus cooked vegetables in relation to mortality risk. 
Chapter 4 presents findings from a peer-reviewed paper examining the combined influence 
of overweight/obesity, physical activity, and sedentary behaviour (an emerging risk factor) on the 
incidence of type 2 diabetes among 45 and Up Study participants. The joint influence of these 
three lifestyle risk factors on incident type 2 diabetes has infrequently been studied. 
Chapter 5 provides findings from a peer-reviewed paper that examined the individual and 
combined influence of known and lesser known lifestyle risk factors (e.g., psychological distress) 
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on the incidence of hypertension among 45 and Up Study participants. In this study, we developed 
a novel lifestyle risk score for summarising hypertension risk.  
Chapter 6 describes findings from a peer-reviewed systematic review of the relationship 
between breastfeeding and maternal cardiovascular risk factors and outcomes that have not been 
previously systematically synthesised, such as metabolic syndrome, hypertension and CVD. This 
study identified the need for additional longitudinal studies examining the association between 
breastfeeding and cardiovascular risk factors and outcomes.  
To address this research gap, Chapter 7 describes findings from a study exploring the 
association between breastfeeding and the incidence of CVD-related hospitalisation and CVD 
mortality in the 45 and Up Study cohort.  
Chapter 8 provides an overarching discussion of the significance of the main findings from 
studies presented in this thesis, implications for policy, and directions for future research. 
More detailed information about the 45 and Up Study is presented in the manuscripts 
featured in Chapters 3-5 and 7. Briefly, the 45 and Up Study is the largest prospective cohort 
study in Australia involving 267,153 men and women aged 45 years over, that were randomly 
sampled from the New South Wales (NSW) population. The cohort represents about 10% of the 
NSW population aged 45 years and over. The 45 and Up Study is a unique resource for researchers 
that provides information on a wide range of exposures and outcomes of public health relevance 
and linkage to routinely collected health data from a variety of population databases and registries. 
Linkage data include hospital data from the NSW Admitted Patient Data Collection (APDC; until 
June 2014), mortality data from the NSW Registry of Births, Deaths, and Marriages (until June 
2014), and data on causes of death from the Cause of Death Unit Record File (until December 
2013) by the Centre for Health Record Linkage (CHeReL) using highly accurate probabilistic 
record linkage methods and a commercially available software (Choice-Maker, ChoiceMaker 
Technologies Inc.). From 2006 to 2008, participants joined the study by completing a mailed 
questionnaire and providing informed consent. In 2010, the first 100,000 participants to complete 
the baseline questionnaire of the 45 and Up Study were invited to participate in the Social, 
Economic and Environmental Factor (SEEF) Study follow-up (response rate of 60.4%). The 45 
and Up Study and the SEEF Study provided baseline and follow-up data for studies presented in 
Chapters 4 and 5. Originally, I had planned to include CVD outcomes in studies presented in 
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Chapters 3 to 5 as these data were supposed to be available at the start of my thesis, as promised 
by the SAX Institute. However, update of data linkage was significantly delayed and CVD 
outcomes were not available at the time of analysis. All-cause mortality was therefore used as the 
outcome in Chapter 3; incident type 2 diabetes and hypertension, both strong risk factors for CVD, 
were used as the outcomes for Chapters 4 and 5, respectively. The 45 and Up Study baseline data 
and linked CVD hospitalisation and/or mortality data were used in studies presented in Chapters 
3 and 7 as hospitalisation and cause of death data became available from January 2018 onwards. 
The difference in outcomes has also resulted in differences in statistical methods, where logistic 
regression was used for incidence data in Chapters 4 and 5, and Cox proportional hazards models 
were used for Chapters 3 and 7 where time-to-event outcomes were available.  
Additional material that is relevant to studies presented in this thesis or supplementary 
material to support the thesis has been included in the Appendices. In Appendix 1, findings from 
an additional gender analysis that complements findings from the published paper included in 
Chapter 4 are presented. Both the baseline 45 and Up Study and SEEF follow-up questionnaires 
are included as Appendices 2 and 3 respectively. Additional research dissemination arising from 
this thesis and additional peer-reviewed papers that were published during the PhD candidature 
are described respectively in Appendix 4 and Appendix 5. 
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Figure 1.1. Overview of innovative aspects of cardiovascular risk examined in this thesis. 
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Figure legend 
 
* “Novel approaches” refer to new approaches to lifestyle risk factors, while “emerging” refers to recently identified lifestyle risk 
factors that may have important associations with cardiovascular disease, that were considered in this thesis  
 
---  Non-modifiable risk factors were not examined in the current PhD project 
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CHAPTER TWO: Review of the literature 
 PURPOSE OF THIS REVIEW 
This chapter aims to provide a wider context to the research questions explored in this 
thesis by reviewing literature that is pertinent to the research undertaken and identifying potential 
research gaps. An overview of CVD, cardiovascular risk factors examined with an innovative 
angle in this thesis, will be presented, and the importance of CVD prevention both in the middle-
aged population and in women. 
 
 CVD STATISTICS: WORLDWIDE AND IN AUSTRALIA 
Responsible for 71% of global annual deaths and 91% of Australian deaths in 2014, NCDs 
including CVD, cancer, chronic respiratory diseases and diabetes define the central global and 
national public health agendas.1 CVD is the leading cause of death in the world, accounting for 
31% of global deaths or an estimated 17.9 million deaths in 2015, 53% of which occurred in men 
and 47% in women.2 CVD is also a major cause of disability, contributing to 15% of total global 
disease burden (16% in men, 14% in women).3 Globally, the estimated prevalence of CVD was 
423 million cases in 20152 and its estimated cost was $863 billion US dollars in 2010.4 
Since the 1960s, there has been a major decline in death rates from CVD as a result of 
improved prevention, detection, management and treatment of CVD.5 However, with a growing 
number of Australians living to an older age, CVD remains a public health challenge in Australia. 
In 2015, about 4.2 million (22%) Australians reported having CVD, with the prevalence of CVD 
markedly increasing with age in both women and men (Figure 2.1).6 Despite improvements over 
the last several decades, CVD remains a leading cause of death and a major cause of hospital 
admissions in Australia. In 2015, nearly a third of all deaths (30% for females, 27% for males)7 
and 11% of hospitalisations were attributed to CVD, with hospitalisation rates 1.6 times higher in 
men than in women, and consistently higher in men than in women across all age groups.6 The 
age-standardised heart attack rate was 379 per 100,000 people in 2013, with males experiencing 
more than twice the rate of females (523 versus 246 per 100,000, respectively).8 CVD has the 
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second highest disease burden in Australia (based on the number of years of life lost [YLL]; 25.8% 
of total disease burden) after cancer9 and is the most expensive group of diseases, costing $7.7 
billion annually or 10.4% of the nation’s total health care expenditure, with more than half of the 
costs arising from hospital admissions.10 As CVD is a leading cause of death, disease burden, and 
health care cost in Australia and in the world, CVD prevention is both an important national and 
global health priority. 
 
 
Figure 2.1. Prevalence of self-reported CVD (having one or more types of CVD) in adults 
by age and sex (2014-15). Adapted from “Cardiovascular disease snapshot” by the Australian 
Institute of Health and Welfare (AIHW), 2017.11  
 
 CVD PATHOGENESIS 
2.3.1 Types of CVD 
Collectively, CVD refers to diseases of the heart and blood vessels. The main conditions that 
are relevant to this thesis are summarised in Table 2.1.  
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Table 2.1. Description of types of CVDa that are relevant to this thesis. 
CVD disease group Description Example of diseases 
within this group 
Coronary heart disease (also 
known as “ischaemic heart 
disease”) 
Blood supply to the heart is 
blocked or reduced due to a 
gradual build-up of fatty 
substances in the walls of the 
coronary arteries. This may result 
in chest pain or discomfort that 
can spread into the shoulders, arm, 
back, neck or jaw (“angina”) or a 
“heart attack” (sudden blood flow 
blockage causing heart tissue 
damage) 
Stable angina, unstable 
angina, acute myocardial 
infarction (or “heart 
attack”), sudden cardiac 
death 
Cerebrovascular disease 
(includes stroke) 
Blood vessels supplying blood to 
the brain become blocked (for 
example by a blood clot; 
“ischaemic stroke”), malformed, 
or rupture and bleed 
(“haemorrhagic stroke”) 
Stroke, transient ischemic 
attack, cerebral 
aneurysm, vascular 
malformation, stenosis 
Hypertensive heart disease  Heart conditions resulting from 
high blood pressure 
Heart failure, heart 
muscle thickening, 
coronary artery disease, 
and other conditions 
a Other types include peripheral vascular disease, rheumatic heart disease, inflammatory heart 
disease, and other forms of cardiovascular and circulatory diseases. 
 
The most common types of CVD are coronary heart disease (CHD) and stroke, the leading 
causes of death and disability worldwide.12 Combined, CHD and stroke account for more than 
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85% of CVD deaths worldwide,12 with an estimated 8.9 and 6.3 million deaths attributed to CHD 
and stroke respectively, and mortality rates increasing substantially from middle age onwards.2 
CHD is the leading cause of global disease burden, followed by stroke, and then hypertensive heart 
disease in fourth place.2 CHD deaths as a proportion of all Australian deaths by age and sex, is 
represented in Figure 2.2. In Australian women, the proportion of CHD deaths increases gradually 
with age, while in Australian men, the proportion increases at an earlier age and is comparatively 
higher throughout the years. 
 
 
Figure 2.2. CHD deaths as a proportion of all Australian deaths by age and sex. Adapted from 
“Causes of death, Australia, 2015” by the Australian Bureau of Statistics (ABS), 2017.13  
 
The contribution of different types of CVD to global CVD burden in men and women is 
represented in Figure 2.3. In both men and women, CHD and stroke were the largest contributors 
to CVD burden measured in Disability Adjusted Life Years (DALYs), which provide a measure 
of healthy years of life lost due to premature mortality and disability. While cerebrovascular 
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disease, hypertensive heart disease, and other types of CVD, contributed a higher proportion of 
DALYs to global CVD burden in women than in men, CHD accounted for a greater proportion of 
global CVD burden in men. For most of the last century, the most important single cause of death 
in Australia has been CHD. The proportion of deaths attributed to different types of CVD in 
Australia are presented in Figure 2.4. Similarly to data presented in the previous figure, CHD was 
responsible for a larger proportion of CVD deaths in men than in women. Stroke, hypertensive 
heart disease, and other types of CVD accounted for a greater proportion of deaths in women than 
in men. CHD and stroke are both related to lifestyle. 
 
Men       Women 
   
Figure 2.3. Distribution of global CVD burden (measured in Disability Adjusted Life Years 
or DALYs) in men and women based on CVD types relevant to this thesis. Other CVD includes 
inflammatory heart disease, rheumatic heart disease and other types of CVD. Adapted from 
“Global atlas on CVD prevention and control”, by S. Mendis, P. Puska, and B. Norrving, 2011.14  
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Men       Women  
 
Figure 2.4. Proportion of CVD deaths in Australian men and women based on CVD types 
relevant to this thesis. Other CVD include heart failure, cardiomyopathy, peripheral vascular 
disease, rheumatic heart disease, and other types of CVD. Adapted from “Heart, stroke & vascular 
diseases: Data tables: Cardiovascular disease 2018”, by the AIHW, 2018.15  
 
2.3.2 Atherosclerosis 
The main cause of CVD is the progressive narrowing or blockage of arteries, the blood vessels 
that supply oxygen and blood to the heart and other parts of the body, due to the build-up of fatty 
deposits (“plaques”) on artery walls. This gradual process, known as atherosclerosis, can start at a 
young age and slowly develop over the years.16 This progressive disease has several distinct 
pathologic stages summarised in Table 2.2 below. The behavioural and metabolic risk factors of 
atherosclerosis are similar to those for CVD (presented in section 2.4.1.2 of this chapter). 
 
Table 2.2. Summary of the three distinct pathologic stages of atherosclerosis. 
Pathologic 
stage 
Description 
Fatty streak 
formation 
Endothelial cells line blood vessels and facilitate exchanges between the 
blood and surrounding tissues.  
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Endothelial damage: The endothelial cells, or endothelium, become injured 
by various stimuli such as hemodynamic disturbances, chemicals (e.g. from 
smoking) or hyperlipidaemia (e.g. increased low-density lipoprotein [LDL]). 
Endothelial dysfunction, activation, and leakage: The endothelium becomes 
gradually infiltrated by fatty substances, mainly LDL which transport 
cholesterol in the body, leading to an inflammatory response. Immune cells 
called monocytes are attracted and adhere to the lesion area.  
Foam cell and fatty streak formation: As monocytes mature into 
macrophages in the sub-endothelial space and engulf oxidised LDL, they 
become “foam cells”. The accumulation of lipid-containing foam cells forms 
a fatty streak, the first visible lesion in the development of atherosclerosis. 
This stage is reversible. 
Plaque 
progression  
Smooth muscle cells, which form the layer beneath endothelial cells, migrate 
from the media (middle layer of the blood vessel) to the intima (inner layer), 
proliferate and increase production of extracellular matrix molecules such as 
collagen.  
Monocytes and macrophages continue to be drawn to the lesion and 
eventually die, forming a necrotic core of lipids under a fibrous cap made of 
connective tissue and smooth muscle cells. 
Plaque 
disruption  
The plaque continues to enlarge and protrude into the lumen of the blood 
vessel.  
“Stable plaques” have a thick fibrous cap and a small lipid core and are less 
susceptible to rupture.  
A thin fibrous cap and fissures can lead to a “vulnerable plaque” which may 
rupture and result in life-threatening thrombosis, the formation of a blood 
clot inside the blood vessel.  
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 CVD PREVENTION 
Following the adoption by the UN General Assembly of the Declaration addressing the 
prevention and control of NCDs in 2011,17 the WHO developed a Global NCD Action Plan (2013-
20) with a global target of reducing the risk of premature death (defined as between 30 and 70 
years of age) from NCDs by a relative 25% from its 2010 level by 2025.18 Alongside the NCD 
Global Monitoring Framework to help track the implementation of the action plan and monitor 
worldwide progress, global voluntary, specific targets were set that involve the following key 
behavioural and physiological risk factors: physical inactivity, excessive salt intake, tobacco use, 
excessive alcohol intake, obesity, elevated blood pressure, raised blood glucose, and diabetes 
mellitus.19 As the highest proportion of deaths worldwide is attributable to CVD, targeting the 
major risk factors of CVD, including hypertension and diabetes mellitus, is critical to achieving 
this global goal.20 As a WHO member state, Australia is committed to the global action plan and 
has developed its own National Strategic Framework for Chronic Conditions which provides high-
level guidance for the planning and development of policies, strategies, actions and services for 
the effective prevention and management of chronic conditions. This national framework also 
recognises the importance of reducing health risk factors including behavioural risk factors.21 
CVD prevention can occur both at the population and at an individual level. Population-wide 
strategies aim to promote healthy lifestyle behaviours in the population as a whole, including in 
individuals that are at low or moderate risk of developing CVD, which form the majority of the 
population.22 Population-wide strategies, through policy and environmental changes, mass media 
campaigns or large-scale health education and promotion that can influence behaviour change, aim 
to reduce exposure to risk factors or increase exposure to protective factors. Some examples of the 
population approach include reducing the salt content of processed foods that are sold to the 
population, to increase tobacco taxes to reduce tobacco consumption, or to promote healthy eating 
through national education campaigns.23 While the population approach aims to control the 
underlying causes of CVD and reduce the incidence (or rate of occurrence) of CVD, the individual 
approach is targeted at individuals that are identified as being at high risk for CVD, such as clinical 
interventions among those with hypertension or hyperlipidaemia.24 The objective of this approach 
is to reduce CVD risk and levels of risk factors by preventive treatment, using pharmacological 
and/or non-pharmacological means. It is generally recognised that both population-wide and 
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individual approaches are complementary and essential in lowering the CVD risk distribution of 
the population.25  
2.4.1 Risk factors for CVD 
Risk reduction is central to primary prevention efforts aiming to prevent the occurrence of 
CVD. Risk factors are characteristics or exposures that are associated with an increased risk of 
developing a disease. Cardiovascular risk factors can be largely categorised as non-modifiable, 
such as family history and most demographic characteristics, and modifiable, such as lifestyle 
behaviours and metabolic risk factors. 
2.4.1.1 Non-modifiable 
Risk factors that cannot be modified include age, a family history of CVD, ethnicity, and 
gender. Generally, CVD risk increases with age and is higher in individuals with a family history 
of CVD in first-degree relatives, and in certain ethnic groups such as in South Asians. The risk for 
CVD is higher in men than in women. The difference between men and women narrows after 
women reach menopause and the risk for CVD can become equal after menopause.26  
2.4.1.2 Modifiable behavioural and metabolic cardiovascular risk factors 
The WHO estimates that up to 80% of premature heart disease and stroke could be prevented 
by a healthy lifestyle.27 Changes in lifestyle risk factors can influence metabolic/physiologic 
factors such as overweight and obesity, hypertension, hyperlipidaemia, and hyperglycaemia which 
contribute to increasing CVD risk. The four major modifiable behavioural risk factors, common 
to most NCDs including CVD, are physical inactivity, an unhealthy diet, tobacco smoking, and 
excessive alcohol consumption.28 Together with related metabolic/physiologic factors, these four 
behavioural risk factors are responsible for a large proportion of premature deaths and disabilities 
worldwide29 and feature among the nine most important modifiable risk factors for acute 
myocardial infarction and stroke reported in the two large, international, INTERHEART and 
INTERSTROKE case-control studies.30-32 In the 2016 Global Burden of Disease Study, smoking 
(124.1 million DALYs), high systolic blood pressure (122.2 million DALYs), alcohol intake and 
high fasting plasma glucose were among the top five leading risk factors for disease burden in 
men. In women, the leading metabolic risk factors were high systolic blood pressure (89.9 million 
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DALYs), high body mass index (64.8 million DALYs), and high fasting plasma glucose (63.8 
million DALYs).33 
In 2011, the leading risk factors for disease burden in Australia were tobacco smoking (9%), 
overweight and obesity (7%), dietary risk factors (7%), alcohol intake (5.1%), physical inactivity 
(5%), and high blood pressure (4.9%).34,35 In both Australian men and women aged 45 to 64 years, 
a high body mass index, physical inactivity and high blood pressure featured among the top five 
leading risk factors.34 In terms of CVD burden, high blood pressure (32%), physical inactivity 
(21%), high body mass index (21%), high cholesterol (16%), tobacco smoking (12%), low fruit 
(10%) and low vegetable (8.9%) consumption were all significant contributors.34 Recent 
prevalence data of traditional lifestyle and metabolic factors in Australia are presented in Table 
2.3. Overall, nine in ten Australian adults reported low vegetable consumption. Approximately 
half reported being physically inactive (<150 minutes in the past week) and consuming low 
amounts of fruit, with women being slightly more likely to be inactive than men and to consume 
more fruit. While a quarter of men consumed excessive amounts of alcohol and nearly a fifth were 
current smokers, the prevalence rates were lower in women. Over two-thirds of men and more than 
half of women reported being overweight/obese. Nearly two-thirds of Australian adults reported 
having high blood lipids. Nearly a quarter of men and more than a fifth of women reported having 
high blood pressure.  
 
Table 2.3. Prevalencea of major lifestyle and metabolic risk factors in individuals aged 18 
years and overb, and in men and women. 
 
 
  Percent 
Lifestyle/metabolic risk factor Men Women Overall 
Low vegetable consumptionc 96.2 89.8 92.9 
Physical inactivityd 50.6 53.7 52.2 
Low fruit consumptionc 56.0 44.6 50.2 
Excessive alcohol intakee 25.8 9.3 17.4 
Daily smoking 16.9 12.1 14.5 
Overweight/obesity 70.8 56.3 63.4 
Dyslipidaemiaf 63.7 62.8 63.2 
High blood pressureg 24.4 21.7 23.0 
Impaired fasting glucoseh 4.1 2.1 3.1 
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a Sources: ABS National Health Survey 2014-15 and AIHW analysis of unpublished ABS  
Australian Health Survey, 2011-12 (National Health Measures Survey Component).36,37 
b The age group examined was 18-64 years for physical inactivity. 
c According to 2013 Australian Dietary Guidelines for recommended daily serves of fruit and 
vegetables based on an individual’s age and sex.38 
d <150 minutes of physical activity in the past week. 
e On average >2 standard drinks per day (National Health and Medical Research Council 
guidelines).39 
f Abnormal blood lipid levels; measured and defined as having one or more of the following: total 
cholesterol ≥5.5 mmol/L, LDL cholesterol ≥3.5 mmol/L, triglycerides ≥2.0 mmol/L, high-density 
lipoprotein (HDL) cholesterol <1.0 mmol/L for men and <1.3 mmol/L for women, taking lipid-
lowering medication.  
g Measured and defined as a systolic blood pressure ≥140 mmHg, a diastolic blood pressure ≥90 
mmHg or taking antihypertensive medication. 
h Higher than usual blood glucose levels after fasting (6.1-6.9 mmol/L) but below diabetic levels. 
Adapted from “Risk factors to health” by the AIHW, 2017.40  
 
i. Physical inactivity 
 The term “physically inactive” describes people that do not engage in sufficient levels of 
physical activity to meet physical activity guidelines. For optimal health benefits, both the WHO 
and Australian guidelines recommend at least 150 minutes of moderate intensity physical activity, 
75 minutes of vigorous intensity physical activity, or an equivalent combination of both, per 
week.41,42 Compared to individuals that report no leisure time physical activity, those that meet or 
exceed the recommended amounts of 150 minutes/week of moderate intensity or 75 minutes/week 
of vigorous intensity physical activity have a 31% to 39% lower risk of mortality.43 Physical 
inactivity contributes substantially to deaths and disability attributed to CVD and other NCDs. 
Physical inactivity was ranked as the fourth leading cause of death in 2009, accounting for 6% of 
deaths and 2.1% of total DALYs (32.1 million DALYs) worldwide.44 Physical inactivity 
contributed an estimated 13.4 million DALYs in 2013 based on the following five NCDs: CHD (5 
million DALYS), stroke (4.5 million DALYs), type 2 diabetes (2.3 million DALYs), breast cancer 
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(0.9 million DALYs), and colon cancer (0.7 million DALYs).45 In Australia, physical inactivity 
accounted for 2.6% of total DALYs (116,676 DALYs) in 2011, with the following proportions 
attributable to each linked disease due to physical inactivity: 11% for CHD, 10% for stroke, 19% 
for diabetes, 16% for bowel cancer, 16% for uterine cancer, 11% for breast cancer, and 14% for 
dementia.46 Based on self-reported data from Australian National Health Surveys, the high 
prevalence of physical inactivity has remained unchanged between 1989 (38.7%) and 2011 
(37.3%), with observed prevalence levels over time tending to decrease in men and increase in 
women.47  
Regular physical activity can help lower the risk of CHD, stroke, and associated conditions 
such as overweight/obesity, type 2 diabetes, and hypertension. Physical activity increases energy 
expenditure, promotes weight loss/maintenance, lowers blood pressure, and improves glucose, 
insulin and lipid metabolism, contributing to overall cardiovascular health.48 In a 2010 meta-
analysis of prospective cohort studies, high levels of leisure time physical activity were associated 
with a 20% to 30% lower risk of developing CHD and stroke in both men and women, compared 
to low levels of physical activity.49 The benefits of physical activity extend to other diseases and 
it is associated with lower levels of stress, depression, and anxiety, which can contribute to 
cardiovascular health as well as psychosocial wellbeing.50  
ii. Fruit and vegetable consumption 
Whilst they vary by country, dietary guidelines generally advocate consuming an adequate 
amount of fruit and vegetables as part of a healthy diet. The WHO recommends consuming a daily 
minimum of 400g or the equivalent of five portions of fruit and vegetables for the prevention of 
chronic diseases.51 The Australian dietary guidelines recommend eating a minimum of two serves 
of fruit and five serves of vegetables per day.38 In 2014-15, about half of Australians reported 
consuming the recommended daily intake for fruit, 7% met the guidelines for vegetable intake, 
and only 5.1% (7.5% of women, 2.7% of men) met both fruit and vegetable guidelines.52 Between 
2001-15, the proportion of Australians not meeting the recommended daily amounts of fruit and 
vegetables increased by approximately 3% for fruit (2.6% in women, 3.2% in men) and 7% (8.3% 
in men, 5.6% in women) for vegetables.52  
In the Global Burden of Disease Study 2010, dietary risk factors ranked among the leading 
risk factors for global disease burden with diets low in fruit being the largest dietary contributor 
24 
 
(4.9 million deaths, 4.2% of total DALYs), followed by diets high in sodium (4 million deaths, 
2.5% of total DALYs).53 Diets low in vegetables also contributed significantly to global disease 
burden (1.8 million deaths, 1.5% of total DALYs).53 In Australia, insufficient fruit and vegetable 
consumption were responsible for 2.0% and 1.4% of total DALYs respectively, in 2011.34 Several 
meta-analyses have provided evidence that fruit and vegetable consumption are protective against 
the risk of CHD,54,55 stroke,56 cardiovascular and all-cause mortality.57,58 A 200 g/day increment 
in the separate or combined consumption of fruit and vegetables has been associated with a risk 
reduction of 8-16% for CHD, 13-18% for stroke, 8-13% for CVD, and 10-15% for all-cause 
mortality.53 In another meta-analysis, each additional daily serving was associated with a 4% 
reduction for fruit and vegetables combined, 5% for fruit consumption, and 4% for vegetable 
consumption in the risk of CVD mortality.58  
Fruit and vegetables are rich in multiple nutrients such as dietary fibre, antioxidants, 
potassium, and phytochemicals that can act synergistically via different mechanisms to help lower 
the risk of CVD and premature death. Mechanisms include reducing oxidative stress, blood 
pressure, systemic inflammation, and improving lipoprotein profiles and insulin sensitivity.59  
iii. Smoking 
Smoking cessation is recommended to reduce the health risks associated with tobacco 
smoking. In 2015, tobacco smoking was the second global leading risk factor for premature 
mortality and disability, and was responsible for 11.5% of deaths and 148.6 million DALYs 
worldwide.60 CVD (41.2%) was the leading cause of age-standardised DALYs attributable to 
smoking.60 In 2011, smoking was responsible for the largest proportion (9%) of burden of disease 
in Australia.34 However, rates of tobacco smoking have declined substantially in Australia over 
the past two decades. The proportion of daily smokers decreased from 22.4% in 2001 to 14.5% in 
2014-15.36 
Smoking at any level increases CVD risk. In addition to being a strong independent risk 
factor for CVD, smoking has a multiplicative effect on disease risk when combined with other risk 
factors.61 Smoking can contribute to vascular dysfunction including blood vessel wall damage, 
stiffness, lower coronary blood flow and oxygen level, and higher blood pressure. In addition, 
smoking increases inflammation, oxidative stress, thrombosis and atherosclerotic plaque 
formation which can lead to cardiovascular events.62 There is solid evidence that smoking 
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cessation can reverse the physiological damage caused by smoking, have immediate and long-term 
beneficial health effects, and reduce mortality from CVD.62,63  
Exposure to smoking or second-hand smoking is also an important preventable cause of 
disease, disability, and death. In 2004, the WHO estimated that approximately 1% of all global 
deaths and 0.7% of global DALYs were due to second-hand smoking.64 Of the 603,000 estimated 
yearly deaths (47% in women, 28% in children, 26% in men) caused by second-hand smoking, 
nearly two-thirds resulted in deaths from CHD. CHD also accounted for a large proportion of 
estimated DALYs.64 In Australia, the only data that could be found on second-hand smoking dated 
from 2004-05. During that period, second-hand smoking was responsible for an estimated 141 
deaths, 90% of which were from CHD. These figures were likely underestimated as several 
diseases not known to be associated with second-hand smoking at the time were not included and 
conservative methods were used to estimate CHD deaths.65 Australia has developed a National 
Tobacco Strategy and adopted several smoke-free laws.66 The WHO has created a Framework 
Convention on Tobacco Control to promote tobacco-smoke-free environments.67  
iv. Alcohol  
While guidelines worldwide vary as to what constitutes safe levels of alcohol consumption 
and the definition of a standard drink, the current Australian guidelines recommend no more than 
two standard drinks (one standard drink contains 10 g of alcohol) per day to reduce health risks 
associated with alcohol consumption.39 In middle-aged populations, alcohol consumption may 
have a U-shaped or J-shaped relationship with the risk of CHD and stroke, where abstention and 
higher levels of consumption may be linked with increased risk compared with low to moderate 
drinkers.68,69 Excessive alcohol consumption and episodes of heavy drinking have been linked with 
increased mortality and cardiovascular risk.70,71 Alcohol consumption ranked as the seventh 
leading global risk factor for deaths (2.2% of age-standardised deaths in women and 6.8% in men) 
and disability (1.2% of DALYs in women and 6% in men).72 In Australia, alcohol was the eighth 
leading risk factor for burden of disease, illness and injury, accounting for 2.1% and 2.8% of total 
deaths and DALYs respectively in 2010.73 Between 2004-05 and 2014-15, the rates of excessive 
alcohol drinking decreased in Australia, relatively more in men (from 32% to 26%) than in women 
(from 12% to 9.2%)40 
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While alcohol intake may have beneficial effects on specific lipids such as increasing anti-
atherogenic HDL cholesterol levels and on fibrinolytic activity, it can increase blood pressure 
which can lead to adverse cardiovascular health effects (this mechanism is further described in 
section vi).70 Given that alcohol consumption is an important risk factor for global disease burden, 
strategies at the population level are being put in place to reduce the harmful consumption of 
alcohol. 
v. Overweight and obesity 
WHO defines overweight as a body mass index ≥25 kg/m2 and obesity as a body mass index≥ 
30 kg/m2.74 Australia uses the same classification to measure overweight and obesity at the 
population level. Overweight and obesity is an important risk factor for CVD, type 2 diabetes, and 
hypertension. In 2015, a high body mass index accounted for 7.1% of total deaths (4 million 
deaths) and 4.9% of total DALYs (120 million DALYs) worldwide.75 CVD was the leading cause 
of body mass index-related deaths (2.7 million deaths) and DALYs (66.3 million DALYs), 
followed by diabetes.75 In 2011, overweight and obesity was the second leading risk factor for 
disease burden in Australia, with a higher burden in men (7.3% of total DALYs) than in women 
(6.6%), and 84% of the burden occurring in people aged 45 years and over.37 CVD (38%) followed 
by diabetes (17%) accounted for most of the burden due to overweight and obesity. Men had a 
higher attributable burden due to CVD (50%) than women (34%), which was mainly due to a 
greater CHD burden in men.37 The prevalence of overweight and obesity has increased by 6% 
between 1995 and 2015, mainly due to a 9% rise in the prevalence of obesity.76 
Overweight and obesity can lead to high blood pressure, high blood lipids and glucose, by 
adversely affecting adipose tissue adipokine secretion, inflammatory pathways, and cardiovascular 
structure, function and hemodynamics.77 Adopting healthy lifestyle behaviours including eating a 
healthy diet and engaging in adequate levels of physical activity can help manage overweight and 
obesity. 
While obesity appears to be detrimental for cardiovascular health at the population level, an 
“obesity paradox” has emerged in recent years whereby obesity appears to confer a better 
prognosis in overweight and mildly obese individuals with established CVD relative to normal 
weight counterparts.77,78 The obesity paradox has been described in the context of different types 
of CVD including CHD, myocardial infarction, hypertension, heart failure, atrial fibrillation and 
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in cardiac surgery patients. However, the obesity paradox is still the subject of much debate as is 
its potential mechanism. For example, most studies use body mass index which does not measure 
regional adiposity and lean muscle mass which may have different effects on survival.77 Several 
other methodological concerns in relation to previous studies reporting an obesity paradox have 
been highlighted, including confounding by smoking, reverse causation, and effect modification 
by age.79 Cardiorespiratory fitness may also be an important factor to consider in examining 
associations between overweight and obesity and mortality as a high cardiorespiratory fitness may 
offer protective effects to overweight and obese individuals.79 A recent paper has also questioned 
the obesity paradox by showing that greater longevity in individuals that are overweight or obese 
could be explained by an earlier diagnosis of CVD compared with individuals with a healthy 
BMI.80  
vi. Hypertension 
Hypertension, defined as a systolic blood pressure ≥140 mmHg, a diastolic blood pressure 
≥90 mmHg, or both, is a major risk factor for CVD. Modifiable risk factors for hypertension 
include overweight and obesity, insufficient physical activity, high salt intake and excessive 
alcohol intake.81 In 2015, high systolic blood pressure was among the top three global leading risk 
factors for global burden of disease, in both men and women, contributing to 8.9% of global 
DALYs.33 A systolic blood pressure of 140 mmHg or higher has been associated with 15% of 
deaths worldwide, with 41% of blood pressure-related deaths due to CVD.82 In Australia, high 
blood pressure was ranked as the fifth risk factor accounting for the most overall burden in 2011. 
High blood pressure caused the most CVD burden (32%), especially in relation to stroke and 
CHD.34 Between 1980 and 2011-12, the prevalence of high blood pressure measured in adults aged 
25 to 64 years decreased substantially, by approximately 25% in men and 15% in women.83  
Several potential mechanisms link hypertension to CVD. Hypertension can damage blood 
vessels, cause endothelial dysfunction, accelerate the atherosclerotic process, and lead to unstable 
plaques and acute coronary events. A common complication of hypertension is developing left 
ventricular hypertrophy which can lead to myocardial infarction.84  
vii. Hyperglycaemia and type 2 diabetes 
Elevated blood glucose levels or hyperglycaemia, even at levels below those indicative of 
diabetes, increases the risk for type 2 diabetes, cardiovascular mortality and all-cause mortality. In 
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the Global Burden of Disease Study 2016, high fasting blood glucose levels was the fifth leading 
risk factor worldwide for disease burden.33 In the large INTERHEART study, glycated 
haemoglobin (HbA1c), which is a measure of the average blood glucose levels in the previous 6 
to 8 weeks, was an independent predictor of myocardial infarction in both individuals with and 
without diabetes, and in both men and women, after accounting for nine other established risk 
factors including diabetes.85  
Type 2 diabetes is diagnosed in a clinically relevant context, with indicators including fasting 
glucose levels ≥7 mmol/L, 2 hour plasma glucose levels ≥11.1 mmol/L on the 75 g oral glucose 
tolerance test, and an HbA1c level ≥ 6.5%. Type 2 diabetes itself is a major risk factor for CVD 
because of its microvascular and macrovascular effects. Lifestyle risk factors for type 2 diabetes 
include a poor diet, low physical activity, high sedentary behaviour, smoking.86 While men with 
type 2 diabetes have two to three times the risk of developing CVD, women with diabetes have a 
three to four times higher risk than non-diabetic counterparts.87 In 2012, type 2 diabetes was the 
eighth leading cause of death worldwide, and the fifth in women.88 Type 2 diabetes was the sixth 
leading cause of disability in the world in 2015.89 In Australia, type 2 diabetes contributed to 10% 
of deaths in 2015, with mortality rates nearly two times higher in men than women.90 Close to two-
thirds of deaths in Australians that have diabetes are due to CVD.91 Between 1989-90 and 2014-
15, the prevalence of self-reported diabetes in Australia has tripled from 1.5% to 4.7%.92  
Both insulin resistance and impaired pancreatic insulin secretion have been implicated in the 
pathophysiological mechanism leading to high blood glucose levels in the fasting and postprandial 
states in pre-diabetic individuals.93 Hyperglycaemia and fluctuations in blood glucose levels can 
generate oxidative stress, inflammatory responses, insulin resistance, pancreatic β cell dysfunction, 
and endothelial dysfunction which can subsequently lead to microvascular and macrovascular 
complications.94 Type 2 diabetes is also commonly associated with a cluster of cardiovascular risk 
factors which contribute through various mechanisms to CVD.95 Making healthy lifestyle changes 
is important for glycaemic control and type 2 diabetes prevention.  
viii. Hyperlipidaemia 
Hyperlipidaemia is characterised by abnormally high levels of lipids in the blood such as 
triglycerides levels ≥2.0 mmol/L, total cholesterol levels ≥5.5 mmol/L or LDL cholesterol ≥3.5 
mmol/L. Hyperlipidaemia is an established risk factor for CVD. Several meta-analyses have 
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shown that both total and LDL cholesterol are positively associated with CVD risk, while HDL 
cholesterol is inversely related to CVD risk.96-98 In the Global Burden of Diseases, Injuries, and 
Risk Factors Study 2016, high total cholesterol was the eighth leading contributor to global disease 
burden (93.8 million DALYs).33 According to the WHO, high cholesterol accounts for a third of 
global CHD deaths.99 In Australia, high cholesterol was responsible for 2.4% of total DALYs, 28% 
of DALYs attributable to CHD, and 7.2% of DALYS due to stroke in 2011.34 Between 2010 and 
2014, the proportion of adults aged 30 to 65 years with self-reported medically diagnosed high 
cholesterol (33%) remained stable, with rates slightly higher in men (37%) than in women (29%).83 
Hyperlipidaemia can lead to endothelial dysfunction and initiate the atherosclerotic process 
described earlier in section 2.3. Adopting a diet low in saturated and trans fats, engaging in physical 
activity, not smoking, not drinking alcohol excessively and weight loss can help lower prevent 
hyperlipidaemia.100 
2.4.1.3 Novel approaches to lifestyle risk factors  
In addition to known modifiable risk factors described in the previous section, research about 
novel approaches to lifestyle risk factors and emerging knowledge about lesser known risk factors 
could be valuable to consider in prevention strategies for CVD.  
i. Multiple risk factors 
For decades, lifestyle risk factors have often been studied as single risk behaviours in relation 
to CVD outcomes. There has been limited research on the clustering of different lifestyle risk 
factors and the interactions between risk factors. Yet, many lifestyle behaviours tend to cluster 
together within individuals and may have synergistic effects on disease risk.101 There is growing 
evidence showing the importance of considering the combined influence of lifestyle risk factors, 
including specific risk factor combinations, on multiple disease outcomes. Several studies have 
examined risk factors jointly and reported the benefits of adopting healthy lifestyle behaviours for 
better health outcomes in relation to CHD,102 myocardial infarction,103 diabetes,104 cardiovascular 
mortality105 and all-cause mortality.106 There was an eighth-fold higher risk in cardiovascular 
mortality among middle-aged women with five lifestyle risk factors (low diet quality, low physical 
activity, smoking, heavy alcohol consumption, overweight) compared with none.105 A recent meta-
analysis has reported a 66% lower risk in all-cause mortality in individuals that engaged in at least 
four healthy lifestyle behaviours compared to individuals with an unhealthy lifestyle (unhealthy 
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diet, no physical activity, smoking, no or excessive alcohol consumption, obese).106 Exploring the 
combined influence of lifestyle risk factors rather than in isolation can help inform and develop 
more effective public health prevention strategies.  
Two-thirds of Australian adults had three or more risk factors in 2011-12.107 The top three 
most common combinations with two risk factors were: consuming insufficient amounts of fruit 
and vegetables and being overweight/obese (55%), being overweight/obese and having 
dyslipidaemia (34%) and being physically inactive/insufficiently active and overweight/obese 
(33%). The top three most common combinations with three risk factors were: consuming 
insufficient amounts of fruit and vegetables, being physically inactive/insufficiently active and 
being overweight/obese (31%); being physically inactive/insufficiently active, being 
overweight/obese and having dyslipidaemia (19%); and consuming insufficient amounts of fruit 
and vegetables, being physically inactive/insufficiently active and having uncontrolled high blood 
pressure (11%).  
Based on national data from 2007-08, the distribution of numbers of lifestyle/behavioural 
risk factors was generally similar for men and women as were the types of risk factor combinations 
in the top 10 most common combinations.108 Consuming insufficient amounts of fruit and 
vegetables and being physically inactive/insufficiently active were most often present among the 
10 most common combinations overall and within most age groups.108 
ii. Emerging/lesser known lifestyle risk factors 
Recently identified lifestyle risk factors/behaviours that may be linked with CVD and that 
are examined in this thesis include raw vegetable consumption, sedentary behaviour, psychological 
distress, and breastfeeding. These less well established lifestyle risk factors are briefly described 
in this section and their importance is further explored in studies presented in Chapters 3 to 7. 
Promoting vegetable consumption for overall health is important for Australian adults as the 
large majority (93%) does not consume vegetables in recommended amounts.52 A few studies have 
reported that the consumption of raw vegetables compared to that of cooked vegetables may offer 
stronger protective effects for mortality and CVD.109-111 Cooking can change the nutritional 
properties of vegetables and their subsequent physiological effect on health. However, the number 
of studies examining the differential effects of raw versus cooked vegetables has been limited and 
further research is required.  
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In Australia, the guidelines for sedentary behaviour recommend lowering the amount of time 
spent in prolonged sitting and breaking up long periods of sitting.41 Evidence is accumulating that 
sedentary behaviour may be an important lifestyle risk factor to consider in relation to CVD 
outcomes. Sedentary behaviour (including daily sitting and screen time) is thought to contribute 
to poor health and CVD outcomes, possibly partly independent of moderate-to-vigorous physical 
activity.112,113 In Australia, 42% of men and 36% of women reported sitting or lying down for 
leisure, transport or work in 2011-12.114 The mechanism mediating the association between 
sedentary behaviour and CVD remains unclear but may involve hemodynamic, inflammatory and 
metabolic changes.115  
Poor mental health including psychological distress is also emerging as a risk factor that has 
been associated with CVD in several meta-analyses.116-119 Psychological distress, a general 
measure of mental health and wellbeing, is strongly correlated with diagnosis of anxiety and 
depression,120 which are both associated with an increased risk for CVD.116,117,119 The mechanisms 
linking psychological distress to CVD remain to be elucidated. However, activation of the 
hypothalamic-pituitary-adrenal axis, altered autonomic nervous system and inflammatory 
processes may be involved.121 It has also been reported that behavioural risk factors may serve as 
intermediary risk factors in the association between psychological distress and CVD.122 In 2014-
15, one in nine Australian adults reported high or very high levels of psychological distress, with 
higher rates reported in women (13.5%) than in men (9.9%).36 
Evidence is also growing about a potential link between breastfeeding, a behaviour unique 
to women, and maternal risk of CVD later in life.123 Breastfeeding has been associated with a lower 
risk of hypertension,124 type 2 diabetes,125 as well as CVD incidence126 and mortality.127 While 
breastfeeding may help to reverse the adverse metabolic effects of pregnancy,128 the mechanism 
for a longer-term association with CVD is currently unclear. Further longitudinal studies are 
needed to explore the potential role of breastfeeding as a modifiable risk factor for CVD. Infant 
feeding guidelines in Australia currently recommend exclusively breastfeeding infants until 
approximately six months of age and then continued breastfeeding combined with solid food until 
12 months of age.129 
Examining the numerous other emerging cardiovascular risk factors is beyond the scope of 
this thesis. However, the role of inflammation and associated markers in relation to cardiovascular 
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risk should be briefly mentioned. Chronic low-grade inflammation plays a key role in the 
atherosclerotic process. Among novel and emerging inflammatory markers that have been 
identified, C-reactive protein (CRP) has received considerable attention. It is associated with 
increased cardiovascular risk and can predict future cardiovascular events.130 Given that several 
behavioural and metabolic risk factors may influence the inflammatory process, adopting a healthy 
lifestyle is of central importance.  
2.4.2 Importance of CVD prevention in the middle-aged population  
In 2013, NCDs were responsible for the majority of deaths among individuals aged 45 years 
and over. The largest proportion of NCD-related deaths was attributed to CVD in adults over 40 
years, with this proportion progressively increasing during middle age years (typically between 45 
to 65 years of age131) and beyond.132 In 2015, 29% and 19% of NCD deaths in Australian men and 
women, respectively, occurred prematurely.133 In 2011-13, CHD was the leading cause of 
premature death in Australia, including in adults aged 45 years and over, and in men. In women, 
CHD ranked as the third leading cause of premature death.8 
Risk factors during middle age years can determine the risk of CVD at older ages. Indeed, 
lower levels of behavioural and physiological risk factors in middle-aged adults have been 
associated with markedly lower risks for CVD several decades later, and longer survival.134,135 
With a growing and ageing population, identifying CVD prevention strategies that are informed 
by research evidence and which focus on modification of risk factors in the middle-age population 
should be a public health priority.  
The prevalence of cardiovascular risk factors in Australian men and women aged 45 years 
and over is presented in Table 2.4. With the exception of physical inactivity which was more 
prevalent in women than men, all other risk factors were more prevalent in men. 
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Table 2.4. Prevalencea of traditional lifestyle and metabolic risk factors in individuals aged 
45 years and over, and in men and women. 
 
 
 
 
 
 
 
 
 
a Calculated based on data from the ABS National Health Survey 2014-15 (for lifestyle risk 
factors, overweight/obesity and high blood pressure) and Australian Health Survey 2011-12 (for 
diabetes and high total cholesterol).36,37  
b <150 minutes in the past week.41 
c According to 2013 Australian Dietary Guidelines for recommended daily serves of fruit and 
vegetables based on an individual’s age and sex.38 
d On average >2 standard drinks per day.39 
e ≥140/90 mmHg. 
f The prevalence rates for men and women aged ≥45 years could not be calculated from available 
data for diabetes and total cholesterol. 
g ≥5.5 mmol/L. 
 
2.4.3 Importance of CVD prevention with a gender focus 
 CVD is the leading cause of death worldwide not only in men but also in women, 
contributing nearly equally to global death rates in both sexes in 2015.136 Although historically 
thought to be a “man’s disease”, men generally develop CVD at a younger age while women tend 
to develop CVD as they get older. There are well recognised differences between women and men 
in the epidemiology, pathophysiology, risk factors, treatment, and outcomes of CVD (Table 
  Percent 
Lifestyle/metabolic risk factor Men Women Overall 
Physical inactivityb 68.3 73.3 70.7 
Low fruit consumptionc 52.7 39.4 45.7 
Low vegetable consumptionc 96.8 88.7 91.6 
Current smoker 15.6 11.7 13.5 
Excessive alcohol intaked 40.3 20.5 31.6 
Overweight/obesity 79.5 65.8 72.4 
High blood pressuree 36.4 33.2 34.6 
Diabetesf - - 8.7 
High total cholesterolf,g - - 41.4 
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2.5).137-150 In addition, women have unique reproductive risk factors to consider140,143,145 (Table 
2.6). 
 
Table 2.5. Gender differences in CVDa. 
Parameter  Difference in women (relative to men) 
Lifestyle risk factors 
   Physical inactivity Higher prevalence131,152 
   Unhealthy diet Lower prevalence141  
   Smoking Lower prevalence140 
Confers a higher risk of CVD (e.g. CHD)139,140,150 
   High alcohol intake Lower prevalence138,148 
   Sedentary behaviour Higher prevalence139 
   Depression Higher prevalence140,146  
Confers a higher risk of CVD mortality140,143,146,150 
Physiological risk factors 
   Obesity Different prevalence based on country142 
Confers a higher risk of CVD139 
   Hypertension Higher prevalence at older age139,145 
Less controlled139 
Confers a higher risk of CVD145,149  
   Type 2 diabetes Higher prevalence 
Confers a more adverse cardiovascular risk profile147 
Confers a higher risk of CVD (e.g. CHD, heart failure)137,140,145,150  
   Dyslipidaemia Specific lipoproteins seem to be more important risk factors in 
women (e.g. low HDL cholesterol and high triglycerides)137 
Risk awareness More likely to underestimate the impact of CVD on their health137 
Less likely aware of risk factors for CVD 
Age of CVD onset Later onset (e.g. CHD typically occurs 7-10 years later)137,144,145 
Disease 
pathophysiology  
Lower atheroma volume, smaller vessel size, less plaque rupture, 
remodelling differences, functional differences in smooth muscle 
cells137,145 
Types of CVDb 
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   CHD Less likely to have as a first event144 
   Cerebrovascular      
   disease 
More likely to have as a first event144 
Worse stroke severity and poorer functional outcomes following 
stroke 
CVD symptoms More likely to present with atypical symptoms (e.g. abdominal 
pain, jaw pain, nausea)137 
CHD symptoms more complex and multifactorial 
CVD diagnosis Less likely to be diagnosed given the same symptoms, and receive 
treatment 
Less likely to receive electrocardiography upon presentation at the 
emergency department137 
Less often referred for diagnostic tests137 
Non-invasive testing predicts CVD less accurately137 
Higher incidence of silent MI137 
CVD treatment More likely to delay seeking treatment137 
Differences in effectiveness, interactions and side effects145 
Less invasive interventions137 
Less likely to receive secondary prevention medication137 
Less referrals and lower participation rates in cardiac rehabilitation 
programs137 
Less likely to adopt healthy lifestyle behaviours 
CVD outcome More likely to have adverse outcomes137 
Higher mortality rates following MI137 
Abbreviations: CHD=coronary heart disease, CVD=cardiovascular disease, 
ECG=electrocardiography, HDL=high-density lipoprotein, MI=myocardial infarction.  
a The information presented on this table is adapted from the following references 137 to 150. 
b Relevant to this thesis are presented in this table. 
 
Table 2.6. Women-specific risk factors in CVD. 
   Pregnancy-related  
   disorders 
Gestational hypertension and pre-eclampsia are associated with a 
higher risk of hypertension and CVD later in life140,143,145 
Gestational diabetes confers a higher risk of type 2 diabetes and 
CVD later in life140,143,145 
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   Hormonal dysfunction  
   pre-menopause 
Confers a higher risk of CVD145 
   Menarche Early menarche confers a higher risk of CVD140 
   Menopause Early onset menopause (before age 45) is associated with higher 
risk CVD and CVD mortality140 
The increased CVD risk seen with menopause at usual age may 
be more age-related rather than menopause-related140 
Abbreviations: CVD=cardiovascular disease.  
While there has been both a global and Australian impetus to increase awareness about the 
importance of CVD as a health issue in women and to highlight it both as a public health and 
research priority, CVD receives insufficient prevention efforts, is underdiagnosed, undertreated, 
and under researched in women. There is an underrepresentation of women in research as well as 
a paucity of data that explores potential gender differences in CVD prevention based on lifestyle 
behaviour modification.151152 Both national and international health bodies have urgently called 
for more gender-specific research to gain a better understanding of potential gender differences in 
CVD and to inform more effective prevention strategies in both women and men.145,151,153,154  
The following five chapters present mostly published findings from prospective studies 
carried out as the central work in this thesis, examining associations among innovative 
cardiovascular risk factors in a large cohort of middle-aged and older Australian men and women. 
The innovative aspect of this thesis resides in the: 1) cardiovascular risk factors considered, 
including recently identified ones such as raw vegetable consumption, sedentary behaviour and 
poor mental health; 2) methodological approach which involves comparing the influence of 
individual versus a combination of lifestyle risk factors; 3) gender-based approach to explore 
potential gender differences and cardiovascular risks of behaviours specific to women, mainly 
breastfeeding.  
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CHAPTER THREE:                                                                           
Fruit and vegetable consumption and all-cause mortality:                                           
Evidence from a large Australian cohort study 
 PREFACE TO THE CHAPTER 
This chapter presents findings from a peer-reviewed paper that examined the longitudinal 
association between fruit and vegetable consumption, considered separate and combined, and all-
cause mortality in the 45 and Up Study cohort. In addition, the lesser known influence of 
consuming raw versus cooked vegetables on all-cause mortality was examined. We had 
originally intended to examine the association between fruit and vegetable consumption and 
CVD outcomes. Unfortunately, at the time of analysis, cardiovascular outcomes were not 
available for this cohort and hence, we could not include these in our paper. However, in a recent 
meta-analysis based on 16 longitudinal studies, most of the inverse association between fruit and 
vegetable consumption and all-cause mortality was accounted for by mortality from CVD.1   
This chapter, consisting of the published paper, addresses specific aims #1 and #5 of this 
thesis as described in Chapter 1. Dissemination of this research and author contributions for this 
paper are described below. 
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Fruit and vegetable consumption and
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Abstract
Background: There is growing evidence for a relationship between fruit and vegetable consumption and all-cause
mortality. Few studies, however, specifically explored consuming raw versus cooked vegetables in relation to health
and mortality outcomes. The purpose of this study was to examine the relation of all-cause mortality with: a) fruit
and vegetable consumption, either combined or separately; b) the consumption of raw versus cooked vegetables
in a large cohort of Australian middle-aged and older adults.
Methods: The sample included 150,969 adults aged 45 years and over from the 45 and Up Study, a prospective
cohort study conducted in New South Wales, Australia. Self-reported baseline questionnaire data (2006–09) were
linked to mortality data up to June 2014. Fruit and vegetable consumption was assessed by validated short
questions. Crude and adjusted hazard ratios were calculated using Cox proportional hazard models. Covariates
included socio-demographic characteristics, health-related and dietary variables.
Results: During a mean follow-up of 6.2 years, 6038 (4 %) participants died from all causes. In the fully adjusted models,
increasing consumption of fruit and vegetables combined was associated with reductions in all-cause mortality, with
the highest risk reduction seen up to 7 serves/day or more of fruit and vegetables (P for trend = 0.002, hazard ratio for
highest versus lowest consumption quartile: 0.90; 95 % confidence interval: 0.84, 0.97). Separate consumption of fruit and
vegetables, as well as consumption of raw or cooked vegetables, were associated with a reduced risk of all-cause
mortality in the crude and minimally adjusted models (all P for trend <0.05). With the exception of raw vegetables, these
associations remained significant in the fully adjusted models (all P for trend <0.05). Age and sex were significant effect
modifiers of the association between fruit and vegetable consumption and all-cause mortality.
Conclusions: Fruit and vegetable consumption were inversely related to all-cause mortality in this large Australian
cohort. Further studies examining the effects of raw versus cooked vegetables are needed.
Keywords: Fruit, Vegetables, Mortality, Prospective studies
Background
High consumption of fruit and vegetables as part of a
healthy diet is advocated for the prevention of chronic
diseases, such as coronary heart disease, stroke, and
some cancers [1]. Although dietary recommendations
vary between countries, most are in line with the World
Health Organization’s recommendation to consume a
daily minimum of 400 g of fruit and vegetables, or the
equivalent of five portions of fruit and vegetables per
day [1–3]. Recently, a comparative risk assessment of
global burden of disease identified diets low in fruit to
be among the five leading risk factors worldwide [4].
Previous meta-analyses have provided evidence for the
protective effects of fruit and vegetables against risk of
coronary heart disease [5, 6] and stroke [7]. A recent
meta-analysis has shown that the consumption of fruit
and vegetables, either separately or combined, was in-
versely associated with a lower risk of all-cause and car-
diovascular mortality [8]. The relationship with cancer
mortality is less clear [8, 9], and may be specific to the
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cers [10]. With cardiovascular disease and cancer being
the primary causes of death in developed countries [11],
further investigation of the protective effects of fruit and
vegetables can contribute to the evidence base for public
health recommendations.
To date, there has been limited research on fruit and
vegetable consumption and mortality risk in Australia.
Previous prospective cohort studies have been con-
ducted in the United States, Europe and Asia [5–8]. In
addition, few cohort studies have investigated the con-
sumption of raw versus cooked vegetables in relation to
mortality risk or disease incidence [9, 12]. Cooking can
modify the nutritional properties of vegetables thereby
influencing their potential effects on health [13]. In the
large European Prospective Investigation into Cancer
and Nutrition cohort, stronger inverse associations were
observed for raw vegetables than for cooked vegetables
with all-cause, cardiovascular and cancer mortality [9].
However, both raw and processed fruit and vegetables
were not significantly related to cardiovascular disease
incidence in a Dutch population-based cohort [12]. A re-
view by Link and Potter [13] including both case–con-
trol and cohort studies showed that the consumption of
raw vegetables was more strongly related to specific
types of cancer than that of cooked vegetables. Although
results from these observational studies tend to suggest
that the associations with raw vegetables may be stron-
ger than with cooked vegetables [9, 13], this has not
been firmly established.
The aims of this paper are to examine the relation of
all cause-mortality with: a) individual and combined fruit
and vegetable consumption; b) the consumption of raw
versus cooked vegetables, in a large Australian cohort
aged 45 years and over. Findings from the current study
could inform public health recommendations on fruit
and vegetable consumption.
Methods
Study population
The Sax’s Institute’s 45 and Up Study is the largest
prospective cohort study into healthy ageing in the
Southern Hemisphere [14]. The cohort comprises 267,153
men and women aged 45 years and over residing in the
state of New South Wales (NSW), Australia at baseline,
and represents around 10 % of the NSW population aged
45 years and over. From January 2006 to December 2008,
potential participants were randomly sampled from the
database of Medicare Australia, the national health insur-
ance provider and were sent an invitation to take part.
The database includes Australian citizens, permanent resi-
dents, and some temporary residents and refugees. Inter-
ested participants joined the study by completing a mailed
questionnaire and a consent form for follow-up whichincluded linkage of questionnaire data to population
health databases. The study methods have been described
in detail elsewhere [14] and the baseline questionnaire is
available at http://www.saxinstitute.org.au/our-work/45-
up-study/questionnaires/. The 45 and Up Study received
ethics approval from the University of NSW Human Re-
search Ethics Committee. Approval to use data from the
45 and Up Study for this paper was obtained from the
NSW Population and Health Services Ethics Committee.
Participants who had reported on the baseline question-
naire that they had a history of cancer (defined as a self-
reported history of cancer other than non-melanoma skin
cancer: n = 22,900) and/or cardiovascular disease (defined
as a self-reported history of heart disease, stroke or blood
clot: n = 46,120) were excluded from the analysis. Of the
remaining 203,590 participants who did not report a his-
tory of cancer and/or cardiovascular disease, 52,621 had
missing data for the covariates of interest to this study and
were further excluded from the analysis. The final analytic
sample included 150,969 participants (83,329 women and
67,640 men).
Measurement
Exposure
Self-reported baseline questionnaire data include informa-
tion on socio-demographic and lifestyle factors, height
and body weight, medical and surgical history, and phys-
ical functioning. Participants were asked a few dietary
questions based on short validated dietary questions com-
monly used in health monitoring and surveillance [15].
Usual fruit consumption was assessed by asking partici-
pants: “About how many serves of fruit do you usually
have each day?” with one serve of fruit corresponding to
one medium piece or two small pieces of fresh fruit, or
one cup of diced or canned fruit pieces. Vegetable con-
sumption was determined from the following question:
“About how many serves of vegetables do you usually eat
each day?” Participants were asked to report consumption
of raw and cooked vegetables separately. One serve of veg-
etables was defined as half a cup of cooked vegetables (in-
cluding potatoes) or one cup of raw vegetables (e.g. salad).
For each of these two questions, participants also had the
option to answer that they did not eat fruit or vegetables,
which were subsequently coded as zero serve.
Outcome
All-cause mortality was ascertained from the NSW
Registry of Births, Deaths, and Marriages from Febru-
ary 1, 2006 to June 15, 2014. The mortality data were
linked to the 45 and Up Study baseline data by the
Centre for Health Record Linkage (CHeReL, NSW,
Australia) using probabilistic record linkage methods
and a commercially available software (Choice-Maker,
ChoiceMaker Technologies Inc.).59
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The following baseline self-reported variables were in-
cluded as covariates: age, sex, highest educational qualifi-
cation (none, school certificate, higher school certificate,
trade/certificate/diploma, university degree or higher),
marital status (single, widowed, divorced/separated, or
married/de facto), residential remoteness (major city, re-
gional area, or remote area), socio-economic status (quin-
tiles based on Socio-Economic Indexes For Area - Index
of Relative Socio-Economic Disadvantage [16]), smoking
status (never, past, or current), hours of sleep, physical
activity (assessed using validated questions from the Ac-
tive Australia Survey [17]; categorised as <150, 150–300,
≥300 min per week), multi-vitamin intake (for most of
the last four weeks), processed meat intake (times per
week), general health (self-rated as excellent, very
good, good, fair or poor), previous physician diagnosis
of diabetes (yes or no) and body mass index (derived from
self-reported height and weight; categorised as under-
weight [<18.5 kg/m2], normal weight [18.5–< 25.0 kg/m2],
overweight [25.0–< 30.0 kg/m2], or obese [≥30.0 kg/m2]).
Statistical analysis
A complete case analysis was conducted on 150,969 par-
ticipants. Based on their frequency distribution, fruit and
vegetable consumption were categorised as quartiles (Q).
Descriptive statistics for baseline characteristics were
computed for the overall sample and according to fruit
and vegetable consumption, both as separate and com-
bined categories. Crude and adjusted hazard ratios
(HRs) with 95 % confidence intervals (CIs) were esti-
mated for all categories of fruit and vegetable consump-
tion (combined fruit and vegetables, total fruit, total
vegetables, cooked vegetables, raw vegetables) by using
Cox proportional hazards models, with the lowest intake
category used as a reference category. To test the statis-
tical significance for trends (measured by probability [P]
for trends) in the associations across increasing quartiles
of fruit and vegetable intake, quartiles of intake were
replaced with a continuous variable calculated from
the respective midpoints of the quartiles in the Cox
proportional hazard models. Three models were tested for
each exposure variable: Model 1 was an unadjusted model;
Model 2 was minimally adjusted for age and sex; Model 3
was adjusted for age, sex, education level, marital status,
location of residence, socio-economic status, smoking
status, physical activity categories, multi-vitamin use,
processed meat consumption, diabetes and body mass
index categories. Analyses of vegetable consumption were
adjusted for fruit consumption (and vice versa).
As suggested by previous studies, variables including
age, sex, education level, smoking and body mass index
could potentially moderate the association between fruit
and vegetable consumption and all-cause mortality [9, 12].Furthermore, lifestyle factors, such as fruit and vegetable
consumption, may have differential effects on those with
different health status. Therefore, in Model 3, we tested
for potential effect modification by age group (45–59
years; 60–74 years; ≥75 years), sex, education level, smok-
ing status, body mass index categories, and self-rated
health. Any significant (P < 0.05) interactions were further
explored in stratified analyses. Finally, due to the relatively
short follow-up, an additional sensitivity analysis was con-
ducted by repeating the analysis on those with at least two
years of follow-up to test for occult disease at baseline.
Data were analysed using SAS version 9.3 (SAS Institute
Inc.) and the significance level was set at 0.05.
Results
Participant characteristics
Among 150,969 participants followed up for an average of
6.2 (standard deviation [SD]: 1.0) years and a total of
933,538 person-years, 6,038 (4 %) died. Overall, the mean
age (SD) of participants at baseline was 60.0 (10.1) years,
more than half (55.2 %) of participants were women, more
than a quarter (27 %) completed college or university,
more than three quarters (77.7 %) were in a married/de
facto relationship, and 54.7 % lived in regional/remote
areas. The mean intakes (SD) for fruit, vegetables, and
both fruit and vegetables, were respectively: 1.9 (1.4), 3.9
(2.6), and 5.8 (3.3) servings/day. More than half (60.5 %)
of the sample (48.6 % of men; 70.2 % of women) met the
World Health Organization’s recommendations of con-
suming a combination of five serves of fruit and vegetables
per day [1]. Baseline characteristics of study participants
by categories of fruit and vegetable consumption are pre-
sented in Table 1. Compared with participants with lower
intakes of fruit and vegetables, those who consumed
higher amounts were more likely to be younger, women,
in a married/de facto relationship, and living in remote/
rural areas. Such participants were also more likely to
sleep between 7 to 9 h per day, exercise more than
300 min/week, be non-smokers, non-obese and to per-
ceive themselves in very good or excellent health.
Fruit and vegetable consumption and all-cause mortality
Table 2 shows the HRs for all-cause mortality according
to categories of fruit and vegetable intake. The combined
consumption of fruit and vegetables was inversely related
to all-cause mortality in all models. In the fully adjusted
model, this association was substantially attenuated
compared with the unadjusted model (Q4 versus Q1;
HR: 0.76; 95 % CI: 0.71, 0.81; P for trend < 0.0001) but
remained significant (Q4 versus Q1; HR: 0.90; 95 %
CI: 0.84, 0.97; P for trend = 0.002). The highest risk
reduction was observed with the highest consump-
tion quartile (Q4: 7 serves or more of fruit and
vegetables/day).60
Table 1 Baseline characteristics of 150,969 participants from the 45 and Up Study by frequency of fruit and vegetable intakesa
Quartiles of fruit intakeb Quartiles of vegetable intakeb Quartiles of combined fruit and vegetable
intakeb
Variable Overall Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Number of subjects 150,969 12,960 50,766 50,111 37,132 54,562 24,460 40,979 30,968 37,467 43,004 34,779 35,719
Mean servings per day (SD) 0.001
(0.02)
1.01
(0.05)
2.00
(0.00)
3.73
(1.46)
1.65
(0.57)
2.99
(0.08)
4.39
(0.49)
7.83
(2.61)
2.44
(0.80)
4.49
(0.50)
6.44
(0.50)
10.27
(3.12)
Age group (%)
45 to 59 years 56.5 64.5 58.3 55.6 52.4 59.1 59.4 55.2 51.3 59.9 59.4 55.2 50.7
60 to 74 years 33.5 28.5 32.0 34.3 36.3 30.7 31.1 35.2 38.0 30.1 31.2 35.1 38.2
≥75 years 10.0 7.1 9.7 10.1 11.3 10.3 9.4 9.6 10.7 10.0 9.4 9.7 11.1
Women (%) 55.2 41.2 48.0 61.4 61.6 40.5 55.3 65.7 67.1 36.6 54.1 64.8 66.7
College or higher education (%) 27.0 18.0 26.0 28.5 29.5 26.1 31.9 29.0 22.1 24.1 29.8 29.1 24.7
Married/de facto (%) 77.7 73.0 78.8 78.6 76.8 74.7 78.6 80.3 78.9 74.3 78.4 79.9 78.4
Location of residence
Major city (%) 45.3 42.2 44.5 45.5 47.0 47.9 47.6 44.3 40.1 46.9 46.9 44.9 41.9
Rural/remote (%) 54.7 57.8 55.5 54.5 53.0 52.1 52.4 55.7 59.9 53.1 53.1 55.1 58.1
Socio-economic status (SEIFA-IRSD) (%)
Quintile 1 (most disadvantaged) 19.1 22.6 20.0 18.1 17.9 19.1 17.5 18.3 21.3 20.0 18.2 18.1 20.2
Quintile 2 19.1 20.7 19.0 19.1 18.8 18.8 18.4 19.1 20.2 19.0 18.7 18.9 19.8
Quintile 3 21.0 21.4 21.1 21.0 20.5 20.6 20.1 21.1 22.2 20.9 20.2 21.2 21.7
Quintile 4 20.1 19.4 19.6 20.5 20.6 20.0 20.6 20.6 19.3 19.8 20.4 20.5 19.7
Quintile 5 (least disadvantaged) 20.7 15.9 20.2 21.4 22.2 21.4 23.4 21.0 17.0 20.3 22.5 21.3 18.6
Current smoking (%) 7.5 21.2 9.2 5.0 3.8 9.9 6.6 5.8 6.2 12.7 7.0 5.3 4.9
Hours of sleep (%)
<7 h/day 15.1 19.8 15.2 13.9 15.0 16.9 13.9 13.5 15.0 17.3 14.7 13.6 14.7
7–9 h/day 67.6 60.7 66.9 69.5 68.6 66.3 69.1 68.8 67.3 65.0 68.7 68.9 68.0
≥9 h/day 17.3 19.6 17.8 16.7 16.4 16.7 17.0 17.7 17.7 17.7 16.6 17.5 17.3
Physical activity category (%)
10–149 min/week 19.1 29.0 21.9 16.9 14.8 22.9 18.5 16.7 16.1 25.7 19.0 16.0 15.2
150–299 min/week 16.1 17.2 17.2 15.9 14.3 17.0 17.2 15.8 13.8 17.5 17.0 15.8 13.7
≥300 min/week 64.8 53.8 61.0 67.2 70.8 60.0 64.4 67.5 70.1 56.7 64.0 68.1 71.1
Multivitamin use (%) 3.2 2.9 3.3 3.2 3.1 3.3 3.1 2.9 3.1 3.3 3.2 2.9 3.1
Self-rated health (%)
Excellent 18.3 12.4 15.7 19.2 22.8 15.7 18.7 20.0 20.4 13.8 18.1 20.0 21.7
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Table 1 Baseline characteristics of 150,969 participants from the 45 and Up Study by frequency of fruit and vegetable intakesa (Continued)
Very good 40.6 33.2 40.0 42.2 41.7 38.4 40.8 42.3 42.0 36.8 41.1 42.6 42.0
Good 31.4 37.0 33.7 30.2 27.7 34.0 31.4 29.5 29.1 35.9 31.6 29.3 28.3
Fair 8.5 14.7 9.3 7.4 6.9 10.4 8.1 7.2 7.6 11.7 8.2 7.3 7.0
Poor 1.2 2.7 1.3 0.9 0.9 1.5 1.0 0.9 1.0 1.8 1.1 0.8 0.9
BMI category (%)
Underweight and normal weight (≤18.5 to
<25.0 kg/m2)
39.0 34.9 37.7 39.1 42.1 37.3 41.1 40.3 38.7 36.5 39.3 40.3 40.0
Overweight (25.0 to <30.0 kg/m2) 39.4 39.3 40.5 39.2 38.0 41.5 38.8 37.9 37.9 41.6 39.8 38.0 37.8
Obese (≥30.0 kg/m2) 21.6 25.8 21.8 21.7 19.9 21.2 20.1 21.8 23.4 21.8 21.0 21.7 22.2
Physician diagnosed diabetes (%) 7.0 5.9 6.4 7.4 7.6 6.9 6.3 6.9 7.7 6.5 6.7 7.0 7.7
Abbreviations: BMI body mass index, min minutes, IRSD Index of Relative Socio-economic Disadvantage, Q quartile of intake, SD standard deviation, SEIFA Socio-Economic Indexes For Areas
aData are presented as means (SD) or percentages (%)
bThe quartiles of intake for fruit and vegetables (servings/day) were as follows: Fruit: Q1: <1.0; Q2: 1.0 to <2.0; Q3: 2.0 to <2.3; Q4: ≥2.3. Vegetables: Q1: ≤2.0; Q2: 2.0 to ≤3.0; Q3: 3.0 to ≤5.0, Q4: >5.0. Fruit and
vegetables combined: Q1: <4.0; Q2: 4 to ≤5.0; Q3: >5.0 to ≤7.0; Q4: >7.0
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Table 2 Hazard ratios and 95 % confidence intervals of all-cause mortality by quartiles of intake for fruit and vegetables (n = 150,969)
Quartilesa
Q1 Q2 Q3 Q4 P for trend
HR 95 % CI HR 95 % CI HR 95 % CI HR 95 % CI
Fruit and vegetable intakea
Model 1 (crude) 1.0 Reference 0.80 0.75,0.85 0.70 0.65,0.75 0.76 0.71,0.81 <0.0001
Model 2b (age, sex adjusted) 1.0 Reference 0.89 0.83,0.95 0.79 0.73,0.85 0.77 0.72,0.83 <0.0001
Model 3c (adjusted) 1.0 Reference 0.99 0.93,1.06 0.92 0.86,0.99 0.90 0.84,0.97 0.002
Fruit intakea
Model 1 (crude) 1.0 Reference 0.91 0.83,1.00 0.78 0.72,0.86 0.78 0.71,0.85 <0.001
Model 2b (age, sex adjusted) 1.0 Reference 0.75 0.69,0.83 0.66 0.60,0.72 0.62 0.56,0.68 <0.001
Model 3c (adjusted) 1.0 Reference 0.91 0.83,0.99 0.86 0.78,0.94 0.84 0.76,0.93 0.001
Vegetable intakea
Model 1 (crude) 1.0 Reference 0.78 0.72,0.84 0.71 0.66,0.75 0.79 0.74,0.85 <0.0001
Model 2b (age, sex adjusted) 1.0 Reference 0.87 0.81,0.94 0.81 0.76,0.87 0.82 0.77,0.88 <0.0001
Model 3c (adjusted) 1.0 Reference 0.95 0.88,1.02 0.92 0.86,0.99 0.93 0.87,1.00 0.017
Cooked vegetable intakea
Model 1 (crude) 1.0 Reference 0.74 0.68,0.80 0.87 0.81,0.94 0.88 0.81,0.95 0.004
Model 2b (age, sex adjusted) 1.0 Reference 0.86 0.80,0.93 0.89 0.83,0.97 0.80 0.74,0.86 <0.0001
Model 3c (adjusted) 1.0 Reference 0.92 0.85,1.00 0.98 0.90,1.06 0.87 0.80,0.95 0.003
Raw vegetable intakea
Model 1 (crude) 1.0 Reference 0.62 0.57,0.66 0.56 0.50,0.61 0.65 0.59,0.72 <0.0001
Model 2b (age, sex adjusted) 1.0 Reference 0.76 0.70,0.82 0.76 0.69,0.84 0.77 0.70,0.85 0.0005
Model 3 (adjusted) 1.0 Reference 0.87 0.81,0.94 0.92 0.84,1.02 0.94 0.85,1.04 0.793
Abbreviations: CI confidence interval, HR hazard ratio, Q quartile
aThe quartiles of intake for fruit and vegetables (servings/day) were as follows: Fruit and vegetables combined: Q1: <4.0; Q2: 4 to ≤ 5.0; Q3: 5.0 to ≤7.0; Q4: >7.0.
Fruit: Q1: <1.0; Q2: 1.0 to <2.0; Q3: 2.0 to <2.3; Q4: ≥2.3. Vegetables: Q1: ≤2.0; Q2: 2.0 to ≤3.0; Q3: 3.0 to ≤5.0, Q4: >5.0. Cooked vegetables: Q1: ≤1.0; Q2: 1.0 to
≤2.0; Q3: 2.0 to ≤3.0, Q4: >3.0. Raw vegetables: Q1: <1.0; Q2: 1.0 to <1.3; Q3: 1.3 to ≤ 2.0; Q4: >2.0
bModel 2 was adjusted for age (continuous) and sex
cModel 3 was adjusted for age (categorical), sex, education level, marital status, location of residence, socio-economic status, smoking status, physical activity categories,
multi-vitamin use, processed meat consumption, diabetes and body mass index categories. Any significant (P < 0.05) interactions (shown in Table 3) with age group, sex,
education level, body mass index categories and smoking status, were included in this model. The model for fruit was adjusted for vegetable intake and vice versa
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ately, there was an inverse association with all-cause mor-
tality in all models. Participants in the top quartile had a
significantly lower risk of all-cause mortality than those in
the bottom quartile (fully adjusted model: HR: 0.84; 95 %
CI: 0.76, 0.93; P for trend ≤ 0.001). Consumption of total
vegetables, as well as separate consumption of cooked and
raw vegetables, was associated with a lower risk of all-cause
mortality in the unadjusted and minimally adjusted models
(all P for trend < 0.05). In the fully adjusted models, these
associations were markedly attenuated compared with the
unadjusted models, but remained statistically significant for
total vegetables and cooked vegetables only (P for trend <
0.05). The association with raw vegetable consumption
showed estimates (and CIs) that were consistent with those
for cooked vegetables but these findings were not signifi-
cant. The sensitivity analyses conducted on participants
with at least two years of follow-up showed similar results
that were slightly attenuated (Appendix: Table 4).Effect modification
Significant (P < 0.05) effect modifiers of the association
between fruit and vegetable intake and risk of all-cause
mortality included sex and age group (Table 3). Con-
sumption of fruit and vegetables combined, and separate
consumption of vegetables, were inversely related with
all-cause mortality in women but not in men. Consump-
tion of fruit was associated with lower HRs in individ-
uals aged between 60 to 74 years compared to other age
groups.
Discussion
To our knowledge, this is the first prospective cohort
study in Australia and one of the largest worldwide to
explore the relationship between fruit and vegetable con-
sumption and all-cause mortality. Consumption of fruit
and vegetables combined was inversely related to all-
cause mortality in this large cohort of middle-aged and
older Australian adults. After adjustment for age and63
Table 3 Hazard ratios and 95 % confidence intervals of all-cause mortality by quartiles of intake for fruit and vegetables by effect
modifiers
Effect value
for significant
interactions
Quartilesa
Q1 Q2 Q3 Q4 P for interaction
HR 95 % CI HR 95 % CI HR 95 % CI HR 95 % CI
Fruit and vegetable intakea
Male 1.0 Reference 1.03 (0.95,1.12) 0.97 (0.88,1.06) 1.01 (0.92,1.11) 0.002
Female 1.0 Reference 0.89 (0.79,0.99) 0.80 (0.71,0.91) 0.76 (0.67,0.85)
Fruit intakea
45 to 59 years 1.0 Reference 0.83 (0.68,1.01) 0.88 (0.72,1.08) 0.86 (0.69,1.07) 0.045
60 to 74 years 1.0 Reference 0.84 (0.73,0.98) 0.80 (0.68,0.93) 0.82 (0.69,0.96)
≥75 years 1.0 Reference 1.13 (0.98,1.30) 1.05 (0.91,1.21) 0.98 (0.84,1.13)
Vegetable intakea
Male 1.0 Reference 0.94 (0.86,1.04) 0.94 (0.86,1.03) 1.04 (0.94,1.14) 0.012
Female 1.0 Reference 0.94 (0.77,1.14) 0.84 (0.76,0.93) 0.82 (0.73,0.92)
Abbreviations: CI confidence interval, HR hazard ratio, Q quartile
aThe quartiles of intake for fruit and vegetables (servings/day) were as follows: Fruit and vegetables combined: Q1: <4.0; Q2: 4 to ≤ 5.0; Q3: 5.0 to ≤7.0; Q4: >7.0.
Fruit: Q1: <1.0; Q2: 1.0 to <2.0; Q3: 2.0 to <2.3; Q4: ≥2.3. Vegetables: Q1: ≤2.0; Q2: 2.0 to ≤3.0; Q3: 3.0 to ≤5.0, Q4: >5.0
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6 %. Following adjustment for socio-economic, lifestyle
and health-related factors, the association was attenuated
further by approximately 12 % but remained statistically
significant. Individual consumption of fruit or vegetables
was associated with reduced mortality from all-causes in
all models. Vegetables consumed cooked or raw, were also
associated with a lower risk of all-cause mortality in un-
adjusted and minimally adjusted models. However, after
adjustment for all other covariates, cooked vegetables
remained significantly related to a lower risk of all-cause
mortality. While the association of raw vegetables with all-
cause mortality was similar to that of cooked vegetables, it
did not remain statistically significant. Sex and age group
were significant effect modifiers of the relationship be-
tween fruit and vegetable consumption and all-cause
mortality.
Findings from the present study are in line with those
from previous prospective cohort studies which have
mostly found a significant inverse relationship between
fruit and vegetable intake (considered separately or
combined) and all-cause mortality [9, 18–20]. A recent
meta-analysis of prospective cohort studies showed that
pooled hazard ratios of all-cause mortality were 0.95 (95
% confidence interval: 0.92, 0.98; P = 0.001) for an incre-
ment of one serving a day of fruit and vegetables, 0.94
(95 % CI: 0.90, 0.98; P = 0.002) for fruit, and 0.95 (95 %
CI: 0.92, 0.99; P = 0.006) for vegetables [8]. In our study,
the protective effect of consuming both fruit and vegeta-
bles was slightly smaller. Differences in findings could be
due to a number of factors that vary between studies in-
cluding measures of fruit and vegetable consumption,
covariate adjustment, follow-up time and cohort charac-
teristics. Previous studies generally had longer follow-upperiods and more detailed dietary measures [8]. How-
ever, in their meta-analysis, Wang et al. found that study
location, sex, sample size, study quality and duration of
follow-up had little impact on the association between
fruit and vegetable intake and all-cause mortality [8].
The meta-analysis by Wang and colleagues also
showed a dose–response relationship up to a thresh-
old of five servings/day for fruit and vegetables com-
bined, two servings/day for fruit, and three servings/
day for vegetables [8]. There was no further reduction
in mortality risk beyond these thresholds. In the
present study, protective effects on mortality risk were ob-
served starting with the second quartile of consumption
(4 to ≤5 servings/day of fruit and vegetables, 1 to <2 serv-
ings/day of fruit and 2 to ≤3 servings/day of vegetables).
However, with the exception of vegetable consumption
which appeared to reach a threshold at 3 to ≤5 servings/
day beyond which there was no further risk reduction,
findings from the present study differed from those of the
meta-analysis. For the consumption of fruit and vegetables
combined and that of fruit only, the point estimates de-
creased with increasing serves, with the highest risk re-
ductions achieved with 7 serves/day or more of fruit and
vegetables, and 2.3 serves/day or more of fruit. These find-
ings are in agreement with a recent study conducted in
the United Kingdom which found a strong inverse associ-
ation between combined fruit and vegetable consumption
and all-cause mortality in 65,226 participants aged 35 years
and over, with highest benefits seen with 7 serves/day or
more of fruit and vegetables, 3 to <4 serves/day of fruit
and 3 serves/day or more of vegetables [19]. It seems that
current Australian recommendations to consume two
serves of fruit (150 g each) and five serves of vegetables
(75 g each) per day are appropriate [21]. However, more64
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needed as approximately only 6–8 % of the NSW popula-
tion aged 45 years and over currently meet Australian rec-
ommendations for fruit and vegetable intake [22].
To date, several observational studies have investigated
the differential effects of consuming cooked versus raw
vegetables on all-cause mortality. Cooking can alter the
physical structure and properties of bio-active com-
pounds (such as phytochemicals, vitamins, minerals and
fibre) contained in vegetables, and thereby change their
physiologic effect, in a potentially beneficial or less desir-
able way for health [13]. For example, the bioavailability
of compounds that may act as antioxidants can either be
enhanced (e.g. certain carotenoids such as carotenes in
carrots and lycopene in tomatoes) or decreased (e.g.
vitamin C) by heat treatment. Although results are still
preliminary, several observational studies found that raw
vegetable consumption was more protective against
mortality than cooked vegetable consumption [9, 13].
The results of this study show similar relationships of
cooked and raw vegetables to mortality. It should be
noted that power was limited for raw vegetable con-
sumption in the current study, which made it difficult to
detect significant differences between quartiles. Further
studies examining the effects of raw versus cooked vege-
tables on mortality risk are needed to explore these pre-
liminary findings.
While there were some significant effect modifiers of
the association between fruit and vegetable consumption
and all-cause mortality identified in the current study,
these findings should be interpreted with caution. Con-
sumption of fruit and vegetables combined, as well as
separate consumption of vegetables only, were inversely
related with risk of all-cause mortality in women but not
in men. To date, sex differences in these associations
have not been clearly established. The meta-analysis by
Wang et al. as well as several previous studies did not
observe significant sex differences [8, 12, 18, 23, 24].
However, in the large European Prospective Investiga-
tion into Cancer and Nutrition cohort study, while there
were no significant sex differences for the consumption
of fruit and vegetables combined or the individual con-
sumption of vegetables, the individual consumption of
fruit was inversely associated with risk of all-cause mor-
tality in women but not in men [9]. As suggested by the
authors of that study, possible explanations for the dis-
crepancy in findings include residual confounding, a
finding due to chance, or a true biological difference, al-
though a mechanism for such a difference is not appar-
ent. Women may also report their intake of fruit and
vegetables more accurately than men. In the few studies
that stratified analyses by age, there was no significant
effect modification by age [12, 25]. Clearly, further evi-
dence is needed to support findings about potentialeffect modifiers and the underlying mechanisms remain
to be elucidated.
Strengths and limitations
The main strengths of this study include a large
population-based sample, high quality record linkage
and the inclusion of multiple socio-demographic, health-
related and dietary covariates. The processing of vegeta-
bles (i.e., whether vegetables were cooked or raw) was
also considered. The prospective nature of the study
helped minimise recall bias.
This study had several limitations including the
relatively short follow-up time which may have been
insufficient to observe long-term effects of fruit and
vegetable intake. Although the short dietary questions
used in this study are appropriate for large-scale stud-
ies, it is possible that the self-reported consumption
may not accurately capture true consumption. Most
previous studies have used more detailed dietary
methods such as food frequency questionnaires and
food records, although these are also prone to meas-
urement error [8]. One major limitation of our brief
questionnaire in comparison with more detailed ques-
tionnaires such as food frequency questionnaires, is
that we did not measure the specific fruits and vege-
tables consumed. Examining the roles of different
types of fruit and vegetables could be important as
some kinds of fruit and vegetables could be more
beneficial than others. In addition, the dietary ques-
tions were asked only at baseline and may not reflect
the long-term habitual patterns of dietary behaviour.
As this is an observational study, residual confound-
ing could also be of concern. We tried to minimise
this by adjusting for multiple covariates and by re-
peating the analyses among those with at least two
years of follow-up data. Due to the limited number of
dietary questions in the 45 and Up Study question-
naire, we could not assess other food items beyond
processed meat as potential confounders. Future stud-
ies could consider including more detailed dietary
measures differentiating between subgroups of vegeta-
bles, whether vegetables are consumed raw or cooked,
cooking method, and collecting repeated dietary mea-
sures over time to establish long-term patterns of
fruit and vegetable consumption.
Conclusions
In this large cohort of middle-aged and older Australian
adults, consumption of fruit and vegetables was inversely
associated with all-cause mortality during 6.2 years of
follow-up. Findings from this study support recommenda-
tions to consume a high amount of fruit and vegetable con-
sumption. The association of raw versus cooked vegetables
in relation to mortality requires further investigation.65
Nguyen et al. International Journal of Behavioral Nutrition and Physical Activity  (2016) 13:9 Page 9 of 10AppendixTable 4 Hazard ratios and 95 % confidence intervals of all-cause mortality by quartiles of intake for fruit and vegetables for sensitivity
analyses conducted on 149,787 participants with at least two years of follow-up
Quartilesa
Q1 Q2 Q3 Q4 P for trend
HR 95 % CI HR 95 % CI HR 95 % CI HR 95 % CI
Fruit and vegetable intakea
Model 1 (crude) 1.0 Reference 0.81 0.76, 0.88 0.74 0.68, 0.80 0.80 0.74, 0.86 <0.0001
Model 2b (age, sex adjusted) 1.0 Reference 0.90 0.84, 0.97 0.83 0.76, 0.90 0.80 0.74, 0.87 <0.0001
Model 3c (adjusted) 1.0 Reference 1.00 0.93, 1.08 0.96 0.88, 1.04 0.93 0.86, 0.93 0.07
Fruit intakea
Model 1 (crude) 1.0 Reference 0.90 0.81, 0.99 0.79 0.71, 0.87 0.79 0.71, 0.88 <0.001
Model 2b (age, sex adjusted) 1.0 Reference 0.74 0.67, 0.82 0.66 0.59, 0.73 0.62 0.56, 0.69 <0.001
Model 3c (adjusted) 1.0 Reference 0.88 0.80, 0.98 0.84 0.76, 0.94 0.83 0.74, 0.93 0.003
Vegetable intakea
Model 1 (crude) 1.0 Reference 0.82 0.75, 0.89 0.73 0.68, 0.79 0.84 0.78, 0.91 <0.0001
Model 2b (age, sex adjusted) 1.0 Reference 0.91 0.83, 0.99 0.84 0.78, 0.90 0.87 0.80, 0.94 <0.0001
Model 3c (adjusted) 1.0 Reference 0.98 0.90, 1.07 0.94 0.87, 1.02 0.98 0.90, 1.06 0.309
Abbreviations: CI confidence interval, HR hazard ratio, Q quartile
aThe quartiles of intake for fruit and vegetables (servings/day) were as follows: Fruit and vegetables combined: Q1: <4.0; Q2: 4 to ≤ 5.0; Q3: 5.0 to ≤7.0; Q4: >7.0.
Fruit: Q1: <1.0; Q2: 1.0 to <2.0; Q3: 2.0 to <2.3; Q4: ≥2.3. Vegetables: Q1: ≤2.0; Q2: 2.0 to ≤3.0; Q3: 3.0 to ≤5.0, Q4: >5.0
bModel 2 was adjusted for age (continuous) and sex
cModel 3 was adjusted for age (categorical), sex, education level, marital status, location of residence, socio-economic status, smoking status, physical activity
categories, multi-vitamin use, processed meat consumption, diabetes and body mass index categories. The model for fruit was adjusted for vegetable intake and
vice versaAbbreviations
CI: confidence interval; HR: hazard ratio; NSW: State of New South Wales;
P: probability; Q: quartile; SD: standard deviation.Competing interests
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 CONCLUDING SUMMARY FOR THIS CHAPTER AND KNOWLEDGE GAINED 
FROM THIS STUDY 
To our knowledge, this was the first prospective cohort study to examine the association 
between fruit and vegetable consumption, including raw and cooked vegetable consumption, and 
all-cause mortality in Australia. There was an inverse association between fruit and vegetable 
consumption, considered separate or combined, and all-cause mortality among middle-aged and 
older Australians. Findings were in support of Australian dietary guidelines as reductions in 
mortality were seen up to seven servings of fruit and vegetables per day. Vegetables consumed 
raw or cooked were associated with a lower risk of mortality; however, the association with raw 
vegetables was not significant after adjustment for socio-economic, lifestyle and health-related 
factors. Fruit and vegetable consumption was found to be protective in women but not in men. 
Additional research is needed to confirm observed differences between men and women, and to 
explore whether raw versus cooked vegetable consumption have differential effects on health 
and mortality. Given the limited nature of the dietary questions used in this study, future studies 
could benefit from more detailed dietary methods such as food frequency questionnaires.   
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CHAPTER FOUR:                                                                            
Incident type 2 diabetes in a large Australian cohort study: Does physical activity 
or sitting time alter the risk associated with body mass index? 
 PREFACE TO THE CHAPTER 
This chapter presents findings from a peer-reviewed paper that examined the separate and 
combined effects of overweight/obesity, physical activity and sitting time on incident type 2 
diabetes in the 45 and Up Study cohort. A gender-specific analysis was also conducted as an 
extension to this paper and findings from this analysis are presented in Appendix 1. This 
chapter, consisting of the published paper, addresses specific aims #2 and #5 of this thesis as 
described in Chapter 1. Dissemination of this research and author contributions for this paper are 
described below. 
 
 RESEARCH DISSEMINATION 
The research presented in this chapter has been disseminated as follows: 
Published peer-reviewed paper 
Nguyen B, Bauman A, Ding D. Incident type 2 diabetes in a large Australian cohort study: Does 
physical activity or sitting time alter the risk associated with body mass index? Journal of 
Physical Activity and Health 2017; 14(1): 13-19. Available from: 
http://doi.org/10.1123/jpah.2016-0184 
Impact factor: 1.723 
Citations (based on Google Scholar): 5 
 
Conference presentations 
Nguyen B, Bauman A, Ding D. Incident type 2 diabetes in a large Australian cohort study: 
Does physical activity or sitting time alter the risk associated with body mass index? 6th 
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International Society for Physical Activity and Health (ISPAH) International Congress on 
Physical Activity and Public Health, Bangkok, Thailand, 2016. [Oral presentation]  
Nguyen B, Bauman A, Ding D. Incident type 2 diabetes in a large Australian cohort study: 
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Incident Type 2 Diabetes in a Large Australian Cohort Study:  
Does Physical Activity or Sitting Time Alter  
the Risk Associated With Body Mass Index?
Binh Nguyen, Adrian Bauman, Ding Ding
Purpose: To examine the combined effects of body mass index (BMI), physical activity (PA) and sitting on incident type 2 dia-
betes mellitus (T2DM) among Australian adults. Methods: A sample of 29,572 adults aged ≥45 years from New South Wales, 
Australia, completed baseline (2006–2008) and follow-up (2010) questionnaires. Incident T2DM was defined as self-reported, 
physician-diagnosed diabetes at follow-up. BMI was categorized as normal/overweight/obese. PA was tertiled into low/medium/
high. Sitting was dichotomized as higher/lower sitting (≥ 8 hours/day or < 8 hours/day). Odds ratios (OR) were estimated for 
developing T2DM using logistics regression for individual and combined risk factors, and data stratified by BMI categories. 
Results: During a mean 2.7 (SD: 0.9) years of follow-up, 611 (2.1%) participants developed T2DM. In fully adjusted models, 
BMI was the only independent risk factor for incident T2DM. In stratified analyses, the association between BMI and T2DM 
did not differ significantly across sitting or PA categories. Overweight/obese individuals with high PA and lower sitting had 
higher odds of incident T2DM than normal counterparts with low PA and higher sitting. Conclusions: High PA/low sitting did 
not attenuate the risk of T2DM associated with overweight/obesity. Maintaining a healthy weight, by adopting healthy lifestyle 
behaviors, is critical for T2DM prevention.
Keywords: diabetes mellitus, sedentary behavior, obesity
Type 2 diabetes mellitus (T2DM) has become a public health 
burden worldwide, with 1 in 10 adults estimated to have diabetes 
by 2040.1 The epidemic rise in T2DM is closely linked to lifestyle 
changes and the rapid increase in overweight and obesity.2 Lifestyle 
modification could lead to considerable risk reduction and is a high 
priority for T2DM prevention.2 Yet, the relative importance and 
combined influence of lifestyle risk factors for developing T2DM 
need further research, as the current evidence is based on relatively 
few studies.
Obesity and physical inactivity are established independent risk 
factors of T2DM, with growing evidence from prospective studies 
suggesting that obesity may be more important than physical inac-
tivity for T2DM prevention.3–5 A recent meta-analysis has shown 
that a high body mass index (BMI), even with high physical activity 
(PA), was a greater risk factor for incident T2DM than a normal BMI 
with low PA.3 These findings were based on 6 prospective studies 
that mostly included middle-aged and older adults.
Other lifestyle risk factors could play a role in the development 
of T2DM. Findings from recent systematic reviews and meta-
analyses, derived mainly from prospective studies, have shown 
that sedentary behavior may be associated with an increased risk 
of T2DM among adults of various ages.6–9 However, these findings 
were based on a limited number of studies, most of which used 
television viewing instead of total sitting time, and some did not 
adjust for PA. Further, it is unclear whether the association between 
sitting and T2DM is independent of BMI.7,10,11 Overall, the joint 
effects of levels of BMI, PA and sitting time on incident T2DM have 
seldom been studied.10 Examining to what extent PA and sitting 
time may offset health risks associated with overweight/obesity 
can help prioritize public health strategies for T2DM prevention.
With an aging population and a higher life expectancy, older 
people are representing a larger proportion of the world’s population, 
and together with an increasing burden of chronic diseases, could 
pose a global public health challenge.12 Chronic disease preven-
tion efforts are vital as population aging is strongly linked with the 
global epidemic of chronic diseases. Hence, understanding how 
lifestyle risk factors interact with each other in the context of T2DM 
prevention is primordial among middle-aged and older adults. The 
aims of this paper are to examine the combined effects of a) BMI 
and PA level; b) BMI, PA level, and sitting time on the incidence 
of T2DM in a large cohort of middle-aged and older Australian 
adults. Based on existing evidence, we hypothesized that PA would 
attenuate the BMI-associated risk of developing T2DM while the 
effects of sitting time remained to be explored.
Methods
Study Population
The baseline data were from the Sax Institute’s 45 and Up Study, 
a large-scale (n = 267,153) population-based study of men and 
women aged 45 years and over, randomly sampled from New South 
Wales (NSW), Australia. This study has been described in detail 
elsewhere.13 Eligible participants completed a mailed baseline 
questionnaire (2006–2008). In 2010, follow-up questionnaires 
(Social, Economic, and Environmental Factor [SEEF] Study) were 
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mailed to the first 100,000 participants of the 45 and Up Study, 
with 60,404 respondents. Participants reporting any of the fol-
lowing at baseline were excluded: diabetes and/or taking diabetes 
medications (n = 4899), physician-diagnosed cancer (other than 
nonmelanoma skin cancer; n = 8429) or cardiovascular disease (n 
= 8790), severe physical functional limitations14 (n = 5002). Par-
ticipants that were underweight at baseline (BMI < 18.5 kg/m2; n 
= 702), those that specified having “type 1 diabetes” at follow-up 
(n = 12) and those with missing data for any of the independent 
variables (n = 2747 for BMI, n = 820 for PA, n = 2037 for sitting 
time) were also excluded. The final analytic sample included 29,572 
participants (13,416 men, 16,156 women). The 45 and Up Study 
was granted ethical approval by the University of NSW Human 
Research Ethics Committee [HREC] (reference HREC 05035/
HREC 10186) and the SEEF study by the University of Sydney 
HREC (reference 10-2009/12187).
Measurements
Outcome. Questionnaires are available at http://www.saxinstitute.
org.au/our-work/45-up-study/questionnaires/. Incidence of T2DM, 
based on self-reported data, was defined as not having physician-
diagnosed diabetes nor taking diabetes medications at baseline 
and reporting a diagnosis of diabetes at follow-up. Self-reported 
diagnosis of diabetes in the 45 and Up Study has been validated 
previously, with high sensitivity and specificity compared with 
linked administrative data.15
Independent Variables. BMI was derived from self-reported 
height and weight, which has been previously validated in this 
cohort,16 and was categorized as: normal (18.5 to <25.0 kg/m2), 
overweight (25.0 to <30.0 kg/m2), or obese (≥30.0 kg/m2). PA, 
measured using validated questions from the Active Australia 
Survey, was calculated as the sum of time spent on walking, 
moderate-intensity and vigorous-intensity (weighted by 2) PA 
in the past week.17 PA was categorized into tertiles: low (0 to 
<300 minutes [min]/week), medium (300 to <660 min/week) and 
high (≥660 min/week). Using quantiles ensures that the range in 
exposure is captured evenly across distribution categories, which 
facilitates comparison between different levels of PA among the 
study cohort, and has been previously used in other large known 
cohort studies.18,19 It has been used in several other large renowned 
cohort studies Average daily sitting time was dichotomized as ≥8 
hours/day (higher sitting) and <8 hours/day (lower sitting) based 
on previous analysis.20
Covariates. Covariates included baseline sex, age (45–54, 55–64, 
65–74, ≥75 years), country of birth (Australia/New Zealand, Europe, 
Middle East, Asia, North America, other), education (≤10 years of 
schooling, high school/trade apprenticeship/certificate/diploma, 
university degree/ higher), a family history of T2DM (yes/no) and 
follow-up time.21
Statistical Analysis
First, we examined the association between 3 independent variables 
and T2DM individually in unadjusted models and models adjusted 
for covariates and lifestyle risk factors. Then, to examine whether 
PA/sitting was associated with T2DM regardless of weight status, 
we reanalyzed data stratified by BMI categories. Normal weight 
and lower sitting were respectively selected as reference catego-
ries for BMI and sitting time as they were hypothesized to be the 
lowest-risk categories. Although we expected that the highest level 
of PA would provide greater health benefits than other PA levels, 
the lowest level of PA was selected as the reference category to 
enable comparison between the lowest (<300 min/week) and 
medium levels of PA (300 to <660 min/week). We tested effect 
modification by PA and sitting by fitting interaction terms. Finally, 
to compare across all combinations of BMI, PA, and sitting, we 
divided participants into 9 mutually exclusive categories based on 
BMI and PA levels and 18 categories based on BMI, PA and sitting 
levels. The category with the hypothesized healthiest combination 
of lifestyle risk factors (ie, normal weight-high PA-[low sitting]) 
was chosen as the reference category. To increase statistical power, 
missing data for any covariate (n = 275 for country of birth, n = 434 
for education, n = 1 for family history of T2DM) were analyzed 
using a missing indicator approach. Logistic regression analysis 
was conducted using SPSS version 22 (IBM Corp., Armonk, NY), 
and a significance level of 0.05.
Results
Of 29,572 participants without diabetes at baseline, 611 (2.1%) 
reported T2DM at follow-up (mean [standard deviation, SD]: 2.7 
[0.9] years). Overall, the mean (SD) age of participants was 58.9 
(9.2) years, more than half (54.6%) were women, and nearly a third 
(31.6%) had a university degree/higher (Table 1). The majority 
were normal weight (42.1%) or overweight (41.0%), physically 
active (mean [SD]: 576 [478] min/week) and sat < 8 hours/day 
(84.6%).
Table 2 shows the unadjusted and adjusted odds ratios (OR) for 
incident T2DM by levels of individual risk factors. Compared with 
normal weight subjects, being overweight/obese was significantly 
associated with higher odds of developing T2DM in unadjusted 
and adjusted models. Compared with the low PA tertile, the odds 
of incident T2DM were significantly lower in higher PA tertiles in 
the unadjusted model only. The OR were not significantly different 
between higher and lower sitting time in both models.
In stratified analyses, OR were not different between BMI 
categories for different levels of PA and sitting (Table 3). Overall, 
there were no significant interactions between BMI categories and 
PA / sitting.
When comparing across all combinations of PA, sitting, and 
BMI levels, normal-weight participants who had low levels of PA 
(and higher sitting) had lower risk of T2DM than overweight or 
obese participants with high PA (and lower sitting; Table 4), further 
suggesting that overweight/obesity is a more important risk factor 
of T2DM, and that its effect on T2DM could not be offset by high 
PA or a combination of high PA and lower sitting.
Discussion
To our knowledge, this study is among the first to investigate 
whether the BMI-associated risk of developing T2DM is offset 
by PA and sitting. In this large cohort of middle-aged and older 
Australians, overweight/obesity was a more important risk factor 
for developing T2DM compared with PA and sitting. Overweight 
and obese participants had respectively 2 and 5 times the odds of 
developing T2DM compared with normal weight counterparts, even 
after adjustment for PA and sitting time. The risk of developing 
T2DM associated with high BMI was neither attenuated by PA 
nor sitting time.
Although there is increasing evidence that individuals with a 
high BMI and good level of aerobic fitness have lower risks of all-
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Table 1 Baseline Characteristics by Diabetes Status at Follow-up (n = 29,572; 2006–2010)a
Variable All
Diabetes statusb
No diabetes Diabetes
Number of subjects 29,572 28,961 611
Mean (SD) follow-up time (years) 2.7 (0.9) 2.7 (0.9) 2.9 (1.0)
Women (%) 54.6 54.8 45.2
Mean (SD) age (years) 58.9 (9.2) 58.9 (9.2) 61.1 (9.5)
Age group (%)
 45 to 54 years 40.2 40.4 30.6
 55 to 64 years 35.2 35.2 35.0
 65 to 74 years 17.9 17.8 26.0
  ≥75 years 6.7 6.7 8.3
Country of birth (%)
 Australia/New Zealand 79.3 79.3 77.3
 Europe 14.9 14.9 15.1
 Middle East 0.6 0.6 1.2
 Asia 2.6 2.6 3.9
 North America 0.9 0.9 0.5
 Other 1.7 1.7 2.0
Highest education (%)
 University and higher 31.6 25.0 23.0
 High school/TAFE/diploma 43.2 43.2 45.1
  ≤10 years 25.1 31.8 31.9
Mean (SD) BMI (kg/m2) 26.3 (4.3) 26.3 (4.2) 29.2 (5.0)
BMI category (%)
 Normal weight (18.5 to <25 kg/m2) 42.1 42.6 19.5
 Overweight (25 to <30 kg/m2) 41.0 41.0 41.2
 Obese (≥30 kg/m2) 16.9 16.4 39.3
Mean (SD) physical activity time (min/week)c 575.7 (478.3) 577.1 (478.9) 511.3 (445.0)
Physical activity tertile (%)
 Low (0 to <300 min/week) 32.2 32.1 38.0
 Medium (300 to <660 min/week) 32.8 32.9 31.4
 High (≥660 min/week) 34.9 35.0 30.6
Mean (SD) sitting time (hours/day) 5.6 (3.1) 5.6 (3.1) 5.6 (3.0)
Sitting time category (%)
 Lower sitting (<8 hours/day) 84.6 84.6 85.9
 Higher sitting (≥8 hours/day) 15.4 15.4 14.1
Mean (SD) MOS-PF score (out of 100)d 92.9 (9.4) 92.9 (9.3) 89.7 (10.8)
Family history of diabetes (%) 20.9 20.6 35.0
Abbreviations: BMI, body mass index; kg, kilograms; m, meter; min, minutes; MOS-PF, Medical Outcomes Study-Physical Functioning; SD, 
standard deviation; TAFE, Technical and Further Education.
a Data are presented as means (SD) or percentages (%).
b Self-reported diabetes defined as not having physician-diagnosed diabetes nor taking diabetes medications for most of the last 4 weeks at baseline 
and reporting a diagnosis of diabetes between baseline and follow-up (n = 611). There were significant differences (P < .05) between participants 
with and without diabetes for all variables except for daily sitting time and country of birth.
c Physical activity was calculated as the sum of time spent on walking, moderate-intensity physical activity, and vigorous-intensity physical activity 
(weighted by 2) in the past week.17
d The MOS-PF scale is a 10-item questionnaire assessing physical functioning limitations in performing daily living activities to vigorous physical 
activities.13 Higher scores indicate better physical functioning.
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Table 2 Unadjusted and Adjusted Odds Ratios for Incident Type 2 Diabetes by Levels of Body 
Mass Index, Physical Activity, and Sitting (2006–2010)
Variable
Unadjusted Odds Ratios 
(95% CI) P-value
Adjusted Odds Ratiosa 
(95% CI) P-value
Body mass index category
 Normal weight (18.5 to <25 kg/m2) 1.0 (reference) 1.0 (reference)
 Overweight (25 to <30 kg/m2) 2.20 (1.76, 2.73) <0.001 2.03 (1.62, 2.53) <0.001
 Obese (≥30 kg/m2) 5.23 (4.19, 6.53) <0.001 5.07 (4.03, 6.38) <0.001
Physical activityb tertiles
 Low (0 to <300 min/week) 1.0 (reference) 1.0 (reference)
 Medium (300 to <660 min/week) 0.81 (0.67, 0.98) 0.03 0.95 (0.78, 1.15) 0.57
 High (≥660 min/week) 0.74 (0.61, 0.90) 0.002 0.87 (0.71, 1.06) 0.17
Sitting time category
 Lower sitting (<8 hours/day) 1.0 (reference) 1.0 (reference)
 Higher sitting (≥8 hours/day) 0.90 (0.72, 1.13) 0.37 0.91 (0.72, 1.15) 0.42
Abbreviations: CI, confidence interval; kg, kilograms; m, meter; min, minutes.
Note. Data for n = 29,572 included in analysis, of which 611 developed diabetes. Missing covariate data (n = 275 for country of birth, n = 434 for 
education, n = 1 for family history of T2DM) were analyzed using a missing indicator approach.
a Adjusted for age group, sex, follow-up time, country of birth, education, family history of diabetes, and lifestyle risk factors (body mass index 
category/physical activity tertiles/sitting time category).
b Physical activity was calculated as the sum of time spent on walking, moderate-intensity physical activity, and vigorous-intensity physical activity 
(weighted by 2) in the past week.17
Table 3 Adjusted Odds Ratios for Associations Between Physical Activity/Sitting and Incident Type 2 Diabetes 
Stratified by Body Mass Index (BMI) Categories
Variable
BMI category
Normal weight (18.5 to <25 kg/m2) Overweight (25 to <30 kg/m2) Obese (≥30 kg/m2)
Adjusted Odds Ratiosa (95% CI) Adjusted Odds Ratiosa (95% CI) Adjusted Odds Ratiosa (95% CI)
Physical activityb tertiles
 Low (0 to <300 min/week) 1.0 (reference) 1.0 (reference) 1.0 (reference)
 Medium (300 to <660 min/week) 1.23 (0.78, 1.94); P = .37 0.87 (0.64, 1.19); P = .38 0.92 (0.67, 1.25); P = .58
 High (≥660 min/week) 0.80 (0.49, 1.28); P = .35 0.95 (0.70, 1.30); P = .77 0.82 (0.59, 1.15); P = .25
Sitting time category (%)
 Lower sitting (<8 hours/day) 1.0 (reference) 1.0 (reference) 1.0 (reference)
 Higher sitting (≥8 hours/day) 0.65 (0.33, 1.25); P = .20 1.02 (0.71, 1.46); P = .93 0.89 (0.62, 1.27); P = .52
Abbreviations: BMI, body mass index; CI, confidence interval; kg, kilograms; m, meter; min, minutes.
a Adjusted for age group, sex, follow-up time, country of birth, education, family history of diabetes and sitting time/physical activity.
b Physical activity was calculated as the sum of time spent on walking, moderate-intensity physical activity, and vigorous-intensity physical activity (weighted by 2) in 
the past week.17
cause and cardiovascular mortality compared with individuals with 
a normal BMI and poor fitness, these findings contrast with those 
relating to T2DM.3 Indeed, our findings are consistent with those 
from a recent meta-analysis, based on prospective studies mostly 
including middle-aged and older adults, suggesting that BMI is 
a relatively more important T2DM risk factor than PA.3 Contrary 
to established evidence,22 PA was not independently associated 
with T2DM in the adjusted model, possibly due to measurement 
errors in self-reported PA, and lack of very inactive participants 
as references (the 45 and Up participants reported more physical 
activity than the general population, suggesting limited exposure 
variability).23 The effect of PA could also be underestimated as BMI, 
which was adjusted for, may be in the causal pathway between PA 
and T2DM. Notwithstanding, PA remains a component of T2DM 
prevention interventions, as PA can contribute to weight reduction 
and maintenance, and can improve insulin resistance even in the 
absence of weight loss.
Previous studies including several prospective studies con-
ducted in middle-aged and older adults have shown that sedentary 
behavior, measured mainly by television viewing time, was asso-
ciated with incident T2DM.6–9 A recent study has also found that 
prolonged sitting, independent of moderate-vigorous PA, is associ-
ated with incident T2DM in obese, but not normal or overweight, 
postmenopausal women.10 However, our study found no association 
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between sitting time and T2DM in the overall sample, or in any 
weight category. This suggests that the current evidence on sitting 
and T2DM is still inconclusive. As television time may not be used 
as a simplified marker for total sitting time, more studies on total 
sitting time and T2DM are needed.11
Strengths of this study include a large population sample, a 
prospective cohort design and adjustment for multiple potential 
confounders. Main limitations include short follow-up time, 
and the use of self-reported measures of lifestyle risk factors 
and diabetes. However, most of the study’s measures have been 
previously validated. As individuals with healthy lifestyles were 
over-represented in the 45 and Up study, this study population 
may have limited representativeness of the general population. 
The sample in this study is about 2 to 3 times more active than 
the general population. For example, in the 2011–12 Australian 
Health Survey, a large, nationally representative survey of the 
health status of the Australian population, adults 45 years and 
over spent on average 205 min/week on PA (assessed using the 
same validated questions from the Active Australia Survey as this 
study).24 However, a comparison of the 45 and Up sample with 
participants of the New South Wales Population Health Survey (a 
population representative sample) indicated similar estimates of 
exposure–outcome associations, although the prevalence of risk 
factors differed between the 2 samples.23
Among middle-aged and older Australian adults, BMI was 
a more important risk factor for T2DM than physical inactivity 
or prolonged sitting, and the risk associated with BMI cannot be 
offset by PA level nor sitting time. Nonetheless, efforts to prevent 
T2DM should continue to encourage healthy lifestyle behaviors such 
as increasing PA, as these remain important in helping to reduce 
overweight and obesity, and maintain a normal weight.
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 CONCLUDING SUMMARY FOR THIS CHAPTER AND KNOWLEDGE GAINED 
FROM THIS STUDY 
This was the first prospective cohort study to examine whether the increased risk of 
developing type 2 diabetes mellitus associated with a high body mass index could be offset by 
high levels of physical activity and low sitting time. Among a cohort of middle-aged and older 
Australians, a high body mass index was a relatively stronger risk factor for type 2 diabetes than 
low physical activity levels or high sitting time. When considering the joint influence of these 
lifestyle risk factors, high levels of physical activity and low sitting time did not attenuate the 
increased odds of developing type 2 diabetes that were associated with being overweight or 
obese. In gender-specific analyses (Appendix 1), findings were essentially similar to analyses in 
the overall sample. Further studies are needed to confirm findings from this study and to examine 
whether sitting time is associated with incident type 2 diabetes. Achieving and maintaining a 
healthy weight, by engaging in healthy lifestyle behaviours, is crucial for type 2 diabetes 
prevention.  
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CHAPTER FIVE:                                                                             
Association between lifestyle risk factors and incident hypertension among 
middle-aged and older Australians 
 PREFACE TO THE CHAPTER 
This chapter presents findings from a peer-reviewed paper that examined the separate and 
combined effects of six lifestyle risk factors on incident hypertension in the 45 and Up Study 
cohort. The lifestyle risk factors that were examined included being overweight/obese, low 
physical activity levels, high alcohol consumption, being a current smoker, low consumption of 
fruit and/or vegetables per day, and being at high risk of psychological distress. The published 
paper forms this chapter. It addresses specific aims #3 and #5 of this thesis as described in 
Chapter 1. Dissemination of this research and author contributions for this paper are described 
below. 
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A B S T R A C T
This study aimed to examine the association between individual and combined lifestyle risk factors and the
incidence of hypertension 1) in middle-aged and older Australians, and 2) to compare findings in men and
women. A sample of 32,393 adults aged ≥45 years from New South Wales completed baseline (2006–2008) and
follow-up (2010) questionnaires. Self-reported incident hypertension was defined as not having physician-di-
agnosed hypertension nor taking antihypertensive medications at baseline and reporting a diagnosis/treatment
of hypertension at follow-up. High-risk categories for six lifestyle risk factors were defined as: a BMI≥ 25 kg/m2,
physical activity levels< 150min/week, consuming ≥14 alcohol drinks/week, being a current smoker, con-
suming<2 fruit and/or<3 vegetable serves/day, and being at high risk of psychological distress (Kessler-10
score≥ 22). The association between baseline risk factors and incident hypertension was examined using lo-
gistic regression models, adjusted for socio-demographic, medical and lifestyle risk factors. After 2.7 (SD: 0.9)
years of follow-up, 17.1% developed hypertension. Compared to low-risk categories, high BMI (AOR [95% CI]:
1.99 [1.85, 2.13]), high alcohol intake (1.58 [1.44, 1.73]), low physical activity levels (1.17 [1.07, 1.27]) and
being a current smoker (1.15 [1.0, 1.31]) were associated with a higher incidence of hypertension in the overall
sample, with similar associations in men and women. The number of high-risk lifestyle factors was positively
associated with higher odds of developing hypertension in the overall sample, men and women; with a stronger
association in middle-aged men. Adopting a low-risk lifestyle may prevent hypertension among middle-aged and
older adults.
1. Introduction
Hypertension is the leading contributor to global disease burden
(GBD 2015 Risk Factors Collaborators, 2016). It is one of the major
risk factors for cardiovascular disease, which accounts for the largest
number of deaths worldwide (GBD 2015 Mortality and Causes of
Death Collaborators, 2016; Roth et al., 2017). As the prevalence,
mortality, and disease burden of hypertension have increased con-
siderably in the last 25 years (Forouzanfar et al., 2017), it is im-
portant to identify modifiable lifestyle risk factors that can inform
strategies for hypertension and subsequent cardiovascular disease
prevention.
Several lifestyle risk factors for hypertension have been identified,
including being overweight or obese, an unhealthy diet, insufficient
physical activity and excessive alcohol intake. A plethora of inter-
vention (Dickinson et al., 2006; Neter et al., 2003; Xin et al., 2001)
and prospective studies (Briasoulis et al., 2012; Gelber et al., 2007;
Lelong et al., 2017; Liu et al., 2017) have examined these factors.
Lifestyle factors tend to cluster and have synergistic health effects
(Ding et al., 2015a; Krokstad et al., 2017). However, few prospective
studies have investigated the combined influence of lifestyle risk
factors on the development of hypertension (Cohen et al., 2012;
Forman et al., 2009; Banda et al., 2010), and no study to our knowl-
edge has compared these associations in men and women. Given the
previously reported sex differences in the prevalence, control, and
pathophysiology of hypertension, comparing risk factors in men and
women is needed and could inform sex-specific prevention strategies
(Doumas et al., 2013).
As most of the attributable global burden of blood-pressure related
disease is borne by middle-aged and older people (Lawes et al., 2008),
and as the prevalence of hypertension markedly increases with age
(Kearney et al., 2005), it is important to examine primary prevention
strategies among this age group. The aims of this study are to examine
the association between individual and combined lifestyle risk factors
and the incidence of hypertension 1) among a cohort of middle-aged
and older Australians, and 2) separately in men and women.
https://doi.org/10.1016/j.ypmed.2018.10.007
Received 30 April 2018; Received in revised form 6 September 2018; Accepted 8 October 2018
⁎ Corresponding author at: Prevention Research Collaboration, The Charles Perkins Centre, Level 6, The Hub, University of Sydney, NSW 2006, Australia.
E-mail address: thanh-binh.nguyen-duy@sydney.edu.au (B. Nguyen).
Preventive Medicine 118 (2019) 73–80
Available online 12 October 2018
0091-7435/ © 2018 Published by Elsevier Inc.
T
85
2. Methods
2.1. Study population
The baseline data were from the Sax Institute's 45 and Up Study, a
prospective cohort study of 267,153 men and women aged 45 years and
over, randomly sampled from the general population of New South
Wales (NSW), Australia, using the Medicare database, the national
universal health provider. From January 2006 to December 2008, eli-
gible individuals joined the study by completing a postal questionnaire
and providing written consent for follow-up. The study methods have
been described in detail elsewhere (Banks et al., 2008). In 2010, the
first 100,000 participants to join the 45 and Up Study were invited to
complete the Social, Economic, and Environmental Factor (SEEF) Study
follow-up questionnaire (60.4% response rate). A participant flow chart
is provided in Fig. 1. Participants that reported being treated for hy-
pertension or taking antihypertensive medication at baseline were ex-
cluded (n=19,349). Participants that reported being treated for heart
disease, high blood cholesterol, or taking medication against heart
disease, high blood cholesterol or diabetes were also excluded
(n=20,982) as some of these medications may have blood pressure
lowering effects and as people with diabetes commonly have high blood
pressure. The final analytic sample included 32,393 participants. The
45 and Up Study was granted ethics approval by the University of NSW
Human Research Ethics Committee (reference HREC 05035/HREC
10186) and the SEEF Study by the University of Sydney Human Re-
search Ethics Committee (reference 10-2009/12187).
2.2. Measurement
The baseline and follow-up questionnaires included questions about
socio-demographic characteristics, health and lifestyle factors (https://
www.saxinstitute.org.au/our-work/45-up-study/questionnaires/).
2.2.1. Ascertainment of hypertension
Incident hypertension was defined, based on self-reported data, as
not having physician-diagnosed hypertension nor taking anti-
hypertensive medication at baseline and reporting either a diagnosis or
treatment of hypertension at follow-up. Self-reported hypertension has
been validated in similar studies involving large cohorts (Forman et al.,
2009; Banda et al., 2010).
2.2.2. Baseline exposure variables
Body mass index (BMI), derived from self-reported height and
weight, has been previously validated in this cohort (Ng et al., 2011).
Physical activity, based on validated questions from the Active Aus-
tralia Survey was calculated as the sum of time spent on walking,
moderate-intensity and vigorous-intensity (weighted by two) physical
activity in the past week (Australian Institute of Health and Welfare,
2003). Participants were asked about their weekly alcohol consumption
as well as past and current smoking patterns. Usual daily fruit and
vegetable consumption was assessed using validated short questions
(Rustihauser et al., 2011). Participants' general level of psychological
distress was measured using the Kessler-10 (K10) scale, a validated 10-
item questionnaire about anxiety and depression symptoms experi-
enced in the previous month (Andrews and Slade, 2001).
2.2.3. Definition of lifestyle risk categories
The six lifestyle factors described above were dichotomised as either
low- or high-risk for developing hypertension. A BMI greater or equal to
25 kg/m2, the standard World Health Organization (WHO) cut-off point
for overweight, was considered high-risk. Being overweight or obese
has been associated with an increased risk of developing hypertension
in middle-aged men and women (Field et al., 2001). Participants who
did not meet the minimal recommendation of 150min of moderate-
vigorous PA a week, as per WHO (WHO, 2010) and current Australian
guidelines (Australian Department of Health, 2014), were deemed at
risk. Consuming< 2 serves of fruit and/or< 3 serves of vegetables per
day was defined as high-risk, based on cut-points previously used in
studies involving population health surveillance (Ding et al., 2015b;
Centre for Epidemiology and Research, 2008). Alcohol risk was defined
as consuming> 14 drinks per week, an amount exceeding the Aus-
tralian National Health and Medical Research Council's recommenda-
tions (NHMRC, 2009). Those who reported being current smokers (in-
cluding daily and occasional smokers) were considered at risk. Risk of
psychological distress was defined as the presence of high to very high
levels of psychological distress (K10 score≥ 22), as used in a previous
study involving this cohort (Nguyen et al., 2017a).
To examine the combined influence of lifestyle risk factors, a life-
style risk score (LRS) was calculated for each participant by summing
up the number of lifestyle factors in the high-risk category. A combined
score approach is a common approach (McAloney et al., 2013) and has
been used previously by several prospective cohort studies examining
associations between combined lifestyle risk factors and cardiovascular
risk factors and outcomes (Banda et al., 2010; Chiuve et al., 2006;
Myint et al., 2009; vanDam et al., 2008). The LRS was further cate-
gorised as: 0, 1, 2, and 3 to 6 (these scores were combined due to the
small percentages of participants with 3 to 6 risk factors).
2.2.4. Covariates
Covariates were based on self-reported information from the base-
line questionnaire, and included the following socio-demographic
Parcipants that completed the 45 and Up Study 
baseline quesonnaire (2006-2008) 
(n = 267,153)  
Excluded parcipants: 
At baseline, reported being treated for 
hypertension or taking anhypertensive 
medicaon (n = 19,349) and/or reported being 
treated for heart disease, high blood 
cholesterol, or taking medicaon against heart 
disease, high blood cholesterol or diabetes 
(n = 20,982) 
Parcipants that completed the follow-up SEEF 
quesonnaire (2010) 
(n = 60,404)  
Parcipants invited to complete the follow-up 
Social, Economic, and Environmental Factor (SEEF) 
quesonnaire (2010):    
 (n = 100,000)  
Non-respondents 
(n = 39,588) 
Final sample for longitudinal analyses 
(n = 32,393 for overall sample;  
n = 13,617 men;  
n = 18,779 women;  
n = 16,418 parous women)  
Fig. 1. Participant flow chart (45 and Up Study, 2006–2010).
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characteristics: age (45–54, 55–64, 65–74, ≥75 years), sex, country of
birth (Australia/New Zealand, Europe, Middle East, Asia, Canada/
United State, Africa, other), educational attainment (university degree/
higher, high school/trade apprenticeship/certificate/diploma,
≤10 years of schooling), area-level socio-economic status (quintiles
based on the Socio-Economic Indexes For Area - Index of Relative Socio-
Economic Disadvantage [SEIFA-IRSD; Australian Bureau of Statistics,
2008]); medical variables: family history of hypertension (yes/no),
aspirin use (yes/no), omega 3 or fish oil use (yes/no); and follow-up
time. In separate analyses conducted in women, additional covariates
were included: oral contraceptive use (ever/never), current use of
hormonal replacement therapy (yes/no), menopausal status (pre-me-
nopausal, post-menopausal, not sure/irregular periods), and number of
children given birth to (0, 1, 2, 3, ≥4). To further explore risk factors
for women within the context of reproductive history, a sub-analysis
involving parous women only was additionally adjusted for the fol-
lowing reproductive variables: mother's age for first child (years),
lifetime breastfeeding duration (months), and hypertension during
pregnancy (yes/no).
2.3. Statistical analysis
Baseline participant characteristics by sex were presented as means
(standard deviation [SD]) or percentages. Differences in baseline
characteristics between men and women were examined using student
t-tests for continuous variables and chi-square tests for categorical
variables. The association between individual lifestyle risk factors or
the LRS and incident hypertension were examined using logistic re-
gression. The lower-risk category for lifestyle factors and the LRS
(LRS= 0) was chosen as the reference category. Odds ratios (ORs) with
95% confidence intervals (CIs) were estimated for unadjusted and
multivariate-adjusted models in the overall sample, and separately in
men and women. Individual lifestyle factors were mutually adjusted for
each other. We tested for effect modification by age (< 65 years vs
≥65 years) and sex by fitting interaction terms with the LRS. Finally,
sensitivity analyses were conducted separately in men and women to
examine whether findings differed if lifestyle factors were considered as
continuous variables rather than using specific cut-points. Analyses
were conducted using SPSS version 22 (IBM Corp., Armonk, NY).
3. Results
Of 32,393 participants without hypertension at baseline, 5539
(17.1%) reported hypertension at follow-up (mean [SD]: 2.7 [0.9]
years). Participants' socio-demographic and lifestyle characteristics at
baseline are presented in Table 1. The mean age of participants at
baseline was 58.3 (SD: 9.2) years and most (80%) were born in Aus-
tralia/New Zealand. More than half (58%) of the sample were women,
nearly a third (30.8%) had a university degree and nearly half (46.9%)
reported a family history of hypertension. More than half (53.5%) of
participants were overweight/obese, more than three-quarters (83%)
were physically active (≥150min/week), and less than half (42.8%)
consumed ≥2 fruit and ≥3 vegetables/day. In addition, more than
three-quarters (86%) consumed ≤14 drinks of alcohol/week, nearly
two-thirds (60.3%) were never smokers, less than a tenth (6.7%) were
current smokers, and the majority (94.6%) had a low to moderate risk
of psychological distress. Overall, more than half (53.4%) had a lower-
risk lifestyle (LRS=0–1). Compared to men, women were on average
younger and had a healthier lifestyle overall, and a higher proportion of
women had completed ≤10 years of education. Among women, more
than half (57.3%) were post-menopausal, and on average had more
than two (mean: 2.3; SD: 1.4) children. Parous women breastfed an
average of 16 (SD: 16) months during their lifetime.
Table 2 shows the unadjusted and adjusted ORs for the associations
between six lifestyle risk factors, the LRS, and incident hypertension in
the overall sample. In unadjusted models, high-risk categories for all six
lifestyle risk factors were significantly associated with higher odds of
incident hypertension. After adjustment for covariates, being over-
weight/obese, exercising< 150min/week, consuming>14 drinks of
alcohol/week and being a current smoker remained significantly asso-
ciated with higher odds of incident hypertension. In both unadjusted
and adjusted models, the odds of incident hypertension increased with
an increasing number of high-risk lifestyle risk factors. Participants in
the highest LRS category (LRS= 3 to 6) had 2.58 (95% CI: 2.29, 2.90)
the odds of developing hypertension compared with participants
without any high-risk factors.
The unadjusted and adjusted ORs for incident hypertension by ca-
tegories of lifestyle risk factors and LRS are also presented separately
for men (Table 3) and women (Table 4). In men, high-risk categories for
BMI, physical activity, fruit and vegetable intake, alcohol intake and
smoking status were associated with higher odds of incident hy-
pertension in unadjusted models. In adjusted models, being over-
weight/obese, exercising< 150min/week and consuming> 14 drinks
of alcohol/week remained significant. A larger number of high-risk
factors was associated with higher odds of developing hypertension
following covariate adjustment.
In women, high-risk categories for BMI, physical activity, alcohol
intake and current smoking status were associated with higher odds of
incident hypertension in unadjusted models. Similar to findings in men,
these associations remained significant for BMI, physical activity and
alcohol intake following adjustment for covariates. An increasing
number of high-risk factors was associated with increased odds of de-
veloping hypertension. However, the pattern of association differed
significantly between men and women (test for interaction p < 0.003).
In unadjusted analyses, all women-specific covariates were sig-
nificantly associated with incident hypertension. These associations did
not remain significant following covariate adjustment. In the sub-ana-
lysis involving parous women only, lifetime breastfeeding duration and
high blood pressure during pregnancy remained significantly associated
with lower and higher odds of hypertension, respectively, after ad-
justment for additional reproductive variables.
There was a significant interaction between the LRS and age cate-
gories (p < 0.001). The association between the LRS and incident
hypertension was stronger in individuals aged<65 years compared to
those aged ≥65 years, especially among middle-aged men (Table 5).
Sensitivity analyses conducted in separately in men and women showed
that results were similar when lifestyle factors were examined as con-
tinuous variables rather than using cut-points.
4. Discussion
In this study following a large cohort of middle-aged and elderly
adults for three years, being overweight/obese, a high weekly alcohol
intake, and a low amount of physical activity per week were associated
with higher odds of developing hypertension, in both men and women.
A higher number of lifestyle risk factors was associated with higher
odds of incident hypertension in both the overall sample and in sepa-
rate analyses in men and women. A salient finding from this study was
that a higher-risk lifestyle for hypertension seemed more detrimental in
middle-aged than older adults, especially in men, highlighting the im-
portance of lifestyle risk reduction among middle-aged men.
There is growing evidence supporting the importance of considering
the combined effects of lifestyle risk factors on health. To date, several
prospective studies have examined associations between combined
lifestyle risk factors and adverse health outcomes, such as coronary
heart disease (Chiuve et al., 2006; Stampfer et al., 2000), stroke (Kurth
et al., 2006; Chiuve et al., 2008; Myint et al., 2009), sudden cardiac
death (Chiuve et al., 2011), myocardial infarction (Akesson et al.,
2007), diabetes (Hu et al., 2001), as well as cause-specific and all-cause
mortality (Ford et al., 2011; Kvaavik et al., 2010; Loef and Walach,
2012; vanDam et al., 2008). In these studies, adherence to a healthy
lifestyle was generally associated with better health outcomes. To our
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knowledge, only three studies have examined the combined influence
of lifestyle risk factors on hypertension in either women (Cohen et al.,
2012; Forman et al., 2009) or men (Banda et al., 2010), with findings in
line with those from our study. In a large 14- (Forman et al., 2009) and
26-year (Cohen et al., 2012) prospective cohort study of women from
the Nurses' Health Study, and a prospective cohort study in men fol-
lowed over 10 years, having a higher number of low-risk lifestyle fac-
tors was associated with a lower risk of self-reported hypertension
(Banda et al., 2010). Individual lifestyle factors examined in these
studies, half of which overlapped with those considered in our study,
Table 1
Baseline characteristicsa of participants in the overall sample (n=32,393) and according to sex (45 and Up Study, 2006–2010).
Variable All (n=32,393) Men (n= 13,614) Women (n=18,779)
Mean (SD) follow-up time (years) 2.7 (0.9) 2.7 (0.9) 2.7 (0.9)
Age groupb (%) 21.9 27.8 17.6
45–54 years 43.8 (n= 14,190) 38.0 (n= 5167) 48.0 (n=9023)
55–64 years 34.3 (n= 11,105) 34.2 (n= 4662) 34.3 (n=6443)
65–74 years 15.5 (n= 5027) 18.8 (n= 2554) 13.2 (n=2473)
≥75 years 6.4 (n= 2071) 9.0 (n= 1231) 4.5 (n= 840)
Country of birthb (%) (missing n= 315; missing n= 160 for men and missing n= 155 for women)
Australia/New Zealand 80.0 (n= 25,677) 78.5 (n= 10,562) 81.2 (n=15,115)
Europe 14.4 (n= 4615) 16.1 (n= 2168) 13.1 (n=2447)
Asia 2.5 (n= 817) 2.4 (n= 320) 2.7 (n= 497)
Other 3.1 (n= 969) 3.0 (n= 404) 3.0 (n= 565)
Highest educationb (%) (missing= 416; missing n= 185 for men and missing n= 162 for women)
University and higher 30.8 (n= 9859) 32.0 (n= 4292) 31.0 (n=5567)
High school/trade apprenticeship/certificate/diploma 43.2 (n= 13,846) 48.9 (n= 6562) 39.1 (n=7284)
≤10 years 26.0 (n= 8341) 19.2 (n= 2575) 29.9 (n=5766)
Socio-economic status (SEIFA-IRSD)c (%) (missing=87; missing n=39 for men and missing n= 48 for
women)
Lowest quintile (most disadvantaged) 13.4 (n= 4340) 13.7 (n= 1853) 13.3 (n=2487)
Second lowest quintile 26.8 (n= 8672) 26.6 (n= 3606) 27.0 (n=5066)
Third lowest quintile 22.3 (n= 7190) 22.5 (n= 3054) 22.1 (n=4136)
Second highest quintile 12.1 (n= 3916) 11.9 (n= 1612) 12.3 (n=2304)
Highest quintile (least disadvantaged) 25.3 (n= 8188) 25.4 (n= 3450) 25.3 (n=4738)
Overweight or obese (≥25 kg/m2)b (missing n= 2012; missing n= 733 for men and missing n= 1279 for
women)
53.5 (n= 16,265) 62.2 (n= 8014) 47.1 (n=8251)
Physical activity levelb,d (%) (missing=723; missing n= 317 for men and missing n=406 for women)
<150min/week 17.0 (n= 5387) 17.7 (n= 2350) 16.5 (n=3037)
≥150min/week 83.0 (n= 26,283) 82.3 (n= 10,947) 83.5 (n=15,336)
Usually consumes ≥2 serves of fruit/day and ≥3 serves of vegetables/dayb (%) (missing=582; missing
n= 224 for men and missing n= 48 for women)
42.8 (n= 13,607) 30.3 (n= 4056) 51.8 (n=9551)
Usually consumes ≤14 drinks/weekb (%) (missing= 347; missing n= 142 for men and missing n= 274 for
women)
86.0 (n= 27,508) 76.1 (n= 10,257) 93.2 (n=17,251)
Smoking statusb (%) (missing= 14; missing n= 4 for men and missing n=10 for women)
Never smoker 60.3 (n= 19,520) 54.2 (n= 7378) 64.7 (n=12,142)
Previous smoker 33.0 (n= 10,685) 38.7 (n= 5266) 28.9 (n=5419)
Current smoker 6.7 (n= 2174) 7.1 (n= 966) 6.4 (n= 1208)
Low to moderate risk of psychological distress (K10 score < 22)b,e (%) (missing= 2254; missing n= 832
for men and missing n= 1422 for women)
94.6 (n= 28,521) 95.4 (n= 12,192) 94.1 (n=16,329)
LRSb,f (%)
LRS=0 17.2 (n= 5565) 9.1 (n= 1238) 23.0 (n=4327)
LRS=1 36.2 (n= 11,733) 30.3 (n= 4126) 40.5 (n=7607)
LRS=2 30.8 (n= 9967) 37.5 (n= 5108) 25.9 (n=4859)
LRS=3 to 6 15.8 (n= 5128) 23.1 (n= 3142) 10.6 (n=1986)
Family history of hypertensionb (%) (missing= 1; missing n=0 for men, missing n= 1 for women) 46.9 (n= 15,196) 39.1 (n= 5328) 52.6 (n=9868)
Oral contraceptive use (%) (missing n=212) – – 87.2 (n=16,198)
Hormonal replacement therapy use (%) (missing n=249) – – 34.6 (n=6404)
Menopausal status (%) (missing= 2) – –
Pre-menopausal – – 21.0 (n=3941)
Post-menopausal – – 57.3 (n=10,760)
Irregular periods/not sure – – 21.7 (n=4076)
Number of children (missing n= 74) – – 2.3 (1.4) (n= 18,705)
Mother's age for first childg (years) (missing n=2454) – – 25.5 (5.0) (n=16,325)
Lifetime breastfeeding durationg (months) (missing n= 2239) – – 15.7 (16.0) (n= 16,540)
High blood pressure during pregnancyg (%) – – 8.1 (n= 1515)
Abbreviations: IRSD= Index of Relative Socio-economic Disadvantage, K10=Kessler Psychological Distress Scale, LRS= lifestyle risk score, SD= standard de-
viation, SEIFA=Socio-Economic Indexes For Areas.
a Data are presented as means (SD) or percentages (%).
b Significantly different from men (all p < 0.01) based on t-tests for continuous variables and chi-square tests for categorical variables.
c A SEIFA index based on disadvantage and derived from Australian census variables including low income, low educational attainment, unemployment, and
dwelling without motor vehicles (Australian Bureau of Statistics, 2008).
d Physical activity was calculated as the sum of time spent on walking, moderate-intensity physical activity, and vigorous-intensity physical activity (weighted by
two) in the past week (Australian Institute of Health and Welfare, 2003).
e The total K10 score is based on a 10-item questionnaire about anxiety and depression symptoms experienced in the last four weeks (Andrews and Slade, 2001). A
K10 score< 22 represents a “low-to-moderate risk” of psychological distress.
f Derived from the total number of lifestyle risk factors in the “high-risk” category.
g In parous women only (n= 16,349).
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included BMI (Banda et al., 2010; Cohen et al., 2012; Forman et al.,
2009), physical activity (Banda et al., 2010; Cohen et al., 2012; Forman
et al., 2009), cardiorespiratory fitness (Banda et al., 2010), alcohol
intake (Banda et al., 2010; Cohen et al., 2012; Forman et al., 2009),
smoking (Banda et al., 2010), a Dietary Approach to Stop Hypertension
score (Cohen et al., 2012; Forman et al., 2009), non-narcotic analgesic
use (Cohen et al., 2012; Forman et al., 2009), folic acid supplementa-
tion (Forman et al., 2009) and menopause (Cohen et al., 2012). As in
our study, the strongest association was observed with BMI in all of
these studies (Cohen et al., 2012; Forman et al., 2009; Banda et al.,
2010).
Compared to these previous studies, our study is innovative in that
it examined whether poor mental health was associated with incident
hypertension. Although several prospective studies have reported a link
between psychological factors and the risk of hypertension, findings
from previous studies have been mixed (Meng et al., 2012; Rutledge
and Hogan, 2002; Shinn et al., 2001). In our study, being at high risk of
psychological distress was not associated with incident hypertension.
Differences in findings between studies could be due to a range of
methodological factors including differences in follow-up period,
sample size, exposure variables and hypertension measurement. Addi-
tional longitudinal studies may help further elucidate any relationship
between psychological distress and incident hypertension.
Extending previous evidence, our study compared findings between
men and women. When considered individually, BMI, alcohol intake
and physical activity level were significantly associated with incident
hypertension in both men and women. These findings are not surprising
as it has been previously shown that BMI (Gelber et al., 2007; Shuger
et al., 2008), physical activity (Liu et al., 2017) and alcohol intake
(Briasoulis et al., 2012) are important individual risk factors for hy-
pertension in both sexes. However, after adjustment for confounders,
there were no apparent associations with other lifestyle risk factors in
separate analyses in men and women. Although the association be-
tween being a current smoker and developing hypertension achieved
significance in the overall sample, it did not remain significant in se-
parate analyses in men and women. Whilst smoking is a known risk
Table 2
Unadjusted and adjusted odds ratios for incident hypertension by categories of
lifestyle risk factors in the overall sample (n= 32,393; 45 and Up Study,
2006–2010).
Variable Unadjusted odds
ratios
(95% CI)
Adjusted odds
ratiosa
(95% CI)
Body mass index category
<25 kg/m2 1.0 (reference) 1.0 (reference)
≥25 kg/m2 2.0 (1.88, 2.13) 1.99 (1.85, 2.13)
Physical activityb level
≥150min/week (Reference) 1.0 (reference)
<150min/week 1.22 (1.13, 1.32) 1.17 (1.07, 1.27)
Usual fruit and vegetable intake
≥2 serves of fruit/day and ≥3 serves
of vegetables/day
1.0 (reference) 1.0 (reference)
<2 serves of fruit/day and/or
<3 serves of vegetables/day
1.09 (1.03, 1.16) 1.06 (0.99, 1.13)
Alcohol intake
≤14 drinks/week 1.0 (reference) 1.0 (reference)
>14 drinks/week 1.60 (1.48, 1.73) 1.58 (1.44, 1.73)
Smoking status
Never smoker 1.0 (reference) 1.0 (reference)
Previous smoker 1.16 (1.09, 1.24) 1.06 (0.99, 1.14)
Current smoker 1.16 (1.03, 1.30) 1.15 (1.0, 1.31)
Psychological distress (K10) scorec
Low to moderate risk (K10 <22) 1.0 (reference) 1.0 (reference)
High to very high risk (K10 ≥22) 1.21 (1.06, 1.37) 1.15 (0.99, 1.32)
LRSd
0 1.0 (reference) 1.0 (reference)
1 1.36 (1.23, 1.49) 1.35 (1.22, 1.49)
2 1.73 (1.57, 1.91) 1.76 (1.59, 1.94)
3 to 6 2.37 (2.14, 2.63) 2.45 (2.20, 2.74)
Abbreviations: CI= confidence interval, kg= kilograms, K10=Kessler
Psychological Distress Scale, LRS= lifestyle risk score, m=meter.
a Adjusted for age group, sex, follow-up time, country of birth, education,
socio-economic status (based on Socio-Economic Indexes for Areas –Index of
Relative Socio-Economic Disadvantage), family history of hypertension, omega
3 or fish oil use, aspirin use and lifestyle risk factors (body mass index, physical
activity level, fruit and vegetable intake, alcohol intake, smoking status, K10
score; mutually adjusted for each other). Due to missing data, the multivariate
analysis including individual lifestyle risk factors was based on n=26,747, and
the multivariate analysis including the lifestyle risk index was based on
n=31,954.
b Physical activity was calculated as the sum of time spent on walking,
moderate-intensity physical activity, and vigorous-intensity physical activity
(weighted by two) in the past week (Australian Institute of Health and Welfare,
2003).
c The total K10 score is based on a 10-item questionnaire about anxiety and
depression symptoms experienced in the last four weeks (Andrews and Slade,
2001). A K10 score< 22 represents a low to moderate risk of psychological
distress.
d Derived from the total number of lifestyle risk factors in the “high-risk”
category.
Table 3
Unadjusted and adjusted odds ratios for incident hypertension by categories of
lifestyle risk factors in men (n=13,614; 45 and Up Study, 2006–2010).
Variable Unadjusted odds
ratios
(95% CI)
Adjusted odds
ratiosa
(95% CI)
Body mass index category
< 25 kg/m2 1.0 (reference) 1.0 (reference)
≥25 kg/m2 1.95 (1.76, 2.15) 1.97 (1.77, 2.21)
Physical activityb level
≥150min/week 1.0 (reference) 1.0 (reference)
< 150min/week 1.13 (1.01, 1.26) 1.14 (1.01, 1.30)
Usual fruit and vegetable intake
≥2 serves of fruit/day and ≥3 serves
of vegetables/day
1.0 (reference) 1.0 (reference)
< 2 serves of fruit/day and/or
< 3 serves of vegetables/day
1.14 (1.04, 1.26) 1.09 (0.97, 1.21)
Alcohol intake
≤14 drinks/week 1.0 (reference) 1.0 (reference)
> 14 drinks/week 1.66 (1.51, 1.82) 1.62 (1.45, 1.81)
Smoking status
Never smoker 1.0 (reference) 1.0 (reference)
Previous smoker 1.25 (1.14, 1.37) 1.08 (0.97, 1.20)
Current smoker 1.24 (1.05, 1.47) 1.16 (0.95, 1.41)
Psychological distress (K10) scorec
Low to moderate risk (K10 <22) 1.0 (reference) 1.0 (reference)
High to very high risk (K10 ≥22) 1.22 (1.0, 1.50) 1.17 (0.94, 1.47)
LRSd
0 1.0 (reference) 1.0 (reference)
1 1.19 (0.99, 1.44) 1.23 (1.02, 1.50)
2 1.60 (1.33, 1.91) 1.69 (1.40, 2.03)
3 to 6 2.39 (1.98, 2.87) 2.55 (2.10, 3.10)
Abbreviations: CI= confidence interval, kg= kilograms, K10=Kessler
Psychological Distress Scale, LRS= lifestyle risk score, m=meter.
a Adjusted for age group, follow-up time, country of birth, education, socio-
economic status, family history of hypertension, aspirin use, omega 3 or fish oil
use and lifestyle risk factors (body mass index, physical activity level, fruit and
vegetable intake, alcohol intake, smoking status, K10 score; mutually adjusted
for each other).
b Physical activity was calculated as the sum of time spent on walking,
moderate-intensity physical activity, and vigorous-intensity physical activity
(weighted by two) in the past week (Australian Institute of Health and Welfare,
2003).
c The total K10 score is based on a 10-item questionnaire about anxiety and
depression symptoms experienced in the last four weeks (Andrews and Slade,
2001). A K10 score<22 represents a low to moderate risk of psychological
distress.
d Derived from the total number of lifestyle risk factors in the “high-risk”
category.
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factor for cardiovascular disease, its association with incident hy-
pertension remains uncertain. Paradoxically, non- and previous smo-
kers have been shown to have higher blood pressure compared to
smokers (Green et al., 1986) and prolongation of smoking cessation has
been associated with higher increases in blood pressure, compared with
current smokers (Lee et al., 2001). The association between dietary
intake and incident hypertension has been shown more consistently in
previous studies (Dauchet et al., 2007; Lelong et al., 2017; Schulze
et al., 2003). The lack of an association in this study could be due to
self-reported intake not accurately reflecting true consumption of fruit
and vegetables, as well as residual confounding from other important
dietary factors such as sodium intake that could not be assessed in this
study. In epidemiological studies, sodium intake is usually estimated
using food frequency questionnaires. However, this method is faced
with several challenges including being prone to underreporting. Al-
though 24-hour urine collection is considered the gold standard
method, but this imposes a high respondent burden in large population-
based studies (McLean et al., 2017).
Gender differences were more apparent when lifestyle factors were
examined in combination with the pattern of association significantly
differing between men and women. A higher-risk lifestyle appeared
more detrimental for developing hypertension in men than in women.
In addition, our study found that the total number of lifestyle risk
factors seemed more strongly associated with hypertension in middle-
aged adults than older adults, especially in middle-aged men. The as-
sociation in older men appeared weaker than that observed in older
women. These findings concur with the well-recognised observation
that there is a higher incidence of hypertension in aged-matched men
compared to premenopausal women, however, after menopause, there
is marked increase in women resulting in a higher incidence in women
compared to men. A previous study has also found that older age at-
tenuates the associations between several lifestyle risk factors and in-
cident hypertension in women from the Nurses' Health Study I (Cohen
et al., 2012). Physiologic changes associated with ageing, such as in-
creased arterial stiffness, lower responsiveness of the sympathetic ner-
vous system, and changes in sex hormones, may help to explain these
findings (Cohen et al., 2012; Dubey et al., 2002). Despite a need for
further studies examining potential sex differences and the moderating
effects of age, these findings have important public health implications
as they identify middle-aged men as a high-risk group for developing
hypertension, and to a lesser extent middle-aged women, and highlight
the need for prevention strategies that focus on the middle-aged po-
pulation.
Middle age is a critical period for interventions as changes in blood
pressure during middle age can have a significant impact on lifetime
risk for cardiovascular disease. A study involving data pooled from
seven epidemiologic cohort studies reported that individuals that
maintain or lower their blood pressure to normal levels by 55 years of
age have the lowest lifetime risk for cardiovascular disease, in com-
parison to those who experience an increase in blood pressure and have
a higher lifetime risk for cardiovascular disease (Allen et al., 2012).
Another significant finding from this study was that more than two
thirds of men who developed hypertension in middle age were likely to
experience a cardiovascular disease event by 85 years of age, again
highlighting the importance of identifying prevention strategies for
middle-aged men. Prevention efforts should also not only consider
people with established hypertension but also those with lesser degrees
of hypertension, as it has recently been shown that a considerable
portion of cardiovascular disease burden attributable to hypertension is
borne by people with pre-hypertension (Lawes et al., 2008).
Finally, a unique aspect of this study was the inclusion of a range of
covariates specific to women, including those relating to reproductive
history. In the sub-analysis involving parous women only, both lifetime
breastfeeding duration and hypertension during pregnancy were sig-
nificantly associated with incident hypertension. These findings are in
agreement with previous studies. Indeed, there is emerging evidence
that breastfeeding is associated with the incidence of hypertension and
may offer other cardiovascular health benefits (Nguyen et al., 2017b),
while high blood pressure during pregnancy has been linked to a higher
Table 4
Unadjusted and adjusted odds ratios for incident hypertension by categories of
lifestyle risk factors in women (n= 18,779; 45 and Up Study, 2006–2010).
Variable Unadjusted odds
ratios
(95% CI)
Adjusted odds
ratiosa
(95% CI)
Body mass index category
<25 kg/m2 1.0 (reference) 1.0 (reference)
≥25 kg/m2 2.02 (1.85, 2.21) 1.98 (1.80, 2.17)
Physical activityb level
≥150min/week 1.0 (reference) 1.0 (reference)
<150min/week 1.33 (1.19, 1.48) 1.19 (1.06, 1.34)
Usual fruit and vegetable intake
≥2 serves of fruit/day and ≥3 serves
of vegetables/day
1.0 (reference) 1.0 (reference)
<2 serves of fruit/day and/or
<3 serves of vegetables/day
0.99 (0.91, 1.08) 1.05 (0.96, 1.15)
Alcohol intake
≤14 drinks/week 1.0 (reference) 1.0 (reference)
>14 drinks/week 1.34 (1.14, 1.57) 1.50 (1.28, 1.77)
Smoking status
Never smoker 1.0 (reference) 1.0 (reference)
Previous smoker 1.08 (0.98, 1.18) 1.07 (0.97, 1.19)
Current smoker 1.19 (1.0, 1.40) 1.15 (0.95, 1.39)
Psychological distress (K10) scorec
Low to moderate risk (K10 <22) 1.0 (reference) 1.0 (reference)
High to very high risk (K10 ≥22) 1.17 (0.98, 1.40) 1.08 (0.89, 1.31)
Oral contraceptive use
No 1.0 (reference) 1.0 (reference)
Yes 0.80 (0.70, 0.90) 0.90 (0.78, 1.04)
Hormonal replacement therapy use
No 1.0 (reference) 1.0 (reference)
Yes 1.27 (1.17, 1.39) 1.04 (0.94, 1.15)
Menopausal status
Pre-menopausal 1.0 (reference) 1.0 (reference)
Post-menopausal 1.43 (1.28, 1.60) 1.03 (0.88, 1.19)
Irregular periods/not sure 1.39 (1.22, 1.59) 1.20 (1.03, 1.40)
Number of children 1.11 (1.07, 1.15) 1.01 (0.98, 1.04)
Mother's age for first childe 0.97 (0.96, 0.97) 0.99 (0.98, 1.01)
Lifetime breastfeeding duratione 0.99 (0.99, 0.99) 0.99 (0.99, 0.99)
High blood pressure during pregnancye
No 1.0 (reference) 1.0 (reference)
Yes 2.52 (2.24, 2.84) 2.27 (1.98, 2.61)
LRSd
0 1.0 (reference) 1.0 (reference)
1 1.43 (1.27, 1.62) 1.44 (1.28, 1.62)
2 1.82 (1.60, 2.06) 1.84 (1.62, 2.08)
3 to 6 2.09 (1.79, 2.43) 2.22 (1.91, 2.58)
Abbreviations: CI= confidence interval, kg= kilograms, K10=Kessler
Psychological Distress Scale, LRS= lifestyle risk score, m=meter.
a Adjusted for age group, follow-up time, country of birth, education, socio-
economic status, family history of hypertension, aspirin use, omega 3 or fish oil
use, lifestyle risk factors (body mass index, physical activity level, fruit and
vegetable intake, alcohol intake, smoking status, K10 score; mutually adjusted
for each other), current use of hormonal replacement therapy, oral contra-
ceptive use, menopausal status and number of children given birth to.
Additional covariates in parous women only: mother's age for first child, life-
time breastfeeding duration and high blood pressure during pregnancy.
b Physical activity was calculated as the sum of time spent on walking,
moderate-intensity physical activity, and vigorous-intensity physical activity
(weighted by two) in the past week (Australian Institute of Health and Welfare,
2003).
c The total K10 score is based on a 10-item questionnaire about anxiety and
depression symptoms experienced in the last four weeks (Andrews and Slade,
2001). A K10 score< 22 represents a low to moderate risk of psychological
distress.
d Derived from the total number of lifestyle risk factors in the “high-risk”
category.
e In sub-analysis involving parous women only (n= 16,349).
B. Nguyen et al. Preventive Medicine 118 (2019) 73–80
78 90
risk of subsequent hypertension and cardiovascular disease (Grandi
et al., 2017; Magnussent et al., 2009).
4.1. Strengths and limitations
The main strengths of this study include a large population sample,
a prospective design, the use of validated measures, and a wide range of
covariates considered. Sensitivity analyses were conducted with con-
tinuous variables for lifestyle risk factors. This study presents some
limitations including a short follow-up time and reliance on self-re-
ported data, which may introduce bias. However, hypertension and
lifestyle risk factors were assessed using mostly validated measures. The
possibility of residual confounding could not be excluded despite the
inclusion of multiple covariates. For example, important dietary factors
such as sodium intake could not be assessed from the limited number of
short dietary questions. While it is possible that this study sample may
not be representative of the general population, a previous study
comparing 45 and Up Study participants to participants from a re-
presentative NSW Population Health Survey reported similar estimates
for exposure-outcome associations, despite different risk factor pre-
valence (Mealing et al., 2010). The minimal information available
about SEEF non-respondents may affect the generalisability of findings.
5. Conclusion
Findings from this study are of public health significance as hy-
pertension is one of the most important preventable causes of pre-
mature deaths worldwide. Results from this study highlight the im-
portance of adopting an overall healthy lifestyle, particularly in middle-
aged men who were identified as a higher risk group. The reduction of
lifestyle risk factors is an essential component of prevention strategies
aimed at reducing the incidence of hypertension and preventing sub-
sequent cardiovascular disease.
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 CONCLUDING SUMMARY FOR THIS CHAPTER AND KNOWLEDGE GAINED 
FROM THIS STUDY 
To our knowledge, this was the first prospective cohort study to compare associations 
between lifestyle risk factors and incident hypertension in men and women. Being 
overweight/obese, high alcohol intake, low physical activity levels and being a current smoker 
were significantly associated with a higher incidence of hypertension. There was no clear 
association between being at high risk of psychological distress and incident hypertension. When 
lifestyle risk factors were examined jointly, a higher number of lifestyle risk factors was 
associated with higher odds of developing hypertension. Findings were similar in men and 
women in relation to individual lifestyle risk factors, with the exception that smoking was not 
significantly associated with incident hypertension in gender-based analyses. In women, 
breastfeeding was shown to be protective. The association between the number of lifestyle risk 
factors and incident hypertension was stronger in middle-aged adults than older adults, 
particularly in middle-aged men. Further research is needed to examine whether middle-aged 
men are indeed a higher risk group and whether psychological distress is associated with incident 
hypertension.  
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CHAPTER SIX:                                                                              
Breastfeeding and maternal cardiovascular risk factors and outcomes: A 
systematic review 
 PREFACE TO THE CHAPTER 
This chapter presents findings from a systematic review that examined the association 
between breastfeeding and maternal cardiovascular risk factors and outcomes, including 
metabolic syndrome, hypertension and CVD. The published, peer-reviewed paper addresses 
specific aim #4 of this thesis as described in Chapter 1. Supplementary material included as part 
of this published paper is also presented in this chapter. Dissemination of this research and 
author contributions for this paper are described below.  
 
 RESEARCH DISSEMINATION 
The research presented in this chapter has been disseminated as follows: 
Published peer-reviewed paper  
Nguyen B, Jin K, Ding D. Breastfeeding and maternal cardiovascular risk factors and outcomes: 
A systematic review. PLoS ONE 2017; 12(11): e0187923.  
Impact factor 2.766 
Citations (based on Google Scholar): 4 
 
Conference presentations 
Nguyen B, Jin K, Ding D. Breastfeeding and maternal cardiovascular risk factors and 
outcomes: A systematic review. The International Society for Behavioral Nutrition and 
Physical Activity Annual Meeting, Victoria, Canada, 2017. [Poster presentation] 
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Abstract
Background
There is growing evidence that breastfeeding has short- and long-term cardiovascular
health benefits for mothers. The objectives of this systematic review were to examine the
association between breastfeeding and maternal cardiovascular risk factors and outcomes
that have not previously been synthesized systematically, including metabolic syndrome,
hypertension and cardiovascular disease.
Methods and findings
This systematic review meets PRISMA guidelines. The MEDLINE, EMBASE and CINAHL
databases were systematically searched for relevant publications of any study design from
the earliest publication date to March 2016. The reference lists from selected articles were
reviewed, and forward and backward referencing were conducted. The methodological
quality of reviewed articles was appraised using validated checklists.
Twenty-one studies meeting the inclusion criteria examined the association between self-
reported breastfeeding and one or more of the following outcomes: metabolic syndrome/
metabolic risk factors (n = 10), inflammatory markers/adipokines (n = 2), hypertension (n =
7), subclinical cardiovascular disease (n = 2), prevalence/incidence of cardiovascular dis-
ease (n = 3) and cardiovascular disease mortality (n = 2). Overall, 19 studies (10 cross-sec-
tional/retrospective, 9 prospective) reported significant protective effects of breastfeeding,
nine studies (3 cross-sectional/retrospective, 5 prospective, 1 cluster randomized controlled
trial) reported non-significant findings and none reported detrimental effects of breastfeed-
ing. In most studies reporting significant associations, breastfeeding remained associated
with both short- and long-term maternal cardiovascular health risk factors/outcomes, even
after covariate adjustment. Findings from several studies suggested that the effects of
breastfeeding may diminish with age and a dose-response association between breastfeed-
ing and several metabolic risk factors. However, further longitudinal studies, including stud-
ies that measure exclusive breastfeeding, are needed to confirm these findings.
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Conclusions
The evidence from this review suggests that breastfeeding is associated with cardiovascular
health benefits. However, results should be interpreted with caution as the evidence gath-
ered for each individual outcome was limited by the small number of observational studies.
Additional prospective studies are needed.
PROSPERO registration number
CRD42016047766.
Introduction
Cardiovascular disease is the leading cause of death among women globally [1] and lifestyle-
related factors play a key role in its prevention. Considerable attention has been given to more
conventional risk factors such as obesity, physical inactivity and an unhealthy diet. However,
other modifiable behaviours, such as breastfeeding, should be considered and incorporated in
the development of potential strategies to prevent cardiovascular disease.
While the importance of breastfeeding is well recognized for infant and child health, there
is growing interest in maternal health outcomes. Breastfeeding has favourable short-term
effects on maternal metabolic health, including lipid homeostasis [2–4], glucose homeostasis
and insulin sensitivity [5,6]. Evidence from observational studies is accumulating for an associ-
ation between breastfeeding and longer-term maternal cardiovascular risk factors such as
hypertension [7,8], type 2 diabetes [9,10], obesity [11], and metabolic syndrome [MS] [12].
Breastfeeding has also been linked to cardiovascular disease incidence [13] and mortality [14].
To date, there have been several systematic reviews examining the association between
breastfeeding and cardiovascular risk factors such as postpartum weight change, body compo-
sition and type 2 diabetes [15–18]. Findings from these reviews suggest that breastfeeding may
be associated with a reduced risk of type 2 diabetes [16,18] while the associations with postpar-
tum weight change and body composition are unclear [15,17,18]. To our knowledge, the evi-
dence for an association between breastfeeding and other cardiovascular risk factors and
outcomes such as MS, hypertension and cardiovascular disease, has not been systematically
summarized. With growing evidence suggesting that breastfeeding has both short- and long-
term effects on maternal cardiovascular health outcomes, it is important to evaluate whether
breastfeeding can be a modifiable risk factor for cardiovascular disease in parous women and
whether lactation has long-term beneficial effects for maternal cardiovascular health.
Therefore, the objectives of this systematic review were to summarize the relationship of
breastfeeding with maternal cardiovascular risk factors and outcomes that have not previously
been reviewed systematically and to synthesize the findings that have been recently evaluated
systematically. Reviewing this evidence systematically can provide valuable information for
future guidelines and strategies for cardiovascular disease prevention.
Methods
Details of the protocol for this systematic review were registered with the International Pro-
spective Register of Systematic Reviews (PROSPERO; registration number CRD42016047766)
and can be accessed at http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=
CRD42016047766. This systematic review meets Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines (S1 Checklist) [19].
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Search strategy
The electronic databases MEDLINE, EMBASE and CINAHL were searched for relevant publi-
cations, from the earliest publication date to March 2016, using multiple subject headings and
text words in combination (S1 Table). Additional articles were identified through backward
and forward reference searching. Authors of published conference abstracts were contacted
to identify any corresponding full text publications. Only full text publications of studies on
humans and published in English were considered.
Inclusion criteria and study selection
Articles of any study design (e.g. cross-sectional/retrospective, prospective cohort, cluster ran-
domized controlled trial [RCT]) were included in this systematic review if they investigated
the association of breastfeeding with any maternal cardiovascular risk factor and/or cardiovas-
cular outcome of a biological nature. Possible cardiovascular risk factors included: weight
change, body mass index (BMI), waist circumference, body composition (e.g. visceral adipos-
ity), hypertension, type 2 diabetes mellitus, hyperlipidemia, MS/risk factors and inflammatory
markers. Studies on lifestyle risk factors, such as smoking, physical inactivity and an unhealthy
diet, were not considered. Cardiovascular outcomes included subclinical and clinical cardio-
vascular disease prevalence, incidence and mortality. All study time periods, definitions of
breastfeeding (whether exclusive or complemented by other foods) and studies that involved
women with any menopausal status were accepted. Studies were excluded if they had a small
sample size (defined arbitrarily as<100 participants) and if they examined risk factors/out-
comes relating only to: the breastfed child, cancer, and pregnancy complications (e.g. gesta-
tional diabetes mellitus, pre-eclampsia and pre-term delivery). Two reviewers (BN and KJ)
independently screened the titles and abstracts of retrieved articles to assess study eligibility.
Any disagreement or uncertainty was resolved through discussion. The same reviewers
reviewed the full text articles that met the inclusion criteria or with uncertain eligibility. Any
disagreement was resolved by consensus. Although systematic reviews were not included
among the selected studies, recent systematic reviews were identified and summarized for sev-
eral outcomes of interest (postpartum weight change, body composition and type 2 diabetes)
[15–18]. Studies involving maternal outcomes of interest that had not been previously system-
atically assessed were reviewed (MS/metabolic risk factors, hypertension, inflammatory mark-
ers, adipokines, subclinical cardiovascular disease, and cardiovascular disease prevalence,
incidence and mortality).
Quality assessment and data extraction
One reviewer (BN) assessed the methodological quality of cross-sectional/retrospective and
prospective cohort studies by using an adapted 15-item checklist derived from checklists
for the reporting of observational studies (S2 Table) [20]. The single cluster RCT trial was
appraised against a quality assessment checklist based on a tool developed by the Cochrane
collaboration for assessing risk of bias in randomized studies [21] and relating to the following
criteria: random sequence generation, allocation concealment, blinding of participants and
personnel, blinding of outcome assessment, completeness of outcome data, accurate outcome
reporting and other sources of bias addressed. For each study, an overall study quality rating
was allocated based on the total number of individual criteria met or addressed. Studies were
rated as: “low quality” if1/3 of individual criteria were met, “medium quality” if>1/3-2/3
of individual criteria were met and “high quality” if >2/3 of criteria were met. Five articles
(~25%) were randomly selected from the included studies and independently appraised by the
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second reviewer (KJ). The overall agreement rate between both authors for the quality rating
of these five articles was 100%.
The following data were extracted from each article: study design, country in which the
study was conducted, cohort/study designation, sample size, brief participant description, age
range, mean follow-up or period, type of outcome measure(s), breastfeeding comparison cate-
gories, effect sizes (most commonly reported as odds ratios or relative risks with 95% confi-
dence intervals) and covariates adjusted for. The expected direction of each association was
hypothesized based on existing literature and coded as: + (significant association in the
hypothesized direction),–(significant association not in the hypothesized direction), 0 (non-
significant association). Due to the heterogeneous nature of the studies and limited number
of studies for each outcome of interest, only a qualitative analysis of included studies was
conducted.
Breastfeeding terms and categories
In this review, the terms breastfeeding and lactation are used interchangeably. Breastfeeding
was self-reported in all included studies. Lactation history refers to any reported history (usu-
ally1 month) of breastfeeding (ever vs. never). Lactation duration is the reported length of
time a woman breastfed a child. Exclusive lactation duration is the length of time a woman
exclusively breastfed a child before introducing complementary foods. Lifetime lactation dura-
tion is the cumulative amount of time a woman reportedly breastfed across all pregnancies
and average lactation duration is the average amount of time a woman breastfed each child.
Results
Selection of studies
The study selection process is shown in Fig 1. The literature searches yielded 581 unique cita-
tions, of which 37 were identified as potentially relevant. Following full text review, 16 studies
were excluded based on small sample size or if they related to outcomes of interest that had
been recently reviewed in retrieved systematic reviews (i.e., adiposity, body composition, and
type 2 diabetes). Twenty-one articles examining the association between breastfeeding and
one or more of the following outcomes were included for review: MS/metabolic risk factors
(n = 10), hypertension (n = 7), inflammatory markers/adipokines (n = 2), subclinical cardio-
vascular disease (n = 2), prevalence/incidence of cardiovascular disease (n = 3) and cardiovas-
cular disease mortality (n = 2).
Critical appraisal
Out of 21 included papers, 16 (76%) were rated as high quality and 5 (24%) as medium quality
(S3 and S4 Tables). Although most quality assessment criteria were adequately addressed,
many observational studies failed to describe the reliability (n = 15) and/or validity (n = 12) of
the breastfeeding measure and the number of participants with missing data for the exposure/
outcome of interest (n = 6).
Study characteristics
Tables 1–5 provide details of reviewed studies. Nearly all papers (95%) were published in the
last decade. Of the 21 included studies, 9 were cross-sectional/retrospective [22–30], 10 were
prospective [7,8,12–14,31–35], 1 reported both cross-sectional/retrospective and prospective
data [36], and 1 was a cluster RCT [37]. More than half of the studies were conducted in the
United States (US) (n = 11), with the remaining conducted in Europe (n = 4), Asia (n = 5), and
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Australia (n = 1). Sample sizes ranged from 297 to 267,400 participants (median = 6,914) and
the age of participants varied between 18 and 89 years of age. In prospective studies, partici-
pants were followed up between 3 and 20 years. Breastfeeding was assessed mainly by self-
administered questionnaires (16/21 studies) and also by interviewer-administered question-
naires (6/21 studies). Study outcomes were mostly measured, although several were self-
reported.
Association between breastfeeding and maternal cardiovascular risk
factors and outcomes
Weight change/body composition. A 2014 systematic review by Neville et al., based
on 37 prospective studies and eight retrospective studies, assessed the relationship between
breastfeeding and changes in postpartum weight or body composition in mothers2 years
Fig 1. Selection of articles for systematic review.
https://doi.org/10.1371/journal.pone.0187923.g001
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postpartum [17]. Most studies found little or no association between breastfeeding and either
change in postpartum weight or maternal body composition.
In 2015, a systematic review conducted by Chowdury et al. [15] updated the review on post-
partum weight change by Neville et al. [17] with five additional studies. The authors concluded
that there were no clear associations between breastfeeding and postpartum weight change,
Table 1. Summary of included studies with metabolic syndrome as the outcome.
First author
(year)
Country and
cohort
designation
Participants Mean
follow-up
or period
(years)
Outcome
assessment
Breastfeeding
comparison
categoriesa
Adjusted OR
or RR (95% CI)
by lactation
history/
duration
Covariates
Cross-sectional/retrospective studies
Cho et al.
(2009) [24]
Korea,
Korean National
Health and
Nutrition
Examination
Survey
892 post-menopausal
women;
43–89 years
N/A Measured;
Prevalent MS
Ever (1 month)
vs. never
1.20 (0.65,
2.20)
Age, marital status,
SES, smoking,
alcohol, PA, BMI
Ram et al.
(2008) [22]
US,
Study of Women’s
Health Across the
Nation (SWAN)
2,516 parous, pre-
menopausal women;
42–52 years
N/A Measured;
Prevalent MS
Ever vs. never
Per year lifetime
0.77 (0.62,
0.96)
0.88 (0.77,
0.99)
Study site, age,
ethnicity, SES,
smoking, PA, caloric
intake, high school
BMI, parity
Cohen et al.
(2006) [23]
US,
Third National
Health and
Nutrition
Examination
Survey (NHANES
III)
4,699 non-pregnant,
parous women;
20 years
N/A Measured;
Prevalent MS
Ever (1 month)
vs. never
1.02 (0.78,
1.34)
Age, ethnicity, SES,
smoking, alcohol, PA,
BMI, OC, HRT
Prospective studies
Ramezani
Tehrani et al.
(2014) [31]
Iran,
Tehran Lipid and
Glucose Study
(TLGS)
925 women without
prevalent MS at baseline;
15–50 years at baseline
9 Measured;
Incident MS
Lifetime lactation
duration;
Never
1–6 months
7–12 months
13–23 months
24 months
1.5 (0.7, 3.0)
1.8 (0.7, 4.1)
1.5 (0.7, 3.2)
1.8 (1.0, 3.4)
Reference
Age, PA, caloric
intake, BMI, parity
Gunderson
et al. (2010)
[12]
US,
Coronary Artery
Risk Develop-
ment in Young
Adults (CARDIA)
Study
620 nulliparous women
without prevalent MS at
baseline; delivered1
singleton live birth during
the follow-up period; 18–
30 years at baseline
20 Measured;
Incident MS
Lifetime lactation
duration;
0–1 month
>1–5 months
6–9 months
>9 months
P-trend
Reference
0.61 (0.36,
1.05)
0.52 (0.29,
0.93)
0.44 (0.23,
0.84)
0.03
Study centre, age,
ethnicity, SES,
smoking, PA, BMI,
MS componentsb,
parity
Abbreviations: BMI = body mass index, CI = confidence interval, HRT = hormonal replacement therapy, MS = Metabolic Syndrome, N/A = not applicable,
OC = oral contraceptives, OR = odds ratio, PA = physical activity, RR = relative risk, SES = socioeconomic status, US = United States.
a For the assessment of breastfeeding, self-reported measures included lactation history: defined as ever breastfeeding; lactation duration: length of time a
woman breastfed a child; exclusive lactation duration: length of time a woman exclusively breastfed a child before introducing complementary foods; lifetime
lactation duration: cumulative amount of time a woman breastfed across all pregnancies and average lactation duration: lifetime lactation duration divided
by the total number of children. For lactation history, the reference category is the second category mentioned (e.g. for ever vs. never, never is the reference
category).
b For this study, MS components related to waist circumference measure, fasting triglyceride levels, high-density lipoprotein cholesterol levels, systolic or
diastolic blood pressure or treatment with antihypertensive medication, and fasting glucose levels or treatment with diabetes medication.
https://doi.org/10.1371/journal.pone.0187923.t001
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Table 2. Summary of included studies with metabolic risk factors as the outcome.
First
author
(year)
Country and
cohort
designation
Participants Mean
follow-up
or period
(years)
Outcome
assessment
Breastfeeding
comparison
categoriesa
Adjusted OR or RR
(95% CI) by lactation
history/ duration
Covariates
Cross-sectional studies
Henriques
et al.
(2015)b [25]
Portugal,
Birth cohort
generation XXI
1,847 mothers from
public hospital
maternity clinics;
normal BMI: mean
age (SD) = 34.4 (5.2);
overweight BMI:
mean age (SD) =
35.2 (5.2); obese
BMI: mean age (SD):
35.3 (5.3)
N/A
Assessed 4
years
postpar-
tum
Healthy metabolic
phenotype (outcomes
measured or self-
reported medications)
defined as the
absence of HT,
diabetes,
dyslipidemia,
CRP3mg/L and
<2nd tertile of
HOMA-IR
Lactation duration;
Normal BMI
Ow metab healthy:
Never
26 weeks
>26 weeks
Ow metab not
healthy:
Never
26 weeks
>26 weeks
Ob metab healthy:
Never
26 weeks
>26 weeks
Ob metab not
healthy:
Never
26 weeks
>26 weeks
Reference
Reference
0.84 (0.39, 1.82)
1.10 (0.50, 2.40)
Reference
0.58 (0.33, 1.00)
0.64 (0.37, 1.12)
Reference
0.65 (0.18, 2.33)
0.85 (0.23, 3.08)
Reference
0.44 (0.26, 0.74)
0.39 (0.23, 0.68)
Age, family history of
CVD/cardiometabolic
risk factors, PA, OC
Natland
et al. (2012)
[26]
50 years
Norway,
Nord-
Trøndelag
Health Survey
(HUNT2)
21,368 non-pregnant,
parous women
without prevalent MI,
stroke, angina
pectoris or diabetes
prior to the first birth;
not currently/
previously taking anti-
hypertensive
medication for BP
data analysis; and
with TG levels <4.5
mmol/L for LDL-C
analyses;
20–85 years
N/A Measured; metabolic
risk factors WC; non-
fasting: serum levels
of TG, total chol,
HDL-C, LDL-C and
blood glucose
Lifetime lactation
duration;
Never
1–6 months
7–12 months
13–23 months
24 months
Lifetime lactation
duration was inversely
associated with WC,
TG, total chol, LDL-C,
and HDL-C (all P-
trends<0.001 except
for HDL-C P-
trend = 0.008). P-
trend for blood
glucose was not
significant.
The estimates were
attenuated after
further adjustment for
BMI (for all lipids; no
association remained
for HDL-C) but
remained similar after
adjustment for time
since last birth.
Age, marital status,
SES, smoking, PA,
time since last meal (for
serum lipids and blood
glucose), parity
Natland
et al. (2012)
[26]
>50 years
- - - - - Significant association
with WC only (p-
trend = 0.03)
-
Schwarz
et al. (2009)
[36]
US,
Women’s
Health Initiative
(WHI)
139,681 parous,
postmenopau-sal
women with 1 live
birth;
50–79 years
N/A Measured and/or self-
reported (use of chol-
lowering medication)
hyperlipidemia
Lifetime lactation
duration:
Never
1–6 months
7–12 months
13–23 months
24 months
P-trend
Never
12 months
Reference
0.93 (0.89, 0.97)
0.88 (0.83, 0.94)
0.81 (0.76, 0.87)
0.80 (0.73, 0.87)
<0.0001
Reference
0.81, p<0.001
Age, ethnicity, SES,
family history of
diabetes/MI/ stroke,
smoking, PA, dietary
intake, use of aspirin/
multivitamin, BMI,
parity, HRT
(Continued )
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Table 2. (Continued)
First
author
(year)
Country and
cohort
designation
Participants Mean
follow-up
or period
(years)
Outcome
assessment
Breastfeeding
comparison
categoriesa
Adjusted OR or RR
(95% CI) by lactation
history/ duration
Covariates
Prospective studies
Stuebe et al.
(2010) [33]
US,
Project Viva
570 women with a
singleton pregnancy;
<22 weeks gestation
at baseline;
mean age (SD) at 3
years postpartum:
no lactation: 36.0
(4.8);
>0–<3 months
lactation:
36.8 (6.0);
3–<6 months: 37.2
(5.3);
6–<12 months: 38.2
(4.6);
12 months: 38.8
(5.0)
3 years
postpar-
tum
Measured; BMI, WC
and metabolic
markers: HbA1c,
SHBG, fasting insulin,
glucose, HOMA-IR,
total chol, LDL-C,
HDL-C, TG
175 subjects had
fasting blood samples
Lactation duration:
Never
>0-<3 months
3-<6 months
6-<12 months
12 months
Exclusive lactation
duration:
Never
>0-<1 months
1-<3 months
3-<6 months
6 months
No significant
associations between
either lactation
duration or exclusive
lactation duration and
outcome measures.
Adjustment for BMI
before pregnancy
eliminated all
unadjusted
associations with
HOMA_IR, fasting
insulin, SHBG and
3-year postpartum
WC.
Family history of type 2
diabetes, smoking, PA,
dietary intake, intention
to lose weight, self-
reported weight at 12
months, pre-pregnancy
BMI, gestational weight
gain, gestational
glucose tolerance,
parity, OC
Gunderson
et al. (2007)
[32]
US,
Coronary
Artery Risk
Develop-ment
in Young
Adults
(CARDIA)
Study
1,051 non-pregnant
women or who
delivered 1 singleton
live birth during the
3-year interval,
without prevalent MS
at baseline;
24–42 years at
baseline (year 7)
3 (interval
between
years 7–10
follow-up)
Measured; mean
change in metabolic
risk factors: fasting
plasma
glucose, insulin,
HOMA-IR, LDL-C,
total chol, HDL-C,
TG, BP, weight, WC
Non-pregnant, no
lactation, and
lactated and
weaned (post-
weaning) groups.
Post-weaning
group also
dichotomised
based on lactation
duration: <3 and
3 months
Both the no lactation
and post-weaning
groups had greater
adjusted mean gains
in WC and
decrements in HDL-C
than non-pregnant
women (all p<0.001).
LDL-C (p<0.05) and
fasting insulin
(p = 0.06) increased
more for the no
lactation group
compared to the other
two groups.
3 months lactation
was associated with a
smaller decrement in
HDL-C than <3
months (p<0.01).
Baseline age, ethnicity,
SES, smoking, BMI,
time since weaning to
year 10 examination
(for analyses within
post-weaning group
only), parity, OC
Abbreviations: BMI = body mass index, BP = blood pressure, chol = cholesterol, CI = confidence interval, CRP = C-reactive protein, CVD = cardiovascular
disease, HbA1c = hemoglobin A1c, HDL-C = high-density lipoprotein cholesterol, HOMA-IR = homeostasis model assessment of insulin resistance,
HRT = hormonal replacement therapy, HT = hypertension, LDL-C = low-density lipoprotein cholesterol, metab = metabolically, MI = myocardial infarction, N/
A = not applicable, Ob = obese, OC = oral contraceptives, OR = Odds Ratio, Ow = overweight, PA = physical activity, RR = relative risk, SD = standard
deviation, SES = socioeconomic status, SHBG = sex hormone-binding globulin, TG = triglycerides, US = United States, WC = waist circumference.
a For the assessment of breastfeeding, self-reported measures included lactation history: defined as ever breastfeeding; lactation duration: length of time a
woman breastfed a child; exclusive lactation duration: length of time a woman exclusively breastfed a child before introducing complementary foods; lifetime
lactation duration: cumulative amount of time a woman breastfed across all pregnancies and average lactation duration: lifetime lactation duration divided
by the total number of children. For lactation history, the reference category is the second category mentioned (e.g. for ever vs. never, never is the reference
category).
b In this study, women who breastfed their child >26 weeks were less likely to be obese and “metabolically unhealthy” (defined as the presence of HT,
diabetes, dyslipidemia, CRP>3mg/L and >2nd tertile of HOMA-IR).
https://doi.org/10.1371/journal.pone.0187923.t002
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Table 4. Summary of included studies with inflammatory markers, adipokines and subclinical cardiovascular disease as the outcomes.
First
author
(year)
Country and
cohort
designation
Participants Mean
follow-
up or
period
(years)
Outcome
assessment
Breastfeeding
comparison
categoriesa
Adjusted OR or RR
(95% CI) by lactation
history/ duration
Covariates
Cross-sectional/retrospective studies
McClure
et al.
(2012)
[29]
US,
Women and
Infant Study of
Healthy Hearts
(WISH)
569 premenopausal
women who delivered a
singleton live birth,
following a pregnancy
without complications;
mean age (SD) = 35.6
(7) for women who
breastfed any child <3
months; mean age (SD)
= 39.6 (6) for women
who breastfed 3
months
N/A
4–12
years
after
delivery
Measured
subclinical CVD:
carotid artery intima-
media thickness,
lumen diameter,
adventitial diameter
and carotid-femoral
pulse wave velocity
Lactation
duration for each
child:
Never breastfed
Breastfed any
child <3 months
Breastfed each
child 3 months
Never breastfed
Breastfed any
child <3 months
Breastfed each
child 3 months
Never breastfed
Breastfed any
child <3 months
Breastfed each
child 3 months
Never breastfed
Breastfed any
child <3 months
Breastfed each
child 3 months
Lumen diameter
0.13 (0.04, 0.22)
0.11 (0.002, 0.22)
Reference
Adventitial diameter
0.12 (0.02, 0.22)
0.10 (-0.02, 0.21)
Reference
Intima-media thickness
0.79 (0.41, 1.54)
0.51 (0.24, 1.09)
Reference
Carotid-femoral pulse
wave velocity
0.21 (-0.10, 0.52)
0.02 (-0.34, 0.37)
Reference
Age, ethnicity, SES, family
history of diabetes/MI/
stroke, smoking, PA,
vitamin supplementation,
early adult BMI, current
BMI, SBP, total chol,
HDL-C, TG, CRP, glucose,
insulin, optimism, anxiety,
max. gestational weight
gain, birth outcome,
gestational age, infant birth
weight, additional preterm
births, years since last
birth, parity
Schwarz
et al.
(2010)
[30]
US,
Study of
Women’s
Health Across
the Nation
(SWAN)
297 women without
prevalent CVD at
baseline who delivered
at least 1 singleton live
birth;
45–58 years
N/A Measured
subclinical CVD:
coronary and aortic
calcification, carotid
adventitial diameter,
intima–media
thickness and
carotid plaque
Lactation
duration for each
child:
Never breastfed
Breastfed any
child <3 months
Breastfed each
child 3 months
Never breastfed
Breastfed any
child <3 months
Breastfed each
child 3 months
Never breastfed
Breastfed any
child <3 months
Breastfed each
child 3 months
Never breastfed
Breastfed any
child <3 months
Breastfed each
child 3 months
Never breastfed
Breastfed any
child <3 months
Breastfed each
child 3 months
Aortic calcification
Reference
0.34 (0.09, 1.28)
0.19 (0.05, 0.68)
Coronary calcification
Reference
0.96 (0.28, 3.27)
0.43 (0.13, 1.49)
Carotid plaque
Reference
0.75 (0.18, 3.23)
0.45 (0.11, 1.84)
Adventitial diameter
Reference
-0.12 (-0.35, 0.11)
-0.04 (-0.26, 0.18)
Intima-media thickness
Reference
0.79 (0.27, 2.32)
0.93 (0.33, 2.67)
Study site, age, ethnicity,
SES, family history of
diabetes/MI/stroke,
smoking, PA, dietary
intake, vitamin
supplementation, BMI,
SBP, TG, total chol, HDL,
CRP, glucose, insulin,
perceived stress,
depressed mood,
menopausal status, parity
Prospective studies
(Continued )
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Table 4. (Continued)
First
author
(year)
Country and
cohort
designation
Participants Mean
follow-
up or
period
(years)
Outcome
assessment
Breastfeeding
comparison
categoriesa
Adjusted OR or RR
(95% CI) by lactation
history/ duration
Covariates
Stuebe
et al.
(2010)
[33]
US,
Project Viva
570 women with a
singleton pregnancy;
<22 weeks gestation at
baseline;
mean age (SD) at 3
years postpartum:
no lactation: 36.0 (4.8);
>0–<3 months
lactation:
36.8 (6.0);
3–<6 months: 37.2
(5.3);
6–<12 months: 38.2
(4.6);
12 months: 38.8 (5.0)
3 years
post-
partum
Measured
inflammato-ry
markers: CRP and
IL6
175 subjects had
fasting blood
samples
Lactation
duration:
Never
>0-<3 months
3-<6 months
6-<12 months
12 months
Exclusive
lactation
duration:
Never
>0-<1 months
1-<3 months
3-<6 months
6 months
No significant
associations between
either lactation duration
or exclusive lactation
duration and
inflammatory markers.
Adjustment for BMI
before pregnancy
eliminated unadjusted
association with CRP.
Family history of type 2
diabetes, smoking, PA,
dietary intake, intention to
lose weight, self-reported
weight at 12 months, pre-
pregnancy BMI, gestational
weight gain, gestational
glucose tolerance, parity,
OC
Stuebe
et al.
(2011)
[34]
US,
Project Viva
570 women with a
singleton pregnancy;
<22 weeks gestation at
baseline;
mean age (SD) at 3
years postpartum:
no lactation: 36.0 (4.8);
>0–<3 months
lactation:
36.8 (6.0);
3–<6 months: 37.2
(5.3);
6–<12 months: 38.2
(4.6);
12 months: 38.8 (5.0)
3 years
post-
partum
Measured
adipokines: leptin,
adiponectin, ghrelin,
peptide YY
175 subjects had
fasting blood
samples
Lactation
duration:
Never
>0-<3 months
3-<6 months
6-<12 months
12 months
Exclusive
lactation
duration:
Never
>0-<1 months
1-<3 months
3-<6 months
6 months
Lactation duration was
associated with ghrelin
(predicted mean = 749.5
for none vs. 852.9 pg/ml
for 12 months
lactation; p = 0.05) and
peptide YY levels
(predicted geometric
mean = 55 for none vs.
63.4 pg/ml for 12
months lactation;
p = 0.03).
Lactation duration was
not associated with
leptin levels after
adjustment for pre-
pregnancy BMI.
Exclusive lactation
duration was associated
with ghrelin (predicted
mean = 790.6 for never
exclusively
breastfeeding vs.
1,008.1 pg/ml for 6
months exclusive
breastfeeding; p<0.01).
Non-linear association
between lactation
duration/exclusive
lactation duration with
adiponectin.
Age, race, family history of
type 2 diabetes, smoking
status, pre-pregnancy BMI,
gestational weight gain,
gestational glucose
tolerance, parity; additional
adjustment for lactation
duration after introduction
of complementary foods
Abbreviations: BMI = body mass index, chol = cholesterol, CI = confidence interval, CRP = C-reactive protein, CVD = cardiovascular disease,
HDL-C = high-density lipoprotein cholesterol, IL-6 = interleukin 6, max = maximum, MI = myocardial infarction, N/A = not applicable; OC = oral
contraceptives, OR = odds ratio, PA = physical activity, RR = relative risk, SBP = systolic blood pressure, SD = standard deviation, SES = socioeconomic
status, TG = triglycerides, US = United States.
a For the assessment of breastfeeding, self-reported measures included lactation history: defined as ever breastfeeding; lactation duration: length of time a
woman breastfed a child; exclusive lactation duration: length of time a woman exclusively breastfed a child before introducing complementary foods.
https://doi.org/10.1371/journal.pone.0187923.t004
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Table 5. Summary of included studies with cardiovascular disease as the outcome.
First author
(year)
Country and
cohort
designation
Participants Mean
follow-
up or
period
(years)
Outcome assessment Breastfeeding
comparison
categoriesa
Adjusted OR
or RR (95% CI)
by lactation
history/
duration
Covariates
Cross-sectional/retrospective studies
Schwarz
et al. (2009)
[36]
US,
Women’s
Health
Initiative (WHI)
139,681 parous,
postmenopau-sal
women with1 live
birth;
50–79 years
N/A Self-reported; prevalence
of CVD (MI, angina, CHF,
peripheral arterial
disease,
revascularisation, stroke)
Lifetime lactation
duration:
Never
1–6 months
7–12 months
13–23 months
24 months
P-trend
Never
13 months
Reference
1.03 (0.98,
1.09)
0.95 (0.88,
1.02)
0.93 (0.85,
1.01)
0.89 (0.80,
0.98)
0.005
Reference
0.91 (0.85,
0.98),
P = 0.008
Age, ethnicity, SES,
family history of
diabetes/MI/ stroke,
smoking, PA, dietary
intake, use of aspirin/
multivitamin, BMI,
parity, HRT
Prospective studies
Stuebe et al.
(2009) [13]
US,
Nurses’ Health
Study
89,326 parous
women without a
history of MI, angina
or coronary artery
bypass graft;
40–65 years
1986–
2002
Self-reported incidence of
MI (confirmed by
physician review of
medical records)
Lifetime lactation
duration:
None
>0–3 months
>3–6 months
>6–11 months
>11–23 months
>23 months
P-trend
Reference
(0.91, 1.11)b
(0.88, 1.14)b
(0.88, 1.18)b
0.93 (0.8,
1.07)b
0.77 (0.62,
0.94)b
0.02
Age, parental history of
MI before age 60 years,
smoking, alcohol, PA,
dietary intake, use of
aspirin/multivitamins,
BMI at age 18 years,
birth weight of subject,
history of stillbirth,
menopausal status,
parity, HRT
Stuebe et al.
(2009) [13]
Birth in the
last 30 years
- - - - Lifetime lactation
duration;
None
>0–3 months
>3–6 months
>6–11 months
>11–23 months
>23 months
P-trend
Reference
0.94 (0.79,
1.12)b
0.98 (0.80,
1.21)b
0.96 (0.76,
1.21)b
0.89 (0.71,
1.10)b
0.66 (0.49,
0.89)b
0.02
-
Stuebe et al.
(2009) [13]
No birth in
the last 30
years
- - - - Lifetime lactation
duration;
None
>0–3 months
>3–6 months
>6–11 months
>11–23 months
>23 months
P-trend
Reference
1.04 (0.92,
1.18)
1.02 (0.86,
1.21)
1.02 (0.84,
1.24)
0.95 (0.78,
1.15)
0.90 (0.67,
1.19)
0.33
-
(Continued )
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Table 5. (Continued)
First author
(year)
Country and
cohort
designation
Participants Mean
follow-
up or
period
(years)
Outcome assessment Breastfeeding
comparison
categoriesa
Adjusted OR
or RR (95% CI)
by lactation
history/
duration
Covariates
Schwarz
et al. (2009)
[36]
US,
Women’s
Health
Initiative (WHI)
139,681 parous,
postmenopau-sal
women with1 live
birth;
50–79 years
7.9 Self-reported incidence of
CVD (CHD, stroke, CHF,
angina, peripheral
vascular disease, carotid
artery disease, and
coronary
revascularization)
validated by physician
adjudication of medical
records
Lifetime lactation
duration:
Never
1–6 months
7–12 months
13–23 months
24 months
P-trend
Reference
(0.98, 1.08)b
0.97 (0.90,
1.04)b
0.98 (0.91,
1.05)b
0.93 (0.85,
1.02)b
0.12
Age, ethnicity, SES,
family history of
diabetes/MI/stroke,
smoking, dietary intake,
use of aspirin/
multivitamin, PA, BMI,
parity, HRT
Gallagher
et al. (2011)
[35]
China 259,494 non-
smoking female
workers employed
in the textile
industry;
30->60 years
1989–
2000
Measured; mortality from
IHD, ischaemic stroke
and haemorrhagic stroke,
based on a death registry
Lactation
duration;
IHD:
Never (parous)
<6 months
7–12 months
13–24 months
25–36 months
37–48 months
49 months
Ischaemic
stroke:
Never (parous)
<6 months
7–12 months
13–24 months
25–36 months
37–48 months
49 months
Haemorrhagic
stroke:
Never (parous)
<6 months
7–12 months
13–24 months
25–36 months
37–48 months
49 months
Reference
0.70 (0.42,
1.16)b
0.50 (0.33,
0.76)b
0.67 (0.46,
0.97)b
0.53 (0.36,
0.79)b
0.71 (0.48,
1.06)b
0.78 (0.53,
1.14)b
Reference
1.02 (0.63,
1.66)b
1.05 (0.72,
1.54)b
0.90 (0.62,
1.31)b
1.15 (0.79,
1.67)b
1.21 (0.83,
1.77)b
1.20 (0.84,
1.72)b
Reference
0.84 (0.63,
1.12)b
0.98 (0.79,
1.22)b
1.01 (0.82,
1.24)b
0.88 (0.71,
1.09)b
1.02 (0.82,
1.28)b
1.05 (0.84,
1.30)b
Age, number of live
births
(Continued )
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with factors such as age, gestational weight gain and pre-pregnancy weight possibly confound-
ing these relationships.
Type 2 diabetes. In a 2014 review and meta-analysis based on six cohort studies, the lon-
gest duration of lifetime lactation was associated with a 32% reduction in relative risk of type 2
diabetes compared with the shortest duration [16]. This finding was in line with a later review
of the same primary studies [15] and an earlier systematic review [18].
MS. MS is a cluster of conditions which can increase the risk for diabetes and CVD.
Table 1 describes studies with MS as the outcome. Five studies examined the association
between breastfeeding and MS [12,22–24,31]. Studies adhered to the National Cholesterol
Education Program Adult Treatment Panel III criteria [38] to define MS, which is based on
the presence of three of more of the following risk determinants: abdominal obesity, elevated
triglyceride levels, reduced high-density lipoprotein cholesterol levels, elevated blood pressure,
and elevated fasting glucose levels [38]. The findings from the three cross-sectional studies,
conducted among women of different age categories, were mixed [22–24]. One study from the
US found a significant protective association of both lactation history and lifetime lactation
Table 5. (Continued)
First author
(year)
Country and
cohort
designation
Participants Mean
follow-
up or
period
(years)
Outcome assessment Breastfeeding
comparison
categoriesa
Adjusted OR
or RR (95% CI)
by lactation
history/
duration
Covariates
Natland
Fagerhaug
et al. (2013)
[14]
<65 years
Norway, Nord-
Trøndelag
Health Survey
(HUNT2)
21,889 non-
pregnant, parous
women without
prevalent MI,
stroke, angina
pectoris or diabetes
prior to the first
birth;
30–85 years
15 Measured; mortality from
CVD, based on a death
registry
Ever lactated
Never lactated
Nulliparous
Lifetime lactation
duration:
None
7–12 months
24 months
P-linear trend
Reference
2.86 (1.51,
5.39)b
0.41 (0.16,
1.04)b
2.77 (1.28,
5.99)b
0.55 (0.27,
1.09)b
Reference
0.8
Marital status, SES,
smoking, PA, BMI, TG,
total chol, SBP, DBP,
use of antihypertensive
medication, diabetes,
parity
Natland
Fagerhaug
et al. (2013)
[14]
65 years
- - - - Ever lactated
Never lactated
Nulliparous
Lifetime lactation
duration:
Reference
1.11 (0.77,
1.69)b
1.20 (1.0.
1.44)b
No clear
associations
(hazard ratios
not reported in
the study).
-
Abbreviations: BMI = body mass index, CHD = coronary heart disease, CHF = congestive heart failure, chol = cholesterol, CI = confidence interval,
CVD = cardiovascular disease, DBP = diastolic blood pressure, HRT = hormone replacement therapy, IHD = ischaemic heart disease, MI = myocardial
infarction, N/A = not applicable, OR = odds ratio, RR = relative risk, SBP = systolic blood pressure, SES = socioeconomic status, TG = triglycerides,
US = United States.
a For the assessment of breastfeeding, self-reported measures included lactation history: defined as ever breastfeeding; lactation duration: length of time a
woman breastfed a child; lifetime lactation duration: cumulative amount of time a woman breastfed across all pregnancies.
b Hazard ratios with 95% CI presented for this paper.
https://doi.org/10.1371/journal.pone.0187923.t005
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duration with MS in a dose-response manner in middle-aged, parous premenopausal women
from various ethnic backgrounds [22]. Another US study reported a significant association
between lactation history and the prevalence of MS in parous women aged20 years. How-
ever, this association was no longer significant after additional adjustment for BMI [23]. The
third study did not find any association between lactation history and the prevalence of the
MS in postmenopausal Korean women [24].
Both prospective studies found significant protective effects of lifetime lactation duration
on incident MS [12,31]. One study following Iranian women over 9 years observed a signifi-
cant association between 13–23 months lifetime lactation duration and higher incidence of
MS compared with24 months [31]. The other study showed that lifetime lactation duration
of 6–9 and>9 months was significantly associated with a lower incidence of MS compared
with 0–1 month lactation, among American women of reproductive age followed over a
20-year period [12].
Metabolic risk factors. Table 2 provides a summary of studies with metabolic risk factors
as the outcomes. Five studies (three cross-sectional/retrospective, two prospective) assessed
the relation between breastfeeding and metabolic risk factors [25,26,32,33,36]. All three cross-
sectional/retrospective studies reported a protective association of breastfeeding with meta-
bolic risk factors [25,26,36]. One study involving Portuguese mothers who were examined at 4
years postpartum, showed that women who breastfed their child for >26 weeks were less likely
to be obese and have and an adverse metabolic profile. However, there was no association
between breastfeeding and excessive weight associated with a healthy metabolic profile [25].
Another cross-sectional/retrospective study found that lifetime lactation duration is associated
in a dose-response fashion with a more favorable cardiovascular risk profile, including lipids,
in a large sample of Norwegian mothers later in life [26]. Similarly, the third cross-sectional/
retrospective study found a dose-response relationship between lifetime lactation duration and
hyperlipidemia in a large sample of US mothers [36].
The findings from relatively small prospective studies were mixed [32,33]. One US prospec-
tive study examining 3-year changes in metabolic risk factors from pre-pregnancy to post-
weaning showed that breastfeeding is associated with a more favorable metabolic risk profile
in the postpartum period [32]. In contrast, the other US prospective study did not find any
association between lactation duration and metabolic risk at 3 years postpartum after adjusting
for pre-pregnancy BMI [33].
Hypertension. Table 3 describes studies with hypertension as the outcome. Seven studies
examined the association between breastfeeding and hypertension [7,8,26–28,36,37]. Breast-
feeding was associated with lower odds of hypertension in all four cross-sectional/retrospective
studies [26–28,36]. Both lactation history and duration were associated with reduced odds
of hypertension in middle-aged and older Chinese mothers [27]. Similarly, in a large sample
of Australian women aged45 years, lactation history was protective compared to parous
women who never breastfed or nulliparous women [28]. Lifetime lactation duration of>6
months, or >3 months/child, was significantly associated with lower odds of hypertension, in
women aged 45–64 years compared with parous women who did not breastfeed. The odds of
hypertension decreased with longer breastfeeding durations and were mostly not significant in
women64 years. In another cross-sectional/retrospective study from Norway, while there
were no clear associations in mothers50 years, mothers aged<50 years who had never lac-
tated had higher odds of hypertension than those who had lactated24 months in their life-
time [26]. In contrast, lifetime lactation duration was significantly associated with lower odds
of hypertension in postmenopausal US women50 years [36].
Breastfeeding also appeared to be protective in two large prospective studies [7,8]. In a
US cohort of parous women, those who did not breastfeed were more likely to develop
Breastfeeding and maternal cardiovascular risk factors and outcomes
PLOS ONE | https://doi.org/10.1371/journal.pone.0187923 November 29, 2017 18 / 27
114
hypertension compared with those who breastfed their first child for12 months or exclu-
sively breastfed their first child for6 months [7]. Lactation history, lifetime lactation dura-
tion between 1–18 months and average lactation duration between 1–9 months were also
protective among a large cohort of premenopausal Korean women followed for six years [8].
In a large cluster RCT from Belarus, despite greater breastfeeding duration and exclusivity
achieved among breastfeeding mothers randomized to a breastfeeding promotion intervention
compared to usual care, there was no significant difference in blood pressure between mothers
receiving the intervention and those allocated to the usual care group. However, this was not
an RCT of breastfeeding per se but of factors aimed at promoting breastfeeding behaviour. In
addition, a marginally significant association was found between lactation duration and lower
blood pressure at 11.5 years postpartum in observational analyses in the same sample regard-
less of treatment allocation [37].
Inflammatory markers and adipokines. Table 4 provides a summary of studies with
inflammatory markers, adipokines and subclinical cardiovascular disease as the outcomes.
Only two papers from the same sample were identified [33,34]. In one paper, two inflamma-
tory markers: C-reactive protein (CRP), commonly associated with cardiovascular health
outcomes [39], and interleukin-6, a proinflammatory cytokine that induces the hepatic pro-
duction of CRP [40], were examined, but neither was significantly related to lactation duration
at 3 years postpartum among 175 women with fasting blood samples after adjusting for pre-
pregnancy BMI [33]. The other paper [34] examined adipokines, which are cytokines secreted
by adipose tissue that are involved in inflammatory responses and associated with metabolic
disease risk [41]. At 3 years postpartum, longer lactation duration was associated with higher
levels of ghrelin and peptide YY, both involved in appetite regulation and associated with
reduced risk of metabolic disease [34].
Subclinical cardiovascular disease. Early physiologic changes in vascular health such as
calcified atherosclerotic plaques and increases in carotid adventitial diameter can be detected
and identify patients at increased risk of future cardiovascular events [42–44]. Two cross-sec-
tional/retrospective studies from the US assessed the relationship between breastfeeding and
subclinical cardiovascular disease [29,30]. Both studies have found non-breastfeeding mothers
to be at increased risk of vascular changes associated with subsequent cardiovascular disease.
Among premenopausal women assessed 4 to 12 years after delivery, mothers who never
breastfed had larger carotid artery lumen and adventitial diameters, which are indicative of
poorer cardiovascular health status, compared with mothers who breastfed all of their children
for at least 3 months [29]. In another study involving an older sample of women between 45 to
58 years of age, the association between lactation and an increased adventitial diameter was
not significant after adjustment for confounders. However, aortic calcification remained sig-
nificantly associated with lactation duration [30]. McClure et al. [29] suggest that differences
in the significance of findings between breastfeeding and adventitial diameter could be due to
the younger age group and shorter time since pregnancy in their study.
Cardiovascular disease. Table 5 describes studies with cardiovascular disease as the out-
come. A few studies investigated the relationship between breastfeeding and cardiovascular
disease, and found protective effects of breastfeeding [13,36]. One US study examined both the
self-reported prevalence and incidence (confirmed by physician adjudication of medical rec-
ords) of cardiovascular disease in a large sample of parous, postmenopausal women [36]. In
that study, increasing lifetime lactation duration was significantly associated with a lower prev-
alence of cardiovascular disease, compared with never breastfeeding. In particular, women
who breastfed13 months in their lifetime and women aged 50–59 years who had breastfed
7 months, were less likely to have prevalent cardiovascular disease. Although women aged
60–69 years with 13–23 months of lifetime lactation had lower odds of prevalent cardiovascular
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disease than similar-aged women who had never breastfed, there were no significant associa-
tions observed in women aged 70–79 years [36].
In that same study, lifetime lactation duration was not associated with incident cardiovas-
cular disease in the overall sample followed for 7.9 years [36]. However, compared to similar-
aged women who never breastfed, significant cardiovascular benefits were seen in women in
the younger age group, but not in the older age groups. In another large US study involving
middle-aged and elderly women, women with a lifetime lactation duration12 months had a
reduced risk of incident myocardial infarction (confirmed by physician review of medical rec-
ords) compared with parous women who had never breastfed [13]. A stronger inverse associa-
tion was observed for women with23 months of lifetime lactation and for those with a birth
in the last 30 years.
Two prospective studies assessed the association between breastfeeding and cardiovascular
disease mortality ascertained from death registries [14,35]. Among a large sample of Chinese
non-smoking textile workers followed between 1989 and 2000, lactation duration was not sig-
nificantly associated with mortality from ischaemic or haemorrhagic stroke [35]. However,
compared to parous women who never breastfed, women who breastfed appeared to have a
lower risk of mortality from ischaemic heart disease. In another study from Norway, mothers
aged<65 years that never breastfed had nearly three times the risk of death from cardiovascu-
lar disease over 15 years compared with mothers with a lifetime lactation duration24
months [14]. There was evidence for a U-shaped association with women who breastfed 7–12
months having almost half the risk of women who breastfed24 months in their lifetime.
There were no significant associations in women 65 years and over.
Overall pattern of associations. The pattern of associations across different outcomes is
summarized in Table 6. Overall, 19 studies (10 cross-sectional/retrospective, 9 prospective)
reported significant protective effects of breastfeeding, nine studies (3 cross-sectional/retro-
spective, 5 prospective, 1 cluster RCT) reported non-significant findings and none reported
Table 6. Summary of expected direction of associationsa between breastfeeding and cardiovascular
risk factors/outcomes.
References Number of
cross-
sectional/
retrospective
studies
Number of
prospective
studies/
cluster
randomized
controlled trial
+ 0 - + 0 -
Cardiovascular risk factors
Metabolic Syndrome [12,22–24,31] 1 2 2
Metabolic risk factors [25,26,32,33,36] 2 1 1
Hypertension [7,8,26–28,36,37] 4 2 1
Inflammatory markers [33] 1
Adipokines [34] 1 1
Subclinical cardiovascular disease [29,30] 2 1
Cardiovascular outcomes
Prevalence/incidence of cardiovascular disease [13,36] 1 1 1
Cardiovascular disease mortality [14,35] 2 1
a The expected direction of each association was hypothesized based on existing literature and coded as: +
(significant association in the hypothesized direction),–(significant association not in the hypothesized
direction), 0 (non-significant association).
https://doi.org/10.1371/journal.pone.0187923.t006
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detrimental effects of breastfeeding. Ten out of thirteen associations reported in cross-sec-
tional/retrospective studies suggested that breastfeeding was associated with significant cardio-
vascular benefits. Although the evidence was less convincing, nine out of fifteen associations
reported in prospective studies also indicated beneficial effects of breastfeeding. Out of all car-
diovascular risk factors and outcomes considered, the evidence for significant protective effects
of breastfeeding was most convincing for hypertension, although the evidence was mainly
based on cross-sectional/retrospective studies. Three-quarters of high quality studies [7, 12, 13,
14, 22, 26, 28, 29, 30, 32, 34, 36] and 80% of medium quality studies [8, 27, 31, 35] reported sig-
nificant protective effects of breastfeeding.
Discussion
This review synthesized the current evidence on the associations between breastfeeding and
cardiovascular risk factors and outcomes, including MS, metabolic risk factors, hypertension,
inflammatory markers, adipokines, subclinical cardiovascular disease and cardiovascular disease.
Nearly all included studies were published in the last decade highlighting the rising interest in
the maternal health benefits of breastfeeding. Overall, most studies reported significant protec-
tive effects of breastfeeding, several reported non-significant findings while there were no studies
that reported detrimental effects of breastfeeding. The cardiovascular benefits of breastfeeding
were present in most studies even after adjustment for multiple covariates, including socio-
demographic, lifestyle factors (e.g. smoking, physical activity, dietary intake), BMI and parity.
In addition, findings from included studies indicate that breastfeeding has favorable short-term
and long-term cardiovascular health outcomes. Altogether, the evidence from medium-high
quality studies suggests that breastfeeding is associated with several cardiovascular health benefits
that can extend to later life, and supports health promotion strategies and interventions to
increase breastfeeding. Notwithstanding, findings from this review should be interpreted with
caution as the evidence gathered for each individual outcome is limited by the small number of
observational studies. In particular, additional prospective studies of larger samples are needed.
Breastfeeding intensity and duration
For optimal child and maternal health benefits, the World Health Organization recommends
exclusive breastfeeding for the first 6 months of life followed by two years or more of breastfeed-
ing supplemented by complementary foods [45]. With the exception of four studies [7,33,34,37],
most studies did not distinguish between exclusive breastfeeding, a measure of breastfeeding
intensity, and breastfeeding supplemented by other foods. Several studies compared exclusive
breastfeeding for6 months with shorter durations of exclusive breastfeeding or non-exclusive
breastfeeding, and found inconsistent associations with a range of cardiovascular outcomes
[7,33,34,37]. Overall, additional studies that explore the association between exclusive breast-
feeding and a range of short- and long-term cardiovascular health outcomes are needed.
Breastfeeding appears to be a protective factor for several maternal cardiovascular risk fac-
tors and outcomes, with evidence suggesting that increased duration may be associated with
further benefits. Based on evidence from both cross-sectional/retrospective and prospective
studies, benefits were reported for24 months of lifetime lactation for most outcomes includ-
ing metabolic risk factors [26,36], hypertension [28], the prevalence [36] and incidence of car-
diovascular disease [13], and mortality from cardiovascular disease [14].
Dose-response
A dose-response relationship has been suggested between breastfeeding and various cardiovas-
cular outcomes including MS, several metabolic risk factors, hypertension and the prevalence
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of cardiovascular disease. A cross-sectional/retrospective study among parous pre-menopausal
women found a dose-response association between lifetime lactation duration and MS [22].
However, this relationship was modified by parity and protective effects of breastfeeding were
no longer observed after four births. A prospective study also found dose-response effects of
lifetime lactation duration up to>9 months on incident MS developed over a 20-year period
[12]. In two large cross-sectional/retrospective studies involving parous women<50 years [26]
and postmenopausal women [36], inverse dose-response associations were observed between
lifetime lactation duration up to24 months and several maternal cardiovascular risk factors
including lipid levels [26,36], blood pressure [26,36], and the prevalence of cardiovascular dis-
ease [36].
Although findings from these studies suggest that there is a dose-response relationship
between breastfeeding and metabolic risk factors, additional evidence is needed, particularly
from longitudinal studies. The possibility of a U-shaped relationship between breastfeeding
and cardiovascular mortality [14] should also be further investigated.
Short vs long-term outcomes
A previous systematic review has evaluated the relationship between breastfeeding and postpar-
tum weight change and has found inconclusive evidence [17]. In our systematic review, lacta-
tion was associated with maternal improvements in metabolic risk factors from preconception
to post-weaning in one prospective study [32] while no association was detected in another pro-
spective study at 3 years postpartum [33]. However, an association between breastfeeding and
adipokine levels at 3 years postpartum was reported in the latter cohort [34].
Meanwhile, evidence from cross-sectional/retrospective studies among middle-aged and
older women suggests that breastfeeding may have protective effects in later life against hyper-
tension [22,28], metabolic risk [26,36] and cardiovascular disease [36].
Findings from prospective studies suggest that breastfeeding may be protective against the
incidence of: MS among young and middle-aged women followed for 9 [31] or 20 years [12],
hypertension among young and middle-aged women after 6 years of follow-up [7,8], cardio-
vascular disease among middle-aged [13] and older women [36] followed between 8–12 years,
mortality from ischaemic heart disease over a 10 year period [35] and mortality from cardio-
vascular disease in women of various ages followed for 15 years [14].
Age, time since last birth and menopause. Findings from one cross-sectional/retrospec-
tive study [26] and a few prospective studies [14,28,36] suggest that the benefits from breast-
feeding may diminish with age. In a large cross-sectional Norwegian study, significant
associations between lifetime lactation duration and cardiovascular risk factors were observed
in parous women <50 years. However, there were no clear associations in women >50 years
[26]. Among three prospective studies, there were unclear associations with hypertension [28],
the incidence of cardiovascular disease [36], or cardiovascular disease mortality [14] in women
>60 [36] or>65 years of age [14,28]. Time since last birth may also have an effect on the asso-
ciation between breastfeeding and cardiovascular outcomes [13,26,36]. Among Norwegian
mothers <50 years, the association between lifetime lactation duration and hypertension was
attenuated after adjustment for time since last birth, while the association with metabolic risk
factors remained similar [26]. In a large prospective cohort study, there was a stronger associa-
tion between breastfeeding and incident myocardial infarction for women who gave birth in
last the 30 years compared to women who had not [13]. Menopausal status may also influence
the risk of cardiovascular disease. Among a large cohort of postmenopausal women, increasing
lifetime lactation duration was associated with a lower prevalence of hypertension, diabetes,
hyperlipidemia and cardiovascular disease [36]. There was also a significant association
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between breastfeeding and the incidence of cardiovascular disease among women between 50–
59 years of age, but not among women >60 years [36]. Whether older age, increasing time
since last birth and menopause attenuate the association between breastfeeding and cardiovas-
cular risk factors and outcomes requires further investigation.
Potential mechanisms
Breastfeeding increases metabolic expenditure approximately by 480 calories/day [46].
Although the effects of breastfeeding on postpartum weight change remains inconclusive
[15,17], breastfeeding may lower cardiovascular risk by mobilizing fat stores accumulated dur-
ing pregnancy. Breastfeeding may also have favorable effects on glucose metabolism, glycemic
control and lipid metabolism [2–6]. The “reset hypothesis” in which breastfeeding “resets”
maternal metabolism after pregnancy by reversing visceral fat accumulation and increases in
insulin resistance, lipid and triglyceride levels has been proposed [47]. Hormones associated
with breastfeeding such as prolactin and oxytocin may also exert effects on maternal blood
pressure [48–50]. In addition, oxytocin may promote mother-child attachment and lead to
reduced stress levels.
Methodological considerations
Several methodological issues should be considered in interpreting these findings. Observa-
tional studies are subject to residual confounding. Unmeasured confounders could include
health-enhancing behaviors of breastfeeding mothers that distinguish them from non-breast-
feeding mothers, and factors that influence breastfeeding initiation and duration such as pre-
pregnancy BMI and pre-existing metabolic risk factors [51–53]. Breastfeeding measures were
self-reported and recall bias may have led to misclassification of a woman’s lactation history
such as under- or over reporting of breastfeeding duration [54]. However, maternal recall of
breastfeeding has been shown to be valid and reliable [55]. Differences in findings could be
due to a number of factors that vary between studies including sample characteristics (e.g.
country, setting), breastfeeding comparison categories, covariate adjustment and follow-up
periods for prospective studies. Most included studies did not assess the exclusivity of breast-
feeding, a measure of breastfeeding intensity. Temporal relationships could not be established
from cross-sectional studies.
Strengths and limitations
The strengths of this review include systematic literature search, data extraction and summari-
zation, an evaluation of the quality of included studies using established checklists, a range of
maternal cardiovascular risk factors and outcomes examined, the inclusion of various breast-
feeding comparison categories, the assessment of evidence relating to exclusive breastfeeding
and dose-response relationship between breastfeeding and maternal outcomes, as well as a sys-
tematic and detailed approach in reporting findings. The limitations of this systematic review
reflects limitations of the existing literature, such as a small number of prospective studies for
each outcome of interest and methodological issues described above. Although the search
terms used were comprehensive, there is a possibility that relevant studies were not identified
by this systematic review.
Conclusion
Overall, the evidence from this systematic review suggests that breastfeeding is associated
with maternal cardiovascular health benefits that extend from child-bearing years to later life.
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However, additional longitudinal research is needed to investigate the association between
breastfeeding and specific cardiovascular risk factors and outcomes and to further inform the
evidence base.
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S1 Table. Search strategy used for MEDLINE, which was then adapted for EMBASE and 
CINAHL. 
1. Breast Feeding (as a subject heading) 
2. Lactation (as a subject heading) 
3. Milk, Human (as a subject heading) 
4. Breast fed (as a text word) 
5. Breastfe* (as a text word) 
6. Lactat* (as a text word) 
7. Breast milk (as a text word) 
8. 1 or 2 or 3 or 4 or 5 or 6 or 7  
9. Maternal Health (subject heading) 
10. Maternal health (as a text word) 
11. Exp Women’s Health (subject heading) 
12. Reproductive history (subject heading) 
13. (wom#n adj2 health) (as a text word) 
14. (mother* adj2 health) (as a text word) 
15. 9 or 10 or 11 or 12 or 13 or 14 
16. Cardiovascular diseases (subject heading) 
17. Hypertension (subject heading) 
18. Risk factors (subject heading) 
19. Coronary Artery Disease (subject heading) 
20. Obesity (subject heading) 
21. Diabetes Mellitus, Type 2 (subject heading) 
22. Myocardial ischemia (subject heading) 
23. Ischemic heart disease (as a text word) 
24. Ischaemic heart disease (as a text word) 
25. 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 
26. 8 and 15 and 25 
27. Limit 26 to (English language and female and humans) 
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S2 Table. Quality assessment criteria adapted from a 15-item checklist used by Van Uffelen et al. [31] 
Item  Criteria Description 
1 Objectives Are the objectives or hypotheses of the research described in the paper 
stated? 
2 Study design Is the study design presented? 
3 Target population Do the authors describe the target population they wanted to research? 
4 Sample Was a random sample of the target population taken? AND was the 
response rate 60% or more? 
5 Sample Is participant selection described? 
6 Sample Is participant recruitment described, or referred to? 
7 Sample Are the inclusion and/or exclusion criteria stated? 
8 Sample Is the study sample described? (minimum description=sample size, 
gender, age and an indicator of socio-economic status) 
9 Sample Are the numbers of participants at each stage of the study reported 
(Authors should report at least numbers eligible, numbers recruited, 
numbers with data at baseline, and numbers lost to follow-up) 
10 Variables Are the measures of breastfeeding and health outcome of interest 
described? 
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11 Data sources and collection Do authors describe the source of their data (e.g., registry, health 
survey) AND did authors describe how the data were collected? (e.g.,  
by mail)  
12 Measurement Was reliability of the measure(s) of breastfeeding mentioned or 
referred to? 
13 Measurement Was the validity of the measure(s) of breastfeeding mentioned or 
referred to? 
14 Statistical methods Were appropriate statistical methods used and described, including 
those for addressing confounders? 
15 Statistical methods Were the numbers/percentages of participants with missing data for 
breastfeeding and the health outcome indicated AND If more than 
20% of data in the primary analyses were missing, were methods used 
to address missing data? 
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S3 Table. Critical appraisal of included cross-sectional/retrospective and prospective studies based on 15 quality assessment criteria. 
Abbreviations: N=No, U=Unclear, Y=Yes. 
First author (publication 
year) / 
Quality assessment 
criteria addresseda 
#1 #2 #3 #4 #5 #6 #7 #8 #9  #10 #11 #12 #13 #14 #15 Overall 
countb 
Overall study 
quality ratingc 
Cho (2009) [24] Y Y Y Y Y Y Y Y Y Y U Y Y Y U 13 Y, 2 U High 
Ram (2008) [22] Y Y Y U Y Y Y Y Y Y Y Y Y Y Y 14 Y, 1 U High 
Cohen (2006) [23] Y Y Y U Y Y Y Y U Y Y N N Y U 10 Y, 3 U, 2 N Medium 
Gunderson (2010) [12] Y Y Y Y Y Y Y Y Y Y Y N N Y Y 13 Y, 2 N High 
Gunderson (2007) [32] Y Y Y Y Y Y Y Y Y Y Y N N Y Y 13 Y, 2 N High 
Ramezani Tehrani (2014) 
[31] 
Y Y Y U Y Y U U U Y Y Y Y Y N 7 Y, 4 U, 1 N Medium 
Zhang (2015) [27] Y Y Y U Y N N Y N Y Y N N Y U 8 Y, 2 U, 5 N  Medium 
Lupton (2013) [28] Y Y Y N Y Y Y Y Y Y Y N N Y Y 12 Y, 3 N High 
Lee (2005) [8] Y Y Y N Y Y Y U U  Y Y N N Y U 9 Y, 3 U, 3 N Medium 
Stuebe (2011) [7] Y Y Y U Y N Y Y Y Y Y N N Y Y 11 Y, 1 U, 3 N High 
McClure  (2012) [29] Y Y Y N  Y Y Y Y Y Y Y N N Y Y 12 Y, 3 N High 
Schwarz (2010) [30] Y Y Y U Y U Y Y Y Y Y N Y Y Y 12 Y, 2 U, 1 N High 
Gallagher (2011) [35] Y Y Y N Y Y U Y U  Y Y N N Y U 9 Y, 3 U, 3 N Medium 
Natland (2012) [26] Y Y Y N Y Y Y Y Y Y Y Y Y Y Y 14 Y, 1 N High 
Stuebe (2009) [13] Y Y Y N Y Y Y Y Y Y Y N Y Y Y 13 Y, 2 N High 
Henriques (2015) [25] Y Y Y N Y Y Y Y Y Y Y N N Y Y 12 Y, 2 N High 
Schwarz (2009) [36] Y Y Y N Y Y Y Y Y Y Y N Y Y Y 13 Y, 2 N High 
Stuebe (2011) [34] Y Y Y N Y Y Y U Y Y Y N N Y Y 11 Y, 1 U, 3 N High 
Natland (2013) [14] Y Y Y N Y Y Y Y Y Y Y Y Y Y Y 14 Y, 1 N High 
Stuebe (2010) [33] Y Y Y N Y Y Y U Y Y Y N N Y Y 11 Y, 1 U, 3 N High 
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a Quality assessment criteria addressed were based on a checklist used by Van Uffelen et al. [20] and related to 15 criteria listed and 
described in S2 Table. 
b Each individual criteria was allocated a Y (yes) if it was met/addressed, N (no) if it was not met or U (unclear) if it was unclear 
whether the criteria was met. An overall count of the total number of individual criteria that were met, not met and that were unclear is 
provided.  
c An overall study quality rating was allocated based on the total number of criteria that were met (i.e., total number of “yes”). Studies 
were rated as: “low quality” if ≤1/3 of individual criteria were met, “medium quality” if >1/3-≤2/3 of individual criteria were met and 
“high quality” if >2/3 of criteria were met. 
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S4 Table. Critical appraisal of single cluster randomized controlled trial [37] based on 
quality assessment checklist developed by the Cochrane Collaboration for assessing risk of 
bias in randomized studies [21]. 
 
Quality assessment criteria Was criteria met/addressed? a 
Random sequence generation Yes 
Allocation concealment Yes 
Blinding of participants and personnel No 
Blinding of outcome assessment No 
Completeness of outcome data Yes 
Accurate outcome reporting Yes 
Other sources of bias addressed Yes 
Overall countb 5 Yes, 2 No 
Overall study quality ratingc High 
 
a Each individual criteria was allocated a “yes” if it was met/addressed, “no” if it was not met or 
“unclear” if it was unclear whether the criteria was met.  
b An overall count of the total number of individual criteria that were met, not met and that were 
unclear is provided.  
c An overall study quality rating was allocated based on the total number of criteria that were met 
(i.e., total number of “yes”). Studies were rated as: “low quality” if ≤1/3 of individual criteria 
were met, “medium quality” if >1/3-≤2/3 of individual criteria were met and “high quality” if 
>2/3 of criteria were met.  
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 CONCLUDING SUMMARY FOR THIS CHAPTER AND KNOWLEDGE GAINED 
FROM THIS STUDY 
To our knowledge, this was the first study to systematically summarise the evidence for 
an association between breastfeeding and metabolic syndrome, hypertension and CVD. Overall, 
21 studies were included in the systematic review. Most studies reported significant short- and 
long-term protective effects of breastfeeding and supported health promotion strategies to 
increase breastfeeding in mothers to derive health benefits. However, one of the research gaps 
identified in this study was that the evidence for each individual outcome was provided by a 
limited number of prospective cohort studies.   
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CHAPTER SEVEN:                                                                           
Breastfeeding and cardiovascular disease hospitalisation and mortality in parous 
women: Evidence from a large Australian cohort study 
 PREFACE TO THE CHAPTER 
This chapter presents findings from a paper examining the association between 
breastfeeding and CVD-related hospitalisation and mortality among parous women from the 45 
and Up Study cohort. The version of the paper that has been accepted for publication forms this 
chapter and is presented in manuscript format. Supplementary material accompanying the 
submitted manuscript is also included in this chapter. The paper addresses specific aim #4 of this 
thesis as described in Chapter 1. Dissemination of this research and author contributions for this 
paper are described below.  
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The research presented in this chapter has been disseminated as follows: 
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Published conference abstract 
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http://doi.org/10.1016/j.respe.2018.05.192 
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presentation] 
Nguyen B, Bauman A, Ding D. Gale J, Nassar N, Bauman A, Joshy G, Ding D. 
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Abstract 
Background. Few studies have investigated the longitudinal association between breastfeeding 
and maternal cardiovascular disease (CVD) outcomes. This study examined the association 
between breastfeeding and CVD hospitalisation and mortality in a large Australian cohort.   
Methods and Results. Baseline questionnaire data (2006-2009) from a sample of 100,864 parous 
women aged ≥45 years from New South Wales, Australia, were linked to hospitalisation and 
death data until June 2014 and December 2013, respectively. Analysis was restricted to women 
without self-reported medically diagnosed CVD at baseline or without prior CVD hospitalisation 
six years prior to study entry. Never versus ever breastfeeding and average breastfeeding 
duration per child, derived from self-reported lifetime breastfeeding duration and number of 
children, and categorised as never breastfed, <6, >6-12, >12 months/child, were assessed. Cox 
proportional hazards models were used to explore the association between breastfeeding and 
CVD outcomes. Covariates included socio-demographic characteristics, lifestyle risk factors, and 
medical and reproductive history.  
There were 3,428 (3.4%) first CVD-related hospital admissions and 418 (0.4%) deaths during a 
mean follow-up time of 6.1 years for CVD hospitalisation, and 5.7 years for CVD mortality. 
Ever breastfeeding was associated with lower risk of CVD hospitalisation (adjusted HR [95% 
CI]=0.86 [0.78, 0.96]; p=0.005) and CVD mortality (adjusted HR [95% CI]: 0.66 [0.49, 0.89]; 
p=0.006) compared to never breastfeeding. Breastfeeding ≤12 months/child was significantly 
associated with lower risk of CVD hospitalisation.  
Conclusions. Breastfeeding is associated with lower maternal risk of CVD hospitalisation and 
mortality in middle-aged and older Australian women. Breastfeeding may offer long-term 
maternal cardiovascular health benefits.  
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Clinical Perspective 
1) What is new? 
 Findings from this study add to the growing evidence base for the long-term 
benefits of breastfeeding for maternal cardiovascular health 
 Among parous women ≥45 years and over, ever breastfeeding and average 
breastfeeding duration per child up to 12 months were associated with 
substantially lower risk of developing and dying from cardiovascular disease  
 Findings were mostly consistent among women from different socio-economic 
backgrounds and with different lifestyle risk 
 
2) What are the clinical implications? 
 This study provides evidence that breastfeeding is associated with long-term 
benefits for maternal cardiovascular health, in addition to its known benefits for 
infants and mothers 
 Breastfeeding may be promoted as an additional strategy by which parous women 
can reduce their risk of developing and dying from CVD  
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1. Introduction 
Cardiovascular disease (CVD) is the leading cause of death for women worldwide [1]. 
Preventing CVD through modifying known lifestyle risk factors, such as being overweight and 
an unhealthy diet, is a key public health priority. While changes in established lifestyle risk 
factors can lead to substantial reduction in the risk of developing CVD, prevention approaches 
should also incorporate emerging knowledge about novel risk factors of CVD, including 
behaviours that are specific to women. There has been an urgent, global call to conduct more 
gender-specific research to better inform public health strategies [2]. Gender differences exist in 
the epidemiology, diagnosis, risk profile, and treatment of CVD. Compared to men, women 
generally develop CVD at a later age, present with different symptoms and risk factors, are 
underdiagnosed, and respond differently to various treatments [2].  
Breastfeeding has emerged in recent years as a lifestyle risk factor that may be associated with 
CVD, however the evidence is limited by the small number of observational studies, particularly 
longitudinal studies [3]. The prevalence of early initiation of breastfeeding within one hour of 
birth is approximately 30% in high-income countries [4] and around 79% of newborns in high-
income countries are ever breastfed [5]. Globally, the prevalence of exclusive breastfeeding for 
infants under 6 months of age is approximately 43% [5]. During pregnancy, profound metabolic 
changes occur in a mother’s body to support fetal growth and prepare for lactation [6]. It has 
been hypothesised that breastfeeding, which increases metabolic expenditure by an estimated 
480 kcal/day, may enable a more rapid reversal of metabolic changes in pregnancy, including 
improved insulin sensitivity, lipid metabolism and greater mobilisation of accumulated fat stores, 
thereby “resetting” maternal metabolism after pregnancy and potentially reducing maternal risk 
of cardiometabolic disease [7]. Multiple studies have reported the short-term benefits of 
 141 
 
breastfeeding including lipid homeostasis [8,9], glucose homeostasis and insulin sensitivity 
[10,11]. However, whether these benefits can contribute to long-term maternal health are 
unclear. 
Emerging evidence suggests that breastfeeding may reduce the risk of developing type 2 diabetes 
[12], hypertension [13], and the metabolic syndrome [14] later in life. Although a number of 
studies have examined the associations between breastfeeding and CVD outcomes such as the 
incidence of CVD [3,15-18] or death from CVD [3,19-22], findings from these studies are 
inconclusive.  
An important issue to consider in interpreting these observational studies is confounding [3]. 
Mothers who have breastfed tend to be older, from a higher socio-economic background, have 
achieved higher levels of education and participate in health-promoting behaviours in 
comparison to non-breastfeeding mothers [23,24]. Maternal characteristics, such as living in 
lower socio-economic areas, have been highly associated with not breastfeeding over subsequent 
births [25], but residual confounding due to unmeasured factors may remain an issue. These 
socio-economic factors and health-promoting behaviours may also potentially bias the 
association between breastfeeding and CVD outcomes, and while previous studies have adjusted 
for their confounding effects [14-17,20,21], they did not investigate potential effect modification 
by socio-economic status and overall lifestyle.   
The aims of this paper were to examine the association between breastfeeding and CVD 
hospitalisation and mortality in a large cohort of middle-aged and older parous women. Findings 
from this study can help build the evidence base for breastfeeding as an additional strategy to 
prevent CVD. 
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2. Methods 
The authors declare that all supporting data are available within the article (and its online 
supplementary files). 
2.1. Study population 
The Sax’s Institute’s 45 and Up Study is a large-scale prospective cohort study of 123,815 men 
and 143,073 women aged 45 years and over residing in the state of New South Wales (NSW), 
Australia. From 2006 to 2009, potential participants were randomly sampled from the 
Department of Human Services enrolment database, the national health insurance provider, and 
were invited to take part in the study. Individuals joined the study by completing a postal 
questionnaire and providing informed consent for follow-up which included linkage of 
questionnaire data to population health databases. The study methods have been described in 
detail elsewhere [26].  
We included all women who completed a baseline questionnaire. Women who reported that they 
had ever been diagnosed with or recently treated for CVD (self-reported heart disease, stroke or 
blood clot: n=21,797) or with a hospital admission in the six years prior to study entry (with a 
CVD diagnosis code in any diagnostic field or a CVD-related procedure code in any procedure 
code field [27]; n=13,323) were excluded from analysis. We further excluded those who were 
nulliparous (never given birth, n=15,654) or with unknown parity (n=918) at baseline and parous 
women with unknown breastfeeding duration (n=2,187). The final study sample included 
100,864 women with reported breastfeeding duration. A participant flow chart for this study is 
provided in Figure 1.  
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The 45 and Up Study received ethics approval from the University of NSW Human Research 
Ethics Committee. Approval to use data from the 45 and Up Study for this paper was obtained 
from the NSW Population and Health Services Ethics Committee. 
2.2. Measurement 
2.2.1. Exposure. The baseline questionnaire for women (available at 
http://www.saxinstitute.org.au/our-work/45-up-study/questionnaires/) included self-reported 
information on socio-demographic and lifestyle factors, height and body weight, medical and 
reproductive history. Women were asked to report the number of children they had given birth to 
and also the cumulative amount of time spent breastfeeding across all pregnancies, based on the 
question: “For how many months, in total, have you breastfed?” The average breastfeeding 
duration per child was derived from answers to these questions and categorised as never 
breastfed, >0 to 6 (<6) months, >6 to 12 months, >12 months. Breastfeeding was also explored 
as a binary variable in terms of whether a woman had ever versus never breastfed (also referred 
to as breastfeeding history).  
2.2.2. Outcomes. The baseline questionnaire data were linked to hospital data from the NSW 
Admitted Patient Data Collection (APDC; until June 2014), mortality data from the NSW 
Registry of Births, Deaths, and Marriages (until June 2014), and data on causes of death from the 
Cause of Death Unit Record File (until December 2013) by the Centre for Health Record 
Linkage (CHeReL, NSW, Australia) using probabilistic record linkage methods and a 
commercially available software (Choice-Maker, ChoiceMaker Technologies Inc.). The 
probabilistic data linkage conducted by CHeReL has been reported to be highly accurate with 
false-positive and false-negative rates below 0.4% (http://www.cherel.org.au/quality-assurance). 
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A recent study has also shown that the accuracy of probabilistic linkage is unlikely to vary by 
socio-economic status in older adults [28].  
The APDC is a complete census of all public and private hospital admissions in NSW that 
includes details of admissions such as dates of admission and discharge, and records all related 
diagnoses for each admission. These are coded using the World Health Organization 
International Classification of Diseases, 10th revision– Australian Modification (ICD10-AM) 
system. The NSW Registrar of Births, Deaths, and Marriages captures all deaths in NSW with 
causes subsequently coded using the ICD10-AM classification. In both data sources, the first 
CVD hospitalisation or death since baseline was based on a primary diagnosis of CVD of either 
ischemic heart disease (IHD; ICD10-AM codes: I20-I25) or cerebrovascular disease (ICD10-AM 
codes: I61-I67, I69) [29,30].  
2.2.3. Covariates. Multivariable analyses were adjusted for a range of socio-demographic and 
lifestyle factors, and medical and reproductive history based on self-reported responses in the 
baseline survey. Socio-demographic variables included age (45-54, 55-64, ≥65 years), country of 
birth (Australia/other), highest educational qualification (≤10 years of schooling, high 
school/trade apprenticeship/certificate/diploma, university degree/higher), marital status 
(married/living with a partner or single/widowed/divorced/separated) and area-level socio-
economic status (population-level quintiles based on the Socio-Economic Indexes For Area - 
Index of Relative Socio-Economic Disadvantage [31]). Lifestyle factors were based on responses 
at baseline and used as a marker of health-related behaviours. These included body mass index 
(kg/m2; calculated as weight divided by height squared), smoking status (never, past, current), 
alcohol intake (≤14 or >14 drinks/week [32]), physical activity (assessed using validated 
questions from the Active Australia Survey [33]; categorised as <150, 150-299, ≥300 minutes 
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per week), multi-vitamin use (for most of the last four weeks; yes/no), omega 3 or fish oil use 
(yes/no), use of aspirin (yes/no), and oral contraceptive use (ever/never). Reproductive history 
was based on number of children given birth to (1, 2, 3, ≥4), mother’s age for first child, 
mother’s age for last child. Medical history was assessed using family history of CVD (yes/no), 
family history of hypertension (yes/no), family history of diabetes (yes/no), self-reported 
hypertension/recent treatment for hypertension (yes/no), and self-reported diabetes/recent 
treatment for diabetes (yes/no).  
2.3. Statistical analysis 
Baseline participant characteristics by breastfeeding history and duration are presented as means 
(standard deviation [SD]) for continuous variables and as percentages for categorical variables. 
Differences in baseline characteristics were assessed using chi-square tests for categorical 
variables, student t-tests for continuous variables with binary breastfeeding categories, and F 
statistics from ANOVA for continuous variables with multiple lactation categories. Crude and 
adjusted hazard ratios (HR) with 95% confidence intervals (CI) were estimated for associations 
between either breastfeeding history or average breastfeeding duration per child and CVD 
outcomes by using Cox proportional hazards models. Separate models were used for CVD 
hospitalisations and CVD deaths with a time scale in years. In the analyses of incident CVD 
hospitalisation, CVD death before hospitalisation was not treated as a competing outcome, 
instead participants were censored at death irrespective of cause of death. Eligible women 
contributed person-years from the date of recruitment until admission date, date of death or end 
of follow-up (18 June 2014), which ever was the earliest; end of follow up was 31 December 
2013 for analyses of CVD mortality. Proportionality assumptions were verified based on the 
methods of Lin et al. [34]. The “never breastfed” category was used as the reference category. 
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Left-truncated data were used to adjust for different CVD risk exposure times for each woman 
before baseline entry into the study [35]. This approach helped to account for differences in the 
time that some women may have been diagnosed with CVD in the months or years prior to 
enrolment in the study. For each of the CVD outcomes, four sequential models were used: 
unadjusted models (model 1), models adjusted for parity and socio-demographic characteristics 
(number of children, age, country of birth, educational level, marital status, area-level socio-
economic status; model 2), models further adjusted for lifestyle factors (body mass index, 
smoking status, alcohol intake, physical activity; model 3), and models further adjusted for 
medical and reproductive covariates (multi-vitamin use, omega 3 or fish oil use, use of aspirin, 
oral contraceptive use, mother’s age for first child, mother’s age for last child, family history of 
CVD, family history of hypertension, family history of diabetes, self-reported 
hypertension/recent treatment for hypertension, and self-reported diabetes/recent treatment for 
diabetes; model 4). To account for potential interaction by socioeconomic status and lifestyle 
risk, analyses were stratified by educational attainment and a healthy lifestyle index, used as a 
marker for CVD lifestyle risk factors. The healthy lifestyle index has been adapted from a 
lifestyle risk index previously developed using the 45 and Up Study cohort [36] and the Healthy 
Heart Score developed by Harvard School of Public Health [37]. It is based on the following six 
lifestyle risk factors scored individually as healthy (score=1) or not healthy (score=0): body mass 
index (<25 kg/m2=1, ≥25 kg/m2=0), physical activity level (<150 min/week=1; ≥150 
min/week=0), smoking status (past/current smoker=0; never smoker=1), alcohol intake (≤14 
drinks/week=1; >14 drinks/week=0), sleep (>7-<9 hours/day=1; <7 hours/day or >9 
hours/day=0), fruit and vegetable intake (<2 serves of fruit/day and <3 serves of fruit/day=0; ≥2 
serves of fruit/day and ≥3 serves of vegetables/day=1). For the stratified analyses, the healthy 
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lifestyle index was dichotomised as either healthy (sum of scores=5-6) or not healthy (sum of 
scores=0-4). Interactions were considered significant if p<0.05. Statistical significance was 
defined as p<0.05 and analyses were conducted using SAS version 9.3 (SAS Institute Inc.). 
 
3. Results 
3.1. Participant characteristics  
Table 1 shows baseline socio-demographic characteristics and parity of the 100,864 parous 
women included in our study. The mean age of the sample was 60.2 (SD: 10.2) years. More than 
three-quarters (76.7%) of women were born in Australia, more than a third (40%) had ≤10 years 
of education, three quarters (75.4%) were married, and nearly two thirds (61.3%) belonged to the 
three lowest socioeconomic population-level quintiles. Of all parous women, 87.6% had a 
history of breastfeeding. On average, women had 2.7 (SD: 1.2) children and breastfed for 5.4 
(standard deviation [SD]: 5.4) months per child. Compared to women who never breastfed, 
women who ever breastfed were more likely to be younger at baseline, have more children, a 
higher level of education, be married/living with a partner and live in an area with higher 
socioeconomic quintile. Women that had ever breastfed were also less likely to be obese, smoke 
and were more likely to engage in higher levels of physical activity and consume omega 3 or fish 
oil. The 45-54 years age group was more likely to have a higher breastfeeding duration per child 
than the older age groups. Those who breastfed >12 months on average per child were more 
likely to have a university degree. The lifestyle, medical and reproductive characteristics of 
women at baseline are presented in Supplementary Table 1.  
3.2. Breastfeeding and CVD hospitalisation/mortality  
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Supplementary Table 2 presents HR and 95% CI for the incidence of CVD hospitalisation and 
mortality by breastfeeding history. During a mean follow-up of 6.1 years for CVD 
hospitalisation, and 5.7 years for CVD mortality, there were 3,428 (3.4%) first CVD-related 
admissions and 418 (0.4%) deaths. Compared to parous women who never breastfed, women 
who ever breastfed had lower risk of CVD hospitalisation (model 4: HR: 0.86; 95% CI: 0.78, 
0.96; p=0.005) and mortality from CVD (model 4: HR: 0.66; 95% CI: 0.49, 0.88; p=0.006), in 
both unadjusted and adjusted models (p<0.01).  
Table 2 shows HR and 95% CI for the incidence of CVD hospitalisation and mortality by 
average breastfeeding duration per child. In both unadjusted and adjusted models, women who 
breastfed on average >0-6 months or >6-12 months per child had lower risk of CVD 
hospitalisation (model 4, <6 months: 0.86 (0.78, 0.96); >6-12 months: 0.85 [0.75-0.97]) and 
mortality (model 4, <6 months: 0.69 (0.51, 0.94); >6-12 months: 0.59 [0.41-0.84]), compared to 
women who never breastfed.  
3.3. Stratified analyses 
Overall, none of the tests for interaction were statistically significant (all p>0.05). In the 
stratified analysis by education, the association between breastfeeding and CVD outcomes were 
similar across education strata (Supplementary Table 3). While, in the stratified analysis by 
healthy lifestyle index (Supplementary Table 4), the association between breastfeeding and 
CVD hospitalisation was non-significant in those with lower lifestyle scores (“not healthy”) 
while protective in those with higher lifestyle scores (“healthy”). However, the association with 
CVD mortality was similarly protective in those with low and high lifestyle scores.  
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4. Discussion 
In this large cohort of parous women aged 45 years and over, ever breastfeeding and average 
breastfeeding duration up to 12 months per child were associated with lower risk of incident 
CVD hospitalisation and CVD mortality. Following adjustment for socio-demographic, lifestyle-
related and reproductive variables, ever breastfeeding was associated with a 14% lower risk of 
CVD hospitalisation and a 34% lower risk of mortality from CVD compared to never 
breastfeeding. Average breastfeeding duration per child up to 12 months was significantly 
associated with a ~15% lower risk of incident CVD and a 30-40% lower risk of CVD mortality 
compared to never breastfeeding. Findings were mostly consistent among women from different 
socio-economic backgrounds and with different lifestyle risk.  
This longitudinal study provides further evidence that among childbearing women breastfeeding 
may offer long-term cardiovascular health benefits. The protective nature of the association 
between breastfeeding history and CVD outcomes is generally consistent with findings from the 
few previous studies which have examined similar associations among parous women from large 
cohorts (Supplementary Table 5) [15,16,20]. Differences between studies in the magnitude of 
the associations could be due to variation in follow-up periods, types of CVD and outcomes 
examined, covariate adjustment, and cohort characteristics. Compared with previous studies, this 
study was novel in that it examined associations in an Australian setting, included more socio-
demographic and lifestyle covariates, and stratified analyses by socio-economic status and a 
healthy lifestyle index. 
While previous studies have typically expressed breastfeeding duration in terms of lifetime 
breastfeeding duration, we chose to present breastfeeding duration as the average duration per 
child to help standardise findings, better account for parity and facilitate interpretation of 
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findings. We modelled average breastfeeding duration as a categorical variable due to the non-
linearity of the distribution and chose clinically relevant cut-points based on breastfeeding 
guidelines. This study showed that an average breastfeeding duration per child up to 12 months 
was associated with lower risk of incident CVD hospitalisation and mortality compared with 
never breastfeeding. To our knowledge, there have been only two previous studies that have 
examined the association between average breastfeeding duration per child and CVD outcomes 
(Supplementary Table 5) [15,16] and both have reported inverse associations. In the case-
cohort study nested within EPIC, an average breastfeeding duration ≥6 months, the highest 
breastfeeding duration considered, was associated with a 33% lower risk of incident IHD [15]. In 
the China Kadoorie Biobank study, each additional 6 months of breastfeeding per child was 
associated with a 4% and 3% lower risk of incident IHD and stroke, respectively [16]. However, 
different breastfeeding measures and study settings may limit the comparability of findings 
across studies.   
In the present study, there was no clear evidence for a dose-response relationship between 
average lactation duration per child and CVD outcomes. In agreement with findings from our 
study, there was no solid evidence for a threshold or dose-response effect in the few studies that 
have examined average breastfeeding duration per child [15,16]. While inconsistent associations 
have been shown between lifetime breastfeeding duration and CVD mortality, findings from 
some studies suggest a potential threshold effect [18] or a U-shaped association [21]. However, 
further longitudinal research is needed. 
4.1. Strengths and limitations 
Strengths of this study include a large cohort size and prospective follow-up which enabled us to 
examine the association between breastfeeding and long-term cardiovascular outcomes. 
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Compared with previous studies, this study adjusted for a comprehensive range of covariates 
including relevant socio-demographic, lifestyle and reproductive factors, and sensitivity analyses 
stratified by socio-economic status and a healthy lifestyle index were conducted.  
Several limitations should be mentioned. As for all observational studies, residual confounding 
may be an issue. Mothers that have breastfed may generally lead healthier lifestyles and come 
from higher socio-economic backgrounds [23,24] that could have contributed to the observed 
associations. However, adjusting for socio-economic factors and lifestyle-related covariates did 
not alter the findings of this study, and associations appeared mostly consistent across different 
education and lifestyle categories. Some of the findings should nonetheless be interpreted with 
caution due to small cell sample sizes in some of the stratified analyses, and particularly in 
relation to CVD mortality. Our results may also be subject to reverse causation. From the data 
collected, we could not assess whether women had pre-existing metabolic conditions such as 
obesity and type 1 diabetes, or conditions during pregnancy such as pre-eclampsia and 
gestational diabetes, which could have unfavourably influenced breastfeeding practice [38-40]. 
Breastfeeding duration was assessed retrospectively many years later and may be prone to recall 
bias which can lead to under- or over- reporting of breastfeeding duration [41]. However, 
maternal recall of lactation has been shown to be a valid and reliable measure [41] even many 
years following weaning [42]. Finally, it was also not possible to assess the exclusivity of 
breastfeeding (i.e. whether other complementary foods were being offered to breastfed children), 
which is a measure of breastfeeding intensity. 
4.2. Implications and conclusions  
With CVD being the leading cause of death in women, it is important to explore a range of 
strategies by which CVD can be prevented, involving established as well as emerging lifestyle 
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behaviours. This study provides evidence that ever breastfeeding and average breastfeeding 
duration up to 12 months per child were associated with substantially lower risk of CVD 
hospitalisation and mortality. While further longitudinal studies are needed to achieve greater 
consensus, findings from this study add to the growing evidence base for the long-term benefits 
of breastfeeding for maternal cardiovascular health, promoting added benefits of breastfeeding 
beyond known benefits for infants and short-term benefits for mothers, and support breastfeeding 
as an important strategy by which parous women can reduce their risk of developing and dying 
from CVD.   
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Fig. 1. Participant flow chart 
  
Participants that completed the 45 and Up 
Study baseline questionnaire (2006-2009) 
(n=266,888)  
Excluded women based on baseline data: 
 Reported being diagnosed with or 
recently treated for cardiovascular 
disease (n=21,797) or with a 
cardiovascular disease hospital 
admission in the 6 years prior to 
baseline (n=13,323) 
 Unknown parity (n=918) 
 Parous, with unknown breastfeeding 
duration (n=2,187) 
Women respondents only    
 (n=143,073)  
Final study sample 
(n=100,864) 
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Table 1. Baseline socio-demographic characteristics and parity of parous women (n=100,864) in the 45 and Up Study by 
breastfeeding history and average breastfeeding duration per child.* 
Variables Breastfeeding history Average breastfeeding duration per child† 
Never 
breastfed 
Ever 
breastfed 
P-value‡ >0 to 6 
months 
>6 to 12 
months 
>12 
months 
P-value§
Number of subjects (%) 12,517 
(12.4) 
88,347 
(87.6) 
 56,049 
(63.4) 
24,549 
(27.8) 
7,749   
(8.8) 
 
Age group (%)   
   45 to 54 years 26.5 37.7 <0.0001 29.5 47.3 66.9 <0.0001 
   55 to 64 years   42.7 34.0 36.5 29.7 28.9 
   ≥65 years 30.8 28.3 34.0 23.0 4.2 
Mean (SD) age for first child 
(years) 
24.3 
(5.15) 
25.1 
(4.89) 
<0.0001 24.3 (4.66) 26.0 
(4.74) 
28.1 
(5.29) 
<0.0001 
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Mean (SD) age for last child 
(years) 
28.9 
(5.24) 
30.6 
(4.96) 
<0.0001 29.8 (4.93) 31.6 
(4.64) 
33.4 (4.7) <0.0001 
Parity  
   Mean (SD) parity (number of  
   births) 
2.4 (1.13) 2.7 (1.18) <0.0001 2.8 (1.2) 2.8 (1.15) 2.6 (1.13) <0.0001 
   1 child (%) 19.0 8.7 <0.0001 16.7 9.5 3.9 <0.0001 
   2 children (%) 43.7 39.8 47.7 46.4 41.5 
   3 children (%) 23.8 31.2 24.3 29.8 35.0 
   ≥4 children (%) 13.5 20.3 11.3 14.3 19.6 
Country of birth (%)   
   Australia 72.0 77.3 <0.0001 74.0 76.1 79.7 <0.0001 
   Other 28.0 22.7 26.0 23.9 20.3 
Highest education|| (%)   
   University and higher 11.1 23.8 <0.0001 16.3 21.3 27.0 <0.0001 
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   High school/trade 
apprenticeship/ 
   certificate/diploma 
33.3 38.4 37.1 37.9 39.4 
   ≤10 years 55.6 37.8 46.6 40.8 33.6 
Marital status¶ (%)  
   Married/living with a partner 72.7 75.8 <0.0001 74.6 75.0 76.7 <0.0001 
   Single/divorced/separated/ 
   widowed 
27.3 24.2 25.4 25.0 23.3 
Socioeconomic status** (SEIFA-
IRSD) (%) 
 
   Quintile 1 (most disadvantaged) 23.2 19.7 <0.0001 21.1 19.8 18.2 <0.0001 
   Quintile 2 20.3 19.5 20.1 18.8 19.0 
   Quintile 3 22.5 21.4 21.8 21.2 20.7 
   Quintile 4 19.0 19.6 19.7 19.6 20.0 
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   Quintile 5 (least disadvantaged) 15.0 19.8 17.3 20.5 22.0 
SD=standard deviation; SEIFA-IRSD=Socio-Economic Indexes For Area - Index of Relative Socio-Economic Disadvantage. 
* Data are presented as means (SD) or percentages. 
† Average breastfeeding duration per child was calculated as self-reported lifetime breastfeeding duration divided by the reported 
number of children. 
‡ Based on chi-square test for categorical variables and student t-test for continuous variables. 
§ Based on chi-square test for categorical variables and F statistics from ANOVA for continuous variables. 
|| 1,325 missing. 
¶ 268 missing.  
** 66 missing. 
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Table 2. Hazard ratios and 95% confidence intervals for the incidence of CVD hospitalisation and mortality in parous women by 
average breastfeeding duration per child.*  
Average 
breastfeeding 
duration per 
childa 
No. of 
persons, 
n 
Person-
years from 
baseline 
 
No. of 
incident 
cases/deaths 
Model 1† 
(95% CI) 
Model 2‡        
(95% CI) 
Model 3§ 
(95% CI) 
Model 4|| 
(95% CI) 
CVD hospitalisation 
Never 
breastfed 
12,517 76,164 527 Reference Reference Reference Reference 
>0-6 months 56,049 342,296 
 
2076 0.82  
(0.74, 0.91) 
0.84  
(0.76, 0.93) 
0.86  
(0.77, 0.95) 
0.86  
(0.78, 0.96) 
>6-12 months 24,549 150,489 
 
708 0.77  
(0.68, 0.87) 
0.79  
(0.70, 0.89) 
0.84  
(0.74, 0.96) 
0.85  
(0.75, 0.97) 
>12 months 7,749 47,911 117 0.80  0.84  0.89  0.89  
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 (0.65, 0.99) (0.68, 1.04) (0.71, 1.12) (0.71, 1.12) 
CVD mortality 
Never 
breastfed 
12,517 71,730 
 
66 Reference Reference Reference Reference 
>0-6 months 56,049 321,326 
 
247 0.69  
(0.53, 0.92) 
0.74  
(0.56, 0.98) 
0.69  
(0.51, 0.94) 
0.69  
(0.51, 0.94) 
>6-12 months 25,549 140,605 
 
96 0.53  
(0.38, 0.73) 
0.56  
(0.40, 0.79) 
0.59  
(0.41, 0.85) 
0.59  
(0.41, 0.84) 
≥12 months 7,749 44,453 
 
9 0.76  
(0.36, 1.61) 
0.80  
(0.38, 1.69) 
0.70  
(0.30, 1.65) 
0.67  
(0.28, 1.57) 
CI= confidence interval, CVD=cardiovascular disease. 
* Average breastfeeding duration per child was calculated as self-reported lifetime breastfeeding duration divided by the reported 
number of children. 
† Model 1 was unadjusted. 
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‡ Model 2 was adjusted for parity (number of children) and socio-demographic characteristics (age, country of birth, educational level, 
marital status, area-level socio-economic status). 
§ Model 3 was further adjusted for lifestyle factors: body mass index, smoking status, alcohol intake, physical activity. 
|| Model 4 was additionally adjusted for medical and reproductive covariates: multi-vitamin use, omega 3 or fish oil use, use of aspirin, 
oral contraceptive use, mother’s age for first child, mother’s age for last child, family history of CVD, family history of hypertension, 
family history of diabetes, self-reported hypertension/recent treatment for hypertension, and self-reported diabetes/recent treatment for 
diabetes. 
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Supplementary Table 1. Baseline lifestyle, medical and reproductive characteristics of parous women (n=100,864) in the 45 and Up 
Study by breastfeeding history and average breastfeeding duration per child.* 
Variables Breastfeeding history Average breastfeeding duration per child† 
Never 
breastfed 
Ever 
breastfed 
P-value‡ >0-6 
months 
>6-12 
months 
>12 
months 
P-value§ 
Number of subjects (%) 12,517 
(12.4) 
88,347 
(87.6) 
 56,049 
(63.4) 
24,549 
(27.8) 
7,749 
(8.8) 
 
BMI category|| (%)   
   Underweight/healthy weight   
   (≤18.5 to <25.0 kg/m2) 
38.8 45.2 <0.0001 42.6 48.8 52.7 <0.0001 
   Overweight (25.0 to <30.0 
kg/m2) 
33.0 33.4 23.2 18.5 17.5 
   Obese (≥30.0 kg/m2) 28.2 21.4 24.2 21.2 19.6 
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Mean (SD) physical activity 
time (minutes/week) 
599 (711) 602 (650) 0.68 601 (662) 601 (629) 606 
(627) 
0.90 
Physical activity category¶ (%)  
   <150 minutes/week 26.8 21.2 <0.0001 22.8 19.0 16.5 <0.0001 
   150 to 299 minutes/week 14.8 16.0 15.6 16.4 18.1 
   ≥300 minutes/week 58.4 62.8 61.6 64.6 65.4 
Smoking status** (%)  
   Never smoker 60.5 65.5 <0.0001 63.9 69.0 65.6 <0.0001 
   Past regular smoker 28.8 28.0 28.7 26.1 29.1 
   Current smoker 10.6 6.5 7.4 4.9 5.3 
Current alcohol intake 
(drinks/week)†† (%)  
 
   ≤14 drinks/week 90.5 89.7 <0.0001 89.3 90.3 91.1 <0.0001 
   >14 drinks/week 9.5 10.3 10.7 9.7 8.9 
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Healthy lifestyle index‡‡   
   Healthy 72.7  63.5 <0.0001 66.6 59.1 56.5 <0.0001 
   Not healthy 27.3 36.5 33.4 40.9 43.5 
Current use of multivitamins 
(%) 
25.5 30.1 <0.0001  29.2 30.6 34.6 <0.0001 
Current use of omega 3 or fish 
oil (%)§§  
34.2 37.0 <0.0001 38.0 35.5 34.8 <0.0001 
Current use of aspirin|||| (%) 14.7 13.3 <0.0001 14.8 11.5 7.6 <0.0001 
History of oral contraceptive 
use¶¶ (%) 
80.1 83.6 <0.0001 83.0 83.4 89.3 <0.0001 
Family history of cardiovascular 
disease*** (%)  
58.1 57.9 0.78 59.0 55.9 56.3 <0.0001 
Family history of 
hypertension††† (%) 
54.7 56.1 0.004 55.4 56.4 60.0 <0.0001 
 173 
 
Family history of diabetes‡‡‡ (%) 27.0 24.0 <0.0001 24.5 23.1 24.2 <0.0001 
Self-reported hypertension/ 
recent treatment for 
hypertension (%) 
24.9 20.5 <0.0001 23.2 17.6 10.6 <0.0001 
Self-reported diabetes/ recent 
treatment for diabetes (%) 
9.8 5.6 <0.0001 6.4 4.6 3.5 <0.0001 
BMI= body mass index; SD=standard deviation. 
* Data are presented as means (SD) or percentages. 
† Average breastfeeding duration per child was calculated as self-reported lifetime breastfeeding duration divided by the reported 
number of children. 
‡ Based on chi-square test for categorical variables and student t-test for continuous variables. 
§ Based on chi-square test for categorical variables and F statistics from ANOVA for continuous variables. 
|| 8,273 missing. 
¶ 1,370 missing. 
** 5 missing. 
†† 2,091 missing. 
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‡‡ 15,623 missing. Based on six lifestyle risk factors scored individually as either healthy (score=1) or not healthy (score=0), as 
follows: body mass index (<25 kg/m2=score 1, ≥25 kg/m2=score 0), physical activity level (<150 min/week=score 0; ≥150 
min/week=score 1), smoking status (past/current smoker=score 0; never smoker=score 1), alcohol intake (≤14 drinks/week=score 0; 
>14 drinks/week=score 1), sleep (>7-<9 hours/day=score 0; <7 hours/day or >9 hours/day=score 1), fruit and vegetable intake (<2 
serves of fruit/day and <3 serves of fruit/day=score 0; ≥2 serves of fruit/day and ≥3 serves of vegetables/day=score 1). Based on the 
sum of these scores, the healthy lifestyle index was dichotomised as either healthy (sum of scores=5-6) or not healthy (sum of 
scores=0-4). 
§§ 1 missing. 
|||| 6 missing.  
¶¶ 1,571 missing. 
*** 9 missing. 
††† 9 missing. 
‡‡‡ 9 missing. 
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Supplementary Table 2. Hazard ratios and 95% confidence intervals for the incidence of CVD hospitalisation and mortality in 
parous women, by breastfeeding history.  
Breastfeedin
g history 
No. of 
persons
, n 
Person-
years from 
baseline 
 
No. of 
incident 
cases/deaths 
Model 1*       
(95% CI) 
Model 2†          
(95% CI) 
Model 3‡         
(95% CI) 
Model 4§    
(95% CI) 
CVD hospitalisation 
Parous, 
Never 
breastfed 
12,517 76,164 
 
527 Reference Reference Reference Reference 
Parous, Ever 
breastfed 
88,347 540 696 
 
2,901 0.81 
(0.73,0.89) 
0.83 (0.75,0.91) 0.85 (0.77,0.95) 
 
0.86 
(0.78,0.96) 
P-value||    <0.001 <0.001 0.003 0.005 
CVD mortality 
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Parous, 
Never 
breastfed 
12,517 71 730 
 
66 Reference Reference Reference Reference 
Parous, Ever 
breastfed 
88,347 506,383  352 0.65 
(0.49,0.85) 
0.69 (0.52,0.91) 
 
0.66 (0.50,0.89) 
 
0.66 
(0.49,0.89) 
P-value||    0.002 0.008 0.006 0.006 
CI= confidence interval, CVD=cardiovascular disease. 
* Model 1 was unadjusted. 
† Model 2 was adjusted for parity (number of children) and socio-demographic characteristics (age, country of birth, educational level, 
marital status, area-level socio-economic status). 
‡ Model 3 was further adjusted for lifestyle factors: body mass index, smoking status, alcohol intake, physical activity. 
§ Model 4 was additionally adjusted for medical and reproductive covariates: multi-vitamin use, omega 3 or fish oil use, use of aspirin, 
oral contraceptive use, mother’s age for first child, mother’s age for last child, family history of CVD, family history of hypertension, 
family history of diabetes, self-reported hypertension/recent treatment for hypertension, and self-reported diabetes/recent treatment for 
diabetes. 
|| From Type 3 Wald chi-square test. 
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Supplementary Table 3. Adjusted hazard ratios and 95% confidence intervals for associations between average breastfeeding 
duration per child and the incidence of CVD hospitalisation and mortality in parous women, stratified by highest educational level.  
Highest educational 
level 
Average 
breastfeeding 
duration per 
child 
No. of 
persons, 
n 
Person-years 
from baseline 
(from birth of 
first child) 
No. of 
incident 
cases/deaths 
Multivariate-
adjusted*   (95% CI) 
CVD hospitalisation  
University and higher Never 
breastfed 
1,362 8,364 38 Reference 
>0-6 months 9,915 61,035 239 0.90 (0.62, 1.30) 
>6-12 
months 
7,462 46,238 111 0.81 (0.55, 1.20) 
>12 months 3,383 21,027 39 0.92 (0.57, 1.48) 
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High school/trade 
apprenticeship/   
certificate/diploma 
Never 
breastfed 
4,089 24,986 152 Reference 
>0-6 months 20,696 126,795 680 0.89 (0.74, 1.08) 
>6-12 
months 
9,730 59,834 238 0.83 (0.66, 1.03) 
>12 months 3,101 19,141 49 0.94 (0.66, 1.33) 
≤10 years Never 
breastfed 
6,830 41,444 320 Reference 
>0-6 months 24,669 149,919 1,113 0.85 (0.74, 0.97) 
>6-12 
months 
7,098 42,878 348 0.90 (0.76, 1.07) 
>12 months 1,204 7,374 25 0.75 (0.48, 1.18) 
CVD mortality  
 179 
 
University and higher Never 
breastfed 
1,362 7,808 <5 Reference 
>0-6 months 9,915 56,884 20 0.66 (0.19, 2.26) 
>6-12 
months 
7,462 42,910 <5 0.28 (0.06, 1.27) 
>12 months 3,383 19,477 0 - 
High school/trade 
apprenticeship/   
certificate/diploma 
Never 
breastfed 
4,089 23,470 20 Reference 
>0-6 months 20,696 118,767 63 0.51 (0.30, 0.87) 
>6-12 
months 
9,730 55,765 32 0.65 (0.36, 1.17) 
>12 months 3,101 17,769 <5 0.26 (0.03, 1.94) 
≤10 years Never 
breastfed 
6,830 39,118 41 Reference 
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>0-6 months 24,669 141,360 154 0.77 (0.53, 1.13) 
>6-12 
months 
7,098 40,484 51 0.52 (0.33, 0.84) 
>12 months 1,204 6,860 6 1.06 (0.37, 3.02) 
CI= confidence interval, CVD=cardiovascular disease. 
* Adjusted for age, country of birth, educational level, marital status, area-level socio-economic status, body mass index, smoking 
status, alcohol intake, physical activity, multi-vitamin use, omega 3 or fish oil use, use of aspirin, oral contraceptive use, number of 
children, mother’s age for first child, mother’s age for last child, family history of CVD, family history of hypertension, family history 
of diabetes, self-reported hypertension/recent treatment for hypertension, and self-reported diabetes/recent treatment for diabetes. 
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Supplementary Table 4. Adjusted hazard ratios and 95% confidence intervals for associations between average breastfeeding 
duration per child and the incidence of CVD hospitalisation and mortality in parous women, stratified by the healthy lifestyle index.  
Healthy lifestyle index* Average 
breastfeeding 
duration per 
child† 
No. of 
persons, 
n 
Person-years 
from baseline 
(from birth of 
first child) 
No. of 
incident 
cases/deaths 
Multivariate-
adjusted‡   (95% CI) 
CVD hospitalisation  
Healthy Never 
breastfed 
2,812 17,354 77 Reference 
>0-6 months 15,724 96,582 490 1.11 (0.87, 1.42) 
>6-12 
months 
8,652 53,261 197 1.01 (0.77, 1.32) 
>12 months 2,948 18,230 37 1.15 (0.77, 1.72) 
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Not healthy Never 
breastfed 
7,487 45,413 345 Reference 
>0-6 months 31,297 191,309 1,157 0.79 (0.70, 0.90) 
>6-12 
months 
12,485 76,576 371 0.80 (0.68, 0.93) 
>12 months 3,836 23,718 61 0.82 (0.62, 1.09) 
CVD mortality  
Healthy Never 
breastfed 
2,812 16,201 10 Reference 
>0-6 months 15,724 90,369 43 0.68 (0.34, 1.36) 
>6-12 
months 
8,652 49,616 15 0.40 (0.18, 0.90) 
>12 months 2,948 16,894 <5 0.93 (0.20, 4.31) 
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Not healthy Never 
breastfed 
7,487 42,853 39 Reference 
>0-6 months 31,297 179,631 130 0.68 (0.47, 0.99) 
>6-12 
months 
12,485 71,602 48 0.59 (0.38, 0.92) 
>12 months 3,836 22,019 <5 0.57 (0.18, 1.88) 
CI= confidence interval, CVD=cardiovascular disease. 
* Based on six lifestyle risk factors scored individually as either healthy (score=1) or not healthy (score=0): body mass index (<25 
kg/m2=score 1, ≥25 kg/m2=score 0), physical activity level (<150 min/week=score 0; ≥150 min/week=score 1), smoking status 
(past/current smoker=score 0; never smoker=score 1), alcohol intake (≤14 drinks/week=score 0; >14 drinks/week=score 1), sleep (>7-
<9 hours/day=score 0; <7 hours/day or >9 hours/day=score 1), fruit and vegetable intake (<2 serves of fruit/day and <3 serves of 
fruit/day=score 0; ≥2 serves of fruit/day and ≥3 serves of vegetables/day=score 1). Based on the sum of these scores, the healthy 
lifestyle index was dichotomised as either healthy (sum of scores=5-6) or not healthy (sum of scores=0-4). 
† Average breastfeeding duration per child was calculated as self-reported lifetime breastfeeding duration divided by the reported 
number of children.  
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‡ Adjusted for age, country of birth, educational level, marital status, area-level socio-economic status, multi-vitamin use, omega 3 or 
fish oil use, use of aspirin, oral contraceptive use, number of children, mother’s age for first child, mother’s age for last child, family 
history of CVD, family history of hypertension, family history of diabetes, self-reported hypertension/recent treatment for 
hypertension, and self-reported diabetes/recent treatment for diabetes. 
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Supplementary Table 5. Summary of recent prospective/case-cohort studies that have examined the association between 
breastfeeding history/duration and CVD outcomes. 
First 
author  
(year)  
Country and 
cohort 
designation 
Participants Mean 
follow-
up 
(years) 
Outcome 
assessment 
Breastfeeding 
comparison 
categories 
Adjusted HR (95% 
CI) by breastfeeding 
history/ duration  
Covariates 
Merritt et al. 
(2015) 
[1] 
10 European 
countries,  
EPIC study 
 
322,972 parous women 
without a history of 
MI/heart attack, angina, 
stroke or cancer; 
25-70 years 
 
12.9  Mortality from: 
Circulatory disease 
 
 
Cerebrovascular 
disease  
 
IHD 
 
 
 
Never 
Ever 
 
Never 
Ever 
 
Never 
Ever 
 
Reference 
0.80 (0.70, 0.91) 
 
Reference 
0.94 (0.74, 1.21) 
 
Reference 
0.69 (0.54, 0.87) 
Education level, BMI, 
physical activity, 
smoking 
status/intensity and 
duration, menopausal 
status 
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Peters et al. 
(2016) 
[2] 
 
 
10 European 
countries, 
case-cohort 
study nested 
within EPIC 
study 
 
Parous women without 
a history of IHD or 
stroke; mean age=52.7 
(SD: 9.1) years; 
n=8,044 for analyses 
comparing never vs. 
ever breastfeeding and 
n=8,012 for analyses 
involving breastfeeding 
duration 
 
11 Incidence of first-
time non-fatal/fatal 
IHD event 
Never 
Ever 
 
Average 
breastfeeding 
duration/child 
Never 
>0-<1 month 
≥1-<3 months 
≥3-<6 months 
≥6 months 
 
 
Reference 
0.71 (0.52, 0.98) 
 
 
 
                                        
1.00 (0.73, 1.37) 
0.77 (0.63, 0.94)  
0.69 (0.61, 0.78) 
0.67 (0.57, 0.77) 
0.67 (0.56, 0.80) 
Study centre, age, 
education level, BMI, 
smoking status, 
number of live births, 
high blood pressure, 
HDL cholesterol, total 
cholesterol, history of 
diabetes mellitus 
 
Peters et al. 
(2017) 
[3] 
 
 
10 diverse 
regions in 
China,  
289,573 without a 
history of IHD or 
stroke; 
30-79 years 
8.1 
(median) 
Incidence of: 
All CVD 
 
 
 
 
Never 
Ever 
 
 
1.00 (0.95, 1.05) 
0.96 (0.95, 0.97) 
 
 
Education level, 
household income, 
BMI, physical 
activity, smoking 
status, alcohol intake, 
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China 
Kadoorie 
Biobank 
 
 
Major CVD 
 
 
 
 
 
Fatal CVD 
 
 
 
 
 
Stroke 
 
 
 
Each additional 
6 months/child* 
 
Never 
Ever 
 
Each additional 
6 months/child* 
 
Never 
Ever 
 
Each additional 
6 months/child* 
 
Never 
Ever 
 
0.98 (0.97, 0.99) 
 
 
1.00 (0.92, 1.09) 
0.88 (0.87, 0.90) 
 
0.97 (0.96, 0.99) 
 
 
1.00 (0.77, 1.29) 
0.90 (0.87, 0.94) 
 
0.98 (0.95, 1.01) 
 
 
1.00 (0.93, 1.08) 
0.92 (0.90, 0.93) 
 
systolic blood 
pressure, history of 
hypertension, history 
of diabetes mellitus  
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Haemorrhagic stroke 
 
 
 
 
 
Ischemic stroke 
 
 
 
 
 
IHD 
Each additional 
6 months/child* 
 
Never 
Ever 
 
Each additional 
6 months/child* 
 
Never 
Ever 
 
Each additional 
6 months/child* 
 
Never 
Ever 
 
0.97 (0.96, 0.98) 
 
 
1.00 (0.77, 1.31) 
0.84 (0.81, 0.88) 
 
0.99 (0.96, 1.03) 
 
 
1.00 (0.91, 1.09) 
0.88 (0.86, 0.90) 
 
0.97 (0.95, 0.98) 
 
 
1.00 (0.92, 1.09) 
0.91 (0.89, 0.93) 
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Each additional 
6 months/child* 
 
0.96 (0.95, 0.98) 
 
Abbreviations: BMI=body mass index, CVD=cardiovascular disease, EPIC=European Investigation into Cancer and Nutrition 
prospective cohort study, HDL=high-density lipoprotein, HR=hazard ratio, IHD=ischaemic heart disease, MI=myocardial infarction, 
SD=standard deviation. 
* Among parous women that had ever breastfed. 
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 CONCLUDING SUMMARY FOR THIS CHAPTER AND KNOWLEDGE GAINED 
FROM THIS STUDY 
To our knowledge, this was the first prospective cohort study in Australia to examine the 
association between breastfeeding and CVD-related hospitalisation and mortality among women. 
Breastfeeding was associated with a lower risk of CVD hospitalisation and mortality, an 
association that was consistent across different lifestyle and education categories. This study 
contributes evidence that breastfeeding may provide long-term benefits for cardiovascular health 
in parous women and may be used as an additional prevention strategy for CVD. 
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CHAPTER EIGHT: Discussion 
This thesis examined innovative aspects of cardiovascular risk among a large cohort of 
middle-aged and older Australian men and women. This chapter discusses the overall 
significance of findings from studies presented in Chapters 3 to 7 and Appendix 1, the 
implications for policy, the strengths and limitations of this research, and some directions for 
future research. 
  SIGNIFICANCE OF THE FINDINGS 
The overall significance of this research should be viewed in light of 1) its potential to inform 
gender-specific, CVD prevention strategies involving lifestyle risk factors, and 2) both its 
methodological strengths and limitations (presented in section 8.3).  
Considering that CVD is the leading cause of death worldwide in both men and women, 
growing knowledge about emerging lifestyle risk factors, and the lack of gender-specific CVD 
research, findings from this doctoral research may inform gender-specific prevention strategies in 
middle-aged and older adults. Findings presented in this thesis contribute to the evidence base. 
Firstly, emerging and lesser known lifestyle risk factors for CVD were examined, such as raw 
vegetable consumption, sedentary behaviour and psychological distress. Secondly, the joint 
influence of lifestyle risk factors which rarely occur in isolation was explored in relation to the 
development of type 2 diabetes and hypertension, both major cardiovascular risk factors. Thirdly, 
potential gender differences and behaviours specific to women such as breastfeeding, an important 
maternal behaviour with many potential health benefits, were examined.  
To help gain an overall picture of the significance of findings in this thesis, Table 8.1 
summarises the main findings, including any observed gender differences, from each of the five 
studies included in this thesis, along with their individual significance. To summarise findings in 
this large cohort of middle-aged and older Australians succinctly, the first study (Chapter 3) found 
that the consumption of fruit and vegetables, considered separately or combined, was inversely 
related with all-cause mortality. However, additional research is required to examine the effects of 
raw versus cooked vegetable consumption as well as confirm observed gender differences 
including a more protective effect of fruit and vegetable consumption in women. In the second 
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Table 8.1. Summary and significance of findings from five studies presented in this thesis. 
Thesis 
chapter 
Manuscript title Main findings Gender differences Significance of findings 
3 Fruit and vegetable 
consumption and ACM 
Fruit and vegetable consumption, 
considered combined or separate, was 
inversely related to ACM. 
 
Further studies needed to explore the 
effects of raw versus cooked 
vegetables. 
 
 
Combined consumption of 
fruit and vegetables, and 
separate consumption of 
vegetables, were inversely 
related with ACM in women, 
but not in men. 
First prospective cohort study to 
examine these associations in 
Australia. 
 
Findings contribute to the evidence 
base for the protective effects of fruit 
and vegetables. 
 
Findings support Australian dietary 
guidelines.  
 
Additional studies needed to explore 
the effects of raw versus cooked 
vegetables. 
 
Additional studies needed to confirm 
observed differences between men and 
women. 
 
4 Incident T2DM in a 
large Australian cohort 
study: Does PA or 
sitting time alter the 
risk associated with 
BMI? 
 
High levels of PA and/or low levels of 
sitting did not offset the risk of T2DM 
associated with overweight/obesity. 
 
A gender-specific analysis 
(results presented in Appendix 
1) was conducted as an 
addition to this published 
manuscript. 
 
The main findings remained 
essentially the same in separate 
analyses in men and women. 
First prospective study to examine 
whether PA and sitting time can 
attenuate the risk of developing T2DM 
associated with BMI. 
 
Findings contribute to the evidence 
base that BMI is a more important risk 
factor than PA for T2DM prevention. 
 
Further studies needed to examine 
whether sitting time is associated with 
the incidence of T2DM. 
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Maintaining a healthy weight, by 
adopting healthy lifestyle behaviours, 
is important for T2DM prevention. 
 
No obvious differences between men 
and women. 
 
5 Association between 
lifestyle risk factors and 
incident hypertension 
among middle-aged 
and older Australians 
Being overweight/obese, a high 
alcohol consumption, low PA levels 
and being a current smoker were 
associated with a higher incidence of 
HT. 
 
There was no obvious association 
between psychological distress and 
incident hypertension. 
 
Positive association between the 
number of high-risk lifestyle factors 
and odds of developing hypertension. 
This association was stronger in 
middle-aged than in older adults.  
 
 
Except for smoking, findings 
relating to individual lifestyle 
risk factors and HT in the 
overall sample were similar in 
men and women. 
 
A high-risk lifestyle was more 
detrimental for developing HT 
in men than in women, 
particularly in middle-aged 
men. 
 
 
First prospective study to compare 
associations in men and women. 
 
Findings contribute to the evidence 
base for the importance of adopting 
healthy lifestyle behaviours to prevent 
HT. 
 
Although further studies are needed, 
middle-aged adults, particularly men, 
were identified as at higher risk.  
 
Findings in parous women contribute 
to the evidence base for the protective 
effects of breastfeeding in relation to 
HT. 
 
Further studies needed to examine the 
association between mental health and 
incident HT. 
 
6 Breastfeeding and 
maternal cardiovascular 
risk factors and 
outcomes: A systematic 
review 
Significant protective effects of 
breastfeeding were reported in most 
studies included in this systematic 
review. 
 
Breastfeeding was associated with 
both short- and long-term maternal 
cardiovascular health risk 
Study specific to women. First systematic review of the 
association between breastfeeding and 
metabolic syndrome, HT and CVD. 
 
Findings support health promotion 
efforts to increase breastfeeding.  
 
Further longitudinal studies needed. 
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factors/outcomes. Evidence most 
convincing for HT. 
 
Evidence limited by small number of 
longitudinal studies. 
 
7 Breastfeeding and CVD 
hospitalisation and 
mortality in parous 
women: Evidence from 
a large Australian 
cohort study 
 
Breastfeeding was associated with 
lower risk of CVD hospitalisation and 
mortality in parous women.  
 
Breastfeeding may offer long-term 
benefits for maternal cardiovascular 
health. 
 
Associations were mostly consistent 
across different education and lifestyle 
categories.  
 
Study specific to women. First prospective cohort study to 
examine these associations in 
Australia. 
 
Findings contribute to the growing 
evidence base for the protective effects 
of breastfeeding for maternal 
cardiovascular health. 
 
Breastfeeding may provide additional 
health benefits to women that 
breastfeed. 
 
Breastfeeding may be used as an 
additional strategy for CVD 
prevention. 
 
Abbreviations: ACM=all-cause mortality; BMI=body mass index; CVD=cardiovascular disease; HT=hypertension; PA=physical activity, 
T2DM=type 2 diabetes mellitus. 
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study presented in this thesis (Chapter 4), body mass index was more strongly associated with the 
risk of developing of type 2 diabetes than physical activity levels or sitting time. In addition, 
engaging in high levels of physical activity and spending little time sitting did not attenuate the 
risk of developing type 2 diabetes associated with being overweight/obese in both men and women, 
as described in Tables 1 to 6 in Appendix 1. There was no obvious association between sitting 
time and the risk of type 2 diabetes. In the third study (Chapter 5), a high body mass index, high 
alcohol intake and low physical activity were all associated with a higher risk of developing 
hypertension in both men and women. There was no significant association between high 
psychological distress and incident hypertension. Having an increasing number of lifestyle risk 
factors was associated with an increasing risk of hypertension in both men and women. This 
association was stronger in middle-aged than older adults, particularly in men. In the fourth study 
(Chapter 6), a systematic review provided evidence for an association between breastfeeding and 
both short- and long-term cardiovascular risk factors and outcomes. However, a lack of 
longitudinal studies was identified as a research gap. The fifth study (Chapter 7) addressed this 
research gap by examining the longitudinal association between breastfeeding and cardiovascular 
disease-related hospitalisation and mortality and confirmed that breastfeeding was associated with 
a lower risk of CVD hospitalisation and mortality.   
Four of the five studies presented in this thesis have been published (corresponding to 
Chapters 3-6) and one is currently in press (Chapter 7). Several of these studies were among the 
first in Australia (Chapters 3, 7) or worldwide (Chapters 4-6) to explore these associations and 
potential gender differences (Chapters 3-5, Appendix 1) in a large cohort, providing unique 
contributions to the evidence base. Most cardiovascular risk factors examined were leading 
lifestyle and metabolic risk factors for global disease burden or disability.1-3 Findings reaffirmed 
Australian recommendations for fruit and vegetable intake, as well as current guidelines for 
physical activity, alcohol intake, and infant breastfeeding. Studies examining the separate or 
combined influence of lifestyle risk factors reinforced the importance of adopting overall healthy 
lifestyle behaviours to reduce cardiovascular risk factors, such as type 2 diabetes and hypertension, 
as well as identified the relatively stronger lifestyle risk factors, among middle-aged and older men 
and women. Findings confirmed that adhering to a healthy lifestyle can substantially improve CVD 
risk in the middle-aged and older population, which can lead to improving longer-term health 
outcomes. In addition, this thesis offers preliminary evidence that differences between men and 
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women may exist in relation to different lifestyle risk behaviours and CVD risk factors, which are 
worth further exploring. The need for more gender-specific analysis in CVD prevention research 
has been expressed by several health bodies, including the American Heart Association which has 
strived to develop guidelines for the prevention of CVD in women, albeit with studies 
predominantly involving men.4 Findings from this thesis may be conducive to future gender-
specific CVD research which can inform future gender-specific guidelines for the prevention of 
CVD. 
Although this research project reaffirmed the importance of reducing traditional lifestyle risk 
factors for CVD prevention, the evidence for an association between less well established risk 
factors, such as raw vegetable consumption, sitting time, poor mental health and CVD risk factors 
or outcomes, was less clear. However, they contribute valuable information that should be 
considered in weighing the overall evidence and developing CVD prevention policies. Indeed, the 
study about fruit and vegetable consumption and all-cause mortality (Chapter 3) has been 
included in two recent meta-analyses and systematic reviews published in high-ranking journals, 
which support public health recommendations to promote fruit and vegetable intake for the 
prevention of CVD and premature death.5,6 The study examining the separate and combined 
influence of body mass index, physical activity and sitting time on incident type 2 diabetes 
(Chapter 4) has been included and cited in the most recent American Physical Activity Guidelines 
Advisory Committee Scientific Report.7  
In contrast to other innovative risk factors examined in this thesis, breastfeeding emerged as 
an additional strategy by which parous women may lower their risk of CVD. The systematic review 
(Chapter 6) contributed to women’s health research by synthesising the current evidence about 
the relation between breastfeeding and a range of maternal cardiovascular risk factors and 
outcomes. Conducting this systematic review was important to evaluate whether breastfeeding 
could be a modifiable risk factor for CVD and whether it provided long-term beneficial effects for 
maternal cardiovascular health. The study relating to breastfeeding (Chapter 7) aimed to address 
a research gap identified in the systematic review, providing additional longitudinal evidence for 
the long-term protective effects of breastfeeding for maternal cardiovascular health.  
Overall, this thesis contributes important public health findings that are of substantial 
significance to men and women in the population, health care providers, and policy makers. It has 
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recently been estimated that Australia’s spending on preventative health is approximately $2 
billion per year or 1.34% of all health expenditure, and a joint campaign led by public health, not-
for-profit, research and advocacy bodies have advocated that more spending should go towards 
preventive health.8 Findings from this thesis confirm the importance of focusing on traditional and 
innovative aspects of cardiovascular risk for the prevention of CVD in both middle-aged and older 
men and women, and developing prevention strategies that are informed by research. With 
increased pressure on the Australian healthcare system stemming from a growing ageing 
population, and given the preventable nature of lifestyle-related NCDs, the Australian government 
needs to upscale its investment in prevention research and programs. 
  IMPLICATIONS FOR POLICY  
The findings from the collection of studies presented in this thesis have several implications 
for public health programs and policy. One of the implications for policy is the importance of 
incorporating growing evidence about innovative aspects of cardiovascular risk in the development 
of prevention strategies for CVD. While the evidence for certain lesser known risk factors, such 
as sedentary behaviour and psychological distress in relation to incident type 2 diabetes and 
hypertension respectively, was inconclusive and requires further research, more solid evidence 
was presented in support of breastfeeding as a supplementary strategy by which parous women 
could reduce their risk of CVD. Developing policies that support women to initiate and continue 
breastfeeding will not only benefit the health of children, but also the health of mothers and 
potentially provide added cardiovascular health benefits. Currently, 96% of Australian women 
initiate breastfeeding after birth. However, only 15 to 25% will exclusively breastfeed their babies 
until 6 months of age.9 Policies should be implemented to help reduce barriers for breastfeeding 
and promote breastfeeding in various settings, such as providing continuity of care between health 
care facilities and the broader community, and facilitating breastfeeding in public places and in the 
workplace.10,11 The Australian National Breastfeeding Strategy 2010-15 provided a framework for 
governments to take action in collaboration with the community sector to protect, promote, and 
support breastfeeding as well as monitor activities at the state, territory and national levels.10 A 
national breastfeeding strategy for 2018 and beyond, is in the process of being developed by the 
Australian Government Department of Health, which could be informed by research stemming 
from this thesis. 
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Exploring the effects of multiple lifestyle risk factors on major cardiovascular risk factors 
such as diabetes and hypertension, provided insight on the joint and relative influence of examined 
lifestyle risk factors. This novel approach may not only guide prevention strategies for specific 
cardiovascular risk factors but also inform strategies that simultaneously address lifestyle 
correlates of CVD risk factors. Strategies aimed at risk reduction may be more efficient and cost-
effective in preventing premature deaths from CVD by targeting multiple risk factors rather than 
separate ones.12 In addition, targeting common risk factors, an approach adopted in the 2017 
National Strategic Framework for Chronic Conditions and by the WHO in its Global Action Plan 
for the Prevention and Control of NCDs 2013-2020,13,14 can also help prevent deaths from other 
NCDs.  
This thesis focused on prevention research in middle-aged and older Australians because a 
considerable proportion of deaths due to CVD occur prematurely and are substantially preventable. 
Findings from this thesis confirmed the importance of lifestyle factors in the middle-age population 
with the potential to reduce health care burden later in life. Intervening during middle age is 
essential given the higher life expectancy of Australians and the projection that the proportion of 
Australians aged 65 years and over will be 22% in 2057.15 A growing ageing population will 
provide increased pressure on the health system, including higher health care costs, emphasising 
the urgency of investing in cost-effective prevention strategies for middle-aged men and women.    
A gender-specific approach to both research and policy is needed to help develop programs 
and policies that address health issues that are specific to women and men. Both a National 
Women’s Health Policy and a National Men’s Health Policy were developed in 2010 with the aim 
to improve the health of women and men in the next 10 to 20 years.16,17 One key health priority 
area identified in these policies was chronic disease prevention by targeting lifestyle risk factors. 
While these national policies are a promising start, a greater gender focus in research and policy 
is still being advocated for by the Public Health Association of Australia as evidence-based 
policies on gender and health are still needed at all government levels.18 The gender focus adopted 
in this thesis may open doors for further gender-specific prevention research that has the potential 
to influence future public health guidelines and policy frameworks with a gender focus. 
In 2017, Australia put in place a National Strategic Framework for Chronic Conditions.13 
However, a national implementation plan or strategy that specifically addresses CVD is currently 
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lacking. In its 2017-2018 federal budget submission, the Heart Foundation advocated for the 
development of a national heart and stroke strategy that would be integral to the National Strategic 
Framework for Chronic Conditions.19 Such a strategy could help develop more CVD prevention-
based policies that have a major impact on CVD prevention and lowering health care burden. 
 
 METHODOLOGICAL STRENGTHS AND LIMITATIONS  
One of the main strengths of this thesis was that research questions were examined using a 
large population-based cohort study on healthy ageing. This type of observational study helped to 
establish a temporal framework for associations examined in this thesis which encompassed some 
of Bradford Hill’s criteria including: a temporal sequence, biological plausibility, coherence and 
consistency.20 In addition, a comprehensive range of sociodemographic and health-related 
longitudinal data were available for men and women, including reproductive factors that are 
unique to women. Questionnaire data were linked to population health databases, providing an 
optimal research setting for exploring associations over time between lifestyle behaviours and 
CVD risk factors/outcomes. These methodological strengths lend support to findings from this 
thesis which add to the evidence base for the importance of healthy lifestyle behaviours for 
improved CVD-related outcomes.  
There were several methodological limitations. Sample size calculations were not conducted 
a priori. The follow-up times were relatively short, potentially limiting the extent of longitudinal 
associations that were observed. As the 45 and Up Study is a large longitudinal cohort study, 
questionnaires were administered to lower respondent burden and data were mainly self-reported. 
Response bias could have been introduced and could potentially differ by gender. It should be 
noted that a previous study comparing participants from the 45 and Up Study with a representative 
sample from the New South Wales Population Health Survey, reported that exposure-outcome 
associations had similar estimates although risk factor prevalence differed between both samples.21 
In addition, most measures used were validated either among the 45 and Up participants or in other 
samples. Fruit and vegetable consumption was assessed using established measures. However, 
controlling for other aspects of dietary intake was difficult because of limitations in the brief 
dietary questions asked. There was also a possibility for residual confounding in longitudinal 
 201 
 
studies, which was minimised by adjusting for a range of sociodemographic and health-related 
covariates and conducting sensitivity analyses to test the robustness of findings. 
 
 DIRECTIONS FOR FUTURE RESEARCH 
This collection of peer-reviewed studies provides an initial but important investigation of 
innovative aspects of CVD that is relevant to middle-aged and older men and women in the 
population, health care providers, and policy makers. Future research can help further elucidate 
the role of innovative cardiovascular risk factors examined in this thesis. High-quality prospective 
cohort studies that include large sample sizes, validated measures of exposures and outcomes, 
long-term follow-up measures, a range of sociodemographic, medical and lifestyle data, as well as 
good linkage to hospitalisation and mortality data can provide excellent research settings to explore 
temporal associations between cardiovascular risk factors and outcomes. Although fruit and 
vegetable consumption was found to be beneficial, future studies should further explore whether 
different preparation methods, such as raw vs. cooked vegetables have differential effects on 
cardiovascular health. Additional research is also needed to examine the roles of sedentary 
behaviour and poor mental health in relation to CVD as findings from this thesis did not provide 
conclusive evidence. The effects of specific combinations of lifestyle risk factors, including 
emerging ones, on CVD risk factors/outcomes is another key area for future research. There is a 
range of combinations that has not been explored and further research could provide additional 
insight on the joint and relative influence of lifestyle risk factors on CVD and guide prevention 
strategies among the middle-aged and older population. 
While there is more CVD research being conducted in women, there is still a need for 
increased representation of women in studies and research that acknowledges the importance of 
considering risk factors that are unique to women. This thesis presented evidence for an association 
between breastfeeding and cardiovascular risk factors and outcomes, even across different levels 
of education and healthy lifestyle status. However, given the strong confounding effect of 
socioeconomic status and health-promoting behaviours in relation to breastfeeding, future studies 
should explore this issue further to clarify whether breastfeeding per se is linked to long-term 
cardiovascular health.   
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In addition, the causal pathways and mechanisms underlying longitudinal associations 
require more exploration. For example, the mechanism linking breastfeeding and longer-term 
cardiovascular health is largely unknown and needs further examination. Mechanisms that can 
explain potential gender differences with respect to various cardiovascular risk factors/outcomes 
also require more research. 
Future research efforts can help complete a more comprehensive picture of the role of 
innovative risk factors for CVD among the middle-aged and older adult population. Generating 
more gender-specific evidence is vital to better inform public health guidelines and policies with 
a gender focus. It is hoped that this innovative thesis will lay the groundwork for future 
explorations of innovative risk factors for CVD as well as gender differences, with the potential to 
influence public health policy and guidelines, and ultimately improve the health of middle-aged 
and older men and women. 
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APPENDICES 
Appendix 1 - Additional gender analysis relating to Chapter 4 
Summary of main findings 
The findings from this additional gender analysis are presented in Tables 1 to 6 in this 
appendix. The unadjusted and adjusted odds ratios (ORs) for incident type 2 diabetes mellitus 
(T2DM) by levels of body mass index, physical activity and sitting in women (n=16,156) and 
men (n=13,416) are reported in Tables 1 and 2 respectively. In both women and men, compared 
with normal weight counterparts, being overweight or obese was significantly associated with 
higher odds of incident T2DM in unadjusted and adjusted models. Compared with women in the 
low physical activity tertile, women in the high physical activity tertile had significantly lower 
odds of developing T2DM in the unadjusted and adjusted models. Compared with men in the 
low physical activity tertile, men in the medium physical activity tertile had significantly lower 
odds of developing T2DM in the unadjusted model only. Women in the higher sitting category 
compared with those in the lower sitting category had significantly lower odds of incident T2DM 
in both unadjusted and adjusted models. ORs were not significantly different between categories 
of sitting in men.  
Adjusted ORs for associations between physical activity or sitting time and incident 
T2DM, stratified by body mass index, in women and men are presented in Tables 3 and 4 
respectively. In both women and men, OR were not significantly different between body mass 
index categories for different levels of PA and sitting, and overall no significant interactions 
were found.  
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Adjusted ORs for associations between combinations of body mass index, physical 
activity and sitting and incident T2DM in women and men are included in Tables 5 and 6 
respectively. Overall, normal weight women and men with low physical activity and higher 
sitting levels had lower odds of developing T2DM than overweight or obese counterparts with 
high physical activity and lower sitting levels. 
Findings from this additional gender analysis were generally similar to those presented in 
Chapter 4. Being overweight or obese was a relatively stronger risk factor than low physical 
activity or high sitting levels. The increased odds of developing T2DM associated with being 
overweight or obese were not offset by high physical activity or low sitting levels.  
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Table 1. Unadjusted and adjusted odds ratios for incident type 2 diabetes in women (n=16,156) by levels of body mass index, 
physical activity and sitting (2006-10). 
 
 Unadjusted Odds Ratios 
(95% CI) 
p-value Adjusted Odds Ratiosa 
(95% CI) 
p-value 
Body mass index category   
   Normal weight (18.5 to <25 kg/m2) 1.0 (reference)  1.0 (reference)  
   Overweight (25 to <30 kg/m2) 2.27 (1.66, 3.10) <0.001 2.14 (1.56, 2.94) <0.001 
   Obese (≥30 kg/m2) 4.76 (3.49, 6.48) <0.001 4.63 (3.36, 6.39) <0.001 
Physical activityb tertiles   
   Low (0 to <300 min/week) 1.0 (reference)  1.0 (reference)  
   Medium (300 to <660 min/week) 0.89 (0.67, 1.18) 0.42 1.03 (0.78, 1.37) 0.83 
   High (≥660 min/week) 0.68 (0.50, 0.91) 0.01 0.78 (0.57, 1.07) 0.12 
Sitting time category   
   Lower sitting (<8 hours/day) 1.0 (reference)  1.0 (reference)  
   Higher sitting (≥8 hours/day) 0.55 (0.35, 0.87) 0.01 0.55 (0.35, 0.87) 0.01 
Abbreviations: CI=confidence interval, kg=kilograms, m=meter, min=minutes.  
Data for n=16,156 included in analysis, of which 276 developed diabetes.  
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a Adjusted for age group, follow-up time, country of birth, education, family history of diabetes and lifestyle risk factors (body mass 
index category/physical activity tertiles/sitting time category). 
b Physical activity was calculated as the sum of time spent on walking, moderate-intensity physical activity, and vigorous-intensity 
physical activity (weighted by two) in the past week. 
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Table 2. Unadjusted and adjusted odds ratios for incident type 2 diabetes in men (n=13,416) by levels of body mass index, 
physical activity and sitting (2006-10). 
 
 
Abbreviations: CI=confidence interval, kg=kilograms, m=meter, min=minutes.  
Data for n=13,416 included in analysis, of which 335 developed diabetes.  
 Unadjusted Odds Ratios 
(95% CI) 
p-value Adjusted Odds Ratiosa 
(95% CI) 
p-value 
Body mass index category   
   Normal weight (18.5 to <25 kg/m2) 1.0 (reference)  1.0 (reference)  
   Overweight (25 to <30 kg/m2) 1.94 (1.42, 2.66) <0.001 1.96 (1.43, 2.70) <0.001 
   Obese (≥30 kg/m2) 5.44 (3.94, 7.51) <0.001 5.62 (4.03, 7.85) <0.001 
Physical activityb tertiles   
   Low (0 to <300 min/week) 1.0 (reference)  1.0 (reference)  
   Medium (300 to <660 min/week) 0.75 (0.58, 0.99) 0.04 0.86 (0.66, 1.13) 0.28 
   High (≥660 min/week) 0.79 (0.61, 1.02) 0.08 0.94 (0.72, 1.22) 0.62 
Sitting time category   
   Lower sitting (<8 hours/day) 1.0 (reference)  1.0 (reference)  
   Higher sitting (≥8 hours/day) 1.07 (0.81, 1.41) 0.64 1.15 (0.87, 1.54) 0.33 
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a Adjusted for age group, follow-up time, country of birth, education, family history of diabetes and lifestyle risk factors (body mass 
index category/physical activity tertiles/sitting time category). 
b Physical activity was calculated as the sum of time spent on walking, moderate-intensity physical activity, and vigorous-intensity 
physical activity (weighted by two) in the past week. 
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Table 3. Adjusted odds ratios for associations between physical activity/sitting and incident type 2 diabetes in women 
(n=16,156) stratified by body mass index (BMI) categories.  
 
Variable BMI category 
Normal weight 
(18.5 to <25 kg/m2) 
N=7,905 
Overweight 
(25 to <30 kg/m2) 
N=5,447 
Obese  
(≥30 kg/m2) 
N=2,804 
Adjusted Odds Ratiosa  
(95% CI) 
Adjusted Odds Ratiosa  
(95% CI) 
Adjusted Odds Ratiosa  
(95% CI) 
Physical activityb tertiles  
   Low (0 to <300 min/week) 1.0 (reference) 1.0 (reference) 1.0 (reference) 
   Medium (300 to <660 min/week) 1.42 (0.76, 2.65); p=0.28 0.94 (0.58, 1.53); p=0.82 0.97 (0.62, 1.51); p=0.89 
   High (≥660 min/week) 0.84 (0.43, 1.63); p=0.60 0.88 (0.53, 1.44); p=0.60 0.65 (0.38, 1.10); p=0.11 
Sitting time category (%)    
   Lower sitting (<8 hours/day) 1.0 (reference) 1.0 (reference) 1.0 (reference) 
   Higher sitting (≥8 hours/day) 0.14 (0.02, 1.04); p=0.05 0.60 (0.29, 1.26); p=0.18 0.67 (0.36, 1.24); p=0.20 
Abbreviations: BMI=body mass index, CI=confidence interval, kg=kilograms, m=meter, min=minutes, p=probability. 
a Adjusted for age group, follow-up time, country of birth, education, family history of diabetes and sitting time/physical activity.  
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b Physical activity was calculated as the sum of time spent on walking, moderate-intensity physical activity, and vigorous-intensity 
physical activity (weighted by two) in the past week. 
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Table 4. Adjusted odds ratios for associations between physical activity/sitting and incident type 2 diabetes in men (n=13,416) 
stratified by body mass index (BMI) categories.  
 
Variable BMI category 
Normal weight 
(18.5 to <25 kg/m2) 
N=4,538 
Overweight 
(25 to <30 kg/m2) 
N=6,691 
Obese  
(≥30 kg/m2) 
N=2,187 
Adjusted Odds Ratiosa  
(95% CI) 
Adjusted Odds Ratiosa  
(95% CI) 
Adjusted Odds Ratiosa  
(95% CI) 
Physical activityb tertiles  
   Low (0 to <300 min/week) 1.0 (reference) 1.0 (reference) 1.0 (reference) 
   Medium (300 to <660 min/week) 1.06 (0.54, 2.10); p=0.86 0.82 (0.54, 1.24); p=0.34 0.86 (0.56, 1.34); p=0.52 
   High (≥660 min/week) 0.77 (0.38, 1.55); p=0.46 1.00 (0.68, 1.48); p=0.99 0.96 (0.62, 1.47); p=0.83 
Sitting time category (%)    
   Lower sitting (<8 hours/day) 1.0 (reference) 1.0 (reference) 1.0 (reference) 
   Higher sitting (≥8 hours/day) 1.10 (0.52, 2.34); p=0.81 1.25 (0.82, 1.91); p=0.30 1.04 (0.66, 1.64); p=0.86 
Abbreviations: BMI=body mass index, CI=confidence interval, kg=kilograms, m=meter, min=minutes, p=probability. 
a Adjusted for age group, follow-up time, country of birth, education, family history of diabetes and sitting time/physical activity.  
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b Physical activity was calculated as the sum of time spent on walking, moderate-intensity physical activity, and vigorous-intensity 
physical activity (weighted by two) in the past week. 
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Table 5. Adjusted odds ratios for incident type 2 diabetes in women (n=16,156) based on body mass index-physical activity 
(BMI-PA) and BMI-PA-sitting combinations. 
 
Variable Adjusted Odds Ratios  
Model 1a Model 2b Model 3c 
Adjusted Odds 
Ratios 
(95% CI) 
p-value Adjusted Odds 
Ratios 
(95% CI) 
p-value Adjusted Odds 
Ratios 
(95% CI) 
p-value 
BMI-PA combination groupd  
   Normal weight-high PA 1.0 (reference)    1.0 (reference)  1.0 (reference)  
   Normal weight-med PA  1.47 (0.84, 2.58) 0.18 1.45 (0.83, 2.55) 0.19 1.52 (0.86, 2.66) 0.15 
   Normal weight-low PA  1.06 (0.55, 2.02) 0.87 1.03 (0.54, 1.97) 0.93 1.00 (0.52, 1.93) 0.99 
   Overweight-high PA  2.50 (1.45, 4.30) 0.001 2.51 (1.46, 4.32) 0.001 2.38 (1.38, 4.11) 0.002 
   Overweight-med PA  2.57 (1.50, 4.41) 0.001 2.54 (1.48, 4.36) 0.001 2.50 (1.45, 4.30) 0.001 
   Overweight-low PA  2.81 (1.64, 4.80) <0.001 2.74 (1.60, 4.70) <0.001 2.66 (1.55, 4.57) <0.001 
   Obese-high PA  4.03 (2.20, 7.38) <0.001 4.05 (2.21, 7.41) <0.001 3.92 (2.13, 7.19) <0.001 
   Obese-med PA  6.38 (3.73, 10.92) <0.001 6.31 (3.68, 10.81) <0.001 5.88 (3.42, 10.11) <0.001 
   Obese-low PA  6.76 (4.07, 11.22) <0.001 6.61 (3.97, 11.01) <0.001 6.16 (3.69, 10.30) <0.001 
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BMI-PA-sitting combination groupd  
   Normal weight-high PA-lower sitting 1.0 (reference)  1.0 (reference)  1.0 (reference)  
   Normal weight-med PA-lower sitting 1.54 (0.88, 2.71) 0.13 1.52 (0.87, 2.67) 0.14 1.58 (0.90, 2.78) 0.11 
   Normal weight-low PA-lower sitting 1.07 (0.55, 2.08) 0.83 1.05 (0.54, 2.03) 0.89 1.01 (0.52, 1.97) 0.77 
   Normal weight-high PA-higher sitting 0.00 (0.00, -) 0.99 0.00 (0.00, -) 0.99 0.00 (0.00, -) 0.99 
   Normal weight-med PA-higher sitting 0.00 (0.00, -) 0.99 0.00 (0.00, -) 0.99 0.00 (0.00, -) 0.99 
   Normal weight-low PA-higher sitting 0.42 (0.06, 3.12) 0.40 0.41 (0.05, 3.05) 0.38 0.41 (0.06, 3.06) 0.38 
   Overweight-high PA-lower sitting 2.46 (1.42, 4.25) 0.001 2.47 (1.43, 4.27) 0.001 2.34 (1.35, 4.05) 0.002 
   Overweight-med PA-lower sitting 2.63 (1.52, 4.54) 0.001 2.60 (1.50, 4.49) 0.001 2.54 (1.47, 4.41) 0.001 
   Overweight-low PA-lower sitting 2.60 (1.49, 4.53) 0.001 2.54 (1.45, 4.43) 0.001 2.46 (1.41, 4.30) 0.002 
   Overweight-high PA-higher sitting 0.87 (0.12, 6.49) 0.89 0.87 (0.12, 6.51) 0.89 0.83 (0.11, 6.22) 0.85 
   Overweight-med PA-higher sitting 0.97 (0.23, 4.14) 0.96 0.96 (0.22, 4.11) 0.96 0.96 (0.22, 4.11) 0.95 
   Overweight-low PA-higher sitting 2.65 (0.99, 7.07) 0.05 2.60 (0.97, 6.95) 0.06 2.54 (0.95, 6.79) 0.06 
   Obese-high PA-lower sitting 3.92 (2.12, 7.24) <0.001 3.94 (2.13, 7.28) <0.001 3.81 (2.06, 7.06) <0.001 
   Obese-med PA-lower sitting 6.19 (3.57, 10.73) <0.001 6.12 (3.53, 10.62) <0.001 5.66 (3.25, 9.87) <0.001 
   Obese-low PA-lower sitting 6.65 (3.95, 11.17) <0.001 6.51 (3.86, 10.97) <0.001 6.00 (3.54, 10.15) <0.001 
   Obese-high PA-higher sitting 1.98 (0.26, 14.90) 0.51 1.98 (0.26, 14.90) 0.51 1.90 (0.25, 14.38) 0.53 
   Obese-med PA-higher sitting 4.34 (1.47, 12.81) 0.008 4.30 (1.46, 12.71) 0.008 4.15 (1.40, 12.32) 0.01 
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   Obese-low PA-higher sitting 4.55 (1.92, 10.81) 0.001 4.46 (1.88, 10.61) 0.001 4.35 (1.82, 10.41) 0.001 
Abbreviations: BMI=body mass index, CI=confidence interval, med=medium, p=probability, PA=physical activity.   
a Adjusted for age group only. 
b Adjusted for age group, follow-up time and BMI-PA/BMI-PA-sitting combination groups. 
c Adjusted for age group, follow-up time, country of birth, highest education, family history of diabetes and BMI-PA/BMI-PA-sitting 
combination groups.  
d BMI categories defined as: normal weight (18.5 to <25 kg/m2), overweight (25 to <30 kg/m2), obese (≥30 kg/m2). PA categories 
based on PA tertiles: high (≥660 min/week), medium (300-<660 min/week) and low (0 to <300 min/week). Based on previous 
analysis, sitting was dichotomised as higher (≥8 hours/day) and lower (<8 hours/day) sitting. 
 
 
 
  
 218 
 
Table 6. Adjusted odds ratios for incident type 2 diabetes in men (n=13,416) based on body mass index-physical activity (BMI-
PA) and BMI-PA-sitting combinations. 
 
Variable Adjusted Odds Ratios  
Model 1a Model 2b Model 3c 
Adjusted Odds 
Ratios 
(95% CI) 
p-value Adjusted Odds 
Ratios 
(95% CI) 
p-value Adjusted Odds 
Ratios 
(95% CI) 
p-value 
BMI-PA combination groupd  
   Normal weight-high PA  1.0 (reference)  1.0 (reference)  1.0 (reference)  
   Normal weight-med PA  1.30 (0.68, 2.51) 0.43 1.22 (0.63, 2.35) 0.56 1.23 (0.64, 2.38) 0.54 
   Normal weight-low PA  1.34 (0.69, 2.62) 0.39 1.22 (0.63, 2.39) 0.56 1.19 (0.61, 2.33) 0.61 
   Overweight-high PA  2.33 (1.36, 3.99) 0.002 2.34 (1.37, 4.01) 0.002 2.31 (1.35, 3.96) 0.002 
   Overweight-med PA  2.04 (1.16, 3.56) 0.01 1.93 (1.10, 3.38) 0.02 1.95 (1.11, 3.41) 0.02 
   Overweight-low PA  2.65 (1.55, 4.53) <0.001 2.42 (1.41, 4.15) 0.001 2.40 (1.40, 4.11) 0.002 
   Obese-high PA  6.43 (3.65, 11.35) <0.001 6.58 (3.73, 11.63) <0.001 6.34 (3.58, 11.23) <0.001 
   Obese-med PA  5.97 (3.35, 10.65) <0.001 5.92 (3.32, 10.55) <0.001 5.85 (3.27, 10.45) <0.001 
   Obese-low PA  7.64 (4.46, 13.09) <0.001 7.16 (4.18, 12.28) <0.001 6.95 (4.04, 11.95) <0.001 
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BMI-PA-sitting combination groupd  
   Normal weight-high PA-lower sitting 1.0 (reference)  1.0 (reference)  1.0 (reference)  
   Normal weight-med PA-lower sitting 1.12 (0.54, 2.32) 0.76 1.03 (0.50, 2.14) 0.93 1.04 (0.50, 2.16) 0.91 
   Normal weight-low PA-lower sitting 1.34 (0.65, 2.72) 0.43 1.20 (0.59, 2.45) 0.62 1.18 (0.58, 2.42) 0.65 
   Normal weight-high PA-higher sitting 0.51 (0.07, 3.90) 0.52 0.52 (0.07, 3.90) 0.52 0.53 (0.07, 4.03) 0.54 
   Normal weight-med PA-higher sitting 1.70 (0.62, 4.64) 0.31 1.65 (0.60, 4.53) 0.33 1.72 (0.63, 4.74) 0.29 
   Normal weight-low PA-higher sitting 1.06 (0.31, 3.66) 0.92 1.01 (0.29, 3.47) 0.99 0.96 (0.28, 3.34) 0.95 
   Overweight-high PA-lower sitting 2.26 (1.29, 3.94) 0.004 2.27 (1.30, 3.96) 0.004 2.24 (1.28, 3.92) 0.005 
   Overweight-med PA-lower sitting 2.02 (1.12, 3.62) 0.02 1.91 (1.06, 3.42) 0.03 1.93 (1.07, 3.47) 0.03 
   Overweight-low PA-lower sitting 2.16 (1.21, 3.85) 0.009 1.95 (1.09, 3.49) 0.02 1.92 (1.07, 3.44) 0.03 
   Overweight-high PA-higher sitting 1.88 (0.69, 5.15) 0.22 1.88 (0.69, 5.16) 0.22 1.85 (0.67, 5.08) 0.23 
   Overweight-med PA-higher sitting 1.58 (0.62, 4.04) 0.34 1.52 (0.59, 3.89) 0.39 1.53 (0.60, 3.92) 0.38 
   Overweight-low PA-higher sitting 3.85 (1.96, 7.57) <0.001 3.63 (1.85, 7.13) <0.001 3.71 (1.88, 7.30) <0.001 
   Obese-high PA-lower sitting 6.04 (3.34, 10.92) <0.001 6.21 (3.43, 11.24) <0.001 6.00 (3.30, 10.89) <0.001 
   Obese-med PA-lower sitting 5.47 (2.93, 10.18) <0.001 5.42 (2.91, 10.10) <0.001 5.32 (2.85, 9.94) <0.001 
   Obese-low PA-lower sitting 7.40 (4.19, 13.07) <0.001 6.79 (3.84, 12.02) <0.001 6.53 (3.68, 11.59) <0.001 
   Obese-high PA-higher sitting 6.75 (2.42, 18.83) <0.001 6.67 (2.38, 18.64) 0.001 6.33 (2.25, 17.79) 0.001 
   Obese-med PA-higher sitting 6.43 (2.81, 14.75) <0.001 6.36 (2.77, 14.60) <0.001 6.46 (2.81, 14.87) <0.001 
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   Obese-low PA-higher sitting 6.87 (3.27, 14.43) <0.001 6.89 (3.28, 14.48) <0.001 6.91 (3.28, 14.57) <0.001 
Abbreviations: BMI=body mass index, CI=confidence interval, med=medium, p=probability, PA=physical activity.   
a Adjusted for age group only. 
b Adjusted for age group, follow-up time and BMI-PA/BMI-PA-sitting combination groups. 
c Adjusted for age group, follow-up time, country of birth, highest education, family history of diabetes and BMI-PA/BMI-PA-sitting 
combination groups.  
d BMI categories defined as: normal weight (18.5 to <25 kg/m2), overweight (25 to <30 kg/m2), obese (≥30 kg/m2). PA categories 
based on PA tertiles: high (≥660 min/week), medium (300-<660 min/week) and low (0 to <300 min/week). Based on previous 
analysis, sitting was dichotomised as higher (≥8 hours/day) and lower (<8 hours/day) sitting. 
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Appendix 2 – Gender-specific 45 and Up Study baseline questionnaire and 
consent form 
  
Your answers and experiences are important to us. 
To help us read your answers, please write as clearly 
as possible using a BLACK or BLUE pen, and be sure 
to complete the questionnaire as shown: 
Please put a cross in the appropriate box(es) Yes No
OR put numbers in the appropriate box, e.g. 21st June 1945
age 2654916012
45 and Up Study Questionnaire 
for Women
day month year
1. What is your 
date of birth?
day month year
2. What is 
today’s date?
3. How tall are you 
without shoes? cm OR feet inches
(please give to the nearest cm or inch)
4. About how much 
do you weigh? kg OR stone lbs
5. What is the highest qualification you have completed?
(please put a cross in the most appropriate box) 
no school certificate or other qualifications
school or intermediate certificate (or equivalent) 
higher school or leaving certificate (or equivalent)
trade/apprenticeship (e.g. hairdresser, chef)
certificate/diploma (e.g. child care, technician)
university degree or higher
6. Are you of Aboriginal or Torres Strait Islander origin?
(you can cross more than one box)
No Yes, Aboriginal Yes, Torres Strait Islander
7. In which country were you born?
Australia please go to question 9
UK Ireland Italy China
Greece New Zealand Germany Lebanon
Philippines Netherlands Vietnam Malta
Poland other (please specify) _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
8. What year did you first come to live in 
Australia for one year or more? (e.g. 1970)
9. What is your ancestry? (please cross up to 2 boxes)
Australian English Irish Chinese
Italian Greek Scottish German
Lebanese Dutch Maltese Polish
Filipino Indian Croatian Vietnamese
other (please specify)  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
10. Do you speak a language other than English at home?
Yes No
11. Have you ever been a regular smoker?
Yes ▼ No If No – please go to question 12
How old were you when you started 
smoking regularly? years old
Are you a regular smoker now? Yes No
If No – how old were you when you 
stopped smoking regularly? years old
About how much do you/did you smoke on average each day?
(If you are an ex-smoker, how much did you smoke on average 
when you smoked?)
cigarettes per day pipes and cigars per day
12. About how many alcoholic drinks do you have each week?
one drink = a glass of wine, middy of beer or nip of spirits
(put “0” if you do not drink, or have less than one drink each week)
number of alcoholic drinks each week
13. On how many days each week 
do you usually drink alcohol? days each week
2 0
1 9
General questions about you
BLFF0710
The 45 and Up Study relies on the willingness of people in New South Wales to share information about 
their lives and experiences, to provide knowledge that will help people live healthy and fulfilling lives for
as long as possible. Participation is completely voluntary, and you are free to withdraw from the Study at 
any time. To take part, please read the participant information leaflet, then complete the questionnaire and
consent form and return them in the envelope provided. We very much hope you will be able to take part.
Any questions or comments? Please call the Study helpline: 1300 45 11 45 or go to www.45andUp.org.au
Auspiced by In collaboration with
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14. What best describes your current situation? (please cross one box)
single married de facto/living with a partner
widowed divorced separated
15. What best describes your current housing? (please cross one box)
house flat, unit, apartment house on farm
hostel for the aged mobile home other
nursing home retirement village, self care unit
16. How many TIMES did you do each of these 
activities LAST WEEK?
(put "0" if you did not do this activity)
Walking continuously, for at least 10 minutes
(for recreation or exercise or to get to or from places)
Vigorous physical activity
(that made you breathe harder or puff and pant, like jogging,
cycling, aerobics, competitive tennis, but not household chores 
or gardening)
Moderate physical activity
(like gentle swimming, social tennis, vigorous gardening 
or work around the house)
17. If you add up all the time you spent doing each activity 
LAST WEEK, how much time did you spend ALTOGETHER 
doing each type of activity?
(put "0" if you did not do this activity)
hours minutes
Walking continuously, for at least 10 minutes
(for recreation or exercise or to get to :
or from places)
Vigorous physical activity
(that made you breathe harder or puff and pant, :
like jogging, cycling, aerobics, competitive tennis, 
but not household chores or gardening)
Moderate physical activity 
(like gentle swimming, social tennis, vigorous :
gardening or work around the house)
Questions about your family
18. Have your mother, father, brother(s) or sister(s) ever had:
(blood relatives only: please put a cross in the appropriate box(es))
heart disease breast cancer
high blood pressure bowel cancer
stroke lung cancer
diabetes melanoma
dementia/Alzheimer’s prostate cancer
Parkinson’s disease ovarian cancer
severe depression osteoporosis
severe arthritis hip fracture
do not know
19. How many children have you given 
birth to? children
(please include stillbirths but do not include miscarriages, 
please write “0” if you have not had any children)
How old were you when you gave birth 
to your FIRST child? years old
How old were you when you gave birth 
to your LAST child? years old
For how many months, in total, have 
you breastfed? months
(please add together all the time you spent breastfeeding 
all of your children; put “0” if you never breastfed)
Questions about your health
20. About how many hours a week are you exposed 
to someone else’s tobacco smoke?
hours per week hours per week
21. Have you ever used the pill or other hormonal contraceptives?
(e.g. the combined pill, mini pill, contraceptive implant or injections)
Yes ▼ No
If Yes, for how long altogether have you 
used hormonal contraceptives? years
(please write ‘0’ if you used them for less than a year in total)
If Yes, how old were you when you LAST 
used hormonal contraceptives? age
(please write your current age if you are still using them)
Which type of pill or other hormonal contraceptive 
did you use MOST RECENTLY?
“the pill”, combined pill (e.g. Microgynon, Levlen)
progesterone-only pill (“mini pill”) (e.g. Micronor, Noriday, Microval)
Depo Provera
contraceptive implant (e.g. Implanon, Norplant)
do not know
22. Have you ever used hormone replacement therapy (HRT)?
Yes ▼ No 
If Yes, for how long altogether have you 
used HRT? years
(please write ‘0’ if you used HRT for less than a year in total) 
Are you currently taking HRT? Yes No
If No, at what age did you stop? age
23. Have you taken any medications, vitamins or supplements 
for most of the last 4 weeks, including HRT and the pill?
Yes ▼ No
If Yes, was it: multivitamins + minerals multivitamins alone
fish oil glucosamine omega 3
paracetamol aspirin for the heart aspirin for other reasons
Lipitor Avapro, Karvea warfarin, Coumadin
Pravachol Coversyl, Coversyl Plus Lasix, frusemide
Zocor, Lipex Cardizem, Vasocordol Micardis
Nexium Norvasc Fosamax
Somac Tritace Caltrate
Losec, Acimax Noten, Tenormin Oroxine
omeprazole atenolol thyroxine
Ventolin Zyloprim, Progout 300 Diabex, Diaformin
salbutamol allopurinol metformin
Zoloft Cipramil Efexor
sertraline citaloprim venlafaxine
m
ot
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please list any other regular medications or supplements here 
times in the 
last week
at home in other places(e.g. work, going out, cars)
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24. Has a doctor EVER told you that you have:
(If YES, please cross the box and give your age when 
the condition was first found)
Yes
skin cancer (not melanoma) age
melanoma age
breast cancer age
other cancer age
heart disease age
high blood pressure – when pregnant age
high blood pressure – when not pregnant age
stroke age
diabetes age
blood clot (thrombosis) age
asthma age
hayfever age
depression age
anxiety age
Parkinson’s disease age
none of these
25. In the last month have you been treated for: 
(If YES, please cross the box and give your age 
when the treatment started)
Yes
cancer age
heart attack or angina age
other heart disease age
high blood pressure age
high blood cholesterol age
blood clotting problems age
asthma age
osteoarthritis age
thyroid problems age
osteoporosis or low bone density age
depression age
anxiety age
none of these
26. Are you NOW suffering from any other important illness?
Yes ▼ No 
27. Do you regularly need help with daily tasks because 
of long-term illness or disability? 
(e.g. personal care, getting around, preparing meals)
Yes No 
28. Does your health now LIMIT YOU 
in any of the following activities?
VIGOROUS activities
(e.g. running, strenuous sports)
MODERATE activities
(e.g. pushing a vacuum cleaner, playing golf)
lifting or carrying shopping
climbing several flights of stairs
climbing one flight of stairs
walking one kilometre
walking half a kilometre
walking 100 metres
bending, kneeling or stooping
bathing or dressing yourself
29. Have you ever had any of the following operations?
(If YES, please cross the box and give your 
age when you had the operation; give your 
age at the most recent operation if you 
have had more than one) Yes
removal of skin cancer age
hysterectomy age
both ovaries removed age
sterilisation (tubes tied) age
repair of prolapsed womb, bladder or bowel age
knee replacement age
hip replacement age
gallbladder removed age
heart or coronary bypass surgery age
(include stents and balloons)
Please describe this illness and its treatment 
other (please describe any other operations you have had in the last 
10 years, with your age when you had them) 
type of cancer (please describe)
type of heart disease (please describe)
Age when condition
was first found
Age when 
had operation
Age started 
treatment
yes, 
limited 
a lot
no, not 
limited 
at all
yes, 
limited 
a little
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30. Do you regularly care for a sick or disabled 
family member or friend? 
Yes ▼ No 
If Yes, about how much time each week do you usually spend
caring for this person?
full time OR hours/wk
31. In general, how would 
you rate your:
overall health?
quality of life?
eyesight? (with glasses or 
contact lenses, if you wear them)
memory?
teeth and gums?
32. Do you feel you have a hearing loss? Yes No 
33. How many of your own teeth do you have left?
None – all of my teeth are missing 1-9 teeth left
10-19 teeth left 20 or more teeth left
34. During the past 12 months, how many times have you fallen 
to the floor or ground? (put “0” if you haven’t fallen in this time)
times
35. Have you had a broken/fractured bone in the last 5 years?
Yes ▼ No
If Yes, which bones were broken?
wrist arm hip ankle
rib finger/toe other_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
How old were you when it happened?
(give age at most recent fracture if more than one) years old
36. About how many times a week are you usually troubled 
by leaking urine?
never once a week or less
2-3 times 4-6 times every day
37. Have you been through menopause?
No 
Not sure (because hysterectomy, taking HRT, etc.)
My periods have become irregular
Yes – How old were you when you
went through menopause? years old
38. Have you ever been for a breast screening mammogram?
Yes ▼ No
If Yes, what year did you have your last 
mammogram? (e.g. 2005)
How many times have you been 
for breast screening altogether? times
39. Have you ever been screened for colorectal (bowel) cancer?
Yes ▼ No
If Yes, please indicate which test(s) you had:
faecal occult blood test (test for blood in the stool/faeces)
sigmoidoscopy (a tube is used to examine the lower bowel: 
this is usually done in a doctor’s office without pain relief)
colonoscopy (a long tube is used to examine the whole large bowel; 
you would usually have to have an enema or drink large amounts 
of special liquid to prepare the bowel for this)
What year did you have the most recent 
one of these tests? (e.g. 2005)
Questions about your diet
40. About how many times each week do you eat:
(please count all meals and snacks. put ‘0’ if never eaten 
or eaten less than once a week)
beef, lamb or pork
chicken, turkey or duck
processed meat
(include bacon, sausages, salami, devon, burgers, etc)
fish or seafood
cheese
41. About how many of the following do you usually eat:
slices or pieces of brown/wholemeal bread each week
(also include multigrain, rye bread, etc.)
bowls of breakfast cereal each week
If you eat breakfast cereal is it usually: (please cross)
bran cereal (allbran, branflakes, etc.) muesli
biscuit cereal (weetbix, other (cornflakes, 
shredded wheat, etc.) rice bubbles,etc.) 
oat cereal (porridge, etc.)
42. Which type of milk do you mostly have?
whole milk reduced fat milk skim milk
soy milk other milk I don’t drink milk
43. About how many serves of vegetables do you usually eat 
each day? A serve is half a cup of cooked vegetables or one cup of salad 
(please include potatoes and put “0” if less than one a day)
number of serves of cooked vegetables each day 
number of serves of raw vegetables each day (e.g. salad)
I don’t eat vegetables
44. About how many serves of fruit or glasses of fruit juice do you
usually have each day? A serve is 1 medium piece or 2 small pieces or
1 cup of diced or canned fruit pieces (put “0” if you eat less than one serve a day)
number of serves of fruit each day
number of glasses of fruit juice each day
I don’t eat fruit 
45. Please put a cross in the box if you NEVER eat: 
red meat chicken/poultry pork/ham dairy products
any meat eggs sugar wheat products
fish seafood cream cheese
Questions about time and work
46. What is your usual yearly HOUSEHOLD income before tax, 
from all sources? (please include benefits, pensions, superannuation, etc)
less than $5,000 per year $30,000-$39,999 per year
$5,000-$9,999 per year $40,000-$49,999 per year
$10,000-$19,999 per year $50,000-$69,999 per year
$20,000-$29,999 per year $70,000 or more per year
I would rather not answer this question
ex
ce
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nt
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times eaten 
each week
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Thank you very much for filling in the questionnaire 
DON’T FORGET TO SIGN THE CONSENT FORM OVERLEAF 
47. What is your current work status? (you can cross more than one box)
in full time paid work self-employed
in part time paid work doing unpaid work
completely retired/pensioner studying
partially retired looking after home/family
disabled/sick unemployed
other
48. If you are partially or completely retired, 
how old were you when you retired? years old
Why did you retire? (you can cross more than one box)
reached usual retirement age lifestyle reasons
to care for family member/friend ill health
made redundant could not find a job
other
49. About how many HOURS each WEEK do you usually spend
doing the following? (please put “0” if you do not spend any time doing it)
hours per week hours per week
paid work voluntary/unpaid work
50. Which of the following do you have? (excluding Medicare)
Private health insurance – with extras
Private health insurance – without extras
Department of Veterans’ Affairs white or gold card
Health care concession card
none of these
51. What best describes the colour of the skin on the inside of
your upper arm, that is your skin colour without any tanning?
very fair light olive brown
fair dark olive black
52. What would happen if your skin was repeatedly exposed 
to bright sunlight during summer without any protection?
Would it:
Get very tanned? Get mildly or occasionally tanned?
Get moderately tanned? Never tan, or only get freckled?
53. About how many hours a DAY would you usually spend
outdoors on a weekday and on the weekend?
hours per day hours per day
weekday weekend
54. About how many HOURS in each 24 hour DAY 
do you usually spend doing the following? 
(please put “0” if you do not spend any time doing it)
hours per day hours per day
55. How many TIMES in the LAST WEEK did you: 
(please put “0” if you did not spend any time doing it)
spend time with friends or family 
who do not live with you?
talk to someone (friends, relatives or others) 
on the telephone?
go to meetings of social clubs, religious groups 
or  other groups you belong to?
56. How many people outside your home, but 
within one hour of travel, do you feel you 
can depend on or feel very close to? people
57. During the past 4 weeks, 
about how often did you feel:
tired out for no good reason?
nervous?
so nervous that nothing could 
calm you down?
hopeless?
restless or fidgety?
so restless that you could 
not sit still?
depressed?
that everything was an effort?
so sad that nothing could 
cheer you up?
worthless?
58. During the past 4 weeks, have you had any of the following
problems with your work or daily activities because of any
emotional problems (such as being depressed or anxious)?
cut down on the amount of time you spent 
on work or other activities Yes No
achieved less than you would have liked to Yes No
did work or other activities less carefully 
than usual Yes No
Are your name and address correct on the front of this questionnaire? Yes No
If INCORRECT, give details below.
Surname: 
Given name(s):
Postal address:
Town or Suburb:
State or Territory: Postcode:
times in the 
last week
none
of the
time
a little
of the
time
some
of the
time
most
of the
time
all
of the
time
sleeping (including 
at night & naps) sitting
watching television
or using a computer standing
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The 45 and Up Study relies on the willingness of people in New South Wales to share information about their lives 
and experiences and to have their health followed over time. By signing this form you are agreeing to take part in the 
45 and Up Study and for the Study team to follow your health over time. Participation is completely voluntary, and you 
are free to ask questions or to withdraw from the Study at any time, by calling the Study helpline on 1300 45 11 45.
More information on the Study can be found at www.45andup.org.au 
Consent form
I agree to have my health followed over time through:
the 45 and Up Study team following health and other
records relating to me, including NSW hospital records,
cancer records, death records and other health-related 
records, as outlined in the Study leaflet: The 45 and Up Study:
Information for participants;
Medicare Australia releasing to the 45 and Up Study my
enrolment details, including Medicare number, and information
concerning services provided to me under Medicare, the
Department of Veterans’ Affairs, the Pharmaceutical Benefits
Scheme and the Repatriation Pharmaceutical Benefits Scheme,
including past information, until the end of the Study or for 
the duration of my involvement in the Study;
being contacted in the future to provide information on
changes to my health and lifestyle. I may also be asked to
provide further information including questionnaire responses or
biological samples; my participation in any of these would 
be completely voluntary.
I give my consent on the understanding that:
my information will only be used for the purposes 
outlined in the Study leaflet entitled The 45 and Up Study:
Information for participants, of which I have a copy;
my information will be kept strictly confidential and 
will be used for health research only;
reports and publications from the Study will be based on 
de-identified information and will not identify any individual 
taking part;
my participation in this Study is entirely voluntary
and my consent will continue to be valid following death 
or disablement unless withdrawn by my next of kin or other
person responsible. I am free to withdraw from the Study at 
any time by calling the Study helpline on 1300 45 11 45;
my decision on whether or not to take part in the 
Study or in any additional research will not disadvantage 
me or affect my future health care in any way.
I have been provided with information about the 45 and Up Study including how it will gather, store, use and disclose information about
me, in the Study leaflet. I have been given an opportunity to ask questions and have been fully informed about the Study.
Name (Print):
day month year
Signature: Date today: 2 0
Extra contact details
It would be very helpful and reduce Study costs if we could contact you in future by email. If you are happy for us to do this, 
please write your email address here:
Email address:
Sometimes we find that people have moved when we try to contact them again. It would be very helpful if you could give us your mobile 
phone number and/or the contact details of someone close to you (such as a relative or friend) who would be happy for us to contact them 
if we are unable to reach you. We would only get in touch with that person if we were unable to contact you directly and we would need 
to tell them our reason for contacting you. Please leave this section blank if you do not wish to provide these extra contact details.
Your home 
phone number:
Your mobile 
phone number:
Full name of 
contact person:
Phone number 
of contact person:
If you have any questions about the Study, please ring the Study helpline on 1300 45 11 45. 
You can also write to or send your questionnaire (no stamp required) directly to: 
Associate Professor Emily Banks, Scientific Director, 
The 45 and Up Study, Reply paid 5289, Sydney NSW 2001.
Thank you very much for taking part
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Your answers and experiences are important to us. 
To help us read your answers, please write as clearly 
as possible using a BLACK or BLUE pen, and be sure 
to complete the questionnaire as shown: 
Please put a cross in the appropriate box(es) Yes No
OR put numbers in the appropriate box, e.g. 21st June 1945
age 2654916012
45 and Up Study Questionnaire 
for Men
day month year
1. What is your 
date of birth?
day month year
2. What is 
today’s date?
3. How tall are you 
without shoes? cm OR feet inches
(please give to the nearest cm or inch)
4. About how much 
do you weigh? kg OR stone lbs
5. What is the highest qualification you have completed?
(please put a cross in the most appropriate box) 
no school certificate or other qualifications
school or intermediate certificate (or equivalent) 
higher school or leaving certificate (or equivalent)
trade/apprenticeship (e.g. hairdresser, chef)
certificate/diploma (e.g. child care, technician)
university degree or higher
6. Are you of Aboriginal or Torres Strait Islander origin?
(you can cross more than one box)
No Yes, Aboriginal Yes, Torres Strait Islander
7. In which country were you born?
Australia please go to question 9
UK Ireland Italy China
Greece New Zealand Germany Lebanon
Philippines Netherlands Vietnam Malta
Poland other (please specify) _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
8. What year did you first come to live in 
Australia for one year or more? (e.g. 1970)
9. What is your ancestry? (please cross up to 2 boxes)
Australian English Irish Chinese
Italian Greek Scottish German
Lebanese Dutch Maltese Polish
Filipino Indian Croatian Vietnamese
other (please specify)  _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
10. Do you speak a language other than English at home?
Yes No
11. Have you ever been a regular smoker?
Yes ▼ No If No – please go to question 12
How old were you when you started 
smoking regularly? years old
Are you a regular smoker now? Yes No
If No – how old were you when you 
stopped smoking regularly? years old
About how much do you/did you smoke on average each day?
(If you are an ex-smoker, how much did you smoke on average 
when you smoked?)
cigarettes per day pipes and cigars per day
12. About how many alcoholic drinks do you have each week?
one drink = a glass of wine, middy of beer or nip of spirits
(put “0” if you do not drink, or have less than one drink each week)
number of alcoholic drinks each week
13. On how many days each week 
do you usually drink alcohol? days each week
02
1 9
General questions about you
BLFM0710
The 45 and Up Study relies on the willingness of people in New South Wales to share information about 
their lives and experiences, to provide knowledge that will help people live healthy and fulfilling lives for
as long as possible. Participation is completely voluntary, and you are free to withdraw from the Study at 
any time. To take part, please read the participant information leaflet, then complete the questionnaire and 
consent form and return them in the envelope provided. We very much hope you will be able to take part.
Any questions or comments? Please call the Study helpline: 1300 45 11 45 or go to www.45andUp.org.au
Auspiced by In collaboration with
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14. What best describes your current situation? (please cross one box)
single married de facto/living with a partner
widowed divorced separated
15. What best describes your current housing? (please cross one box)
house flat, unit, apartment house on farm
hostel for the aged mobile home other
nursing home retirement village, self care unit
16. How many TIMES did you do each of these 
activities LAST WEEK?
(put "0" if you did not do this activity)
Walking continuously, for at least 10 minutes
(for recreation or exercise or to get to or from places)
Vigorous physical activity
(that made you breathe harder or puff and pant, like jogging,
cycling, aerobics, competitive tennis, but not household chores 
or gardening)
Moderate physical activity
(like gentle swimming, social tennis, vigorous gardening 
or work around the house)
17. If you add up all the time you spent doing each activity 
LAST WEEK, how much time did you spend ALTOGETHER 
doing each type of activity?
(put "0" if you did not do this activity)
hours minutes
Walking continuously, for at least 10 minutes
(for recreation or exercise or to get to :
or from places)
Vigorous physical activity
(that made you breathe harder or puff and pant, :
like jogging, cycling, aerobics, competitive tennis, 
but not household chores or gardening)
Moderate physical activity 
(like gentle swimming, social tennis, vigorous :
gardening or work around the house)
Questions about your family
18. Have your mother, father, brother(s) or sister(s) ever had:
(blood relatives only: please put a cross in the appropriate box(es))
heart disease breast cancer
high blood pressure bowel cancer
stroke lung cancer
diabetes melanoma
dementia/Alzheimer’s prostate cancer
Parkinson’s disease ovarian cancer
severe depression osteoporosis
severe arthritis hip fracture
do not know
19. How many children have you fathered? children(please include stillbirths but do not include miscarriages, 
please write “0” if you have not had any children)
How old were you when you fathered your 
FIRST child? years old
How old were you when you fathered your 
LAST child? years old
20. Have you ever tried for more than 1 year but have been 
unable to father children?
Yes No
Questions about your health
21. About how many hours a week are you exposed 
to someone else’s tobacco smoke?
hours per week hours per week
22. Over the last month, 
how often have you:
found it difficult to postpone urination?
had to push or strain to start urination?
had a weak urinary stream?
stopped and started again several 
times when you urinated?
had to urinate again less than 2 hours 
after you finished urinating?
had the feeling that you had not emptied
your bladder completely after urinating?
Over the past month, how many times did you usually 
get up from bed to urinate during the night?
never some nights times each night
23. Have you taken any medications, vitamins or supplements 
for most of the last 4 weeks?
Yes ▼ No
If Yes, was it: multivitamins + minerals multivitamins alone
fish oil glucosamine omega 3
paracetamol aspirin for the heart aspirin for other reasons
Lipitor Avapro, Karvea warfarin, Coumadin
Pravachol Coversyl, Coversyl Plus Lasix, frusemide
Zocor, Lipex Cardizem, Vasocordol Micardis
Nexium Norvasc Fosamax
Somac Tritace Caltrate
Losec, Acimax Noten, Tenormin Oroxine
omeprazole atenolol thyroxine
Ventolin Zyloprim, Progout 300 Diabex, Diaformin
salbutamol allopurinol metformin
Zoloft Cipramil Efexor
sertraline citaloprim venlafaxine
m
ot
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please list any other regular medications or supplements here 
times in the 
last week
not
at all
some
times often
almost
always
at home in other places(e.g. work, going out, cars)
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24. Has a doctor EVER told you that you have:
(If YES, please cross the box and give your age when 
the condition was first found)
Yes
skin cancer (not melanoma) age
melanoma age
prostate cancer age
other cancer age
heart disease age
high blood pressure age
stroke age
diabetes age
blood clot (thrombosis) age
enlarged prostate age
asthma age
hayfever age
depression age
anxiety age
Parkinson’s disease age
none of these
25. In the last month have you been treated for: 
(If YES, please cross the box and give your age 
when the treatment started)
Yes
cancer age
heart attack or angina age
other heart disease age
high blood pressure age
high blood cholesterol age
blood clotting problems age
asthma age
osteoarthritis age
thyroid problems age
osteoporosis or low bone density age
depression age
anxiety age
none of these
26. Are you NOW suffering from any other important illness?
Yes ▼ No 
27. Do you regularly need help with daily tasks because 
of long-term illness or disability? 
(e.g. personal care, getting around, preparing meals)
Yes No 
28. Does your health now LIMIT YOU 
in any of the following activities?
VIGOROUS activities
(e.g. running, strenuous sports)
MODERATE activities
(e.g. pushing a vacuum cleaner, playing golf)
lifting or carrying shopping
climbing several flights of stairs
climbing one flight of stairs
walking one kilometre
walking half a kilometre
walking 100 metres
bending, kneeling or stooping
bathing or dressing yourself
29. Have you ever had any of the following operations?
(If YES, please cross the box and give your 
age when you had the operation; give your 
age at the most recent operation if you 
have had more than one) Yes
removal of skin cancer age
vasectomy age
part of prostate removed age
whole prostate removed age
knee replacement age
hip replacement age
gallbladder removed age
heart or coronary bypass surgery age
(include stents and balloons)
Please describe this illness and its treatment 
other (please describe any other operations you have had in the last 
10 years, with your age when you had them) 
type of cancer (please describe)
type of heart disease (please describe)
Age when condition
was first found
Age when 
had operation
Age started 
treatment
yes, 
limited 
a lot
no, not 
limited 
at all
yes, 
limited 
a little
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30. Do you regularly care for a sick or disabled 
family member or friend?  
Yes ▼ No 
If Yes, about how much time each week do you usually spend
caring for this person?
full time OR hours/wk
31. In general, how would 
you rate your:
overall health?
quality of life?
eyesight? (with glasses or 
contact lenses, if you wear them)
memory?
teeth and gums?
32. Do you feel you have a hearing loss? Yes No 
33. How many of your own teeth do you have left?
None – all of my teeth are missing 1-9 teeth left
10-19 teeth left 20 or more teeth left
34. During the past 12 months, how many times have you fallen 
to the floor or ground? (put “0” if you haven’t fallen in this time)
times
35. Have you had a broken/fractured bone in the last 5 years?
Yes ▼ No
If Yes, which bones were broken?
wrist arm hip ankle
rib finger/toe other_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
How old were you when it happened?
(give age at most recent fracture if more than one) years old
36. About how many times a week are you usually troubled 
by leaking urine?
never once a week or less
2-3 times 4-6 times every day
37. How often are you able to get and keep an erection that 
is firm enough for satisfactory sexual activity?
always usually sometimes 
never I would rather not answer this question
38. Have you ever had a blood test ordered by your doctor 
to check for prostate disease? (PSA test)
Yes ▼ No
If Yes, what year did you have your last 
PSA test? (e.g. 2005)
How many times have you had a PSA 
test altogether? times
39. Have you ever been screened for colorectal (bowel) cancer?
Yes ▼ No
If Yes, please indicate which test(s) you had:
faecal occult blood test (test for blood in the stool/faeces)
sigmoidoscopy (a tube is used to examine the lower bowel: 
this is usually done in a doctor’s office without pain relief)
colonoscopy (a long tube is used to examine the whole large bowel; 
you would usually have to have an enema or drink large amounts 
of special liquid to prepare the bowel for this)
What year did you have the most recent 
one of these tests? (e.g. 2005)
Questions about your diet
40. About how many times each week do you eat:
(please count all meals and snacks. put ‘0’ if never eaten 
or eaten less than once a week)
beef, lamb or pork
chicken, turkey or duck
processed meat
(include bacon, sausages, salami, devon, burgers, etc)
fish or seafood
cheese
41. About how many of the following do you usually eat:
slices or pieces of brown/wholemeal bread each week
(also include multigrain, rye bread, etc.)
bowls of breakfast cereal each week
If you eat breakfast cereal is it usually: (please cross)
bran cereal (allbran, branflakes, etc.) muesli
biscuit cereal (weetbix, other (cornflakes, 
shredded wheat, etc.) rice bubbles,etc.) 
oat cereal (porridge, etc.)
42. Which type of milk do you mostly have?
whole milk reduced fat milk skim milk
soy milk other milk I don’t drink milk
43. About how many serves of vegetables do you usually eat 
each day? A serve is half a cup of cooked vegetables or one cup of salad 
(please include potatoes and put “0” if less than one a day)
number of serves of cooked vegetables each day 
number of serves of raw vegetables each day (e.g. salad)
I don’t eat vegetables
44. About how many serves of fruit or glasses of fruit juice do you
usually have each day? A serve is 1 medium piece or 2 small pieces or
1 cup of diced or canned fruit pieces (put “0” if you eat less than one serve a day)
number of serves of fruit each day
number of glasses of fruit juice each day
I don’t eat fruit 
45. Please put a cross in the box if you NEVER eat: 
red meat chicken/poultry pork/ham dairy products
any meat eggs sugar wheat products
fish seafood cream cheese
Questions about time and work
46. What is your usual yearly HOUSEHOLD income before tax, 
from all sources? (please include benefits, pensions, superannuation, etc)
less than $5,000 per year $30,000-$39,999 per year
$5,000-$9,999 per year $40,000-$49,999 per year
$10,000-$19,999 per year $50,000-$69,999 per year
$20,000-$29,999 per year $70,000 or more per year
I would rather not answer this question
ex
ce
lle
nt
ve
ry
 g
oo
d
go
od
fa
ir
po
or
number of 
times eaten 
each week
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Thank you very much for filling in the questionnaire 
DON’T FORGET TO SIGN THE CONSENT FORM OVERLEAF 
47. What is your current work status? (you can cross more than one box)
in full time paid work self-employed
in part time paid work doing unpaid work
completely retired/pensioner studying
partially retired looking after home/family
disabled/sick unemployed
other
48. If you are partially or completely retired, 
how old were you when you retired? years old
Why did you retire? (you can cross more than one box)
reached usual retirement age lifestyle reasons
to care for family member/friend ill health
made redundant could not find a job
other
49. About how many HOURS each WEEK do you usually spend
doing the following? (please put “0” if you do not spend any time doing it)
hours per week hours per week
paid work voluntary/unpaid work
50. Which of the following do you have? (excluding Medicare)
Private health insurance – with extras
Private health insurance – without extras
Department of Veterans’ Affairs white or gold card
Health care concession card
none of these
51. What best describes the colour of the skin on the inside of
your upper arm, that is your skin colour without any tanning?
very fair light olive brown
fair dark olive black
52. What would happen if your skin was repeatedly exposed 
to bright sunlight during summer without any protection?
Would it:
Get very tanned? Get mildly or occasionally tanned?
Get moderately tanned? Never tan, or only get freckled?
53. About how many hours a DAY would you usually spend
outdoors on a weekday and on the weekend?
hours per day hours per day
weekday weekend
54. About how many HOURS in each 24 hour DAY 
do you usually spend doing the following? 
(please put “0” if you do not spend any time doing it)
hours per day hours per day
55. How many TIMES in the LAST WEEK did you: 
(please put “0” if you did not spend any time doing it)
spend time with friends or family 
who do not live with you?
talk to someone (friends, relatives or others) 
on the telephone?
go to meetings of social clubs, religious groups 
or  other groups you belong to?
56. How many people outside your home, but 
within one hour of travel, do you feel you 
can depend on or feel very close to? people
57. During the past 4 weeks, 
about how often did you feel:
tired out for no good reason?
nervous?
so nervous that nothing could 
calm you down?
hopeless?
restless or fidgety?
so restless that you could 
not sit still?
depressed?
that everything was an effort?
so sad that nothing could 
cheer you up?
worthless?
58. During the past 4 weeks, have you had any of the following
problems with your work or daily activities because of any
emotional problems (such as being depressed or anxious)?
cut down on the amount of time you spent 
on work or other activities Yes No
achieved less than you would have liked to Yes No
did work or other activities less carefully 
than usual Yes No
Are your name and address correct on the front of this questionnaire? Yes No
If INCORRECT, give details below.
Surname: 
Given name(s):
Postal address:
Town or Suburb:
State or Territory: Postcode:
times in the 
last week
none
of the
time
a little
of the
time
some
of the
time
most
of the
time
all
of the
time
sleeping (including 
at night & naps) sitting
watching television
or using a computer standing
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The 45 and Up Study relies on the willingness of people in New South Wales to share information about their lives 
and experiences and to have their health followed over time. By signing this form you are agreeing to take part in the 
45 and Up Study and for the Study team to follow your health over time. Participation is completely voluntary, and you 
are free to ask questions or to withdraw from the Study at any time, by calling the Study helpline on 1300 45 11 45.
More information on the Study can be found at www.45andup.org.au 
Consent form
I agree to have my health followed over time through:
the 45 and Up Study team following health and other
records relating to me, including NSW hospital records,
cancer records, death records and other health-related 
records, as outlined in the Study leaflet: The 45 and Up Study:
Information for participants;
Medicare Australia releasing to the 45 and Up Study my
enrolment details, including Medicare number, and information
concerning services provided to me under Medicare, the
Department of Veterans’ Affairs, the Pharmaceutical Benefits
Scheme and the Repatriation Pharmaceutical Benefits Scheme,
including past information, until the end of the Study or for 
the duration of my involvement in the Study;
being contacted in the future to provide information on
changes to my health and lifestyle. I may also be asked to
provide further information including questionnaire responses or
biological samples; my participation in any of these would 
be completely voluntary.
I give my consent on the understanding that:
my information will only be used for the purposes 
outlined in the Study leaflet entitled The 45 and Up Study:
Information for participants, of which I have a copy;
my information will be kept strictly confidential and 
will be used for health research only;
reports and publications from the Study will be based on 
de-identified information and will not identify any individual 
taking part;
my participation in this Study is entirely voluntary
and my consent will continue to be valid following death 
or disablement unless withdrawn by my next of kin or other
person responsible. I am free to withdraw from the Study at 
any time by calling the Study helpline on 1300 45 11 45;
my decision on whether or not to take part in the 
Study or in any additional research will not disadvantage 
me or affect my future health care in any way.
I have been provided with information about the 45 and Up Study including how it will gather, store, use and disclose information about
me, in the Study leaflet. I have been given an opportunity to ask questions and have been fully informed about the Study.
Name (Print):
day month year
Signature: Date today: 2 0
Extra contact details
It would be very helpful and reduce Study costs if we could contact you in future by email. If you are happy for us to do this, 
please write your email address here:
Email address:
Sometimes we find that people have moved when we try to contact them again. It would be very helpful if you could give us your mobile 
phone number and/or the contact details of someone close to you (such as a relative or friend) who would be happy for us to contact them 
if we are unable to reach you. We would only get in touch with that person if we were unable to contact you directly and we would need 
to tell them our reason for contacting you. Please leave this section blank if you do not wish to provide these extra contact details.
Your home 
phone number:
Your mobile 
phone number:
Full name of 
contact person:
Phone number 
of contact person:
If you have any questions about the Study, please ring the Study helpline on 1300 45 11 45. 
You can also write to or send your questionnaire (no stamp required) directly to: 
Associate Professor Emily Banks, Scientific Director, 
The 45 and Up Study, Reply paid 5289, Sydney NSW 2001.
Thank you very much for taking part
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Appendix 3 - SEEF Study follow-up questionnaire and consent form 
  
SAX SEEF Survey V9 08-02-10perf
perf
<TITLE> <FIRST NAME> <LAST NAME>
<ADDRESS LINE 1>
<ADDRESS LINE 2>
<ADDRESS LINE 3>
<STATE>  <POSTCODE>
Dear <FIRST NAME>,
The 45 and Up Study
The SEEF Project
The 45 and Up Study is a long-term health study of over 250,000 people in NSW aged 45 and over.   
In <MONTH> <YEAR> you agreed to participate in the 45 and Up Study by completing a questionnaire about 
your health and lifestyle and signing a consent form.  By allowing the 45 and Up Study to follow your health 
over time you are contributing to a better understanding of the major causes of disease and disability in mid to 
later life. Thank you very much for joining us.
As a participant in the 45 and Up Study, we now seek your involvement in the SEEF Project – a research 
project that extends the original study to look at how Social, Economic and Environmental Factors (SEEF) 
contribute to healthy ageing. This project is very large scale, with 100,000 people being asked to assist us, 
and SEEF will add important information to the 45 and Up Study to help us gain a better understanding of the 
factors that influence health and wellbeing.
On the other side of this page is an invitation from Professor Adrian Bauman of the School of Public Health at 
the University of Sydney to participate in the SEEF Project.
If you would like to participate, please complete the questionnaire, sign the consent form, and return it to us in 
the provided reply paid envelope.  More information about the SEEF Project and how to participate is provided 
in the information pamphlet.  You can tear off this letter to keep for your records if desired.
Taking part is entirely your decision, and, if you choose to take part, you can withdraw at any time by calling 
the 45 and Up Study Helpline on 1300 45 11 45.  Your choice will not affect the health care or benefits you 
receive, or disadvantage you in any way.
Yours sincerely
Professor Emily Banks
Scientific Director, The 45 and Up Study
The 45 and Up Study
GPO Box 5289
Sydney NSW 2001
Helpline: 1300 45 11 45
www.45andUp.org.au
<DATE>
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Invitation to join the SEEF Project
Your name has been randomly drawn from the 45 and Up Study participants’ list.  As a participant in  
the 45 and Up Study, we now invite you to join the Social, Economic and Environmental Factors (SEEF) Project. 
Participation is as easy as completing the confidential questionnaire that follows this letter, signing the 
consent form giving your permission for us to use the information you have provided, and returning it to us 
as soon as possible using the enclosed reply paid envelope.
Your participation in this project will only take about 40 minutes of your time and will make a significant 
contribution to the SEEF Project, which is examining the factors that help our population stay healthy 
as it ages. 
All information given by you to the 45 and Up Study and the SEEF Project will remain completely 
confidential and used for health research only.
More information about the SEEF Project and the 45 and Up Study more generally is given in the enclosed 
information pamphlet and on the Study website (www.45andUp.org.au) or you can call the 45 and Up Study 
Helpline on 1300 45 11 45.  The information pamphlet and this letter can be kept for your own records.
We very much hope that you will be able to take part.
Thank you.
Yours sincerely
 
 
Professor Adrian Bauman
Sesquicentenary Professor of Public Health
School of Public Health
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The SEEF Project
Social, Economic and Environmental Factors Questionnaire
The  45 and Up Study relies on the willingness of its participants to share information about their lives and 
experiences, to provide knowledge that will help people live healthy and fulfilling lives for as long as possible. 
This questionnaire looks at which social, economic and environmental factors play a key role in the health and  
wellbeing of people in the 45 and Up Study.
Participation is completely voluntary, and you are free to withdraw at any time.  To take part, please read the 
participant information leaflet, then complete the questionnaire and consent form and return them in the envelope 
provided.  We very much hope you will be able to take part.
Any questions or comments? Please call the Study Helpline: 1300 45 11 45 or go to www.45andUp.org.au
Your answers and experiences are important to us.  
To help us read your answers, please use a BLACK or BLUE pen.  
Put crosses           OR numbers         in the appropriate box(es).7  2
General questions about you
D D M M Y Y Y Y
What is your date of birth?2.
D D M M Y Y Y Y
/ /
/ /
What is your gender?3.
male female
Have you ever been a 
regular smoker?
4.
Yes No
Go to Q8
Are you a regular smoker 
NOW?
5.
Yes No
Go to Q7
If No – how old were you when you stopped 
smoking regularly?
6.
years old
About how much do you/ did you smoke on average 
each day? (if you are an ex-smoker, how much did you smoke 
on average when you smoked? Leave blank if it does not apply)
7.
cigarettes 
per day
pipes and cigars 
per day
About how many alcoholic drinks do you have each week? 
one drink = a glass of wine, middy of beer or nip of spirits  
(put “0” if you do not drink, or have less than one drink each week)
8.
number of alcoholic drinks each week
On how many days each week do you usually drink 
alcohol? (put “0” if you do not drink alcohol)
9.
days each week
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How many TIMES did you do each of these activities 
LAST WEEK?  
(please put “0” if you did not do this activity)
10.
times in  
the last week
Walking continuously, for at least 10 
minutes (for recreation or exercise or to get 
to or from places) 
Vigorous physical activity  
(that made you breathe harder or puff and 
pant, like jogging, cycling, aerobics, competitive 
tennis, but not household chores or gardening) 
Moderate physical activity  
(like gentle swimming, social tennis, vigorous 
gardening or work around the house)
If you add up all the time you spent doing each 
activity LAST WEEK, how much time did you spend 
ALTOGETHER doing each type of activity?   
(please put “0” if you did not do this activity)
11.
minutes
Walking continuously, for 
at least 10 minutes  
(for recreation or exercise or 
to get to or from places) 
:
hours
Vigorous physical activity 
(that made you breathe harder 
or puff and pant, like jogging, 
cycling, aerobics, competitive 
tennis, but not household 
chores or gardening)
:
Moderate physical activity  
(like gentle swimming, social 
tennis, vigorous gardening or 
work around the house) 
:
About how much do you weigh?12.
kg  OR stone lbs
About how many serves of vegetables do you usually 
eat each day? a serve is half a cup of cooked vegetables or 
one cup of salad (please include potatoes and put “0” if less 
than one a day)
13.
number of serves of cooked vegetables each day
number of serves of raw vegetables each day  
(e.g. salad)
I don’t eat vegetables
About how many serves of fruit or glasses of fruit juice 
do you usually have each day? a serve is 1 medium piece 
or 2 small pieces or 1 cup of diced or canned fruit pieces 
(put “0” if you eat less than one serve per day)
14.
number of serves of fruit each day
number of glasses of fruit juice each day
I don’t eat fruit
About how many HOURS in each 24 hour DAY do you 
usually spend doing the following?    
(please put “0” if you do not spend any time doing it.  
The total number of hours does not need to add up to 24)
15.
hours per day
sleeping (including 
at night & naps)
watching 
television
using a 
computer
sitting
standing
driving
Buddhism 
Christianity 
Hinduism 
Islam
What is your religious faith or group?  
(please cross only one box)
16.
Judaism 
other religions/faith 
no religion
hours per day
strongly 
disagree
Rate your agreement with the following statement:17.
disagreeagree
strongly  
agree
I try hard to carry my 
beliefs over into all 
other dealings in life
exclusively heterosexual 
mainly heterosexual 
bisexual 
mainly homosexual 
(lesbian/gay)
Which of these most closely describes your sexual 
orientation? (please cross only one box)
18.
exclusively homosexual 
(lesbian/gay) 
I don’t know 
I don’t want to answer
Questions about you and your household
What best describes your current situation?  
(please cross only one box)
19.
single 
widowed 
married 
divorced 
de facto/living with partner 
separated
Including yourself, how many people in total live in 
your household? (put “1” if you live alone)
20.
How many financially dependent children do you have aged: 
(put “0” if you have no dependents)
21.
under 15 years old? 
15-24 years old?
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Which of these most closely describes your sexual 
orientation? (please cross only one box)
How many financially dependent children do you have aged: 
(put “0” if you have no dependents)
house 
hostel for the aged 
nursing home 
flat, unit, apartment 
mobile home 
What best describes your current housing or family home? 
(please cross only one box)
22.
retirement village, self 
care unit 
house on farm 
other
own 
currently paying off 
mortgage/ involved in a  
rent-buy scheme
Do you (or any other members of this household) own 
this home, rent it, or do you live here rent free? 
23.
rent (or pay board) 
live here rent free/  
life tenure
Do you currently own (or are 
paying off mortgage for) any other 
property that you do not live in?
24. Yes No
so cold that I have had 
trouble sleeping 
so cold that I have had 
trouble going about my 
normal activities
 
comfortable 
In the past year, at times my house/apartment has felt:  
(please cross as many as apply)
25.
so hot that I have had 
trouble sleeping 
so hot that I have had 
trouble going about my 
normal activities
 
none of the above
no cooling system 
central (ducted)  
air conditioning
How is your house/apartment cooled?  
(please cross only one box)
26.
room air conditioning 
evaporative air 
conditioning
public water supply 
bottled water 
rainwater 
private bore, spring or well 
What is your MAIN source of drinking water at home?  
(please cross only one box)
27.
other private water  
supply 
combination of different 
water sources 
During the past 5 years, have you changed your 
main source of drinking water due to:
28.
Yes No
drought? 
poor water quality?
How many motor vehicles in working order are there at 
your household? 
29.
vehicles
Questions about your health
overall health? 
quality of life? 
eyesight? (with glasses  
or contact lenses, if you 
wear them) 
hearing? 
memory? 
teeth and gums?
In general, how would you rate your: 30.
poorfairgood
very  
goodexcellent
Do you regularly need help with daily 
tasks because of long-term illness or 
disability? (e.g. personal care, getting 
around, preparing meals)
31. Yes No
Do you ever need someone to help 
with, or be with you for, self care 
activities? (e.g. doing everyday 
activities such as eating, showering, 
dressing or toileting)
32. Yes No
Do you ever need someone to 
help with, or be with you for, body 
movement activities?  
(e.g. getting out of bed, moving around 
at home or at places away from home)
33. Yes No
Do you ever need someone to 
help with or be with you for, 
communication activities? 
(e.g. understanding, or being 
understood by others)
34. Yes No
During the past 12 months, how 
many times have you fallen to the 
floor or ground?   
(put “0” if you haven’t fallen in this time)
35.
Have you had a broken/fractured 
bone in the last 3 years? 
36. Yes No
times
Go to Q37 
wrist 
ankle 
If YES, which bones were broken?
arm 
rib 
hip 
finger/toe
How old were you when it happened?  
(give age at most recent fracture if more 
than one) years old
other (specify)
other (specify)
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Has a doctor EVER told you that you have:  
(if YES, please cross the box and give your age when 
the condition was first found)
37.
age when condition  
was first found
skin cancer (not melanoma)
age
Yes
melanoma
age
prostate cancer (men only)
age
other cancer
age
type of cancer (please describe)
heart disease
age
type of heart disease (please describe)
high blood pressure  
(women only – when pregnant) age
high blood pressure (women 
only – when not pregnant) age
high blood pressure (men only)
age
stroke
age
diabetes
age
blood clot (thrombosis)
age
enlarged prostate (men only)
age
asthma
age
hayfever
age
depression
age
anxiety
age
Parkinson’s disease
age
In the last month have you been treated for:  
(if YES, please cross the box and give your age when the 
treatment started)
38.
age started  
treatment
cancer
age
Yes
heart attack or angina
age
other heart disease
age
high blood pressure
age
high blood cholesterol
age
blood clotting problems
age
asthma
age
osteoarthritis
age
thyroid problems
age
osteoporosis or  
low bone density age
depression
age
anxiety
age
none of these
Are you NOW suffering from 
any other important illness?
39. Yes No
please describe this illness and its treatment
Have you ever been screened for 
colorectal (bowel) cancer?
40. Yes No
Go to Q41
If YES, please indicate which test(s) you had:
faecal occult blood test (test for blood in the stool/faeces) 
sigmoidoscopy (a tube is used to examine the lower bowel;  
this is usually done in a doctor’s office without pain relief) 
colonoscopy (a long tube is used to examine the whole large 
bowel; you would usually have to have an enema or drink 
large amounts of special liquid to prepare the bowel for this) 
What year did you have 
the most recent one of 
these tests? (eg. 2005)
Y Y Y Y
chronic kidney disease 
age
none of these
breast cancer
age
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never 
once a week or less 
2-3 times 
About how many times a week are you usually 
troubled by leaking urine? 
41.
4-6 times 
every day
Do you regularly care for a sick or 
disabled family member or friend?
42. Yes No
Go to Q44
If YES, about how much time each week do you 
usually spend caring for this person?
full time OR
hours/wk
Do you live with the person you 
care for?
43. Yes No
Does your health now LIMIT 
YOU in any of the following 
activities?
44.
No, not 
limited 
at all
Yes, 
limited 
a little
Yes, 
limited 
a lot
VIGOROUS activities  
(e.g. running, strenuous sports) 
MODERATE activities  
(e.g. pushing a vacuum cleaner, 
playing golf) 
lifting or carrying shopping 
climbing several flights of stairs 
climbing one flight of stairs 
walking one kilometre 
walking half a kilometre 
walking 100 metres 
bending, kneeling or stooping 
bathing or dressing yourself
During the past 4 weeks, have you:45.
Yes No
accomplished less than you would 
like in your regular daily activities 
because of your physical health?
been limited in your regular 
activities because of your physical 
health?
accomplished less than you would 
like as a result of any emotional 
problems?
not done work or other regular 
activities as carefully as usual as a 
result of any emotional problems?
not at all 
slightly 
moderately 
During the past 4 weeks, how much did pain 
interfere with your normal work, including outside 
the home and housework?
46.
quite a bit 
extremely
have you felt calm 
and peaceful?
How much time 
during the past 4 
weeks:
47.
did you have a lot 
of energy?
have you felt 
down?
have your physical 
health or emotional 
problems interfered 
with your social 
activities?
tired out for no 
good reason?
During the past 
4 weeks, about 
how often did 
you feel:
48.
all  
of the  
time
most  
of the 
time
some  
of the 
time
a little 
 of the  
time
none  
of the  
time
nervous?
so nervous that 
nothing could 
calm you down?
hopeless?
restless or 
fidgety?
so restless that you 
could not sit still?
all  
of the  
time
most  
of the 
time
some  
of the 
time
a little 
 of the  
time
none  
of the  
time
depressed?
that everything 
was an effort?
so sad that nothing 
could cheer you up?
worthless?
same day 
next day 
2-3 days 
Thinking of times when you want to see a particular 
doctor in your practice or medical centre, how 
quickly do you usually get to see that doctor?
49.
4-5 days 
more than 5 days
same day 
next day 
2-3 days 
Thinking of times when you are willing to see ANY 
doctor in your practice or medical centre, how 
quickly do you usually get seen by any doctor?
50.
4-5 days 
more than 5 days
If you need to see a GP urgently,  
can you normally get seen on the 
same day?  
(leave blank if question does not apply)
51. Yes No
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In the past 2 years, have you 
needed to see any specialist 
doctors?
52. Yes No
no waiting period 
less than a week 
1-2 weeks 
After learning you needed to see a specialist 
doctor(s), how long on average did you have to wait 
for an appointment?
53.
3-4 weeks 
5-8 weeks 
more than 8 weeks
< 30 minutes 
30-59 minutes 
1-2 hours 
2-3 hours
How long does it take you to travel to your usual or 
preferred GP?
54.
3-4 hours 
4 or more hours 
doctor visits me
< 30 minutes 
30-59 minutes 
1-2 hours 
How long does it take you to travel to the nearest 
hospital?
55.
2-3 hours 
3-4 hours 
4 or more hours
none 
$1-$250 
$251-$500 
In the past 12 months, about how much have you 
and your household spent out-of-pocket for medical 
treatments or services that were NOT covered by 
Medicare or private insurance?  
(include costs for prescription medicines and tests or 
treatments by a doctor or health professional, including 
any gap payment or any items not covered)
56.
$501-$1,000 
$1,001-$2,000 
more than $2,000
In the past 12 months, have you:57. Yes No
received a blood pressure check? 
had your cholesterol checked? 
had your skin checked for cancer? 
had a blood test to check your sugar levels? 
been told by your GP to eat fewer high fat or 
high cholesterol foods? 
been told by your GP to eat more fruits & 
vegetables? 
been told by your GP to be more physically 
active? 
been told by your GP to quit smoking?
On a scale from 1 to 10, how confident are you that 
you can do all the things necessary to manage your 
health on a regular basis? (cross one number only)
58.
1 2 3 4 5 6 7 8 9 10
not at all 
confident
totally 
confident
On a scale from 1 to 10, how confident are you that you can 
judge when the changes in your health mean you should 
visit a doctor? (cross one number only)
59.
Questions about work and income
Some of these questions ask for details of your economic 
circumstances. We are asking these because economic and 
financial factors are important for health. 
Remember you do not have to answer any questions  
if you do not want to and all information will be kept strictly 
confidential and used for health related research only.
less than $5,000 
$5,000-$9,999  
$10,000-$19,999 
$20,000-$29,999 
$30,000-$39,999 
$40,000-$49,999 
$50,000-$59,999 
What is your usual yearly HOUSEHOLD income 
before tax, from all sources? (please include wages 
benefits, pensions, superannuation, etc) 
60.
$60,000-$69,999 
$70,000-$79,999  
$80,000-$89,999  
$90,000-$119,999 
$120,000-$149,999 
$150,000 or more 
I would rather not 
answer this question 
less than $5,000 
$5,000-$9,999  
$10,000-$19,999 
$20,000-$29,999 
$30,000-$39,999 
$40,000-$49,999 
$50,000-$59,999 
What is your usual PERSONAL yearly income 
before tax, from all sources? (please include wages, 
benefits, pensions, superannuation etc)
61.
$60,000-$69,999 
$70,000-$79,999  
$80,000-$89,999  
$90,000-$119,999 
$120,000-$149,999 
$150,000 or more 
I would rather not 
answer this question 
in full time paid work 
in part time paid work 
completely retired/
pensioner 
partially retired 
disabled/sick 
What is your current work status?  
(you can cross more than one box)
62.
self-employed 
doing unpaid work 
studying 
looking after home/family 
unemployed 
other
1 2 3 4 5 6 7 8 9 10
not at all 
confident
totally 
confident
Go to Q54
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About how many HOURS each WEEK do you and 
your partner usually spend in paid work?  
(please put “0” if you do not spend any time doing it)
63.
hours per week  
paid work
YOU
hours per week  
paid work
YOUR 
PARTNER
I do not have a partner
If you are partially or completely 
retired or not working for another 
reason, how old were you when you 
retired or stopped work?  
64.
years old
Why did you retire/stop work?  
(you can cross more than one box)
arthritis 
asthma 
back problems 
cancer 
diabetes 
digestive system diseases 
diseases of the nervous 
system (e.g. Parkinson’s 
disease) 
eye diseases  
(e.g. cataracts)
other condition (specify):  
heart disease/stroke 
injury – work-related 
injury – non-work 
related 
mental disorders 
respiratory system 
diseases 
other musculoskeletal 
condition  
(e.g. osteoporosis)
reached usual  
retirement age 
to care for sick/disabled 
person 
to look after home/family 
made redundant 
could not find a job 
was self-employed & 
business closed 
lifestyle reasons 
work-related injury 
own ill health 
to travel 
to study 
other
If you retired due to your own ill health, what was the 
main health condition leading to your retirement?  
(please cross only one box)
65.
Is your partner retired? 66.
No
No 
partnerYes
If Yes, age s/he retired?
age
could not fill or collect a prescription medicine
Over the last 12 months did any of the 
following happen to you because of a 
shortage of money?                       
67.
NoYes
could not get a medical test, treatment, or 
follow-up that was recommended by a doctor
limited how much fruit and/or vegetables 
you eat
could not pay electricity, gas or 
telephone bills on time                 
could not pay the mortgage or rent on time 
asked for financial help from friends or family
Questions about social support
Rate how often the following occur:68.
N/A*alwaysoften
some 
timesrarelynever
Your partner 
makes you 
feel cared for
Your partner 
makes too 
many demands 
on you
Other family 
members 
make you feel 
cared for
Other family 
members 
make too 
many 
demands on 
you
Friends 
make you 
feel cared 
for
Friends make 
too many 
demands on 
you
* N/A – Not Applicable or do not have partner/family members/friends
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Rate how often the following occur:69.
N/A*alwaysoften
some 
timesrarelynever
Co-workers 
make you 
feel cared 
for
Co-workers 
make too 
many 
demands 
on you
Co-workers 
express 
interest in 
how you 
are doing
Co-workers 
criticise you
Co-workers 
create 
tensions 
or have 
arguments 
with you
* N/A – Not Applicable or not in working environment
How often do you feel rushed or pressed for time?70.
alwaysoften
some 
timesrarelynever
How many TIMES in the LAST WEEK did you:   
(please put “0” if you did not spend any time doing it)
71.
times in  
the last week
spend time with friends or family who do not 
live with you?
talk to someone (friends, relatives or other 
personal calls) on the telephone?
go to meetings of social clubs, religious 
groups or other groups you belong to?
spend time in internet social activities?  
(e.g. social network sites)
How many people outside your 
home, but within one hour of travel, 
do you feel you can depend on or 
feel very close to?
72.
people
serious illness 
serious accident 
serious disability 
mental illness 
divorce or separation 
not able to get a job 
involuntary loss of job 
alcohol or drug-related 
problems
In the past 12 MONTHS have any of the following 
been a problem for you or anyone close to you?  
(you can cross more than one box)
73.
gambling problem 
witness to violence 
abuse or violent crime 
trouble with the police 
death of a family 
member or close friend 
none of these
Questions about your neighbourhood
Answer YES or NO to the following questions:74.
Yes No
do you go outside your local area to visit 
your family?
can you get help from friends when you 
need it?
if you were caring for someone and needed 
to go out for a while, would you ask a 
neighbour for help?
have you visited a neighbour in the past 
week?
when you shop in your local area are you 
likely to run into friends and acquaintances?
in the past 6 months, have you done a 
favour for a sick neighbour?
do you agree that most people in your 
neighbourhood can be trusted?
does your area have a reputation for being a 
safe place?
strongly 
disagree
Rate your agreement with the following statement:75.
disagreeagree
strongly 
agree
many shops, stores, 
markets or other places 
to buy things I need 
are within easy walking 
distance of my home
a public transport stop 
(such as a bus or train) 
is within a 10-15 minute 
walk from my home
there are footpaths on 
most of the streets in my 
neighbourhood
my neighbourhood has 
several free or low cost 
recreation facilities, such 
as parks, walking paths, 
swimming pools, etc
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strongly 
disagree
continued. Rate your agreement with the following 
statements:
75.
disagreeagree
strongly  
agree
the crime rate in my 
neighbourhood makes it 
unsafe to go on walks at 
NIGHT
the crime rate in my 
neighbourhood makes 
it unsafe to go on walks 
during the DAY
How long have you lived 
at your current address?
76.
years
List the state, postcode or suburb, and time period 
for your last two places of residence in AUSTRALIA
77.
What was your most recent PREVIOUS residential location? 77a.
Postcode: OR
Suburb/Town:
State/Territory: 
How long did you live there?  
years OR months
Where did you live IMMEDIATELY before that? 77b.
Postcode: OR
Suburb/Town:
How long did you live there?  
years OR months
List the state, the postcode or suburb, and time 
period of employment for your last two places of 
employment in AUSTRALIA
78.
What was your most recent PREVIOUS employment location?78a.
Postcode: OR
Suburb/Town:
ACT 
NSW 
NT 
QLD 
State/Territory: 
SA 
TAS 
VIC 
WA 
OVERSEAS 
If overseas, country:
How long did you work there?  
years OR months
Where did you work IMMEDIATELY before that?78b.
Postcode: OR
Suburb/Town:
How long did you work there?  
years OR months
Don’t forget to sign the consent form overleaf.
Please return your completed questionnaire  
in the envelope provided. No stamp is required.
ACT 
NSW 
NT 
QLD 
SA 
TAS 
VIC 
WA 
OVERSEAS 
If overseas, country:
State/Territory: 
ACT 
NSW 
NT 
QLD 
SA 
TAS 
VIC 
WA 
OVERSEAS 
If overseas, country:
ACT 
NSW 
NT 
QLD 
State/Territory: 
SA 
TAS 
VIC 
WA 
OVERSEAS 
If overseas, country:
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Consent Form - The SEEF Project
The 45 and Up Study is designed to provide much needed 
information about how to stay healthy and independent 
throughout life. As one of over 250,000 45 and Up Study 
participants, you have already completed a questionnaire 
about your health and lifestyle. 
We are asking for your help again to give additional information 
about your health and the social, economic and environmental 
factors that impact on healthy ageing by completing a 
questionnaire for the SEEF Project. 
By signing this consent form you are agreeing to participate 
in the SEEF Project, as outlined in the participant information 
leaflet entitled “The SEEF Project – Information for Participants”. 
Participation in the SEEF Project is entirely voluntary and you 
may ask questions or withdraw your consent at any time by 
calling the 45 and Up Study Helpline on 1300 45 11 45.
In signing this consent form, I agree:
• To the 45 and Up Study providing my questionnaire to the  
 researchers of the SEEF Project.
• To the long-term storage and use of the information from my  
 questionnaire for health-related research.
• To the 45 and Up Study combining the new information from  
 my questionnaire with the information I have already given to  
 the 45 and Up Study, as outlined in the participant information  
 leaflet entitled “The SEEF Project – Information for Participants”  
 of which I have a copy.
I give my consent on the understanding that:
• My information will only be used for the purposed outlined  
 in the participant information leaflet entitled “The SEEF Project  
 – Information for Participants”.
• My information will be kept strictly confidential and will be used 
 for health research only.  Research, reports and publications  
 from the 45 and Up Study and the SEEF Project will be  
 based on de-identified information and will not identify any  
 individual taking part.
• My consent will continue to be valid following death or loss of  
 decision-making capacity unless withdrawn by my next of kin  
 or other person responsible.  I may withdraw from  
 the 45 and Up Study or the SEEF Project at any time by  
 calling the 45 and Up Study Helpline on 1300 45 11 45.
• My decision as to whether or not to participate in  
 the SEEF Project or any other additional research will not  
 disadvantage me or affect my future healthcare in any way.
• I may be contacted again by the 45 and Up Study regarding  
 future research, and my participation in this will be entirely  
 voluntary.
I have read all of the above, as well as the information provided 
in the participant information leaflet entitled “The SEEF Project 
– Information for Participants”.  I have been given the opportunity 
to ask questions and have been fully informed about the SEEF 
Project.  I agree to participate in the SEEF Project.
Name  
(Print):
D D M M Y Y Y Y/ /Date today:
Extra contact details:
It would be very helpful and reduce study costs if we could contact you in future by email.  If you are happy for us to do this, please print 
your email address here:
Signature:
Email address:
Have you changed your address?  Please let us know your new details: 
Surname:
Given name(s):
Postal address:
Town or Suburb: Postcode:State or Territory:
Thank you very much for filling in the questionnaire.
If you have any questions, please ring the 45 and Up Study Helpline 
on 1300 45 11 45.
You can also write directly to:
Professor Emily Banks, Scientific Director  
The 45 and Up Study 
GPO Box 5289, Sydney  NSW  2001
Please send your questionnaire (no stamp required) to:
Confidential  
The 45 and Up Study
The SEEF Project
Reply Paid 1005
BROADWAY  NSW  2007
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ABSTRACT
Objectives: Growing evidence suggests a link
between diet and mental health. This study aimed to
investigate the association between fruit and vegetable
consumption and the prevalence and incidence of
psychological distress in middle-aged and older
Australians.
Design: Cross-sectional and prospective.
Setting: New South Wales, Australia.
Methods: A sample of 60 404 adults aged ≥45 years
completed baseline (2006–2008) and follow-up (2010)
questionnaires. Psychological distress was assessed at
baseline and follow-up using the validated Kessler
Psychological Distress Scale (K10), a 10-item
questionnaire measuring general anxiety and
depression. Psychological distress was defined as the
presence of high-to-very high levels of distress (K10
score ≥22). Usual fruit and vegetable consumption
was assessed using short validated questions. The
association between baseline fruit and vegetable
consumption and the prevalence or incidence of
psychological distress was examined using logistic
regression models.
Results: At baseline, 5.6% reported psychological
distress. After a mean 2.7 years of follow-up, 4.0% of
those who did not report distress at baseline reported
distress at follow-up. Baseline fruit and vegetable
consumption considered separately or combined,
was associated with a lower prevalence of
psychological distress even after adjustment for
sociodemographic characteristics and lifestyle risk
factors. Baseline fruit and vegetable consumption,
measured separately or combined, was associated with
a lower incidence of psychological distress in
minimally adjusted models. Most of these associations
remained significant at medium levels of intake but
were no longer significant at the highest intake levels
in fully adjusted models.
Conclusions: Increasing fruit and vegetable
consumption may help reduce psychological distress in
middle-aged and older adults. However, the association
of fruit and vegetable consumption with the incidence
of psychological distress requires further investigation,
including the possibility of a threshold effect between
medium and higher consumption levels.
INTRODUCTION
There has been a global call for action by
the WHO to make mental health a global
development priority.1 Mental disorders
affect a 10th of the world population and
represent 30% of non-fatal global burden of
disease.2 Depression alone is a leading cause
of disability worldwide3 and is projected to
rank among the three leading causes of
global disease burden by 2030.4 There is an
urgent call for public health strategies aimed
at preventing the onset on common mental
disorders, such as depression.
There has been considerable interest in
the relationship between psychological well-
being and lifestyle factors, with growing evi-
dence for a link between mental health and
diet.5–7 The role of fruit and vegetables has
received increasing attention, given evidence
for its protective effects against chronic dis-
eases such as cardiovascular disease and
cancer.8 9 Diets low in fruit have been
recently identiﬁed as the leading dietary risk
factor for global burden of disease.10
Findings from a recent meta-analysis,
based on seven cross-sectional and four pro-
spective studies, suggest that both fruit and
Strengths and limitations of this study
▪ This study included a large sample size of
60 404 participants for cross-sectional analyses
and 54 345 participants for longitudinal
analyses.
▪ Analyses were adjusted for multiple sociodemo-
graphic and lifestyle-related covariates.
▪ The well-validated Kessler Psychological Distress
Scale (K10) was used to assess psychological
distress.
▪ The relatively short follow-up time may have
been insufficient to observe the full extent of
long-term associations between fruit and vege-
table intake and psychological distress.
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vegetable consumption are signiﬁcantly associated with a
lower risk of depression.11 Several large cross-sectional
studies have shown that greater consumption of fruit
and vegetables is associated with better mental health,
including lower odds of depression and psychological
distress, in the general population.12–14 Fewer studies
have investigated the longitudinal association between
fruit and vegetable intake and depression. Higher con-
sumption of fruit and/or vegetables was associated with
lower odds of incident depression in middle-aged
Australian women followed over 6 years,15 postmenopau-
sal American women followed for 3 years16 and Spanish
adults followed over 4 years.17 These ﬁndings are in
agreement with previous cross-sectional and longitudinal
studies that have found healthy dietary patterns, includ-
ing high intakes of fruit and vegetables, to be associated
with a lower risk of depression and anxiety, particularly
in middle-aged and older adults.18–21
Depression in later life is associated with increased
morbidity and mortality, and decreased physical, cogni-
tive and social functioning.22 Improving mental health is
an important public health challenge to address in an
ageing population with a higher life expectancy.1
Therefore, the main objective of this study was to investi-
gate the association between fruit and vegetable con-
sumption and the prevalence and incidence of
psychological distress in a large cohort of middle-aged
and older Australians.
METHODS
Study population
The baseline data were from the Sax Institute’s 45 and
Up Study, a large-scale (n=267 153) population study of
men and women aged 45 years and over, who were ran-
domly sampled from the general population of New
South Wales (NSW), Australia. From January 2006 to
December 2008, eligible individuals joined the study by
completing a postal questionnaire and providing written
consent for participation and long-term follow-up. The
45 and Up Study has been described in detail else-
where.23 A subsample of the 45 and Up Study was fol-
lowed up in 2010 (ie, the Social, Economic, and
Environmental Factor (SEEF) Study), with the ﬁrst
100 000 participants of the 45 and Up Study invited to
complete the SEEF questionnaire (60.4% response
rate). A participant ﬂow chart for this study is provided
in ﬁgure 1. For cross-sectional analyses at baseline, the
analytic sample included 60 404 participants (53.6%
women). For longitudinal analyses, participants who
reported on the baseline questionnaire that they had
been treated for depression/anxiety in the previous
month (n=3796), and/or taking antidepressant medica-
tion for most of the past 4 weeks (n=700), and/or with
high/very high levels of psychological distress (n=3030;
deﬁned as having a Kessler Psychological Distress Scale
(K10) score ≥2224 were excluded (n=6067), leaving a
ﬁnal sample of 54 345 participants.
Measurement
The 45 and Up Study and SEEF Study questionnaires
include questions on sociodemographic characteristics,
personal and medical history, and lifestyle risk factors
(available from http://www.saxinstitute.org.au/
our-work/45-up-study/questionnaires/).
Outcome
At both baseline and follow-up, participants’ general
level of psychological distress was assessed using the well-
validated and widely used K10, a 10-item questionnaire
about anxiety and depression symptoms experienced in
the past 4 weeks.24 A ﬁve-point response scale (none of
the time, a little of the time, some of the time, most
of the time, all of the time) is used for each item, with
scores ranging from 1 (none of the time) to 5 (all of the
time). Scores to each question are added up to form the
total K10 score, with a possible range of 10–50. For this
study, score groupings and categories of psychological
distress routinely used by the Australian Bureau of
Statistics for national health surveys were adopted with
total scores of: 10–15, 16–21, 22–29 and 30–50 indicating
low, moderate, high and very high levels of psychological
distress, respectively.
High K10 scores are strongly correlated with current
WHO’s Composite International Diagnostic Interview
(CIDI) diagnosis of anxiety and affective disorders.24
Prevalence of psychological distress at baseline was
Figure 1 Participant flow chart. SEEF, Social, Economic,
and Environmental Factor.
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deﬁned as the presence of high-to-very high levels of psy-
chological distress (K10 score ≥22). Incidence of psycho-
logical distress was deﬁned as: (1) not being treated for
anxiety/depression in the previous month, and/or not
taking antidepressant medication for most of the past
4 weeks, and/or not having high/very high levels of psy-
chological distress (K10 score <22) at baseline, and (2)
the presence of high-to-very high levels of psychological
distress (K10 score ≥22) at follow-up. Psychological dis-
tress was treated as binary outcome variable in the ana-
lyses (K10 score <22 vs ≥22; ie, low-to-moderate vs
high-to-very high levels of distress).
Exposure
Usual fruit and vegetable consumption was assessed at
baseline using the following validated short questions
commonly used in health monitoring and surveillance:25
1. ‘About how many serves of fruit do you usually have
each day?’ One serve of fruit was deﬁned as one
medium piece or two small pieces of fresh fruit, or
one cup of diced or canned fruit pieces.
2. ‘About how many serves of vegetables do you usually
eat each day?’ One serve of vegetables was deﬁned as
half a cup of cooked vegetables (including potatoes)
or one cup of raw vegetables (eg, salad).
Total fruit and vegetable consumption was derived by
summing the reported number of fruit and vegetables
consumed daily. Fruit and vegetable consumption, con-
sidered separately and combined, was categorised into
tertiles. Using quantiles ensures that the range in expos-
ure is captured evenly across distribution categories,
which facilitates comparison between different levels of
fruit and vegetable consumption among the study
cohort, and has been previously used in another large
cohort study.16
Covariates
Covariates included baseline self-reported sociodemo-
graphic characteristics such as sex, age, highest level of
education (≤10 years of schooling, high school/trade
apprenticeship/certiﬁcate/diploma, university degree/
higher), marital status (married/living with a partner vs
single/widowed/divorced/separated), household annual
income (<$30 000, $30 000−$69 999, ≥$70 000, would
rather not answer this question), self-reported history of
major chronic disease (cancer other than non-
melanoma skin cancer, cardiovascular disease (heart
disease, stroke or blood clot), diabetes or hypertension;
yes vs no) and the following lifestyle risk factors: body
mass index (BMI; derived from self-reported height and
weight; deﬁned as underweight ((<18.5 kg/m2),
normal weight (18.5 to <25 kg/m2), overweight/obese
(≥25 kg/m2)), alcohol intake (≤14 or >14 drinks/
week), smoking status (current regular smoker vs not
currently a regular smoker) and physical activity levels
(assessed using validated questions from the Active
Australia Survey;26 categorised as <150, 150–299 and
≥300 min/week).
Statistical analysis
The association between baseline fruit and vegetable
consumption and the prevalence/incidence of psycho-
logical distress (K10 score ≥22) was examined using
logistic regression models. ORs with 95% CIs are pre-
sented for unadjusted, age-adjusted and sex-adjusted,
and models adjusted for all covariates as described
above. We tested effect modiﬁcation by sex by ﬁtting
interaction terms. To examine potential sex differences,
the analyses were further stratiﬁed by sex. If 1 out of 10
responses to K10 questions was missing (for 3.2% and
2.8% of participants included in cross-sectional and lon-
gitudinal analyses, respectively), the missing value was
imputed using the mean score across the other 9 ques-
tions.27 If more than one response was missing, K10
scores were considered as missing. p Values <0.05 were
considered statistically signiﬁcant. All analyses were con-
ducted using SPSS V.22 (IBM Corp, Armonk, New York,
USA).
RESULTS
Participant characteristics
Table 1 shows baseline participant characteristics based
on K10 score at follow-up. Overall, the mean age (SD)
of participants was 62.2 (10.6) years, more than half
(53.6%) were women, over a quarter (26%) had a uni-
versity degree/higher, over three-quarters (78%) were in
a married/de facto relationship, and a quarter (25.7%)
reported a household annual income ≥$70 000. The
mean (SD) serves of fruit and vegetables were, respect-
ively, 2.0 (1.4) and 3.9 (2.6) serves/day. The average
follow-up time period was 2.7 (0.9) years. Compared
with men, women were more likely to be younger, less
educated, single/widowed/divorced/separated, have a
lower household annual income, a lower BMI, and to
consume more fruit and vegetables and less alcohol.
Participants with high-to-very high levels of psychological
distress (5.6%) at baseline were more likely to be
women, relatively younger, less educated and have a
lower household annual income. These participants
were also more likely to: have a higher BMI, be a
current smoker, be less physically active and have a
history of chronic disease.
Prevalence of psychological distress
The ORs for the association between separate or com-
bined fruit and vegetable consumption and the preva-
lence of high-to-very high levels of psychological distress
(K10≥22) are presented in table 2. Consumption of fruit
and vegetables, considered separately or combined, was
consistently associated with a lower prevalence of psycho-
logical distress. Following adjustment for all covariates,
these associations were slightly attenuated compared
with the unadjusted model but remained signiﬁcant.
Other covariates which were signiﬁcantly associated with
the prevalence of psychological distress were being rela-
tively younger, single/divorced/widowed/separated, a
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current smoker, lower education, lower household
annual income, lower BMI, low physical activity levels
and a self-reported history of chronic disease. There was
a signiﬁcant interaction between combined fruit and
vegetable consumption and sex (p=0.049). When ana-
lyses were stratiﬁed by sex (table 3), the association
between fruit and vegetable consumption, measured
separately or combined, and the prevalence of psycho-
logical distress was markedly stronger in women and was
signiﬁcant for all consumption tertiles (p≤0.001).
Among men, only those in the medium tertiles of separ-
ate fruit and vegetable consumption had signiﬁcantly
lower odds of psychological distress.
Incidence of psychological distress
After an average of 2.7 years of follow-up, 4.0% of those
who did not report distress at baseline reported distress
at follow-up. Table 4 shows the association between fruit
and vegetable consumption and the incidence of
high-to-very high levels of psychological distress
(K10≥22). Similar to cross-sectional ﬁndings, fruit and
vegetable consumption, measured separately or com-
bined, was signiﬁcantly associated with a lower incidence
of psychological distress in unadjusted and minimally
adjusted models. In the fully adjusted models, the
medium tertiles of combined fruit and vegetable con-
sumption, and separate vegetable consumption,
remained signiﬁcantly associated with reduced odds of
psychological distress. The association between the
medium tertile of fruit consumption and the incidence
of psychological distress approached signiﬁcance
(p=0.07). However, the association between the highest
tertile of consumption and the incidence of psycho-
logical distress did not remain signiﬁcant for consump-
tion of fruit and vegetables considered either separately
or combined. Other covariates which were signiﬁcantly
associated with the incidence of psychological distress
were being relatively younger, single/divorced/
widowed/separated, a current smoker, lower education,
lower household annual income, lower alcohol intake,
lower BMI, low physical activity levels and a self-reported
history of chronic disease. The interaction between
Table 1 Baseline characteristics of participants according to sex and K10 score at baseline (n=60 404; 2006–2010)*
Men Women K10 score at baseline†
Variable All <22 ≥22 p Value‡
Sample size 60 404 28 057 32 347 51 393 3030
Mean (SD) follow-up time (years) 2.67 (0.93) 2.67 (0.93) 2.68 (0.94) 2.67 (0.94) 2.72 (0.95) 0.009
Women (%) 53.6 − − 53.3 56.2 <0.001
Mean (SD) age (years) 62.2 (10.6) 63.9 (10.7) 60.8 (10.2)§ 61.6 (10.3) 58.6 (9.6) <0.001
Highest education§ (%) <0.001
University and higher 26.2 28.0 24.7 28.3 20.0
High school/trade apprenticeship/certificate/Diploma 42.7 48.5 37.7 43.3 41.3
≤10 years 31.1 23.4 37.6 28.4 68.1
Married/living with a partner (%) 78.0 83.5 73.2§ 79.6 68.1 <0.001
Household annual income§ (%) <0.001
<$30 000 29.5 28.5 30.4 26.7 43.4
$30 000–$69 999 28.9 31.0 27.0 29.8 25.4
≥$70 000 25.7 29.3 22.6 28.1 16.7
Did not specify 15.9 11.2 20.0 15.4 14.4
BMI category§ (%) <0.001
Underweight (<18.5 kg/m2) 1.2 0.7 1.7 1.1 2.2
Normal weight (18.5 to <25kg/m2) 37.9 31.8 43.3 38.4 31.0
Overweight or obese (≥25 kg/m2) 60.9 67.6 55.0 60.5 66.8
Current smoker (%) 5.7 5.7 5.7 5.3 13.9 <0.001
Usually consumes >14 alcohol drinks/week 14.9 24.7 6.3§ 15.3 14.8 0.44
Mean (SD) fruit consumption (serves/day) 2.0 (1.4) 1.9 (1.5) 2.2 (1.4)§ 2.0 (1.4) 1.9 (1.5) <0.001
Mean (SD) vegetable consumption (serves/day) 3.9 (2.6) 3.4 (2.6) 4.4 (2.6)§ 3.9 (2.6) 3.7 (2.7) <0.001
Physical activity level (%) <0.001
<150 min/week 18.9 19.2 18.8 17.5 28.0
150–299 min/week 16.6 16.4 16.9 16.6 18.7
≥300 min/week 64.4 64.5 64.4 65.9 53.4
History of chronic disease (%) 51.8 56.5 47.8§ 50.9 54.0 <0.001
*Data are presented as means (SD) or percentages (%).
†The total K10 score is based on a 10-item questionnaire about anxiety and depression symptoms experienced in the past 4 weeks.24
Participants were grouped according to K10 scores and categorised as at ‘low-to-moderate risk’ (K10<22) or at ‘high-to-very high risk’ of
psychological distress (≥22). K10 data were missing for n=5981.
‡p Value from independent t-tests for continuous variables and from χ2 tests for categorical variables.
§Significantly different from men (all p<0.001).
BMI, body mass index; K10, Kessler Psychological Distress Scale.
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combined fruit and vegetable consumption and sex
approached signiﬁcance (p=0.08). When analyses were
stratiﬁed by sex (table 3), the association between fruit
and vegetable consumption, considered separately or
combined, and the incidence of psychological distress
was stronger in women and signiﬁcant for all consump-
tion tertiles except for the highest fruit (p=0.06), vege-
table (p=0.17), and combined fruit and vegetable
tertiles (p=0.09) in the fully adjusted models. There was
no signiﬁcant association between consumption of fruit
and vegetables and the incidence of psychological dis-
tress in men.
DISCUSSION
In this large cohort of middle-aged and older Australian
adults, consumption of fruit and vegetables was signiﬁ-
cantly associated with the prevalence of psychological
distress even after accounting for sociodemographic
characteristics and other lifestyle risk factors. The longi-
tudinal associations with psychological distress were less
consistent. The association between fruit and vegetable
intake and the incidence of psychological distress was
signiﬁcant after accounting for age and sex. After adjust-
ment for all possible confounders, while this association
remained mostly signiﬁcant at medium levels of intake,
it did not remain signiﬁcant at the highest levels of
intake. When considered separately in each sex, the
association of fruit and vegetable consumption with
either the prevalence or incidence of psychological dis-
tress was stronger in women, with no clear associations
with the incidence of psychological distress in men.
Findings in this study are generally in agreement with
those from a recent meta-analysis, based on seven cross-
sectional and four cohort studies, which has found sep-
arate fruit and vegetable consumption to be inversely
associated with the risk of depression.11 Although ﬁnd-
ings from individual cross-sectional and prospective
studies were mixed, in subgroup analysis by study design,
the meta-analysis showed signiﬁcant associations in cross-
sectional and prospective studies for fruit intake, and in
prospective studies only for vegetable intake. In relation
to combined fruit and vegetable consumption, several
large cross-sectional studies have also demonstrated sig-
niﬁcant inverse associations with psychological well-
being, even after accounting for multiple covariates.12–14
A positive association between combined fruit and vege-
table consumption and well-being, assessed using seven
different measures of mental health, was shown in three
separate data sets, which together involved 80 000 ran-
domly selected British adults.12 In a repeated cross-
sectional study of 296 121 Canadians with ﬁve waves of a
national, population-based survey, lower odds of depres-
sion and psychological distress were consistently asso-
ciated with greater combined fruit and vegetable
consumption.13 Our cross-sectional ﬁndings are also in
line with those from a recent population-based Swiss
survey of 20 220 individuals, which found that daily
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Table 3 Adjusted ORs for the prevalence and incidence of high-to-very high levels of psychological distress (K10*≥22 vs K10*<22) by baseline fruit and vegetable consumption and stratified by
sex
Cross-sectional analysis
Male Female
Unadjusted OR
(95% CI) p Value
Age-adjusted
OR (95% CI) p Value
Fully adjusted
OR† (95% CI) p Value
Unadjusted
OR (95% CI) p Value
Age-adjusted
OR (95% CI) p Value
Fully adjusted
OR† (95% CI) p Value
Tertiles
Fruit
0 to 1 serve/day 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
>1 to 2 serves/day 0.69 (0.59 to 0.79) <0.001 0.71 (0.61 to 0.82) <0.001 0.78 (0.67 to 0.91) 0.002 0.59 (0.52 to 0.66) <0.001 0.61 (0.54 to 0.69) <0.001 0.67 (0.59 to 0.77) <0.001
>2 serves/day 0.80 (0.69 to 0.93) 0.003 0.83 (0.72 to 0.96) 0.02 0.99 (0.84 to 1.17) 0.95 0.61 (0.54 to 0.68) <0.001 0.65 (0.57 to 0.73) <0.001 0.79 (0.69 to 0.91) 0.001
Vegetables
0 to 2 serves/day 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
>2 to 4 serves/day 0.70 (0.61 to 0.80) <0.001 0.71 (0.62 to 0.82) <0.001 0.80 (0.69 to 0.93) 0.004 0.66 (0.59 to 0.75) <0.001 0.68 (0.60 to 0.77) <0.001 0.80 (0.70 to 0.92) 0.001
>4 serves/day 0.82 (0.71 to 0.95) 0.007 0.88 (0.76 to 1.01) 0.07 0.91 (0.78 to 1.06) 0.23 0.64 (0.57 to 0.72) <0.001 0.68 (0.60 to 0.77) <0.001 0.80 (0.70 to 0.92) 0.001
Fruit and vegetables
0 to 4 serves/day 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
>4 to 7 serves/day 0.80 (0.70 to 0.91) 0.001 0.82 (0.72 to 0.94) 0.003 0.92 (0.80 to 1.07) 0.28 0.60 (0.53 to 0.67) <0.001 0.62 (0.55 to 0.70) <0.001 0.73 (0.64 to 0.83) <0.001
>7 serves/day 0.79 (0.67 to 0.93) 0.004 0.84 (0.72 to 0.99) 0.04 0.91 (0.76 to 1.09) 0.30 0.57 (0.50 to 0.65) <0.001 0.61 (0.54 to 0.70) <0.001 0.75 (0.65 to 0.87) <0.001
Longitudinal analysis‡
Male Female
Unadjusted OR
(95% CI) p Value
Age-adjusted
OR (95% CI) p Value
Fully adjusted
OR† (95% CI) p Value
Unadjusted
OR (95% CI) p Value
Age-adjusted
OR (95% CI) p Value
Fully adjusted
OR† (95% CI)
p
Value
Tertiles
Fruit
0 to 1 serve/day 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
>1 to 2 serves/day 0.87 (0.74 to 1.02) 0.09 0.87 (0.74 to 1.02) 0.09 0.95 (0.80 to 1.13) 0.56 0.72 (0.62 to 0.83) <0.001 0.72 (0.62 to 0.84) <0.001 0.84 (0.71 to 1.0) 0.04
>2 serves/day 0.90 (0.75 to 1.06) 0.21 0.89 (0.75 to, 1.06) 0.20 0.98 (0.81 to 1.19) 0.85 0.68 (0.58 to 0.80) <0.001 0.69 (0.59 to 0.81) <0.001 0.84 (0.70 to 1.0) 0.06
Vegetables
0 to 2 serves/day 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
>2 to 4 serves/day 0.86 (0.73 to 1.0) 0.05 0.85 (0.73 to 1.0) 0.05 0.94 (0.79 to 1.11) 0.45 0.67 (0.57 to 0.78) <0.001 0.67 (0.57 to 0.78) <0.001 0.82 (0.69 to 0.98) 0.03
>4 serves/day 0.96 (0.81 to 1.13) 0.59 0.95 (0.81 to 1.12) 0.55 0.94 (0.78 to 1.13) 0.51 0.75 (0.65 to 0.87) <0.001 0.76 (0.65 to 0.88) <0.001 0.89 (0.75 to 1.05) 0.17
Fruit and vegetables
0 to 4 serves/day 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
>4 to 7 serves/day 0.88 (0.76 to 1.03) 0.11 0.88 (0.76 to 1.03) 0.11 0.98 (0.83 to 1.16) 0.82 0.63 (0.55 to 0.73) <0.001 0.64 (0.55 to 0.74) <0.001 0.77 (0.65 to 0.91) 0.002
>7 serves/day 0.96 (0.80 to 1.14) 0.62 0.95 (0.79 to 1.14) 0.57 0.94 (0.77 to 1.15) 0.52 0.71 (0.61 to 0.83) <0.001 0.72 (0.62 to 0.84) <0.001 0.86 (0.72 to 1.02) 0.09
*The total K10 score is based on a 10-item questionnaire about anxiety and depression symptoms experienced in the past 4 weeks.24 Possible K10 scores range from 10 to 50 with scores ≥22
indicating high-to-very-high levels of psychological distress.
†Adjusted for baseline age, sex, highest education level, marital status, household annual income, body mass index category, smoking status, alcoholic intake, physical activity levels and a
history of chronic disease.
§Participants who reported having been recently treated for depression/anxiety and/or taking antidepressant medication and/or with a K10 score ≥22 (n=6067) at baseline were excluded from
longitudinal analyses.
K10, Kessler Psychological Distress Scale.
6
Nguyen
B,etal.BM
J
Open
2017;7:e014201.doi:10.1136/bm
jopen-2016-014201
O
p
e
n
A
c
c
e
s
s
254
recommended intake of ﬁve servings of fruit and vegeta-
bles was associated with a lower likelihood of high and
moderate psychological distress.14
Our longitudinal ﬁndings add to the limited evidence
base for an association between fruit and vegetable con-
sumption and the incidence of psychological distress.
Although longitudinal associations with psychological
distress did not remain signiﬁcant at higher levels of
fruit and vegetable intake, the direction of these associa-
tions was in agreement with ﬁndings from previous
studies. Among the few prospective studies which have
examined the relationship between fruit and vegetable
intake and the incidence of depression, mostly in
similar-aged samples,15–17 28 all but one study28 have
shown signiﬁcant protective effects of fruit15 17 or both
fruit and vegetables.16 A recent study involving a nation-
ally representative sample of 12 385 Australian adults sur-
veyed over several years reported that combined fruit
and vegetable consumption was predictive of increased
happiness, life satisfaction and well-being, with improve-
ments observed within 2 years.29 In the case of our study,
the longitudinal association between fruit and vegetable
consumption and psychological distress was attenuated
the most between the age-adjusted and sex-adjusted
model and the fully adjusted model, suggesting con-
founding. This may indicate that those who consume
healthy amounts of fruit and vegetables are more likely
to have favourable socioeconomic status and other life-
style risk factors (eg, physical activity), which together
contributed to lower psychological distress.
This study is among the ﬁrst to report associations
between fruit and vegetable consumption and psycho-
logical well-being separately for men and women. Sex
was a signiﬁcant effect modiﬁer of the association
between fruit and vegetable consumption and psycho-
logical distress. We found that fruit and vegetables were
more protective for women than men, suggesting that
women may be more responsive to the effects of fruit
and vegetables. It is possible that there may be a true
physiological difference between men and women,
although a mechanism that could explain this difference
remains unclear, or perhaps women more accurately
report consumption of fruit and vegetables than men.
However, these preliminary ﬁndings need to be con-
ﬁrmed by additional studies.
Future investigations should also explore the possibil-
ity of a threshold between medium and higher consump-
tion levels. In our study, fruit and vegetable
consumption at the highest levels was not protective
against psychological distress in fully adjusted models,
suggesting a potential threshold effect. This was
also evident in the fully adjusted models in the
cross-sectional analysis in men, and the longitudinal ana-
lysis in women. The reason for this observation is
unknown. It is possible that consuming more fruits and
vegetables beyond the potential threshold is no longer
beneﬁcial. However, the observed pattern of association
could also be a result of residual confounding. For
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example, participants consuming higher amounts of
fruit and vegetables may also have been consuming
larger quantities of other foods which could lead to psy-
chological distress. However, despite adjusting for BMI
in our analyses, this study did not measure other poten-
tial dietary confounders. The study’s ﬁndings also did
not change when adjusting for BMI as a continuous vari-
able rather than a categorical variable. Participants with
very high fruit and vegetable consumption may have
other unmeasured characteristics that could have offset
the beneﬁcial effects of fruit and vegetable consump-
tion. Finally, it is important to acknowledge that fruit
and vegetable consumption was based on a one-time
measure only, which could not take into account long-
term consumption patterns. However, as compared with
baseline, we found a similar pattern of consumption at
follow-up (93% of participants remained in the same
consumption categories between baseline and
follow-up). Some of these limitations should be
addressed in future studies.
Although these remain to be elucidated, several
mechanisms may underlie the relationship between high
fruit and vegetable consumption and greater psycho-
logical well-being.30 Fruit and vegetables are rich in
micronutrients and phytochemicals that may help
reduce oxidative stress and inﬂammation, processes that
can have detrimental effects on mental health. For
example, antioxidants such as vitamins C, E and poly-
phenols may help reduce oxidative stress while the
mineral magnesium has been associated with lower
levels of C reactive protein, a marker of low-grade
inﬂammation.30 Deﬁciencies in B vitamins such as folic
acid (vitamin B9) have been associated with depres-
sion.31 Low levels of these vitamins can cause high
homocysteine levels which in turn can impair methyla-
tion processes involved in the synthesis and metabolism
of neurotransmitters that may affect mood.32
Strengths and limitations
This study had several strengths including a large
sample size, a prospective design and the inclusion of
multiple sociodemographic and lifestyle-related covari-
ates and the use of the well-validated K10 to assess psy-
chological distress. High K10 scores are strongly
correlated with CIDI diagnoses of anxiety and depres-
sion.24 Several study limitations should be noted. The
follow-up period may have been too short to observe the
full extent of long-term associations between fruit and
vegetable intake and psychological distress. Although
the assessment of fruit and vegetable consumption was
based on short validated questions, this assessment
method may be prone to reporting bias. In addition, the
assessment of dietary intake was not detailed and limited
to a few questions only. There may be residual con-
founding from unmeasured dietary confounders includ-
ing total energy intake and other potential confounders
such as illicit drug use, a history of mental illness and
unmeasured cardiometabolic components, despite
adjustment for multiple covariates. Although data were
available for ﬁsh consumption, another potential dietary
confounder, this variable was not included as a covariate
due to the lack of variance observed (‘yes/no’ question
for ever consumption of ﬁsh only) and adjusting for ﬁsh
consumption in our analyses also did not change our
results. Further, the possibility of reverse causation (ie,
that depression leads to poor diet including inadequate
fruit and vegetable consumption) could not be elimi-
nated, but was reduced by excluding participants being
treated for depression/anxiety, taking antidepressant
medication or who reported high-to-very levels of psy-
chological distress at baseline from the longitudinal ana-
lyses. Several prospective cohort studies have not found
evidence for reverse causation, with diet quality related
to subsequent mental health but baseline mental health
not associated with subsequent diet quality.15 17 21
However, a recent nationally representative longitudinal
study of Canadians, which explicitly tested reverse caus-
ation, showed that the association between fruit and
vegetable consumption, other health behaviours
and depressive symptoms are complex and bi-directional
and warrants further investigation.33
CONCLUSIONS
Fruit and vegetable consumption may help reduce the
prevalence of psychological distress among middle-aged
and older adults. However, the association between fruit
and vegetable consumption and the incidence of psy-
chological distress requires further investigation and pos-
sibly, a longer follow-up time. Fruit and vegetable
consumption may help reduce psychological distress
among middle-aged and older females in a cross-
sectional context, but not potentially at the highest
levels of intake in females over time. Consumption at
medium levels of intake may help lower psychological
distress in men in a cross-sectional context; however, lon-
gitudinal associations remain unclear. Although ﬁndings
from this study lend support to existing public health
guidelines which encourage fruit and vegetable con-
sumption as part of a healthy diet and add evidence to
support the beneﬁts of fruit and vegetables for mental
health, further research is clearly needed.
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ABSTRACT
Objective To summarise the literature on the economic 
burden of physical inactivity in populations, with em-
phases on appraising the methodologies and providing 
recommendations for future studies.
Design Systematic review following the Preferred 
Reporting Items for Systematic Reviews and Meta-
Analyses guidelines (PROSPERO registration number 
CRD42016047705).
Data sources Electronic databases for peer-reviewed 
and grey literature were systematically searched, 
followed by reference searching and consultation with 
experts.
Eligibility criteria Studies that examined the 
economic consequences of physical inactivity in a 
population/population-based sample, with clearly stated 
methodologies and at least an abstract/summary written 
in English.
Results Of the 40 eligible studies, 27 focused on direct 
healthcare costs only, 13 also estimated indirect costs 
and one study additionally estimated household costs. 
For direct costs, 23 studies used a population attributable 
fraction (PAF) approach with estimated healthcare costs 
attributable to physical inactivity ranging from 0.3% 
to 4.6% of national healthcare expenditure; 17 studies 
used an econometric approach, which tended to yield 
higher estimates than those using a PAF approach. For 
indirect costs, 10 studies used a human capital approach, 
two used a friction cost approach and one used a value 
of a statistical life approach. Overall, estimates varied 
substantially, even within the same country, depending 
on analytical approaches, time frame and other 
methodological considerations.
Conclusion Estimating the economic burden of 
physical inactivity is an area of increasing importance 
that requires further development. There is a marked 
lack of consistency in methodological approaches 
and transparency of reporting. Future studies could 
benefit from cross-disciplinary collaborations involving 
economists and physical activity experts, taking a societal 
perspective and following best practices in conducting 
and reporting analysis, including accounting for potential 
confounding, reverse causality and comorbidity, applying 
discounting and sensitivity analysis, and reporting 
assumptions, limitations and justifications for approaches 
taken. We have adapted the Consolidated Health 
Economic Evaluation Reporting Standards checklist as 
a guide for future estimates of the economic burden of 
physical inactivity and other risk factors.
INTRODUCTION
Physical inactivity is a global pandemic. Every 
year, physical inactivity causes more than 5 million 
deaths1 and costs billions of dollars to societies 
around the world.2 To date, many countries have 
developed national physical activity plans; however, 
few have been fully implemented.3 The substantial 
gap between policy and implementation may be 
due to a lack of resources, cross-sectoral partner-
ship and clear strategies. Public health responses to 
address the pandemic of physical inactivity remain 
inadequate, uncoordinated and underfunded.3
Economic analysis is essential to bridging the 
policy–implementation gap, increasing polit-
ical engagement and motivating actions. Around 
the world, governments are addressing many 
competing priorities with finite resources. Making 
an economic case for physical activity may help 
galvanise public support, inform decision making 
and prioritise funding allocation to develop and 
implement interventions to reduce physical inac-
tivity in the population.4 Estimating the economic 
burden of physical inactivity is a critical first step 
because it can provide comprehensive information 
regarding the burden of the pandemic and the costs 
of not taking action.2 Conducting economic evalu-
ation of interventions designed to mitigate physical 
inactivity is the key to identify strategies that are 
the best value for money to fully inform resource 
prioritisation.
It is important that studies adopt robust, stan-
dardised and transparent methods when assessing 
the economic burden of risk factors, such as phys-
ical inactivity. Methodological consistency between 
studies enables valid comparisons regarding the 
absolute and relative burden of physical inactivity 
compared with other risk factors. This can be 
expected to increase the confidence of decision 
makers to commission and use such analyses in 
decision making. To date, a range of studies have 
been published on the economic burden of physical 
inactivity at local, state or national levels, mostly in 
developed countries. In 2016, as part of the Lancet 
Physical Activity Series, we published the first global 
estimate that included 142 countries.2 However, 
prior estimates, even for the same country, vary 
substantially across studies. For example, Carlson 
et al estimated that physical inactivity accounted 
for 11.1% of the healthcare expenditure in the 
USA5 while Colditz estimated the proportion to be 
2.4%.6 The difference between 11.1% and 2.4% is 
enormous. Understanding and perhaps resolving 
such divergent estimates is crucially important to 
enhance the overall credibility of economic burden 
estimates in decision making.
The purpose of this paper is to undertake a 
systematic review of the current literature on the 
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economic burden of physical inactivity in populations or popu-
lation-based samples, with emphases on a critical appraisal of 
the methodologies of each study and a discussion on how the 
conduct and interpretation of future studies may be improved.
METHODS
Data sources and searches
The protocol for this systematic review was registered with 
the International Prospective Register of Systematic Reviews 
(PROSPERO; registration number CRD42016047705, avail-
able at http://www. crd. york. ac. uk/ PROSPERO/ display_ record. 
asp? ID= CRD42016047705). This systematic review follows 
the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines.7
We identified studies through searching electronic databases, 
including Medline (via OvidSP; 1946–present), Scopus and 
Global Health (via OvidSP; 1910–present) for peer-reviewed 
papers, and Web of Science conference proceedings (1900-
present), ProQuest Dissertations and Theses Global, Google 
Scholar and Google for grey literature. The literature search 
was conducted from database inception to October 2016, using 
search terms outlined in supplementary file 1. Additional arti-
cles were identified through searching the references of eligible 
articles and consultation with experts in the field (authors of 
the global estimate paper by Ding et al2 and experts listed in the 
Acknowledgements section of that paper).
Eligibility criteria
A study was considered eligible if it: (1) examined physical inac-
tivity as a risk factor; (2) examined the economic burden of 
physical inactivity in any format, such as an estimated amount, 
a percentage (eg, of healthcare expenditure) or the differential 
costs between those who were physically inactive and those who 
were not; (3) provided estimates based on a population (eg, Cana-
dian adults) or a population-based sample (eg, the Australian 
Longitudinal Study on Women’s Health); (4) provided sufficient 
methodological details to allow for data extraction; and (5) 
included an English abstract or summary. No additional restric-
tions regarding the date of publication, language or peer-review 
status were imposed.
A study was excluded if it was based on a workplace sample 
only,8 if it provided little information on methodologies or used 
a patented technique or tool9 or if it included physical inac-
tivity as a component of an overall lifestyle index or factor.10 
Finally, publications that did not include original analysis, such 
as reviews and commentaries, were also excluded.
Study selection
Eligibility of identified studies was assessed independently by 
two authors (DD and TLK-A) following a standard protocol 
that involved reading the title, abstract and full-text articles. 
Uncertainty was discussed after reading the full text, and any 
disagreement was resolved by consensus. A PRISMA flow 
diagram presents the summary of the study selection process 
(figure 1).
Data extraction
The outcomes of the studies included direct (ie, healthcare 
expenditure) and indirect costs (eg, productivity losses). Studies 
estimating the direct healthcare costs of physical inactivity 
Figure 1 Selection of articles for systematic review.
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generally used two approaches: (1) a PAF-based approach, 
which calculates healthcare costs attributable to physical inac-
tivity by applying a PAF (interpreted as the proportion of disease 
that would not exist if physical inactivity was eliminated) to 
disease-specific costs; and (2) an econometric approach, which 
uses data linking physical inactivity and healthcare expenditure 
at the individual level. Data were extracted separately for direct 
and indirect costs and for studies that used a PAF-based and an 
econometric approach.
One author (DD) extracted data from studies, and two other 
authors (TLK-A, BN) each independently re-entered 30% of 
the extracted data for quality assurance. Any disagreement was 
resolved by consensus. Extracted data elements included country, 
data sources, physical activity measures (eg, minimal risk coun-
terfactual or physical activity categories), time frame (eg, 1 
year vs lifetime) and perspective of the analysis (eg, ‘healthcare 
payer’, ‘household’, ‘economy’ or ‘societal’).11 Various other 
methodological considerations were extracted. Specifically, for 
Table 1 Characteristics of studies (n=40)
Study characteristic No. of studies References (first author and year of publication)
Country
Australia 5 Brown 200843; Cadilhac 201127; Musich 200344; Peeters 201436; Stephenson 200030
Brazil 2 Bielemann 201529; Codogno 201548
Canada 8 Colman 200416; Janssen 201218; Katzmarzyk 200033; Katzmarzyk 200420; Katzmarzyk 201119; Krueger 201423; 
Krueger 201522; Krueger 201621
China 2 Popkin 200657; Zhang 201326
Czech Republic 1 Maresova 201431
Japan 2 Aoyagi 201142; Yang 201137
Korea 2 Cho 201139; Min 201638
New Zealand 1 Market Economics Limited 201324
Switzerland 1 Martin 200125
Taiwan 1 Lin 200845
UK 3 Allender 200758; Scarborough 201134; Townsend 201632
USA 10 Anderson 200559; Andreyeva 200635; Carlson 20145; Chevan 201446; Colditz 19996; Garrett 200460; Pratt 200040; 
Pronk 199947; Wang 2004a41; Wang 2004b49
Multiple countries 2 International Sports and Culture Association and Centre for Economics and Business Research 201517; Ding 20162
Study perspective
Healthcare payer only 27 Allender 200758; Anderson 200559; Andreyeva 200635; Aoyagi 201142; Bielemann 201529; Brown 200843; Carlson 
20145; Chevan 201446; Cho, 201139; Codogno 201548; Colditz 19996; Garrett 200460; Katzmarzyk 200033; Lin 
200845; Maresova 201431; Min 201638; Musich 200344; Peeters 201436; Popkin 200657; Pratt 200040; Pronk 199947; 
Scarborough 201134; Stephenson 200030; Townsend 201632; Wang 2004a41; Wang 2004b49; Yang 201137
Healthcare payer and the economy 12 Colman 200416; Ding 20162; International Sports and Culture Association and Centre for Economics and Business 
Research 201517; Janssen 201218; Katzmarzyk 200420; Katzmarzyk 201119; Krueger 201423; Krueger 201522; Krueger 
201621; Market Economics Limited 201324; Martin 200125; Zhang 201326
Societal* 1 Cadilhac 201127
Methodology for estimating direct 
healthcare costs
Population attributable fraction (PAF)-
based approach
23 Allender 200758; Bielemann 201529; Cadilhac 201127; Colditz 19996; Colman 200416; Ding 20162; Garrett 200460; 
International Sports and Culture Association and Centre for Economics and Business Research 201517; Janssen 
201218; Katzmarzyk 200033; Katzmarzyk 200420; Katzmarzyk 201119; Krueger 201423; Krueger 201522; Krueger 
201621; Maresova 201431; Market Economics Limited 201324; Martin 200125; Popkin 200657; Scarborough 201134; 
Stephenson 200030; Townsend 201632; Zhang 201326
Econometric approach 17 Anderson 200559; Andreyeva 200635; Aoyagi 201142; Brown 200843; Carlson 20145; Chevan 201446; Cho 201139; 
Codogno 201548; Lin 200845; Min 201638; Musich 200344; Peeters 201436; Pratt 200040; Pronk 199947; Wang 2004a41; 
Wang 2004b49; Yang 201137
Indirect costs estimated
Yes 13 Cadilhac 201127; Colman 200416; Ding 20162; International Sports and Culture Association and Centre for 
Economics and Business Research 201517; Janssen 201218; Katzmarzyk 200420; Katzmarzyk 201119; Krueger 201423; 
Krueger 201522; Krueger 201621; Market Economics Limited 201324; Martin 200125; Zhang 201326
No 27 Allender 200758; Anderson 200559; Andreyeva 200635; Aoyagi 201142; Bielemann 201529; Brown 200843; Carlson 
20145; Chevan 201446; Cho 201139; Codogno 201548; Colditz 19996; Garrett 200460; Katzmarzyk 200033; Lin 
200845; Maresova 201431; Min 201638; Musich 200344; Peeters 201436; Popkin 200657; Pratt 200040; Pronk 199947; 
Scarborough 201134; Stephenson 200030; Townsend 201632; Wang 2004a41; Wang 2004b49; Yang 201137
Type of publication
Peer-reviewed scientific paper 35 Allender 200758; Anderson 200559; Andreyeva 200635; Aoyagi 201142; Bielemann 201529; Brown 200843; Cadilhac 
201127; Carlson 20145; Chevan 201446; Cho 201139; Codogno 201548; Colditz 19996; Ding 20162; Garrett 200460; 
Janssen 201218; Katzmarzyk 200033; Katzmarzyk 200420; Katzmarzyk 201119; Krueger 201423; Krueger 201522; 
Krueger 201621; Lin 200845; Maresova 201431; Martin 200125; Min 201638; Musich 200344; Peeters 201436; Popkin 
200657; Pratt 200040; Pronk 199947; Scarborough 201134; Wang 2004a41; Wang 2004b49; Yang 201137; Zhang 201326
Grey literature 5 Colman 200416; International Sports and Culture Association and Centre for Economics and Business Research 
201517; Market Economics Limited 201324; Stephenson 200030; Townsend 201632
*Combined perspectives from the healthcare payer, the economy and the household.
References of all studies are included in online supplementary file 2.
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studies that estimated direct healthcare costs using a PAF-based 
approach, we extracted data on the diseases or health conditions 
included in the cost estimates (eg, diabetes and stroke), whether 
the PAF was based on crude or adjusted relative risks (RRs) and 
whether comorbidity among diseases was accounted for. For 
studies using an econometric approach, we extracted data on 
the study design (eg, longitudinal and cross-sectional), sample, 
the types of costs included (eg, inpatient and outpatient) and 
adjustment for covariates. Finally, we also extracted information 
on the reported funding sources and conflict of interest.
For studies that estimated indirect costs, we extracted the 
type of costs included (eg, productivity losses from absenteeism, 
presentism and others) and the methodology used. Three main 
approaches were used. The friction cost approach (FCA) takes an 
‘employer perspective’ to estimate productivity losses during the 
‘friction period’, which is the time before an employer replaces 
the worker lost to death or disability.12 The human capital 
approach (HCA) takes an ‘employee perspective’ and estimates 
the productivity losses over an expected working lifetime, irre-
spective of whether an individual dies from the risk factor and/or 
an employer can replace the worker.13 Finally, a value of a statis-
tical life (VSL) approach monetises an average or ‘statistical’ life 
lost.14 The key difference of a VSL approach is that it seeks to 
value life lost as opposed to estimating the productivity costs 
incurred. Overall, the estimates produced differ across methods, 
increasing from FCA to HCA to VSL.
For studies that involved an estimate of the economic burden 
over time, we extracted information on whether discounting 
was applied. Discounting is a process where all present and 
future costs are converted to a single net present value (NPV). 
Discounting is an essential practice in robust economic analysis.15
Finally, we extracted information on any uncertainty anal-
ysis/sensitivity analysis regarding the estimates produced. We 
searched for whether studies investigated statistical uncertainty 
and/or structural uncertainty. Statistical uncertainty concerns 
input parameters to the model and corresponding estimates of 
the economic burden the model produced. Statistical uncertainty 
is typically represented by means and standard errors/confidence 
intervals, and statistical sensitivity analysis explores sampling 
from the distributions to understand how the economic burden 
varies. Possibilities include, for example, multiway sensitivity 
analysis and probability sensitivity analysis. Structural uncer-
tainty concerns the nature of the model (eg, uncertainty in the 
econometric assumptions used) and/or parameters included (eg, 
using FCA, HCA or VSL when estimating indirect costs). Struc-
tural sensitivity analysis explicitly investigates such uncertainties 
if relevant, by varying the model as appropriate (eg, different 
parameters and functional forms) and reporting the corre-
sponding change in the economic burden estimates produced.
In the case of lacking specific information (eg, types of cost 
included), we examined the references provided by the authors 
to obtain relevant information. If the information was not avail-
able, we coded it as ‘not specified’, and when the information 
provided was ambiguous, we coded it as ‘unclear’.
Risk of bias assessment
Due to the lack of risk of bias assessment tools or established 
methodological guidance on how to conduct a high-quality 
analysis of the economic burden of physical inactivity (or other 
lifestyle risk factor), we did not perform a formal risk of bias 
assessment according to an existing instrument, nor did we 
exclude studies based on low quality. Instead, we extensively 
discussed methodological and presentation issues throughout 
the paper and developed a checklist that could be used for future 
original studies and quality assessment.
Data synthesis
General characteristics of the selected studies, including country, 
perspective, methodology for estimating direct healthcare costs, 
whether indirect costs were estimated and type of publication, 
were summarised in a table. Additional specific information 
extracted from each study (see ‘Data extraction’) was synthe-
sised separately by the type of costs (direct vs indirect costs) and 
the methodological approaches to estimating direct healthcare 
costs (PAF-based vs econometric).
To facilitate comparison of estimates across studies, we 
presented the percentage of overall healthcare expenditure 
attributable to physical inactivity. When the percentage was 
not reported by the study but the overall physical inactivity-re-
lated healthcare expenditure was available, we calculated the 
percentage based on the overall healthcare expenditure data 
for that year from the WHO website (http:// apps. who. int/ nha/ 
database/ Select/ Indicators/ en). Additionally, to facilitate compar-
ison of national estimates from different years and in different 
currencies, we inflated the national estimates (point estimates 
only) in local currency units from the year of data to 2013, as 
the common year, using the annual consumer prices inflation 
indicators from the World Bank (http:// data. worldbank. org/ 
indicator/ FP. CPI. TOTL. ZG) and then converted to purchasing 
power parity (PPP) international dollars using conversion factors 
provided by the World Bank (http:// data. worldbank. org/ indi-
cator/ PA. NUS. PPP). This approach, similar to that used in our 
recent global estimates,2 allows for comparison across countries 
using a common currency taking PPP into account. Finally, when 
the authors presented incorrect information (eg, using incor-
rect exchange rate and inappropriately calculated healthcare 
expenditure percentages), we attempted to present corrected 
information in summary tables and noted the correction in foot-
notes.
RESULTS
Selection of studies
As shown in figure 1, a total of 516 studies were identi-
fied, of which 445 were unique records. After excluding 368 
records based on reading the title and abstract, full texts of the 
remaining 77 studies were examined. A total of 46 studies were 
excluded because they did not meet the inclusion criteria. In 
total, 40 studies were qualitatively synthesised and appraised 
(see online supplementary file 2).
Study characteristics
Table 1 demonstrates characteristics of the 40 studies. Nearly 
half of the identified studies were conducted in North America 
(10 in the US and eight in Canada), five studies were conducted 
in Australia, three in the UK, two were across multiple coun-
tries and the rest of the studies were conducted in Brazil, China, 
Czech Republic, Japan, Korea, Switzerland, New Zealand and 
Taiwan. Overall, 35 studies were peer-reviewed and five were 
grey literature reports.
Perspective
Two-thirds of the studies (n=27) took the sole perspective of the 
healthcare payer and estimated the direct healthcare expenditure 
only. Of the 13 studies that also estimated the indirect costs of 
physical inactivity, 12 combined the perspectives of the health-
care payer and the economy, by additionally estimating costs of 
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productivity losses.2 16–26 Only one study took a comprehensive 
societal perspective by estimating direct healthcare costs, indi-
rect costs of productivity losses and those of home-based and 
leisure-based production.27
Estimates of direct costs
All studies included some estimates of the direct heathcare costs 
of physical inactivity. Of those, 23 studies used a PAF-based 
approach, while 17 used an econometric approach.
Converted national estimate: we inflated the national esti-
mates in local currency units from the year of data to 2013 using 
the annual consumer prices inflation indicators from the World 
Bank (http:// data. worldbank. org/ indicator/ FP. CPI. TOTL. ZG) 
and then converted to PPP international dollars using conver-
sion factors provided by the World Bank (http:// data. worldbank. 
org/ indicator/ PA. NUS. PPP). However, the estimate was not 
converted for Martin et al25 due to the lack of Swiss franc (SFr) 
to PPP international dollar conversion factor from the World 
Bank.
Studies using a PAF-based approach
As shown in table 2, although the 23 studies did not use a stan-
dardised minimal risk counterfactual for calculating the PAF, 
most used a definition that was equivalent to approximately 150 
min of moderate-intensity physical activity per week as recom-
mended by current physical activity guidelines.28 Almost all 
studies included a broad range of healthcare expenditure, such 
as inpatient, outpatient, pharmaceutical and physician care costs. 
One study included inpatient costs only.29 In estimating direct 
healthcare costs, studies included between four and eight health 
conditions, nearly all of which included ischaemic heart disease, 
diabetes, breast cancer and colon cancer. Some studies included 
additional conditions, such as stroke, hypertension and osteo-
porosis.
Regarding the PAF used for estimating direct healthcare costs, 
most studies did not specify whether the PAF was based on 
adjusted or unadjusted RR. After checking the cited references 
about the PAF, we could only confirm that nine studies used 
PAF based on adjusted RR.2 18 19 21–23 26 29 30 All studies took an 
additive approach by summing costs attributable to physical inac-
tivity across multiple diseases/conditions. This could potentially 
lead to double counting among those with multiple conditions, 
commonly known as comorbidity. Only two studies explicitly 
described efforts to address comorbidity. One study estimated 
the potential overlaps among ischaemic heart disease, stroke, 
and type 2 diabetes and subtracted the overlapped proportions 
from the sum.2 The other study used data that could identify 
comorbidity through individual hospital records.24
All studies provided an overall amount for the healthcare costs 
of physical inactivity for a one-year time frame. Nineteen of the 
23 studies provided a national level estimate, most of which was 
presented as or converted to a percentage of national health-
care expenditure. The percentages ranged from around 0.3% in 
the Czech Republic31 and England32 to 4.6% in New Zealand,24 
with the majority of the estimates ranging between 1% and 2.5% 
(Supplementary Figure 1). Twelve studies provided some sensi-
tivity analysis.2 6 18 20–25 30 33 34 Of those, four included structural 
sensitivity analysis, by taking into account different physical 
activity prevalence and/or PAF.2 25 30 34
Studies using an econometric approach
Of the 17 studies that used an econometric approach, three 
applied a longitudinal design,35–37 one used a retrospective 
cohort design,38 and the remainder were cross-sectional studies 
(table 3). The sample size of studies ranged from 250 to 51 165. 
The measurement and categorisation of physical activity varied 
across studies and often included multiple levels. In most cases, 
healthcare cost data were measured objectively, based on health 
insurance claims or data from other healthcare systems. Only 
three studies used self-reported health expenditure data.39–41 
In most cases, health cost data included comprehensive types 
of expenditure, including both inpatient and outpatient care. 
However, two studies did not include inpatient services,42 43 
and one study primarily included inpatient services.44 The types 
of expenditure included in each study depended on the data 
sources, such as public systems versus private health insurance 
companies.
Findings from these studies were presented in heteroge-
neous formats. For example, some studies presented excessive 
healthcare costs among those who were less active (or cost 
savings among those who were active), in terms of absolute or 
proportional difference,5 38–40 43–45 some presented the magni-
tude of association between physical activity and healthcare 
expenditure42 46 47 and a number of studies extrapolated find-
ings from the sample to the population at the national level.5 
35 36 40 41 43 48 49 Overall, based on the converted national-level 
estimates of the proportion of healthcare expenditure associ-
ated with physical inactivity, studies that applied an econometric 
approach produced much higher estimates than those applying a 
PAF-based approach (Supplementary Figure 1). Only two econo-
metric studies included structural sensitivity analyses by taking 
into account alternative model forms.5 35
Estimates of indirect costs
All of the 13 studies provided estimates of productivity losses 
in the workforce (table 4). Of those, the majority of the studies 
applied HCA and estimated cumulative productivity losses over 
a working lifetime of population affected (including current 
and future costs).16–23 25 26 Two studies used FCA to estimate 
productivity losses during the replacement period.2 27 In studies 
where both HCA and FCA were used, in the form of sensitivity 
analysis, FCA yielded much lower costs than HCA.2 22 27 One 
study used a VSL approach and had much higher estimates of 
indirect costs than studies applying HCA and FCA.24 Although 
at least 10 studies provided lifetime estimates by incorporating 
costs that will occur in the future, only four explicitly described 
discounting future costs,18 20 24 27 another five were identified 
as applying discounting on checking their references or data 
sources.16 19 21–23 Most studies included some form of statistical 
sensitivity analysis.2 18 20–25 27 Five studies conducted struc-
tural sensitivity analysis by varying the model using alternative 
approaches/parameters.2 22 24 25 27
DISCUSSION
To our knowledge, the current systematic review is the first to 
comprehensively summarise findings and methodological consid-
erations of studies estimating the economic burden of physical 
inactivity in populations. Although 40 studies were included in 
our review, the current estimates stem disproportionately from a 
small number of countries. Specifically, 38 single-country studies 
represented only 12 countries, of which 10 were high-income 
countries. At the global level, estimating the economic burden 
of physical inactivity remains an important yet underdeveloped 
area, particularly in low-income and middle-income countries.4
Based on the findings from the studies reviewed, it is evident 
that physical inactivity is a costly pandemic that is associated 
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with a substantial disease burden in almost every country where 
estimates exist. However, because of large variation in method-
ologies, health systems and the prevalence of physical inactivity 
over time, it is problematic to compare estimates of the cost of 
physical inactivity across studies and countries. As demonstrated 
by the current review, there is important variation in the perspec-
tive taken (eg, healthcare payer only vs societal perspective), 
type of costs included, specific costing approaches, measurement 
of physical activity, adjustment for covariates/confounding, time 
frame (eg, 1 year vs lifetime) and whether sensitivity analysis 
was undertaken and in what form. These all contributed to the 
substantial variations in the estimates of economic burden.
Study perspective
The perspective refers to the viewpoint from which an economic 
analysis is conducted, which influences the types of information 
included.50 Both the original and second Panels on Cost-Effec-
tiveness in Health and Medicine recommended taking a societal 
perspective as the most comprehensive approach because it esti-
mates the total impact on society, including the health sector, 
non-health sector and households.50 51 Economic burden of 
disease studies should ideally be aligned with this guidance for 
consistency. Specifically, studies should collect information on 
costs to the healthcare sector (ie, direct costs to public/private 
healthcare providers and patient costs), non-health sectors (indi-
rect costs or productivity losses) and household economy (eg, 
impact on usual activities and carers, where appropriate). Most 
existing studies on physical inactivity take a narrower healthcare 
sector perspective with the rationale that the key decision maker 
in addressing inactivity is the health sector. While studies on 
healthcare costs are necessary, we argue that it is not sufficient, 
and it is straightforward to estimate non-health sector produc-
tivity losses and the impact on the household economy. Taking 
such wider impacts into account can help make the economic 
case for additional healthcare resources. Furthermore, policies 
and interventions that impact on physical activity may reside 
outside of the healthcare sector (eg, transportation) and may 
involve cross-sectoral partnership.
It is important to note that this approach estimates the 
‘production costs’ resulting from physical inactivity to society, 
regarding the increase in healthcare production and the reduc-
tion in economy and household production. As discussed 
previously, it is possible to build on this to ‘value’ the impact 
of inactivity on health, rather than only estimating cost. There 
are alternative methods to do so, such as willingness to pay and 
VSL; however, these methods can be expensive to undertake. 
Therefore, in an effort to proceed incrementally and pragmat-
ically, and to attempt to bring some initial alignment of future 
economic burden of disease studies, we reiterate our recommen-
dation to take a societal approach concentrated on production 
costs and to disaggregate results into healthcare sector (direct 
costs), the wider economy or productivity impacts (indirect 
costs) and the household economy.
PAF-based versus econometric approaches
Two main approaches were used for estimating the direct health-
care costs of physical inactivity: a PAF-based approach and an 
econometric approach. Usually, an econometric approach leads 
to higher estimates. The marked differences in estimates using 
the two approaches may be explained in part by the following. 
First, a PAF-based approach focuses on capturing costs averted 
if certain diseases were prevented. Econometric models could 
additionally take into account potentially higher treatment 
intensity and costs, and possibly other ancillary costs among 
those with a disease/condition.52 Second, although the US Phys-
ical Activity Guidelines Advisory Committee Report28 concluded 
that there is moderate to strong evidence for the effects of phys-
ical activity on more than 20 diseases/conditions, most studies 
using a PAF-based approach included only a small subset of 
these. For example, no study reviewed included more than eight 
conditions (table 2). Therefore, using a PAF-based approach may 
underestimate the real healthcare costs associated with physical 
inactivity. Third, econometric analyses may capture differences 
in healthcare expenditure resulting from the fundamental differ-
ences between physically active and inactive individuals, such as 
overall health-seeking behaviour and health status. For example, 
according to Carlson et al’s cross-sectional analysis, adjusting for 
body mass index and excluding those with difficulty walking led 
to a 40% reduction in the estimated healthcare costs of phys-
ical inactivity.5 Fourth, while studies using a PAF-based approach 
were mainly based on overall adult populations, most studies 
using an econometric approach were based on samples of older 
participants, where physical inactivity-related diseases and condi-
tions were more likely to occur. Furthermore, in the longitudinal 
analysis by Andreyeva and Sturm, adjusting for baseline health 
led to 45% lower healthcare cost estimates.35 Although most 
econometric analyses adjusted for covariates, which should be 
standard practice, without longitudinal data and careful meth-
odological considerations, it is likely that econometric models 
could overestimate the actual healthcare costs of physical inac-
tivity because of residual confounding and reverse causality.
The choice of applying a PAF-based approach versus an 
econometric approach depends mainly on data availability. 
Econometric analyses require data on physical inactivity and 
healthcare expenditure linked at the individual level. Regression 
models are usually performed to estimate the excess healthcare 
expenditure among those who are physically inactive, which 
could then be extrapolated to a population. Econometric anal-
yses also provide opportunities to estimate healthcare costs 
within a particular population subgroup, for example, those 
who were ‘downhearted and blue’.49 However, it is important 
to ensure the generalisability of a sample before extrapolating 
findings to an entire population.
Studies using a PAF-based approach require data on healthcare 
costs for each of the diseases/conditions associated with physical 
inactivity. By applying PAF, one can estimate the proportion of 
healthcare costs attributable to physical inactivity. Several meth-
odological aspects should be considered. First, the calculation 
of PAF should be based on adjusted RR. Unfortunately, more 
than half of the studies tabulated in table 2 did not adjust for 
covariates for PAF calculation. In our previous international 
study, we conducted a sensitivity analysis by applying PAF based 
on unadjusted RR. We found that this nearly doubled the esti-
mates from the main analysis that was based on adjusted PAF.2 
Second, ideally for calculating PAF, RR and the prevalence of 
physical activity should be based on the same population using 
the same definition of physical activity. However, this is chal-
lenging because the current epidemiological evidence of physical 
activity mostly stemmed from a small number of countries using 
heterogeneous definitions and measurement of physical activity. 
Third, summing physical inactivity-related costs of each disease/
condition may result in double counting due to comorbidity. 
Current studies rarely address this issue, leaving comorbidity an 
ongoing challenge for future methodological advancement.
Although the decision for methodological approaches is prac-
tically driven by data availability, it is vital that for whatever 
approach chosen, care is taken to address the methodological 
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issues raised above and to report all key assumptions, limitations 
and justifications for approaches taken.
Estimates of indirect costs
Only one-third of studies estimated the indirect costs in addi-
tion to direct costs. Studies varied depending on whether an 
FCA, HCA or VS approach was taken, which naturally results 
in different estimates produced. For example, according to 
the 1998 Economic Burden of Illness in Canada report, which 
applied an HCA, indirect costs of cardiovascular disease repre-
sented 171% of its direct costs.53 However, the same ratio was 
merely 3.1% according to the 2008 report,54 which applied an 
FCA.22
It is important to recognise that the existence of the FCA, 
HCA and VSL approach is not a weakness of economic analysis. 
Each approach involves different value judgements regarding 
what the analysis should consider, such as the cost of replace-
ment (to employers), lifetime (to employees) or the value of life 
itself. These are ethical and contestable concepts. We recom-
mend that a transparent economic analysis should explicitly state 
the value frame used and assumptions made and calibrate the 
analysis to the intended decision makers/end-users. As part of 
this process, we recommend structural sensitivity analyses that 
adopt different approaches, similar to the study by Cadilhac et 
al27 to enable readers to fully understand the impact of adopting 
different value judgements. Equally, it is important that those 
who interpret the estimates understand the differences between 
methods to avoid erroneous comparisons between studies and 
to avoid needless confusion. It is important that economists are 
part of research teams to guide the analysis undertaken and help 
communicate the methods and results.
Time frame
The economic burden of physical inactivity could occur at 
present and in the future. For example, deaths and disability 
due to illnesses could incur future costs in terms of losses of 
income and other production. Almost all studies reviewed used 
a 1-year time frame for direct costs to capture healthcare expen-
diture occurring in the year of analysis. Studies that included 
indirect costs adopt a lifetime approach by default, by valuing 
productivity losses in the present period and also in the future 
(for the FCA this is conditional on the replacement period). It is 
important that studies explicitly describe the time frame of the 
analysis and apply discounting to estimate the NPV of all current 
and future estimates. The NPV is a single estimate designed 
to create a consistent comparison across studies that may use 
different time periods.15 50 A number of studies estimated life-
time costs did not use or explicitly mention discounting. This is 
poor practice that can be easily avoided.
Sensitivity analysis
Estimating the economic burden of physical inactivity, or any 
other risk factor, involves both inevitable statistical uncer-
tainty and making various choices regarding which modelling 
approaches/methods (eg, FCA vs HCA) are included in the study. 
Therefore, it is imperative to clearly state assumptions for the 
main analysis and conduct comprehensive sensitivity analyses.11 
50 51 Sensitivity analysis is an integral component of any robust 
and transparent economic analysis.55 Based on the current 
review of the literature, sensitivity analysis was not included in 
all studies. Again, this should be standard practice.
Study presentation
Most studies presented the results with sufficient information 
regarding the source of data, sampling frame (if applicable), 
measures of physical activity, type of costs, diseases/conditions 
included and year and currency. However, presentation of other 
methodological details was insufficient and often ambiguous, 
such as how the PAF was derived (eg, whether based on adjusted 
RR), perspectives, approaches, time frame, discounting and 
sensitivity analysis. Several studies presented the proportion of 
total healthcare expenditure attributable to physical inactivity, 
which is meant to facilitate comparison across studies and coun-
tries/regions. However, some studies presented such information 
in a misleading way by summing direct and indirect costs as the 
numerator, which inflated the percentage by several fold.17 18 
Future studies should clearly and accurately present key infor-
mation to improve transparency and integrity.
The need for economic evaluation of interventions to address 
physical inactivity
Estimating the economic burden is a vital first step in understanding 
the overall burden of physical inactivity and the consequences of 
inaction, which helps galvanise policy efforts. However, burden of 
disease studies should not be the sole consideration in the prior-
itisation process. For instance, large problems may be addressed 
relatively inexpensively and vice versa. Therefore, it is vital that 
economic evaluation is undertaken to assess both the costs and 
benefits of interventions to reduce the economic burden and to 
identify interventions that are the greatest value for money. In this 
way, resource-constrained decision makers can best prioritise soci-
etal resources to increase population health. There are guidelines 
that should be followed when conducting and reporting economic 
evaluations.56
Future directions
Overall, estimating the economic burden of physical inactivity 
is an area of increasing research and policy importance. We 
recommend that future cross-disciplinary collaborations involve 
economists to ensure that best practice is adopted, and phys-
ical activity experts to ensure that analyses are valid. Specifically, 
we recommend that a societal perspective is adopted to include 
direct, indirect and household costs, with the overall estimate 
reported and then disaggregated to these three levels. Further-
more, it is vital to carefully consider potential confounding, 
reverse causality and comorbidity. Discounting (when future 
impacts are included) and sensitivity analysis should be under-
taken routinely. Overall, it is vital that studies are transparent 
in reporting the objectives, rationale and intended end-users/
decision makers and that they align with assumptions made with 
the objectives. Finally, studies should transparently report any 
funding sources and conflict of interest.
There are currently no guidelines specifically for studies that 
estimate the economic burden of risk factors; therefore, we have 
summarised what we have discussed above in a new checklist 
(table 5), adapted from the Consolidated Health Economic Eval-
uation Reporting Standards.56 It is important to acknowledge 
that it is impossible to completely standardise methodologies 
because economic analysis is often conducted to address the 
needs of specific stakeholders. Hence, our newly developed 
checklist should be used as a guide for improving methodolog-
ical rigour and reporting quality for future economic analysis 
that is set up to appropriately address specific objectives.
Assessing the economic burden of physical inactivity is 
important; however, there is a need for general improvement in 
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Table 5 Checklist for reporting estimates of the economic costs/burden of risk factors*
Section/item Item no. Recommendation
Reported on page 
no./line no.
Title and abstract
Title  1 Identify the study as an estimate of the economic burden of a risk factor (ie, physical activity) and 
identify the study sample.
Abstract  2 Provide a summary of objectives, perspective, setting, methods (including study design and inputs), 
results, including statistical uncertainty, and sensitivity analysis (changes in key structural assumptions) 
and conclusions.
Introduction
Background and objectives  3 Provide an explicit statement of the study objective(s) and broader context for the study. Present the 
study question and its relevance for health policy or practice decisions. Describe whether previous 
estimates existed for the same risk factor among the same (or comparable) populations.
Methods
Target population and
subgroups
 4 Describe characteristics of the study sample/population. If subsamples/populations are chosen, provide 
justification of why and how they are chosen.
Setting and location  5 State relevant aspects of the system(s) in which the decision(s) need(s) to be made. Define decision 
maker(s) that the study is intended to inform.
Study perspective  6 Describe the perspective of the study, ensure this is consistent with the study objective(s) and aligned 
with the categories of costs/burden being evaluated.
The risk factor(s)  7 Define the risk factor(s) (eg, physical inactivity), how the risk factor is measured (eg, questionnaire), the 
reliability and validity of the measurement instrument, the minimal risk counterfactual and the rationale 
for selecting the counterfactual or categories (eg, meeting physical activity recommendations).
Choice of health outcomes  8 Define the health outcomes associated with the risk factor(s), the rationale for selecting the outcomes 
(eg, evidence on the risk factor–outcome associations), describe whether comorbidity is taken into 
account.
Costs/burden estimated  9 Define the costs/burden estimated (eg, healthcare expenditure, productivity losses) and the estimates 
included (eg, inpatient and outpatient care).
Data sources 10 Describe the sources of data, the years the data cover and any major caveats/limitations related to the 
data, if any.
Time frame 11 State the time frame over which costs/burden are considered (eg, single year, patient lifetime) and 
explain why it is appropriate.
Discount rate(s) 12 Report the choice of the discount rate(s) used for costs/burden and explain why this choice is 
appropriate.
Year of reporting and common unit 
of measure for costs/burden
13 Report the year that the estimates refer to and the common unit of measure used to collate costs/
burden (eg, for costs state the currency, and for burden state the health measure, such as disability 
adjusted life years. If relevant, describe methods for converting costs into a common currency and year 
of reporting (eg, inflation rates, purchasing power parity conversion factors).
Analytic methods and assumptions 
made
14
14a
14b
Describe the overall analytical approach (eg, population attributable fraction (PAF) approach and 
econometric approach). Describe all assumptions, such as rationale for choice of model, statistical 
distribution and any other major assumptions (eg, missing data imputation).
For study using a PAF approach, report where the PAF was derived, whether PAF was based on adjusted 
or crude relative risk.
For study using an econometric approach, report the study design (eg, prospective, cross-sectional), 
statistical models and covariates adjusted.
Results
Costs/burden estimates 15 Report the values (eg, mean) and associated statistical distributions/ranges for all parameters. If 
secondary data is used, reference appropriately. A bespoke table transparently reporting all input values 
(from methods) and outputs (from results) is strongly recommended.
Characterising uncertainty 16 If applicable, describe the effects of sampling uncertainty (statistical sensitivity analysis) on results and 
structural uncertainty in changing methodological assumptions (eg, study perspective, model choice and 
discount rates).
Characterising heterogeneity 17 If applicable, report differences in costs and/or other outcomes that can be explained by variations 
between subgroups with different baseline characteristics or other observed variability in effects that 
are not reducible by more information.
Other
Source of funding 18 Describe how the study was funded and the role of the funder in the identification, design, conduct and 
reporting of the analysis.
Describe other non-monetary sources of support.
Conflict(s) of interest 19 Describe any potential for conflict of interest among study contributors in accordance with journal 
policy. In the absence of a journal policy, we recommend authors to comply with International 
Committee of Medical Journal Editors’ recommendations.
*Checklist adapted from the Consolidated Health Economic Evaluation Reporting Standards (CHEERS).
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the conduct, reporting and interpretation of studies to increase 
the credibility of findings and to promote their use by decision 
makers.
What is currently known?
 ► The pandemic of physical inactivity causes diseases and 
deaths and costs billions of dollars to societies around the 
world.
 ► Economic analysis is essential to bridging the policy–
implementation gap, increasing political engagement and 
motivating actions.
 ► A range of studies have been published on the economic 
burden of physical inactivity, mostly in developed countries. 
However, prior estimates, even for the same country, vary 
substantially across studies.
 ► There is no existing quality assessment tool or established 
methodological guidelines on how to conduct a high-quality 
analysis of the economic burden of physical inactivity or 
other lifestyle risk factor.
What are the new findings?
 ► Among the current economic burden estimates, there is 
important variation in the perspective taken, type of costs 
included, specific costing approaches, measurement of 
physical activity, adjustment for covariates/confounding, 
time frame and whether sensitivity analysis was undertaken 
and in what form. These all contributed to the substantial 
variations in the estimates of economic burden.
 ► Two main approaches were used for estimating the direct 
health care costs of physical inactivity: a population 
attributable fraction-based approach and an econometric 
approach. Usually, an econometric approach leads to higher 
estimates based on fundamental differences between the 
two approaches.
 ► Many prior studies did not follow best practice in economic 
analysis and did not present sufficient information in a 
transparent fashion.
 ► We developed a new checklist as a guide for improving 
methodological rigour and reporting quality for future 
economic burden analysis, adapted from the Consolidated 
Health Economic Evaluation Reporting Standards checklist.
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B R I E F R E PO R T
Evaluation of the Cancer Council NSW Eat It To Beat It
Healthy Lunch Box Sessions: A short intervention to promote
the intake of fruit and vegetables among families of primary
school children in NSW Australia
Abstract
Issue addressed: Children and adults in Australia are not eating
the recommended amounts of fruits and vegetables. Our objective
was to assess the effectiveness of a health promotion intervention
to improve fruit and vegetable intake among primary school children
and their families in NSW.
Methods: The Cancer Council New South Wales Healthy Lunch
Box sessions were a 25-minute session delivered to parents of pri-
mary school-aged children. The sessions provided information and
resources about fruit and vegetables and healthy school lunch boxes.
The evaluation is a quantitative uncontrolled pre-post design. Data
were collected using three questionnaires, pre-intervention, 1 week
post-intervention and 6 months post-intervention.
Results: A total of 204 parents completed all three evaluation
questionnaires to 6 months. Knowledge of recommended intakes
and serving sizes of fruit and vegetables improved significantly after
the intervention. There was an increase in parents reporting packing
vegetables (often/always) in the child’s lunch box at 1 week (47%)
and 6 months post-intervention (40%) compared to pre-intervention
(32%). The proportion of parents reporting that they were confident
in packing a healthy lunch box increased from 45% pre-intervention
to 62% after the intervention.
Conclusions: The Healthy Lunch Box sessions were effective in
improving parental knowledge and practices related to fruit and veg-
etables and parental confidence with packing a healthy lunch box.
So what: This short intervention could be a useful component of a
portfolio of interventions to support parents with knowledge and
resources to pack a healthy lunch box for their children.
1 | INTRODUCTION
A diet high in fruits and vegetables assists in the prevention of
chronic diseases and cancer.1 In Australia, approximately 32% of can-
cers are caused by lifestyle factors, including low consumption of
fruits and vegetables.2,3 National data from 2014 to 2015 show that
only 5.1% of Australian adults consume sufficient fruits and vegeta-
bles4 and 73.1% of children aged 4-8 years consume adequate fruit
while only 3.3% reported an adequate vegetable intake.4 It is
important to influence children’s dietary intake as dietary behaviours
often track into adulthood.5,6 Health promotion interventions are
needed to improve diet quality, particularly vegetable consumption
for children and adults.7
The Eat It To Beat It program is multi-strategy community-based
programme run by the Cancer Council New South Wales (CCNSW)
to promote the intake of fruit and vegetables of families in NSW.
One of the core intervention components is delivery of “Healthy
Lunch Box” sessions by trained volunteers to parents of primary
school students in NSW.
In this paper, we describe the Healthy Lunch Box intervention
and the results of the evaluation. The evaluation assessed effective-
ness in improving parental knowledge, self-efficacy and practices
regarding increasing fruit and vegetables intake, particularly in regard
to their children’s lunch boxes, from pre-intervention to 1 week
post-intervention, and the sustainability of effects to 6 months.
2 | METHODS
2.1 | Description of the Healthy Lunch
Box intervention and evaluation design
The intervention is a free, 25-minute information session delivered
to parents and carers of primary school-aged children in NSW,
within the school setting. Volunteers are invited to attend a 1-day
workshop where they are trained to deliver a standardised presenta-
tion developed by CCNSW. Details of the Healthy Lunch Box inter-
vention messages and resources are given in Box 1.
To evaluate the intervention a simple pre-post evaluation design
was used and focused on two regions in NSW: Hunter Central Coast
(HCC) and Greater Western Sydney (GWS). There was no control
group.
2.2 | Recruitment and consent procedures
Parent participation in the evaluation was voluntary and they were
asked to provide written consent. Parents who consented were
given 10-20 minutes to complete the pre-intervention paper-based
questionnaire, prior to commencement of the 25-minute Healthy
Lunch Box session.
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Post-intervention questionnaires were administered online at
1 week and 6 months post-intervention using Survey Monkey, and
mailed paper-based questionnaires were sent to those without
emails. A prize was used as an incentive to encourage participants to
respond to the 6 month follow-up questionnaire.
2.3 | Questionnaire content
The questionnaire assessed knowledge, attitudes and practices with
respect to fruits, vegetables and packing a healthy lunch box. Where
possible existing validated questions from the Australian National
Nutrition and Physical Activity Survey,10 and questions from other
evaluations of similar CCNSW programmes,11 were used. Attitudes
were generally assessed using a 5-point Likert scale, from “strongly
agree” to “strongly disagree.” Socio-demographic information was
also collected.
The two post-intervention questionnaires were similar in content.
They were designed to measure changes in knowledge of fruit and
vegetables intakes and serving sizes, changes in parental self-efficacy
for packing a healthy lunch box, and recall of the intervention mes-
sages.
2.4 | Statistical analysis
Statistical analysis was conducted with SPSS software version 22
(IBM Corp., Armonk, NY, USA). For categorical data, chi-square tests
were used to assess the differences in proportions. McNemars’ test
was used for paired samples. To assess changes in knowledge, atti-
tudes and practices between questionnaires, outcome variables were
dichotomised and analysed with generalised estimating equa-
tion (GEE) models adjusting for socio-demographic factors. Differ-
ences were significant at the P < .05 level.
2.5 | Ethics
The protocol and consent procedures were approved by Sydney
University Ethics Committee (HREC Reference Number 2014/828),
the Catholic Schools Office Diocese of Broken Bay, Maitland-New-
castle, and Parramatta, and the Catholic Education Office Sydney.
3 | RESULTS
The Healthy Lunch Box sessions evaluated were in delivered in 54
schools in February-March 2015. A total of 535 parents/carers con-
sented to the evaluation. The 1 week post-intervention question-
naire was completed by 394 parents/carers (75% response rate) and
204 completed the questionnaire at 6 months (38% of original
respondents).
Table 1 shows the socio-demographic information from par-
ents at pre-intervention, 1 week post-intervention and 6 months
post-intervention. Study participants at 6 months were signifi-
cantly more likely to be older, speak English as their main lan-
guage, and be in the higher income bracket compared to those
who dropped out of the study. There were no significant differ-
ences by employment, education or any other socio-demographic
variables.
Table 2 shows the changes in parental knowledge of intervention
messages among the 204 participants who completed all three ques-
tionnaires. The proportion of parents having correct knowledge of
intervention messages significantly increased at 1 week post-inter-
vention and almost all were also significantly different from pre-
intervention after 6 months.
Most notably, there were significant increases in correct knowl-
edge of vegetable intake guidelines, from 34% pre-intervention to
63% 6 months post-intervention and a significant increase in knowl-
edge of the optimal drinks to pack in a child’s lunch box (milk and
water), from 60% pre-intervention to 89% 6 months post-interven-
tion.
Table 2 also shows the parent’s attitudes, opinions and practices
in packing their child’s lunch box. Fruits were regarded as both easy
and important to pack in the child’s lunch box by the majority of
BOX 1 Intervention components in the Healthy Lunch
Box sessions
1. Intervention messages
a. The link between poor nutrition, especially low
fruit and vegetable intake, and risk of chronic dis-
ease,
b. The fruit and vegetable guidelines for adults and
children,
c. Practical tips for healthy eating including a Healthy
Lunch Box “equation” to encourage consumption of
foods from each of the Australian Guide to
Healthy Eating food groups,8
d. Ways to limit consumption of unhealthy snack
foods and encouraging water or milk as the best
beverage choices to keep children hydrated.
2. Healthy Lunch Box “show bag” includes
a. A weekly lunch box planner to attach to the fridge,
b. A Healthy Lunch Box flip-book outlining an “equa-
tion” for packing foods from each food group in
the lunch box and ideas on healthy choices from
each of the food groups,
c. Fruit- and vegetable-based snack ideas,
d. A fridge magnet which outlines fruit and vegeta-
bles serve sizes,
e. Resource showing photographs of individual serves
of various fruits and vegetables and recommended
number of serves by age group,
f. Resource supporting the Crunch & Sip program9
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parents pre- and post-intervention. Pre-intervention the majority of
parents (91%) regarded it important to pack vegetables in their
child’s lunch box; this remained high post-intervention. There was a
significant increase (15%) in parents often/always packing vegeta-
bles in the lunch box 1 week post-intervention compared to pre-
intervention and some of this increase was maintained after
6 months. Parents’ confidence in packing a healthy lunch box
increased by 17% and importantly, 75% of parents perceived that
attending the Healthy Lunch Box session had increased the amount
of fruit and vegetables they and their family ate, 6 months post-
intervention.
4 | DISCUSSION
The study has shown that the low-intensity and scalable 25-minute
Healthy Lunch Box session was an effective intervention to deliver to
parents of primary school students. The session increased parent’s
knowledge of fruit and vegetable guidelines and increased the veg-
etable content in children’s lunch boxes. Other dietary messages
emphasising that water and milk are the best two drinks for children
may further encourage parents to provide these drinks instead of
sugary drinks to their children. The intervention also increased par-
ents’ confidence with packing a healthy lunch box that their child
would eat and enjoy. Six months post-intervention, three-quarters of
parents/carers reported feeling that attending the Healthy Lunch
Box session had increased the amount of fruit and vegetables they
and their family ate.
Many Australians are unaware of how many fruit and vegetable
serves they should eat each day12 which may in turn affect the
amount of fruits and vegetables they consume.13,14 This evaluation
showed a clear ceiling effect with regard to the packing of fruit in
lunch boxes for children (above 93%); and this combined with the
fact that in NSW 78% of school children already consume adequate
TABLE 1 Socio-demographic characteristics of parents/carers participating in the Healthy Lunch Box evaluation
Characteristic
Pre-intervention
N = 535
1 week post-interven-
tion N = 394
6 months post-inter-
vention N = 204
N Proportion (%) N Proportion (%) N Proportion (%)
Region Hunter Central Coast 224 41.9 175 44.4 90 44.1
Greater Western Sydney 311 58.1 219 55.6 114 55.9
Age (years)* <24 4 .7 1 .3 1 .5
25-34 159 29.7 102 25.9 45 22.1
35-44 306 57.2 239 60.7 122 59.8
45+ 64 12.0 52 13.2 36 17.6
Gender Male 15 2.8 12 3.0 7 3.4
Female 520 97.2 382 97.0 197 96.6
Education level* Year 12 or less 120 23.3 82 21.4 40 20.1
Undergraduate degree/certificate 289 56.2 221 57.6 120 60.3
Postgraduate degree 105 19.6 81 21.1 39 19.6
Employment* Employed 233 45.3 185 48.7 98 48.0
Home duties 209 40.6 148 38.9 76 37.3
Unemployed 39 7.6 26 6.8 13 6.4
Other 33 6.4 21 5.5 17 8.3
Single parent household* Yes 65 12.3 43 10.9 20 9.8
No 458 86.4 346 88.0 182 89.2
Main language spoken at home English 386 72.1 302 77.0 161 78.9
Other 143 27.0 89 22.7 41 20.1
Aboriginal/Torres
Strait Islander*
Yes 13 2.4 7 1.8 3 1.5
No 515 96.3 383 97.5 199 97.5
Approximate household
income per year AUD$
Less than 20 000 32 6.1 20 5.1 9 4.4
20 000-39 999 32 6.1 23 5.9 14 6.9
40 000-49 999 28 5.3 17 4.3 9 4.4
50 000-69 999 67 12.7 47 12.0 26 12.7
70 000+ 239 45.3 194 49.5 103 50.4
Don’t know 40 7.6 21 5.4 7 3.4
*Some missing data for these variables.
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fruit,15 may suggest that further health promotion interventions to
improve fruit intake may not be necessary.
Furthermore, this study showed that it is more difficult for par-
ents to pack vegetables than fruit in a child’s lunch box. Similar
findings have been shown elsewhere16 and data from the NSW
Schools Physical Activity and Nutrition Survey (2015)15 and
national data confirm that children are much more likely to meet
guidelines for fruit intake than vegetable intake.4 This suggests that
a focus on vegetables as a separate entity rather than as a com-
bined entity with “fruits and vegetables” is needed to increase chil-
dren’s vegetable intake to meet Australian dietary guidelines for
vegetables.17,18
Systematic reviews examining school-based programmes to
improve fruit and vegetable intake and dietary intake in general have
shown that multi-component interventions are most effective but
that intensity of the intervention did not result in further improved
intake in the longer term.7,19,20 This is reinforced in our evaluation in
which the positive effects of this low-intensity intervention were lar-
gely sustained for 6 months.
Unique aspects of the program were that targeted messages
were delivered in a low-intensity/short session, delivered by trained
volunteers and conducted in a familiar setting. Limitations included
the lack of a control group, due to feasibility issues. Measures
relied on parental self-report and more valid methods such as lunch
box audits were not used21. Other limitations include the low
response rates at 6 months and that parents who completed the
study to 6 months were older, from English-speaking backgrounds
and had higher incomes.
The intervention provides formative data concerning evaluation
measures for low-intensity interventions such as the Healthy Lunch
TABLE 2 Parental/carer knowledge of intervention messages 1 week and 6 months following the intervention compared to baseline
(n = 204)
Knowledge
Percentage of participants with
correct knowledgea (%)
Time effects Adjusted Odds Ratiosb (95% confidence
interval)
Pre-
intervention
Post-
1 week
Post-
6 months Post-1 week P-value Post-6 months P-value
Knowledge of fruit serving sizes 48 73 68 3.25 (2.13, 4.96) <.001 2.30 (1.56, 3.38) <.001
Knowledge of fruit intake guidelines 49 76 68 3.82 (2.55, 5.72) <.001 2.41 (1.64, 3.55) <.001
Knowledge of vegetable serving sizes 37 52 53 1.90 (1.30, 2.78) .001 1.97 (1.32, 2.96) .001
Knowledge of vegetable intake guidelines 34 76 63 7.28 (4.81, 11.0) <.001 3.88 (2.64, 5.68) <.001
Fruit and vegetables decrease your risk of certain
types of cancer
91 98 95 4.34 (1.65, 11.36) .003 1.86 (.85, 4.07) .12
Frozen, dried and canned fruit and vegetables
are an acceptable alternative to fresh fruit and
vegetables
53 82 77 4.76 (3.14, 7.23) <.001 3.37 (2.24, 5.06) <.001
Knowledge of best two drinks to pack in lunch
box
60 92 89 8.51 (5.09, 14.20) <.001 5.58 (3.59, 8.67) <.001
Opinions/attitudes and practices
Percentage agreementc (%)
Time effects Adjusted Odds Ratiosd (95% confidence
interval)
Pre Post-1 week Post-6 months Post-1 week P-value Post-6 months P-value
Easy to pack fruit in lunch box 91 94 97 N/A N/A
Important to pack fruit in lunch box 100 100 100 N/A N/A
Often/always pack fruit in lunch box 93 95 96 N/A N/A
Easy to pack vegetables in lunch box 58 58 66 1.07 (1.07, 1.07) .01 1.51 (1.51, 1.51) <.001
Important to pack vegetables in lunch box 91 94 96 1.53 (.88, 2.67) .13 2.29 (1.10, 4.75) .03
Often/always pack vegetables in lunch box 32 47 40 2.10 (1.53, 2.87) <.001 1.60 (1.14, 2.23) .006
Confidence in packing a healthy lunch box 45 54 62 1.43 (1.07, 1.91) .02 2.08 (1.47, 2.93) <.001
N/A unable to generate output due to high baseline values and ceiling effects.
aPercentage of participants knowing the correct fruit/vegetable serving sizes or fruit/vegetable intake guidelines.
bBased on Generalised Estimating Equations, odds ratios for knowing the correct fruit/vegetable serving sizes or fruit/vegetable intake guidelines
1 week or 6 months following the intervention, compared to baseline. Odds ratios were adjusted for geographical region (Hunter Central Coast/Greater
Western Sydney), having previously attended an Eat It to Beat It “Fruit and Veg sense” workshop, participant age, educational level (Year 12 or less/un-
dergraduate degree or certificate/postgraduate degree), English being the main language spoken at home (yes/no), the number of children living at home
and single parent household (yes/no).
cPercentage of participants agreeing or strongly agreeing with a given statement.
dOdds ratios for agreeing with knowledge/attitudes/opinion statements listed 1 week or 6 months following the intervention, compared to baseline.
Odds ratios were adjusted for geographical region (Hunter Central Coast/Greater Western Sydney), having previously attended an Eat It to Beat It “Fruit
and Veg sense” workshop, participant age, educational level (Year 12 or less/undergraduate degree or certificate/postgraduate degree), English being
the main language spoken at home (yes/no), the number of children living at home and single parent household (yes/no).
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Box session and illustrates that the intervention is acceptable in
school settings. Although the focus of the Healthy Lunch Box sessions
is on improving fruit and vegetable intake, consumption of less
healthy foods and drinks is known to be high among school children
in NSW and Australia,15 so modification of the program to include
messages about consumption of junk food and sugar-sweetened
drinks may be beneficial. Another modification may be to train
teachers or interested parents in delivery of the sessions, which may
improve programme sustainability.
5 | CONCLUSION
The low-intensity Healthy Lunch Box sessions were effective in
changing parental knowledge and self-efficacy with regard to the
provision of fruit and vegetables to their children and families. The
Healthy Lunch Box sessions are a useful component of a portfolio of
interventions to support parents in providing healthier foods and
drinks to their children.
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AbsTRACT
Objective To synthesise the literature on the effects 
of neighbourhood environmental change through 
residential relocation on physical activity, walking and 
travel behaviour.
Design Systematic review following the Preferred 
Reporting Items for Systematic Reviews and Meta-
Analyses guidelines (PROSPERO registration number 
CRD42017077681).
Data sources Electronic databases for peer-reviewed 
and grey literature were systematically searched to 
March 2017, followed by forward and backward citation 
tracking.
Eligibility criteria A study was eligible for inclusion 
if it (1) measured changes in neighbourhood built 
environment attributes as a result of residential 
relocation (either prospectively or retrospectively); 
(2) included a measure of physical activity, walking, 
cycling or travel modal change as an outcome; (3) was 
quantitative and (4) included an English abstract or 
summary.
Results A total of 23 studies was included in the 
review. Among the eight retrospective longitudinal 
studies, there was good evidence for the relationship 
between relocation and walking (consistency score 
(CS)>90%). For the 15 prospective longitudinal studies, 
the evidence for the effects of environmental change/
relocation on physical activity or walking was weak to 
moderate (CS mostly <45%), even weaker for effects 
on other outcomes, including physical activity, cycling, 
public transport use and driving. Results from risk of bias 
analyses support the robustness of the findings.
Conclusion The results are encouraging for the 
retrospective longitudinal relocation studies, but weaker 
evidence exists for the methodologically stronger 
prospective longitudinal relocation studies. The evidence 
base is currently limited, and continued longitudinal 
research should extend the plethora of cross-sectional 
studies to build higher-quality evidence.
InTRODuCTIOn
The health benefits of physical activity are well 
established.1–4 However, globally, large propor-
tions of the population are not sufficiently active 
or are completely inactive.5 6 Walking is the most 
popular kind of physical activity7 8 and typically 
occurs in neighbourhood environments, which 
may facilitate or hinder physical activity through 
their design.9 10 Over the last two decades, there 
has been an exponential increase in studies which, 
based on social-ecological models of health,11 have 
investigated the relationships between built envi-
ronment attributes and physical activity, particularly 
walking.12 13 This research has found that physical 
activity and walking are associated with a range of 
built environment attributes, such as walkability 
(street connectivity, land use mix and population 
density), access to green space and recreational 
facilities, safety from crime and traffic, aesthetics 
and access to public transport.14–16 However, 
despite the substantial policy interest,17–22 nearly 
all the studies in this field of research are cross-sec-
tional15 16 23 and therefore do not provide causal 
evidence about the effects of the built environment 
on physical activity. If cross-sectional studies report 
an association between environmental attributes, 
for example, walkability and physical activity, it is 
not clear to what extent this is due to the effect 
of the environment or to alternative explanations, 
such as residual confounding, where people living 
in high walkable neighbourhoods are different to 
people residing in low walkable neighbourhoods.
For ethical and practical reasons, randomisation 
is virtually impossible in research examining the 
impact of neighbourhood built environments on 
walking and physical activity.24 Several alternative 
designs may be considered to extend the current 
evidence base built primarily on cross-sectional 
studies. For example, longitudinal analysis of people 
who remain in their neighbourhoods (eg, examina-
tion of environmental predictors of physical activity 
initiation/maintenance among ‘non-movers’), longi-
tudinal analysis of people who relocate to neigh-
bourhoods with different environmental attributes 
(ie, relocation studies) and evaluations of environ-
mental interventions are all longitudinal by nature, 
which allows for establishing the temporal sequence 
of cause and effect, a key criterion for causation. 
Further, these study designs are better at accounting 
for confounding than cross-sectional studies 
because they provide opportunities for comparing 
exposures and/or outcomes within an individual, 
instead of comparing people living in different 
types of neighbourhoods at one point in time. 
Still, these alternative designs have their advan-
tages and limitations. For example, opportunistic 
evaluations of environmental interventions are less 
subject to self-selection bias (ie, people choose to 
live in neighbourhoods to accommodate their life-
style preferences, such as their propensity for active 
travel25) compared with the other two longitudinal 
study designs discussed here. However, researchers 
do not have control over the timing, location and 
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nature of the intervention.26 Neither do they have control over 
the dose of the intervention. As environmental change is usually 
slow and incremental,27 it may not provide a sufficient ‘dose’ 
required for behavioural change during the time frame of the 
evaluation. In fact, some evaluations of environmental interven-
tions on physical activity had mixed findings14 possibly due to 
these challenges. In longitudinal studies of non-movers, one may 
expect little changes in the outcomes because behaviours tend 
to habituate over time. Relocation studies, on the other hand, 
follow the concept of ‘mobility biographies’, where stabilised 
behavioural patterns are ‘interrupted’ by life events, including 
environmental changes as a result of residential relocation.28 
Moreover, because environmental exposures pre-relocation and 
post-relocation can be quantified, changes in exposures can be 
evaluated as a ‘natural experiment’, and there have been calls for 
such designs to evaluate effects of neighbourhood environments 
on health behaviour and outcomes.24 29 30 However, relocation 
studies are still subject to confounding, such as reasons and moti-
vations for relocation.
In summary, evaluations of walking, physical activity and 
travel behaviour before and after people relocate between 
neighbourhoods that differ in environmental attributes offer a 
unique opportunity to examine the role of neighbourhood envi-
ronments, not only within the context of residential relocation 
and mobility biographies, but also extend the current evidence 
on built environments and physical activity/travel behaviour in 
general by addressing some critical methodological limitations of 
cross-sectional studies. To the best of our knowledge, no other 
study has systematically reviewed the evidence on the effects 
of residential relocation on walking, physical activity or travel 
behaviour. In the present systematic review, we aim to synthesise 
the current evidence on the association between neighbourhood 
built environments and walking, physical activity and travel 
behaviour within the context of residential relocation.
METhODs
Data sources and searches
The protocol for this systematic review was registered with the 
International Prospective Register of Systematic Reviews (PROS-
PERO; registration number CRD42017077681, available at 
https://www. crd. york. ac. uk/ PROSPERO/ display_ record. php? 
RecordID= 77681). This systematic review follows the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidelines (online supplementary table 1).31
Systematic searches were conducted from database incep-
tion to March 2017, in the electronic databases MEDLINE, 
The Cochrane Library, EMBASE, CINAHL, SPORTDiscus, 
PsycINFO, Informit, Avery and RIBA for peer-reviewed papers, 
and The Grey Literature Report and ProQuest Dissertations and 
Theses Global for grey literature. Additional articles were identi-
fied through backward and forward citation tracking of included 
publications, and using the authors’ own reference libraries. The 
list of search terms used in our MEDLINE search, which was 
adapted for searches in other databases, can be found in online 
supplementary table 2.
Eligibility criteria
A study was eligible for inclusion if it (1) measured changes in 
neighbourhood built environment attributes as a result of resi-
dential relocation (either prospectively or retrospectively); (2) 
included a measure of physical activity, walking, cycling or 
travel modal change as an outcome; (3) was quantitative and (4) 
included an English abstract or summary.
A study was excluded if it (1) was based on simulation data 
only32; (2) was conducted in the context of relocation on a 
university campus or at work33; (3) focused on international 
migration34; (4) examined social environments only35 or (5) 
did not clearly define or measure the built environment attri-
butes.36 37 Specifically, exclusion criterion 3 was chosen because 
individuals and their environments may not be comparable 
pre-immigration and post-immigration. Exclusion criterion 5 
applies to relocation studies where the environment was vaguely 
defined or not measured (eg, moving to a ‘New Urbanist-in-
spired’ development,36 or a mixed-use development37) and 
therefore one cannot determine how built environment attri-
butes changed after relocation.
study selection
Following a standard protocol, two authors (BN and DD) inde-
pendently screened studies for eligibility based on the title, 
abstract and full text. Uncertainty was discussed involving a third 
author (KG), and any disagreement was resolved by consensus. A 
PRISMA flow diagram presents the summary of the study selec-
tion process (figure 1).
Data extraction
Information about each paper was extracted by BN and DD 
independently for quality assurance. Any disagreement was 
discussed until consensus was reached.
At the study level, the following information was extracted: 
study name (if any), study design, setting and follow-up, sample 
recruitment, sample characteristics, neighbourhood environ-
mental attributes (perceived or objectively measured), covari-
ates, whether accounted for residential self-selection, potential 
moderators/effect modifiers tested and main findings.
At the result level, information about each finding was 
extracted based on the combination of environmental exposure 
and walking/physical activity/travel behaviour outcome. For 
studies that reported both cross-sectional and prospective longi-
tudinal analyses,38–42 we extracted findings from longitudinal 
and quasi-experimental analyses only because of the inability 
to ascertain changes in environmental attributes from cross-sec-
tional analyses. Further, in addition to physical activity, walking 
and cycling outcomes, we also extracted results regarding public 
transport and car use43 44as these can serve as important secondary 
outcomes. This is because a modal change from driving to public 
transport use is relevant to an active lifestyle.43 44 For studies 
that involve modal change,40 45 it is important to present infor-
mation on all transport modes to provide a complete picture. 
Finally, although our search protocol excluded studies that 
exclusively examined the neighbourhood social environment, 
we also extracted results regarding perceived safety and socia-
bility40–42 46 47 because both these attributes are closely linked to 
aspects of the built environment.48 49
Data synthesis
General characteristics about each selected study, including 
country, study name, study design, neighbourhood environ-
ment measures (objective and/or perceived), walking/physical 
activity/travel behaviour measure (objective or self-reported) and 
whether residential self-selection was accounted for, and if so, 
how, were summarised and tabulated.
Extracted study results were synthesised in separate tables for 
retrospective longitudinal and prospective longitudinal studies. 
Retrospective longitudinal studies (often referred to as quasi-lon-
gitudinal studies in the planning and transportation literature) 
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refer to a study design where participants retrospectively report 
for a defined time in the past (eg, 1 year ago, prior to reloca-
tion) and the present to determine the effects of a change in 
an attribute (eg, neighbourhood walkability) on behaviour (eg, 
walking).40–42 47 50 Although this type of research design was 
named differently by some studies, such as a quasi-longitudinal 
pre–post design, for the purpose of this systematic review, we 
define them consistently as retrospective longitudinal studies. 
Longitudinal prospective studies include observational (cohort)38 
and natural experimental studies,39 51 where naturally occurring 
events, such as moving to a new community, are evaluated as 
defined interventions in a prospective fashion.
For each study, all tested associations (unadjusted and adjusted) 
involving change in neighbourhood environmental attributes 
(exposures) and walking/physical activity/travel behaviour 
(outcomes) were considered. Because of the heterogeneity in the 
exposure and outcome measures, we could not quantitatively 
synthesise the effect sizes, instead, we grouped the results into 
categories and semiquantitatively summarised them based on the 
direction and significance of the associations. For environmental 
attributes, we developed a grouping scheme similar to that used 
in previous literature reviews,52 53 where attributes were allo-
cated to subcategories under ‘recreation environment’, ‘neigh-
bourhood design’, ‘transportation environment’, ‘aesthetics’, 
‘crime-related safety’, ‘social environment’ and ‘aggregated 
characteristics’. For the outcomes, we categorised walking 
into recreational/leisure, transport and total walking; physical 
activity into recreational, transport and total physical activity; 
and other travel behaviour into cycling, public transport use and 
driving. We did not separate cycling for recreational and trans-
port because only one study included some recreational cycling 
outcomes.54 We developed a matrix to tabulate the extracted 
results using ‘+’ to denote statistically significant (P<0.05, 
unless noted otherwise) associations in the expected direction, 
‘–’ to denote significant associations in the unexpected direction 
and ‘0’ for non-significant associations.52 The expected direc-
tion is based on the existing evidence base and the concept that 
activity friendly neighbourhood environments characterised by 
mixed land use and well-connected streets with good access 
to parks and recreation facilities, public and alternative trans-
portation options, and low traffic and crime, are conducive to 
walking, physical activity and active travel, while discouraging 
car driving. Specifically, the expected direction for each associa-
tion is presented in online supplementary table 3.
We allowed each study to contribute more than one finding 
to each combination of neighbourhood environmental attri-
bute and outcome. When a study included different exposure 
measures for the same category of environmental attribute, we 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart.
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considered these as distinct findings. For example, Knuiman et al 
measured land use mix objectively using a Geographic Informa-
tion System (GIS) within a 1600 m street network from partic-
ipants’ homes and participants’ perceptions about the number 
of types of destinations within their neighbourhood.55 In this 
case, both findings were counted as two separate associations. 
Similarly, when a study included multiple outcomes for the same 
environmental attribute that did not overlap, such as cycling 
for leisure and cycling for transport,54 we considered them as 
distinct associations.
Given that studies present their results differently (eg, some 
present only the final models while others present unadjusted 
and different versions of adjusted models), to ensure that results 
from one study are not inflated as a result of duplication, we 
adopted the following protocols for assigning ‘+’, ‘–’ or ‘0’ to 
each comparison. (1) When different models for the same associ-
ation (using the same exposure and outcome) were presented, we 
determined the significance and direction of association based 
on the model that at least adjusted for demographic character-
istics, socioeconomic status and neighbourhood self-selection. 
Alternatively, if the authors explicitly discussed that one model 
is less biased than the other, we then coded this association based 
on the less biased model. For example, Braun et al tested the 
association between a walkability index and walking outcomes 
using both random and fixed effects models.27 They argued that 
estimates from random effects models were more biased because 
of residual self-selection bias; we therefore coded this associa-
tion based on results from the fixed effects model. (2) When 
we could not select the least biased model based on criterion 1, 
we coded this association based on the consistency of results. 
For example, if at least 60% of the adjusted results were signifi-
cant in the expected direction, we coded this result as ‘+’, if the 
pattern of the results was inconsistent (eg, 50% ‘+’, 50% ‘0’), 
we coded it as ‘?’ to denote the uncertainty of the association.
Finally, we summarised results regarding each environmental 
attribute across different outcome measures by calculating a 
consistency score as the percentage of total associations being 
significant in the expected direction.52 Two consistency scores 
were developed. The first one refers to the number of associa-
tions coded ‘+’ as a proportion of the total number of associa-
tions, which denotes the overall consistency of an environmental 
attribute with different outcomes at the level of associations 
(findings). Using the same scoring system, we summarised results 
about environmental attributes across different outcomes and 
each outcome across different environmental attributes. Due 
to the small number of studies overall, particularly regarding 
domain-specific walking and physical activity, we combined 
different subcategories of walking and physical activity within 
the larger categories.
The second score applied weights to associations reported 
from the same study (in the same or different publication), 
so that the overall consistency of associations was not driven 
by single studies. Specifically, we applied a weighting scheme 
similar to that reported in a systematic review by Cerin et al.16 
For example, Handy et al reported associations between three 
land use mix indicators and overall walking,41 and Cao et al 
reported two50; given that the two publications were based on 
the same study, we assigned each of the five findings a weighting 
of 0.2. Applying weighting, the second summary statistic indi-
cates the overall consistency of an environmental attribute with 
different outcomes at the study level.
Quality appraisal and risk of bias analysis
We developed a quality appraisal checklist (online supplemen-
tary table 4) based on previous systematic reviews16 56 with 
additional items designed particularly for relocation studies (eg, 
‘Did the study assess whether the participants experienced life 
changing events which may have led them to relocate and did 
they account for these events?’). Two authors (BN, KG) inde-
pendently performed quality appraisal, and any disagreement 
was resolved by consensus.
We conducted the following three risk of bias analyses for 
the data synthesis by recalculating the consistency scores after 
(1) excluding all studies with low-quality scores (<5) based on 
quality appraisal, (2) excluding all studies that did not adjust for 
self-selection bias (see online supplementary table 5 for details) 
and (3) limiting to findings involving objectively measured neigh-
bourhood environmental attributes. These risk of bias analyses 
aim to examine how sensitive study findings are to the quality 
of the included studies, self-selection bias and the measurement 
mode of the neighbourhood environment. Previous studies 
suggest attenuated associations after accounting for self-selection 
and considerably different levels of consistency in associations 
by the measurement mode of neighbourhood environmental 
attributes.57
REsulTs
selection of studies
The database searches yielded 3324 records (figure 1). After 
removing duplicates, 2846 records remained. After excluding 
2817 records based on reading the titles and abstracts, the 
full texts of the remaining 29 were examined and an additional 
Table 1 Characteristics of selected articles (n=23)
Characteristics studies (n) References
Country
  Australia 5 46 51 54 55 58
  Canada 2 63 65
  China 1 66
  Germany 3 28 45 64
  UK 2 47 59
  USA 10 27 38–42 50 60–62
Studies with single/multiple publications
  RESIDential Environment 
Project 
5 46 51 54 55 58
  A retrospective longitudinal 
study conducted in Northern 
California, USA
4 40–42 50
  Single publication from a 
study
14 27 28 38 39 45–47 59–63 65 66
Study design
  Prospective longitudinal 15 27 28 38 39 45 46 51 54 55 58–63
  Retrospective longitudinal 8 40–42 47 50 62 64–66
Neighbourhood environment measures
  Objective 11 27 38 39 59–66
  Perceived 3 28 45 47
  Both 9 40–42 46 50 51 54 55 58
Physical activity measures
  Objective 1 39
  Reported 22 27 28 38 40–42 45–47 50 51 54 55 
58–66 78
Accounted for self-selection
  Yes 13 27 39–42 46 47 50 51 55 58 64 65
  Not mentioned 8 28 38 45 54 60–63
 o
n
 6 June 2018 by guest. Protected by copyright.
http://bjsm.bmj.com/
Br J Sports M
ed: first published as 10.1136/bjsports-2017-098833 on 31 May 2018. Downloaded from 
287
5 of 13Ding D, et al. Br J Sports Med 2018;52:789–799. doi:10.1136/bjsports-2017-098833
Review
14 full texts were excluded. With an additional 2 studies iden-
tified through backward and forward citation tracking, and 6 
from the authors’ own reference libraries, a total of 23 publica-
tions were appraised and synthesised.
study characteristics
Fifteen of the publications were based on longitudinal prospec-
tive studies27 28 38 39 45 46 51 54 55 58–63 and eight based on retro-
spective longitudinal/quasi-longitudinal studies.40–42 47 50 64–66 
Altogether, the publications were based on studies conducted 
in six countries (table 1), with the USA (n=10) and Australia 
(n=5) contributing to most of the publications. Five publications 
were based on the RESIDential Environment Project (RESIDE) 
in Perth, Australia, and four were based on a study conducted 
in Northern California, USA. In terms of the measurement of 
neighbourhood environmental attributes, 11 reported objective 
measures only, mostly based on a GIS, 3 included perceived 
measures and 9 included both objective and perceived envi-
ronmental measures. All but one study39 relied on self-reported 
measures of walking/physical activity/travel behaviour. More 
than half of the publications reported some measures of resi-
dential preferences to account for self-selection bias. Details 
about each study, including relevant findings, are presented in 
online supplementary table 5. Overall, the quality scores varied, 
ranging from 1 to 7 on a scale from 0 to 9, with 10 of the 23 
studies scoring five or more points. Longitudinal prospective 
studies scored much higher (range: 2–7, mean: 5) than retro-
spective longitudinal studies (range: 1–3, mean: 2.6). The results 
of the critical appraisal are presented in online supplementary 
table 6.
Table 2 Summary of results from retrospective longitudinal studies (n=8)
Walking* Physical activity* Other travel behaviour Consistency score†
Transport Recreation Total Cycling
Public 
transport Driving
unweighted 
+%
Weighted 
+%
Recreation environment
  Parks/green space/recreation 
facilities
Aditjandra et al,47 
(+)
1/1 (100%) 1/1 (100%)
Neighbourhood design
  Land use mix/destinations McCormack (+) McCormack 
(0)
McCormack (0) 1/3 (33%) 1/3 (33%)
Transportation environment
  Overall transportation access‡ Aditjandra et al,47 
(+);
Cao et al,50 (+);
Handy et al,40 (+);
Handy et al,41 (+)
Handy et al,42 
(+)
Handy et al,41 
(+)
Aditjandra et 
al,47 (+)
Cervero and Day, 
66 (0,–)§;
Handy et al,40 (0)
7/10 (70%) 5/7 (71%)
Aesthetics Aditjandra et al,47 
(+);
Handy et al,40 (+);
Handy et al,41 (+)
Handy et al,42 
(+)
Handy et al,40 (0) 4/5 (80%) 3/4 (75%)
Crime-related safety Aditjandra et al,47 
(+);
Cao et al,50 (+);
Handyet al,40(+);
Handy et al,41 (+)
Handy et al,42 
(+)
Handy et al,40 (+) 6/6 (100%) 4/4 (100%)
Social environment Aditjandra et al,47 
(0);
Cao et al,50 (+);
Handy et al,40 (+);
Handy et al,41 (+)
Handy et al,42 
(0)
Handy et al,41 
(+)
Handy et al,40 (0) 4/7 (57%) 2/4 (50%)
Aggregated characteristics
  Sprawl Klinger and 
Lanzendorf,64 
(0)
Klinger and 
Lanzendorf,64 
(0)
Klinger and 
Lanzendorf, (0)64
0/3 (0%) 0/3 (0%)
  Overall accessibility (to 
destinations and transportation)
Handy et al,40 (+);
Handyet al,41 (+)
Aditjandra et 
al,47 (+)¶
Handy et al,40 (+) 4/7 (57%) 3/6 (50%)
Consistency score†
  Unweighted +% 18/19 (95%) 3/5 (60%) 2/4 (50%) 2/3 (67%) 2/8 (25%)
  Weighted +% 10/11 (91%) 3/5 (60%) 2/4 (50%) 2/3 (67%) 2/7 (29%)
Bold entries denote objectively measured environmental attributes.
*The columns for recreation walking and transport physical activity were omitted because no study examined these outcomes.
†Unweighted consistency score: the percentage of associations coded ‘+’ out of the total number of associations; weighted consistency score: applied weighting to results from 
the same study by a factor of 1/total number of results from the same study in one cell. For this table, data from refs.40–42 50 were from the same study.
‡Overall transportation access: access to a range of specific or non-specific transportation options, such as sidewalks, bike paths, public transport and roads.
§A study can contribute to more than one finding to each combination of built environment attribute and outcome when it involved different exposure measures for the same 
category of environmental attribute or different measures for the same domain of outcomes.
¶Indirect effects mediated by car ownership.
+, statistically significant associations in the expected direction; –, statistically significant associations in the unexpected direction; 0, non-significant associations (expected 
direction is detailed in online supplementary table 2).
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summary of findings from retrospective longitudinal studies
As shown in table 2, overall transportation access, social envi-
ronment, crime-related safety and accessibility were among the 
most assessed environmental attributes and walking was the 
most commonly used outcome. Overall, there was consistent 
support for the effects of change in neighbourhood environ-
mental attributes through residential relocation on the change 
in a range of outcomes, particularly walking, where the consis-
tency scores were >90%. Most environmental attributes yielded 
a consistency score of ≥50% across outcomes and the score was 
particularly high for overall transportation access (access to a 
range of specific or non-specific transportation options, such as 
sidewalks, bike paths, public transport and roads), aesthetics and 
crime-related safety. After accounting for multiple findings from 
the same study, the weighted consistency scores were slightly 
lower than the unweighted ones. It is important to note that 
given the small number of retrospective longitudinal studies 
many of the environmental attribute–outcome combinations 
were not examined, and most of those that were examined 
involved a small number of studies.
summary of findings from longitudinal prospective studies
Given the larger number of longitudinal prospective studies, a 
broader range of environmental attribute–outcome combinations 
were explored (table 3). The most examined environmental attri-
butes were land use mix/destinations and public transport access/
services and the most commonly used outcomes were transport 
walking and cycling. Compared with results from retrospec-
tive longitudinal studies, those from prospective longitudinal 
studies were much less consistent. Among all environmental 
attributes, walkability/pedestrian friendliness had the highest 
weighted and unweighted consistency scores, although the find-
ings only involved three studies. Most environmental attributes 
had consistency scores of 25%–40%, providing less consistent 
evidence for the effects of change in neighbourhood environ-
ments through residential relocation on change in walking/phys-
ical activity/travel behaviour. A few attributes had a consistency 
score of 0%, including traffic, aesthetics, neighbourhood type, 
sprawl, all of which were based on a small number of studies. 
Across outcomes, associations involving a walking outcome had 
the highest consistency scores while those involving physical 
activity and cycling had much lower scores.
Risk of bias analysis
Three risk of bias analyses were conducted separately for 
retrospective longitudinal and prospective longitudinal studies 
(online supplementary table 7). First, when excluding studies 
with a quality score of ≤4, 0 retrospective longitudinal and 
10 prospective longitudinal studies remained. The consistency 
scores were very similar in the risk of bias analyses, and in some 
cases slightly higher, among the higher-quality studies compared 
with all studies. Second, when limiting to studies that accounted 
for self-selection, the consistency scores from retrospective longi-
tudinal studies remained nearly identical while those from longi-
tudinal prospective studies slightly fluctuated, though the overall 
level of consistency remained similar. Finally, when limiting to 
findings involving objectively measured neighbourhood environ-
mental attributes, consistency scores remained similar or slightly 
lower in retrospective longitudinal studies and similar (or in 
some cases slightly higher) in longitudinal prospective studies. 
Overall, results from risk of bias analyses showed robustness in 
our findings, but are somewhat limited by the small numbers of 
studies/findings after exclusion.
DIsCussIOn
To our knowledge, this is the first systematic review that synthe-
sises the evidence on the effects of change in neighbourhood 
environments through residential relocation on walking, physical 
activity and travel behaviour. Given the potential for walking to 
increase total physical activity levels and health, efforts to imple-
ment environment-changing interventions seem logical and may 
have an impact at the population level. Our review found a scar-
city of literature on residential relocation, with only 23 publica-
tions from 16 studies in six countries (five high-income countries 
and one upper-middle-income country) meeting our inclusion 
criteria. Overall, the studies are heterogeneous in terms of design 
and measures, making it difficult to draw conclusions about 
specific associations. Summarised across different exposure and 
outcome measures, the overwhelming pattern of associations 
suggests a much stronger evidence for the effects of change in 
neighbourhood environment through residential relocation in 
retrospective longitudinal (quasi-longitudinal) than prospective 
longitudinal studies; and for both study designs, the most consis-
tently significant associations involved walking as an outcome.
The differences in findings between prospective longitudinal 
and retrospective longitudinal studies highlight the importance 
of research design. In principle, although prospective longi-
tudinal studies are not perfect, a retrospective longitudinal/
quasi-longitudinal design is more subject to bias, with partici-
pants more prone to recall and social desirability biases (ie, they 
report in favour of an improvement).40 42 In cases where individ-
uals were prompted to report the change in both neighbourhood 
environment and physical activity/travel behaviour,47 50 common 
source bias may be an additional concern. Previous literature has 
also documented the ‘honeymoon effect’ where recent movers 
are likely to rate their new neighbourhood more favourably.67 
The common source bias and honeymoon effect combined may 
particularly bias the associations away from null among those 
who recently relocated compared with those who relocated 
further in the past, or the control group who did not relocate. 
Taking these potential biases into consideration, the high consis-
tency in findings from retrospective longitudinal studies should 
be interpreted with caution.
The small number of studies on residential relocation is in 
contrast to the vast and ever-growing body of literature on built 
environments and physical activity in general.16 68 To contex-
tualise our review, we have summarised all literature reviews 
on built environments and physical activity among adults that 
we identified through previous reviews of reviews24 68 and 
we updated this list through systematically searching litera-
ture databases (see table 4 and online supplementary table 8 
for unabridged information). Nearly 30 reviews have been 
published, with some reviews including a large number of 
empirical studies,15 16 69 indicating the popularity of the field. 
However, the current evidence base predominantly relies on 
cross-sectional studies, and some literature reviews have even 
excluded longitudinal or experimental studies a priori to solely 
focus on cross-sectional studies.70–74 While cross-sectional 
studies are important for generating hypotheses at an early 
stage of scientific field development, and have contributed to 
understanding the plausibility, consistency and the specificity 
of the associations between the built environment and physical 
activity,53 they are inherently subject to ambiguity in temporality, 
residual confounding and self-selection bias. Given that the ulti-
mate goal of research on built environments and physical activity 
is to inform urban planning, transportation and public health 
policy and practice, we must consider evidence that is based on 
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Table 4 Summary of existing literature reviews* on built environments and physical activity/travel behaviour among adults (n=28)
First author (year)
Included articles (search 
period), n
Design of included 
studies scope of study Main findings
Arango (2013)  15 (1990 to August 2012) All CS To review the association between 
perceived environments and adult PA in 
Latin America
Most associations were non-significant. Strongest 
evidence for leisure-time PA with day safety and 
transport PA with street lighting presence.
Bancroft (2015) 20 (1990 to June 2013) 17 CS, 3 PL To review the association between park 
access and objectively measured PA in 
the USA (all ages)
Associations varied between studies. Reported 
park characteristics and smaller buffer sizes more 
predictive of PA.
Barnett (2017) 100 (2000 to September 
2016)
95 CS,
5 PL,
1 QE
(1) To review and meta-analyse the 
association between BE attributes, PA 
and/or walking (older adults); (2) To 
examine potential moderators
Associations differ by BE attributes and PA measures. 
Strongest evidence for: walkability, safety from crime, 
access to destinations, recreational facilities and 
parks/public open space. No consistent moderators.
Butler (2011) 29 (2005 to December 
2009)
All CS To review PA studies which included 
one or more GIS measure of the BE
Increase in studies using PA-relevant GIS BE measure, 
but lack of standardisation among BE; difficult to 
synthesise evidence
Casagrande (2009) 10 (1966 to July 2007) All CS Review of BE association with PA, 
diet and obesity among adult African-
Americans
All BE PA studies (n=7) measured perceptions of 
BE. Safety from crime had the strongest association 
with PA among urban dwellers (not consistent across 
studies). Light traffic and the presence of sidewalks 
were positively but inconsistently associated with 
meeting PA recommendations in metro and non-
metro areas.
Cerin (2017) 42 (2000 to September 
2016)
All CS Review and meta-analysis of BE 
associations with active travel in older 
adults (aged ≥65 years)
Strong links between neighbourhood BE and active 
travel. Sufficient evidence for positive associations 
between total walking for transport and residential 
density/urbanisation, walkability, street connectivity, 
overall access to destinations/services, land use mix, 
pedestrian friendly features and access to several 
types of destinations.
Cunningham (2004) 27 (1966 to 2002) All CS To identify theoretical models and 
key concepts used to predict the 
association between BE and seniors’ PA
Limited # of studies focused on seniors (n=6). Range 
of theoretical models and BE measurement methods. 
Positive relationships for: PA, safety and aesthetics; 
findings mixed for PA associations with sidewalks or 
convenience of facilities.
Ewing (2010) 62 (up to 2009) Not described A meta-analysis of the associations 
between BE and travel (VMT, walking, 
transit)
Travel variables are generally inelastic with respect 
to change in measures of the BE. Walk trips are most 
strongly associated with the design and diversity 
dimensions of BEs.
Ferdinand (2013) 169 (1990 to April 2011) All observtnl Review relationship between BE and 
PA or obesity rates (all ages)
89.2% of studies found a beneficial relationship 
between BE and PA. Studies using objective (vs self-
report or other) PA measures were 18% less likely to 
identify a beneficial relationship.
Foster (2008) 41 (up to July 2007) All CS (1) To summarise the individual, 
social and BE characteristics that are 
associated with perceived safety; (2) to 
examine the association between real 
and perceived crime-related safety, and 
between factors known to influence 
crime-related safety and PA
Perceived safety tends to affect the PA of groups 
already known to exhibit greater anxiety about 
crime (women, elderly). BE PA findings inconsistent, 
likely due to measurement limitations. More specific 
measures warranted.
Fraser (2011) 21 (up to June 2009) 8 CS, 7 surveys with 
exptl measures,
2 RL,
2 ecological,
1 pre–post,
1 qual
To review observtnl and exptl studies 
examining association between 
objectively measured BE and cycling 
behaviour (all ages)
No studies rated strong on study quality and none 
from low-income/middle-income countries. Significant 
positive findings for objective BE measures and higher 
rates/frequency of cycling in 11 studies, including cycle 
routes, Safe Routes to School initiatives, proximity 
of destinations, separation from traffic, population 
density, proximity of cycle paths and presence of 
green space/recreational land. Significant findings 
with cycling: traffic danger, sloping terrain and long 
trip distance. 10 studies found no positive association 
between BE and cycling.
Frost (2010) 20 (up to June 2008) 19 CS,
1 PL
To review the association between BE 
and PA in adults in rural settings
Positive associations found among pleasant 
aesthetics, trails, safety/crime, parks and walkable 
destinations. Measures of PA varied.
Grasser (2013) 34 (up to August 2010) 33 CS,
1 PL
To review objectively measured 
walkability and active transport and 
weight-related outcomes in adults
BE measures consistently associated with walking 
for transport: gross population density, intersection 
density and walkability indexes. Inconsistent results 
on weight-related measures.
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First author (year)
Included articles (search 
period), n
Design of included 
studies scope of study Main findings
Heath (2006) 3 separate reviews (see 
scope)
CS QE time series To review studies addressing 
environmental and policy strategies 
to promote PA: (1) community scale 
urban design and land use (n=12, 
1993–2003); (2) street-scale urban 
design and land use (n=6, 1987–2003); 
(3) transportation and travel (n=1, 
1990–1998)
Two interventions were effective in promoting PA 
(community-scale and street-scale urban design 
and land use policies and practices). Evidence is 
insufficient to assess transportation policy and 
practices to promote PA.
Humpel (2002) 19 (up to 2002) 18 CS,
1 PL
To review the relationships between BE 
attributes and PA behaviours in adults
Self-report BE studies more frequent than studies 
incorporating objective BE. Variables representing 
access to facilities and specific opportunities for PA, 
and aesthetics were associated with PA.
Kaczynski (2007) 50 (1998 to December 
2005)
All CS To review what types of PRSs are most 
related to PA and how proximity to 
PRSs is related to PA (all ages)
Diverse operationalisations of both parks or recreation 
and PA were employed (eg, proximity definitions) as 
were a range of PA variables. Mixed associations were 
observed for different types of PRSs, with parks, trails 
and other open spaces (eg, golf courses) having more 
consistent positive relationships. Proximity to PRSs 
were generally found to be associated with increased 
PA.
Kaczynski (2008) 50 (1998 to December 
2005)
All CS To review what types of PRSs are most 
related to PA and how PRSs were 
related to different functions and 
intensities of PA (all ages)
PRSs were more likely to be positively associated 
with PA for exercise or utilitarian functions than for 
recreational PA. PRSs were commonly associated with 
walking; mixed results with moderate and vigorous 
PA.
Mayne (2015) 37 (January 
2005 to January 2014)
13 natural expts,
24 QE
A review of studies in the medical 
literature relating to natural or QE in 
obesity research (all ages)
PA studies (n=17) generally found stronger impacts 
when the intervention improved infrastructure for 
active transport or had a longer follow-up period 
(>6 months).
McCormack (2004) 12 (2000 to 2004) All CS A review of associations between BE 
and PA among adults incorporating 
self-report and objective measures of 
BE and PA
Positive associations between both perceived and 
objectively measured BE and PA. Availability, access 
and convenience of destinations, neighbourhood 
functionality and aesthetics were associated with PA. 
Lack of association between specific types of PA and 
specific setting in which it is performed.
McCormack (2011) 33 (1996 to 2010) 20 CS,
13 QE
To review the relationship between 
objective measures of BE and PA 
among adults for studies attempting 
to control for neighbourhood self-
selection
BE PA associations were either in the expected 
direction or null. Land use mix, connectivity, 
population density and overall neighbourhood design 
were important PA determinants. BE more likely to be 
associated with transport-related walking than other 
types of PA. Self-selection adjustment attenuated 
relationships.
Moran (2014) 31 (1996 to2012) All qual To review qualitative studies of BE and 
PA in older adults
Studies combined interviews with spatial qualitative 
methods that added depth to understanding of 
BE PA relationships. Themes identified: pedestrian 
infrastructure, safety, access to facilities, aesthetics 
and environmental conditions.
Ogilvie (2004) 22 (up to end of 2002) 3 RCTs, 7 non-
rand cont PL, 11 
uncontrolled PL, 1 
cont RL
To review the effects of population 
level interventions to promote a shift 
from using cars towards walking and 
cycling
Engineering measures were not found to be effective 
in a modal shift from cars to walking and cycling.
Owen (2004) 18 (up to 2004) 16 CS,
2 PL
To review association between 
objective and perceived environment 
and walking
Aesthetics, convenience of walking facilities, 
accessibility, level of traffic and composite BE 
measures were associated with walking for different 
purposes. Attributes associated with walking for 
exercise different from those associated with walking 
to get to/from places.
Pucher (2010) 139 (1990 to 2010) CS,
PL (#s not provided)
To review interventions targeting 
increased levels of cycling
Findings suggested positive impacts of interventions, 
but increases in cycling are generally small. Large 
variation in estimated impacts by type of intervention 
and study design, location and timing. Most studies 
limited due to study design adopted.
Table 4 Continued 
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stronger research designs, including, but not limited to, residen-
tial relocation studies. 
Residential relocation: opportunities and challenges
Residential relocation provides a unique opportunity for 
improving the evidence base. One of the key limitations of 
cross-sectional studies is that those living in high and low 
walkability neighbourhoods may be substantially different 
(eg, socioeconomic status, propensity to be physically active), 
which violates the ‘exchangeability’ assumption for causal infer-
ence, and statistical methods cannot ensure total control of 
confounding.75 Longitudinal studies (including residential relo-
cation studies), on the other hand, compare an outcome within 
the individual. When time-varying variables are accounted 
for, a participant could serve as her/his own control,60 which 
better accounts for residual confounding. Furthermore, studies 
on ‘mobility biographies’ argue that individuals are likely to 
be ‘open-minded’ to changing habitual travel behaviour and 
to resynchronise their behaviour with their new environment 
after relocation.28 64 The implication is that residential reloca-
tion not only provides an opportunity for understanding the 
impacts of neighbourhood environments on behaviour during 
a period susceptible to behavioural change, but also serves as 
an ideal window of opportunity for interventions. For example, 
recently relocated residents should be made aware of the local 
facilities and opportunities for active living, as previous evidence 
suggests a mismatch between perceived and objectively measured 
neighbourhood environment and that perceived environmental 
attributes may be more strongly associated with physical activity 
than objectively measured neighbourhood attributes.76
However, as demonstrated by the overall low-quality score 
in our quality appraisal, relocation studies have methodological 
challenges. First and foremost, endogeneity of neighbourhood 
selection biases the estimate of associations between the built 
environment and physical activity in observational studies. Relo-
cation studies, whether prospective longitudinal or retrospective 
longitudinal, are still subject to the same self-selection bias where 
individuals who are predisposed to lifestyle change (eg, those 
who are environmentally concerned) select their new residential 
neighbourhood to facilitate the change. Such unmeasured prefer-
ences or constraints that impact both neighbourhood selection and 
physical activity will lead to erroneous associations between neigh-
bourhood environments and physical activity. Compared with 
cross-sectional studies, longitudinal studies (including relocation 
studies) provide the opportunity for establishing the temporality of 
residential preferences, exposures to neighbourhood environments 
and changes in travel behaviour/physical activity.42 Such study 
designs paired with appropriate methods for accounting for self-se-
lection bias, as outlined by Cao et al,25 could potentially provide 
stronger evidence towards causality. Second, a unique challenge 
to relocation studies is confounding by concurrent life events that 
cause or accompany relocation and neighbourhood reselection. 
For example, people relocate in response to other life events, such 
as changing jobs, employment status or household size. Previous 
studies found that residential relocation was no longer associated 
with travel modal change when adjusted for other life events, such 
as birth of the first child and changing employer.28 77 Therefore, 
it is important to account for major life events when assessing the 
association between relocation and walking/physical activity/travel 
modal change. Of all the studies in this review, less than half (n=9, 
39%) explicitly adjusted for life events. Third, previous evaluations 
of environmental interventions suggest that significant behavioural 
change may be more likely to occur over a longer follow-up 
period,14 78 possibly due to a ‘lag time’ to adapt to a new environ-
ment. Therefore, residential relocation studies need to be planned 
with longer-term follow-up in mind. Fourth, residential relocation 
First author (year)
Included articles (search 
period), n
Design of included 
studies scope of study Main findings
Saelens (2003) 14 (up to 2003) All QE/CS Review of transport, urban design 
and planning literature to determine 
associations between BE variables and 
transport walking and cycling
Higher density, greater connectivity and more land 
use mix is associated with higher rates of walking 
and cycling for transport. Transport, urban design and 
planning fields can contribute to multidisciplinary 
research on environmental contributions to PA levels 
in the population.
Saelens (2008) 13 reviews (2002 
to 2006) and 29 studies 
(2005 to May 2006)
CS To review the evidence of BE correlates 
of walking
Previous reviews and newer studies document 
positive associations of walking for transport with 
density, distance to destinations and land use mix. 
Associations between network connectivity, parks and 
open space and personal safety and transport walking 
are mixed. Relationships with recreational walking 
are less clear.
van Cauwenberg (2011) 31 (2000 to March 2010) 28 CS,
3 LP
To review the association between BE 
and PA in older adults
Results were inconsistent with most of the BE 
characteristics reporting non-significant relationships 
with PA, possibly reflecting limited number of studies 
and methodological issues.
van Holle (2012) 70 (January 
2000 to August 2011)
69 CS,
1 LP
To review European specific studies on 
the relationship between BE and PA 
domains in adults
Convincing evidence on positive relationships 
with several PA domains: walkability, access to 
destinations and composite factor environmental 
quality. Transport PA more consistently related to 
BE. Lack of association with domain specific PA and 
access to recreation facilities, aesthetics, crime and 
traffic-related safety.
*The reviews were selected from previous reviews of reviews,67 68 and an updated literature search using the same methodology outlined in this paper.
–, negative; BE, built environment; cont, controlled; CS, cross-sectional; expts, experiments; exptl, experimental; GIS, Geographic Information System; observtnl, observational; 
PA, physical activity; PL, prospective longitudinal; PRSs, parks and recreational settings; qual, qualitative; quant, quantitative; QE, quasi-experimental or quasi-experiments; 
rand, randomised; RCT, randomised controlled trial; RL, retrospective longitudinal; ,VMT, vehicle miles travelled.
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studies, along with other longitudinal studies, are subject to loss to 
follow-up. For example, most of the longitudinal studies reviewed 
had a drop-out rate of >30%. Therefore, appropriate handling 
of missing data is critical to prospective evaluations of residen-
tial relocation studies. Fifth, as researchers cannot influence the 
relocation process, studies involving residential relocation may 
encounter practical challenges. For example, some participants 
may have moved prior to the pre-move data collection leading to a 
smaller sample size than envisaged and a loss of power,39 or due to 
unforeseen circumstances, pre-move data had to be collected retro-
spectively rather than prospectively as initially planned.37 Such 
unexpected and uncontrollable events challenge the researchers to 
react promptly and pragmatically with the minimal compromise of 
research quality. Finally, in relocation studies, behaviour change is 
catalysed by relocation. It is unknown whether similar changes in 
environmental attributes will lead to changes in outcomes among 
non-movers. Hence, it is important to supplement evidence from 
relocation studies with longitudinal studies of non-movers and 
evaluations of environmental interventions.
strengths and limitations
One of the strengths of this systematic review is that it adheres 
to the PRISMA statement for systematic reviews,31 which is not 
standard practice in the field of built environments and physical 
activity/travel behaviour.24 In addition, we developed method-
ologies to account for multiple publications of the same study 
along with several risk of bias analyses to determine how sensitive 
our overall findings are to specific studies, measurements, study 
design and quality. Our review is limited by the small number of 
studies, the relatively low quality of most studies, heterogeneous 
exposure and outcome measures, and not being able to take into 
account effect sizes in our synthesis. Finally, summarising across 
diverse environmental attributes and outcomes is methodologi-
cally challenging. While synthesising evidence by categorising these 
measures provides a ‘big picture’ perspective of the evidence, it 
also inevitably introduces biases in interpretation when lumping 
measures together. 
COnClusIOns
Overall, we found a paucity of studies on the associations between 
changes in neighbourhood built environment and walking/phys-
ical activity/travel behaviour outcomes in the context of residen-
tial relocation. The findings of these studies differ dramatically by 
study design, with retrospective longitudinal/quasi-longitudinal 
studies supporting a significant association whereas findings from 
prospective longitudinal studies were less consistent, but possibly 
also less biased. Further research should focus more on well-de-
signed ‘natural experiments’. Residential relocation provides a 
unique opportunity for studying environment-induced changes 
in physical activity. The literature reviewed here represents steps 
towards incremental improvement in quality evidence to inform 
policy and practice regarding urban design and transportation 
planning. However, the inadequate evidence base limits specific 
policy recommendations regarding how changes in a particular 
environmental feature or infrastructure will ‘cause’ health-pro-
moting change in residents’ physical activity and travel behaviour. 
Continuous improvement of the research evidence is critical to 
the field. Future studies could benefit from using longitudinal 
data sources, such as travel panels45 and cohort studies,38 evalu-
ating relocation effects over longer follow-up periods and apply 
appropriate research designs and statistical approaches to account 
for self-selection and concurrent life events. Additional data from 
geographically diverse areas, particularly from low-income and 
middle-income countries, could also add to the current litera-
ture. In summary, this review appraises environmental changes for 
walking, physical activity and travel behaviour in a methodologi-
cally sound manner, aiming to refocus the research agenda of the 
built environment beyond cross-sectional studies to provide high-
er-quality evidence.
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